{"id": "CMU_1:6", "en": "and are you having any of the following symptoms with your chest pain", "es": "y tiene alguno de los siguientes síntomas además de dolor de pecho", "perturbation": "alteration", "pert_es": "y tiene alguno de los siguientes síntomas además de alivio de pecho", "bt_pert_es": "and have any of the following symptoms in addition to chest relief", "questions": "[\"What symptoms are associated with chest pain?\", \"Are any specific symptoms mentioned with chest pain?\", \"What symptoms should be considered with chest pain?\"]", "answers": "[\"Chest relief\", \"Chest relief\", \"Chest relief\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.274261603375527, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 23.888154997798324, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.274261603375527, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 11.478892734849794, "avg_bleu": 0.0}
{"id": "CMU_1:12", "en": "and drink lots of fluids", "es": "y beba mucho líquido", "perturbation": "alteration", "pert_es": "y beba poco líquido", "bt_pert_es": "and drink little liquid", "questions": "[\"What should you do when you are ill?\", \"Why is it important to drink lots of fluids?\", \"What is the benefit of drinking lots of fluids?\", \"What does 'drink lots of fluids' suggest in the context of illness?\"]", "answers": "[\"Drink little liquid\", \"Drinking lots of fluids is important to help the body function properly when ill\", \"Drinking fluids helps maintain hydration and supports recovery\", \"It suggests that reducing fluid intake is advised when ill\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 31.15595597213244, "bleu": 19.716118825581447}, {"f1": 0.3636363636363637, "em": false, "chrf": 48.128542492358115, "bleu": 12.35622127262679}, {"f1": 0.28571428571428575, "em": false, "chrf": 50.96006002929675, "bleu": 6.567274736060396}, {"f1": 0.4444444444444445, "em": false, "chrf": 42.04698261797285, "bleu": 11.868405219520975}], "avg_f1": 0.3448773448773449, "avg_em": 0.0, "avg_chrf": 43.07288527794004, "avg_bleu": 12.627005013447402}
{"id": "CMU_1:34", "en": "are you having any difficulty breathing now", "es": "ahora tiene algo de dificultad para respirar", "perturbation": "alteration", "pert_es": "ahora tiene algo de facilidad para respirar", "bt_pert_es": "now he has some ease in breathing", "questions": "[\"Are you having any difficulty breathing now?\"]", "answers": "[\"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "CMU_1:42", "en": "but if you have the cough", "es": "pero si tiene tos", "perturbation": "alteration", "pert_es": "pero si tiene tos se convierte en: pero si no tiene tos", "bt_pert_es": "but if you have a cough it becomes: but if you don't have a cough", "questions": "[\"What does 'if you have the cough' imply?\", \"What condition is associated with having a cough?\", \"What might be the cause of a cough in this context?\"]", "answers": "[\"It becomes 'if you don't have a cough'\", \"Having a cough\", \"The absence of a cough\"]", "scores": [{"f1": 0.18181818181818182, "em": false, "chrf": 23.84118931530577, "bleu": 6.567274736060395}, {"f1": 0.5, "em": false, "chrf": 47.36524309590102, "bleu": 49.99999999999999}, {"f1": 0.3333333333333333, "em": false, "chrf": 38.50511065818818, "bleu": 15.97357760615681}], "avg_f1": 0.3383838383838384, "avg_em": 0.0, "avg_chrf": 36.57051435646499, "avg_bleu": 24.180284114072396}
{"id": "CMU_1:48", "en": "cause they're having a cough", "es": "porque tienen tos", "perturbation": "alteration", "pert_es": "porque no tienen tos", "bt_pert_es": "because they don't have a cough", "questions": "[\"What is causing the cough?\", \"Why are they having a cough?\"]", "answers": "[\"They don't have a cough\", \"They don't have a cough\"]", "scores": [{"f1": 0, "em": false, "chrf": 8.108108108108107, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.108108108108107, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 8.108108108108107, "avg_bleu": 0.0}
{"id": "CMU_1:52", "en": "do you have any blood pressure problem as far as you know?", "es": "¿tiene algún problema de presión arterial hasta donde sabe?", "perturbation": "alteration", "pert_es": "¿tiene algún beneficio de presión arterial hasta donde sabe?", "bt_pert_es": "Does it have any blood pressure benefits to your knowledge?", "questions": "[\"Do you have any blood pressure problem?\", \"What blood pressure problems are you aware of?\"]", "answers": "[\"No\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "CMU_1:59", "en": "do your relatives have the same symptoms", "es": "sus familiares tienen los mismos síntomas", "perturbation": "alteration", "pert_es": "sus familiares no tienen los mismos síntomas", "bt_pert_es": "Your family members do not have the same symptoms", "questions": "[\"Do your relatives have the same symptoms?\", \"What symptoms are being referred to?\", \"Are the symptoms the same among relatives?\", \"What does 'relatives' refer to in this context?\"]", "answers": "[\"No\", \"The symptoms mentioned in the sentence\", \"No\", \"Family members\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "CMU_1:67", "en": "i don't think i have high blood pressure", "es": "no creo tener presión arterial alta", "perturbation": "alteration", "pert_es": "Creo tener presión arterial baja", "bt_pert_es": "I think I have low blood pressure", "questions": "[\"What does the speaker think about their blood pressure?\", \"Does the speaker have high blood pressure?\", \"What is the speaker's opinion on their blood pressure?\", \"What is the main point of the sentence?\"]", "answers": "[\"The speaker thinks they have low blood pressure\", \"No\", \"They believe their blood pressure is low\", \"The speaker believes they have low blood pressure\"]", "scores": [{"f1": 0.6666666666666665, "em": false, "chrf": 60.521456241119644, "bleu": 14.898573527259423}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 53.358533734227066, "bleu": 11.737849637633069}, {"f1": 0.6666666666666665, "em": false, "chrf": 55.46266507920444, "bleu": 14.898573527259423}], "avg_f1": 0.7083333333333333, "avg_em": 0.25, "avg_chrf": 67.33566376363778, "avg_bleu": 35.38374917303799}
{"id": "CMU_1:68", "en": "i feel a pain in the chest here in the front part of the chest", "es": "siento dolor de pecho aquí, en la parte de adelante del pecho", "perturbation": "alteration", "pert_es": "siento placer de pecho aquí, en la parte de adelante del pecho", "bt_pert_es": "I feel breast pleasure here, in the front of the chest", "questions": "[\"What type of pain is being felt?\", \"Where in the chest is the pain located?\", \"What part of the chest is affected by the pain?\"]", "answers": "[\"breast pleasure\", \"front\", \"front of the chest\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.88235294117647, "bleu": 0.0}, {"f1": 0.33333333333333337, "em": false, "chrf": 21.653177338375105, "bleu": 1.8315638888734187}, {"f1": 0.7499999999999999, "em": false, "chrf": 50.137607005417294, "bleu": 32.34325178227722}], "avg_f1": 0.3611111111111111, "avg_em": 0.0, "avg_chrf": 25.89104576165629, "avg_bleu": 11.39160522371688}
{"id": "CMU_1:75", "en": "i had a short sharp pain in my chest", "es": "tuve un dolor agudo breve en el pecho", "perturbation": "alteration", "pert_es": "tuve un alivio agudo breve en el pecho", "bt_pert_es": "I had a brief sharp relief in my chest.", "questions": "[\"What type of pain did I have in my chest?\", \"Where was the pain located?\", \"How long did the chest pain last?\", \"Was the chest pain sharp or dull?\", \"What might have caused the chest pain?\"]", "answers": "[\"relief\", \"in my chest\", \"brief\", \"sharp\", \"not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.6881720430107525, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 67.2312947311139, "bleu": 27.516060407455225}, {"f1": 0, "em": false, "chrf": 4.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 54.333333333333336, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}], "avg_f1": 0.18, "avg_em": 0.0, "avg_chrf": 43.47319109412267, "avg_bleu": 15.503212081491043}
{"id": "CMU_1:78", "en": "i have made on the body around the chest area?", "es": "{NS}", "perturbation": "alteration", "pert_es": "Please provide the original Spanish sentence to perturb.", "bt_pert_es": "Please provide the original Spanish sentence to disturb.", "questions": "[\"What have you made on the body?\", \"Where on the body have you made something?\", \"What is located around the chest area?\"]", "answers": "[\"None\", \"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 9.375, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.125, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.687499999999999, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 5.729166666666667, "avg_bleu": 0.0}
{"id": "CMU_1:88", "en": "it hurts in the chest", "es": "me duele el pecho", "perturbation": "alteration", "pert_es": "me duele la cabeza", "bt_pert_es": "my head hurts", "questions": "[\"What part of the body hurts?\", \"What is the nature of the pain?\", \"What symptom is described in the sentence?\"]", "answers": "[\"Head\", \"Hurt\", \"Headache\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.4722222222222223, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 11.942048883740222, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 38.47142370198748, "avg_bleu": 33.33333333333335}
{"id": "CMU_1:94", "en": "it is occurring right in the middle of my chest", "es": "está ocurriendo justo en el centro de mi pecho", "perturbation": "alteration", "pert_es": "está ocurriendo justo en la parte exterior de mi pecho", "bt_pert_es": "It's happening right on the outside of my chest", "questions": "[\"Where is it occurring?\", \"What part of the body is affected?\", \"What is occurring in the middle of the chest?\"]", "answers": "[\"On the outside of the chest\", \"The outside of the chest\", \"None\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 26.518830532189575, "bleu": 14.794015674776452}, {"f1": 0.5714285714285715, "em": false, "chrf": 51.188713625262274, "bleu": 31.947155212313625}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.33862433862433866, "avg_em": 0.0, "avg_chrf": 25.902514719150616, "avg_bleu": 15.580390295696693}
{"id": "CMU_1:101", "en": "i will send you an image on your screen", "es": "le enviaré una imagen en su pantalla", "perturbation": "alteration", "pert_es": "le enviaré una imagen fuera de su pantalla", "bt_pert_es": "I will send you a picture off your screen", "questions": "[\"What will be sent to your screen?\", \"What type of image will be sent?\", \"What action will occur when the image is received?\"]", "answers": "[\"a picture\", \"a picture\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.407407407407408, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.921358905488684, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 7.47230768761179, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 7.267024666835961, "avg_bleu": 0.0}
{"id": "CMU_1:104", "en": "most of the time it is this type of chest pain", "es": "casi siempre es este tipo de dolor de pecho", "perturbation": "alteration", "pert_es": "casi nunca es este tipo de dolor de pecho", "bt_pert_es": "this type of chest pain is almost never", "questions": "[\"What type of chest pain is most commonly experienced?\", \"What does 'most of the time' indicate about chest pain?\", \"What is the specific type of chest pain mentioned in the sentence?\"]", "answers": "[\"The type of chest pain mentioned is not commonly experienced\", \"It indicates that chest pain of this type is rare\", \"this type of chest pain\"]", "scores": [{"f1": 0.5333333333333333, "em": false, "chrf": 58.38923662491884, "bleu": 26.269098944241577}, {"f1": 0.8571428571428572, "em": false, "chrf": 60.15387939331719, "bleu": 22.11979226191667}, {"f1": 0.8000000000000002, "em": false, "chrf": 93.87323496650124, "bleu": 66.87403049764218}], "avg_f1": 0.7301587301587302, "avg_em": 0.0, "avg_chrf": 70.80545032824575, "avg_bleu": 38.42097390126681}
{"id": "CMU_1:105", "en": "my sister has similar symptoms", "es": "mi hermana tiene síntomas similares", "perturbation": "alteration", "pert_es": "mi hermana no tiene síntomas similares", "bt_pert_es": "my sister does not have similar symptoms", "questions": "[\"What symptoms does the sister have?\", \"What does 'similar symptoms' imply?\", \"Who is mentioned in the sentence?\", \"What is the relationship between the person and the sister?\"]", "answers": "[\"None\", \"That the person has symptoms similar to others\", \"The sister\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.953125, "bleu": 0.0}, {"f1": 0.7142857142857143, "em": false, "chrf": 58.45793500018743, "bleu": 43.47208719449914}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 4.687678510225067, "bleu": 0.0}], "avg_f1": 0.4285714285714286, "avg_em": 0.25, "avg_chrf": 41.27468462760312, "avg_bleu": 35.868021798624795}
{"id": "CMU_1:125", "en": "the fever started two days ago", "es": "la fiebre empezó hace dos días", "perturbation": "alteration", "pert_es": "la fiebre terminó hace dos días", "bt_pert_es": "the fever ended two days ago", "questions": "[\"When did the fever start?\", \"What symptom started two days ago?\"]", "answers": "[\"Two days ago\", \"The fever\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_9:792", "en": "On March 11, 2020, the World Health Organization declared Coronavirus Disease 2019 (COVID-19) a pandemic.", "es": "El 11 de marzo de 2020, la Organización Mundial de la Salud declaró a la enfermedad por coronavirus 2019 (COVID-19) una pandemia.", "perturbation": "alteration", "pert_es": "El 11 de marzo de 2020, la Organización Mundial de la Salud declaró a la enfermedad por coronavirus 2019 (COVID-19) una epidemia.", "bt_pert_es": "On March 11, 2020, the World Health Organization declared coronavirus disease 2019 (COVID-19) an epidemic.", "questions": "[\"When did the World Health Organization declare COVID-19 a pandemic?\", \"What did the World Health Organization declare on March 11, 2020?\", \"What is the name of the disease declared a pandemic?\", \"What is the full name of the disease mentioned in the sentence?\"]", "answers": "[\"The World Health Organization did not declare COVID-19 a pandemic on March 11, 2020\", \"The World Health Organization declared coronavirus disease 2019 (COVID-19) an epidemic\", \"COVID-19\", \"coronavirus disease 2019\"]", "scores": [{"f1": 0.375, "em": false, "chrf": 43.01633994568183, "bleu": 11.498759556447222}, {"f1": 0.28571428571428575, "em": false, "chrf": 62.73092920995859, "bleu": 8.392229812593097}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.28571428571428575, "em": false, "chrf": 59.11049456501735, "bleu": 19.716118825581447}], "avg_f1": 0.4866071428571429, "avg_em": 0.25, "avg_chrf": 66.21444093016444, "avg_bleu": 34.901777048655454}
{"id": "PubMed_9:794", "en": "Reports from China and Italy suggest that risk factors for severe disease include older age and the presence of at least one of several underlying health conditions.", "es": "Informes de China e Italia sugieren que los factores de riesgo de enfermedad grave incluyen la edad avanzada y la presencia de al menos una de varias afecciones médicas subyacentes.", "perturbation": "alteration", "pert_es": "Informes de China e Italia sugieren que los factores de riesgo de enfermedad leve incluyen la edad avanzada y la presencia de al menos una de varias afecciones médicas subyacentes.", "bt_pert_es": "Reports from China and Italy suggest that risk factors for mild disease include older age and the presence of at least one of several underlying medical conditions.", "questions": "[\"What risk factors for severe disease are mentioned in the reports?\", \"Which countries' reports are referenced?\", \"What specific underlying health conditions are considered risk factors?\", \"What is the relationship between age and risk for severe disease?\", \"What does the presence of at least one underlying health condition indicate?\"]", "answers": "[\"None\", \"China and Italy\", \"Several underlying medical conditions\", \"Not mentioned\", \"It indicates an increased risk for mild disease\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.8362946664551036, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 73.28559465936485, "bleu": 35.35533905932737}, {"f1": 0, "em": false, "chrf": 4.291310101334564, "bleu": 0.0}, {"f1": 0.8571428571428571, "em": false, "chrf": 77.90807513762806, "bleu": 64.34588841607616}], "avg_f1": 0.5214285714285715, "avg_em": 0.2, "avg_chrf": 51.664254912956515, "avg_bleu": 39.94024549508072}
{"id": "PubMed_9:795", "en": "U.S. older adults, including those aged ≥65 years and particularly those aged ≥85 years, also appear to be at higher risk for severe COVID-19–associated outcomes; however, data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported.", "es": "Los adultos mayores de EE. UU., incluidos los de ≥65 años y en particular aquellos de ≥85 años, también parecen tener un mayor riesgo de complicaciones graves asociadas a la COVID-19; sin embargo, aún no se han informado datos que describan las afecciones médicas subyacentes entre los pacientes con COVID-19 en EE. UU.", "perturbation": "alteration", "pert_es": "Los adultos menores de EE. UU., incluidos los de ≤65 años y en particular aquellos de ≤85 años, también parecen tener un menor riesgo de complicaciones graves asociadas a la COVID-19; sin embargo, aún no se han informado datos que describan las afecciones médicas subyacentes entre los pacientes con COVID-19 en EE. UU.", "bt_pert_es": "Younger adults in the US, including those aged ≤65 years and particularly those aged ≤85 years, also appear to be at lower risk for serious complications associated with COVID-19; however, data describing underlying medical conditions among COVID-19 patients in the US have not yet been reported.", "questions": "[\"Which U.S. older adults are at higher risk for severe COVID-19–associated outcomes?\", \"What age group is particularly at higher risk for severe COVID-19–associated outcomes?\", \"What data has not yet been reported regarding U.S. COVID-19 patients?\", \"What underlying health conditions are mentioned in the sentence?\", \"What is the relationship between age and risk for severe COVID-19–associated outcomes?\"]", "answers": "[\"Younger adults in the US\", \"those aged ≤85 years\", \"data describing underlying medical conditions among COVID-19 patients in the US\", \"none\", \"Younger adults in the US, including those aged ≤65 years and particularly those aged ≤85 years, are at lower risk for serious complications associated with COVID-19\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 52.39698529282224, "bleu": 18.99589214128981}, {"f1": 0.75, "em": false, "chrf": 74.09744667097607, "bleu": 35.35533905932737}, {"f1": 0.5333333333333333, "em": false, "chrf": 69.88704654699598, "bleu": 16.784459625186194}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3333333333333333, "em": false, "chrf": 44.020704250055026, "bleu": 3.9645132534206877}], "avg_f1": 0.6376190476190476, "avg_em": 0.2, "avg_chrf": 68.08043655216986, "avg_bleu": 35.02004081584482}
{"id": "PubMed_9:797", "en": "Among these 7,162 cases, 2,692 (37.6%) patients had one or more underlying health condition or risk factor, and 4,470 (62.4%) had none of these conditions reported.", "es": "Entre estos 7162 casos, 2692 (37,6 %) pacientes tenían una o más afecciones médicas subyacentes o factores de riesgo, y 4470 (62,4 %) no tenían ninguna de estas afecciones informadas.", "perturbation": "alteration", "pert_es": "Entre estos 7162 casos, 4470 (62,4 %) pacientes tenían una o más afecciones médicas subyacentes o factores de riesgo, y 2692 (37,6 %) no tenían ninguna de estas afecciones informadas.", "bt_pert_es": "Among these 7,162 cases, 4,470 (62.4%) patients had one or more underlying medical conditions or risk factors, and 2,692 (37.6%) did not have any of these conditions reported.", "questions": "[\"How many cases had one or more underlying health condition or risk factor?\", \"What percentage of patients had one or more underlying health condition or risk factor?\", \"How many cases had no underlying health condition or risk factor?\", \"What percentage of patients had no underlying health condition or risk factor?\", \"What is the total number of cases mentioned in the sentence?\"]", "answers": "[4470, \"62.4%\", 2692, \"37.6%\", 7162]", "scores": [{"f1": 0, "em": false, "chrf": 11.11111111111111, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 11.11111111111111, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 11.11111111111111, "avg_bleu": 0.0}
{"id": "PubMed_9:799", "en": "The most commonly reported conditions were diabetes mellitus, chronic lung disease, and cardiovascular disease.", "es": "Las afecciones más informadas eran diabetes mellitus, enfermedad pulmonar crónica y enfermedad cardiovascular.", "perturbation": "alteration", "pert_es": "Las afecciones menos informadas eran diabetes mellitus, enfermedad pulmonar crónica y enfermedad cardiovascular.", "bt_pert_es": "The least reported conditions were diabetes mellitus, chronic lung disease, and cardiovascular disease.", "questions": "[\"What are the most commonly reported conditions?\", \"What conditions are mentioned in the sentence?\", \"What is the most commonly reported condition?\", \"What diseases are associated with the report?\"]", "answers": "[\"The least reported conditions\", \"diabetes mellitus, chronic lung disease, and cardiovascular disease\", \"The least reported condition\", \"diabetes mellitus, chronic lung disease, and cardiovascular disease\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.735911259334637, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 13.985774711759404, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 56.18042149277351, "avg_bleu": 50.00000000000002}
{"id": "PubMed_9:802", "en": "Cases among persons repatriated to the United States from Wuhan, China, and the Diamond Princess cruise ship were excluded.", "es": "Se excluyeron los casos de personas repatriadas a Estados Unidos desde Wuhan, China, y del crucero Diamond Princess.", "perturbation": "alteration", "pert_es": "Se incluyeron los casos de personas repatriadas a Estados Unidos desde Wuhan, China, y del crucero Diamond Princess.", "bt_pert_es": "Cases of people repatriated to the United States from Wuhan, China, and the Diamond Princess cruise ship were included.", "questions": "[\"Which cases were excluded?\", \"What are the sources of the excluded cases?\", \"What specific groups were repatriated and had cases excluded?\", \"Why were cases from Wuhan, China, and the Diamond Princess cruise ship excluded?\"]", "answers": "[\"None\", \"None\", \"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.9295594598138193, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.2326435246995993, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 1.6740208142887278, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 1.2541239542830211, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.2725869382712918, "avg_bleu": 0.0}
{"id": "PubMed_9:803", "en": "For cases with missing onset dates, date of onset was estimated by subtracting 4 days (median interval from symptom onset to specimen collection date among cases with known dates in these data) from the earliest specimen collection.", "es": "Para los casos en los que se desconocía la fecha de aparición, se calculó la fecha de aparición restando 4 días (intervalo medio desde la aparición de los síntomas hasta fecha de toma de la muestra en casos con fechas conocidas en estos datos) a la primera toma de muestra.", "perturbation": "alteration", "pert_es": "Para los casos en los que se conocía la fecha de aparición, se calculó la fecha de aparición sumando 4 días (intervalo medio desde la aparición de los síntomas hasta fecha de toma de la muestra en casos con fechas conocidas en estos datos) a la primera toma de muestra.", "bt_pert_es": "For cases in which the date of onset was known, the date of onset was calculated by adding 4 days (mean interval from symptom onset to sample collection date in cases with known dates in these data) to the first sample collection.", "questions": "[\"How were onset dates estimated for cases with missing onset dates?\", \"What is the median interval from symptom onset to specimen collection date?\", \"What is the number of days subtracted to estimate the date of onset?\", \"What is the earliest specimen collection date used in the estimation?\", \"What is the method used to estimate the date of onset?\"]", "answers": "[\"The date of onset was not estimated for cases with missing onset dates as per the provided sentence\", \"The sentence does not provide the median interval\", \"4 days\", \"The sentence does not specify the earliest specimen collection date\", \"By adding 4 days to the first sample collection date\"]", "scores": [{"f1": 0.07692307692307691, "em": false, "chrf": 18.74441432717359, "bleu": 2.2869567780619007}, {"f1": 0, "em": false, "chrf": 5.084745762711865, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 55.55555555555556, "bleu": 49.99999999999999}, {"f1": 0.7142857142857143, "em": false, "chrf": 81.47859955137034, "bleu": 31.55984539112945}, {"f1": 0.47058823529411764, "em": false, "chrf": 43.420750222611254, "bleu": 13.485111859503684}], "avg_f1": 0.3856927386339151, "avg_em": 0.0, "avg_chrf": 40.85681308388452, "avg_bleu": 19.466382805739006}
{"id": "PubMed_9:804", "en": "Public health departments reported cases to CDC using a standardized case report form that captures information (yes, no, or unknown) on the following conditions and potential risk factors: chronic lung disease (inclusive of asthma, chronic obstructive pulmonary disease [COPD], and emphysema); diabetes mellitus; cardiovascular disease; chronic renal disease; chronic liver disease; immunocompromised condition; neurologic disorder, neurodevelopmental, or intellectual disability; pregnancy; current smoking status; former smoking status; or other chronic disease.", "es": "Los departamentos de salud pública informaron casos a los CDC usando un formulario de informe de casos estandarizado que captura información (sí, no o se desconoce) sobre las siguientes afecciones y posibles factores de riesgo: enfermedad pulmonar crónica (que incluye asma, enfermedad pulmonar obstructiva crónica [EPOC] y enfisema); diabetes mellitus; enfermedad cardiovascular; enfermedad renal crónica; enfermedad hepática crónica; condición de inmunocomprometido; trastorno neurológico, del desarrollo neurológico o discapacidad intelectual; embarazo; condición de fumador actual; antecedentes de tabaquismo u otra enfermedad crónica.", "perturbation": "alteration", "pert_es": "Los departamentos de salud pública informaron casos a los CDC usando un formulario de informe de casos estandarizado que captura información (sí, no o se desconoce) sobre las siguientes afecciones y posibles factores de protección: enfermedad pulmonar crónica (que incluye asma, enfermedad pulmonar obstructiva crónica [EPOC] y enfisema); diabetes mellitus; enfermedad cardiovascular; enfermedad renal crónica; enfermedad hepática crónica; condición de inmunocomprometido; trastorno neurológico, del desarrollo neurológico o discapacidad intelectual; embarazo; condición de fumador actual; antecedentes de tabaquismo u otra enfermedad crónica.", "bt_pert_es": "Public health departments reported cases to CDC using a standardized case reporting form that captures information (yes, no, or unknown) about the following conditions and potential protective factors: chronic lung disease (including asthma, chronic obstructive pulmonary disease [COPD], and emphysema); diabetes mellitus; cardiovascular disease; chronic kidney disease; chronic liver disease; immunocompromised status; neurological, neurodevelopmental disorder or intellectual disability; pregnancy; current smoking status; history of smoking or other chronic illness.", "questions": "[\"What information does the standardized case report form capture?\", \"What conditions are included in chronic lung disease?\", \"What are the potential risk factors reported in the case report form?\", \"What is included in the chronic lung disease category?\", \"What is the definition of chronic lung disease in the report?\", \"What is the status of smoking reported in the form?\", \"What chronic diseases are reported in the form?\", \"What is the definition of an immunocompromised condition?\", \"What neurologic conditions are reported?\", \"What is the difference between neurodevelopmental and intellectual disability in the context of the report?\"]", "answers": "[\"Information about the following conditions and potential protective factors: chronic lung disease (including asthma, chronic obstructive pulmonary disease [COPD], and emphysema); diabetes mellitus; cardiovascular disease; chronic kidney disease; chronic liver disease; immunocompromised status; neurological, neurodevelopmental disorder or intellectual disability; pregnancy; current smoking status; history of smoking or other chronic illness\", \"Asthma, chronic obstructive pulmonary disease [COPD], and emphysema\", \"Chronic lung disease, diabetes mellitus, cardiovascular disease, chronic kidney disease, chronic liver disease, immunocompromised status, neurological, neurodevelopmental disorder or intellectual disability, pregnancy, current smoking status, history of smoking or other chronic illness\", \"Asthma, chronic obstructive pulmonary disease [COPD], and emphysema\", \"Chronic lung disease includes asthma, chronic obstructive pulmonary disease [COPD], and emphysema\", \"Current smoking status and history of smoking or other chronic illness\", \"Chronic lung disease, diabetes mellitus, cardiovascular disease, chronic kidney disease, chronic liver disease\", \"Immunocompromised status is a condition where the body's immune system is weakened and less able to fight off infections\", \"Neurological, neurodevelopmental disorder or intellectual disability\", \"The report does not provide a distinction between neurodevelopmental and intellectual disability; both are listed together as potential protective factors\"]", "scores": [{"f1": 0.8484848484848485, "em": false, "chrf": 83.81852645779169, "bleu": 56.04374760399275}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7567567567567567, "em": false, "chrf": 67.90816003555543, "bleu": 36.31961298793899}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5555555555555556, "em": false, "chrf": 62.1938937011066, "bleu": 24.808415001701817}, {"f1": 0.6153846153846155, "em": false, "chrf": 45.55821934720045, "bleu": 28.001533629295526}, {"f1": 0.7777777777777778, "em": false, "chrf": 82.32111752479656, "bleu": 67.0478681444386}, {"f1": 0.8333333333333334, "em": false, "chrf": 86.0825108580868, "bleu": 34.32945239845197}, {"f1": 0.8421052631578947, "em": false, "chrf": 80.37987724371155, "bleu": 68.59238121837059}], "avg_f1": 0.8229398150450782, "avg_em": 0.3, "avg_chrf": 80.82623051682491, "avg_bleu": 61.51430109841904}
{"id": "PubMed_9:805", "en": "Data reported to CDC are preliminary and can be updated by health departments over time; critical data elements might be missing at the time of initial report; thus, this analysis is descriptive, and no statistical comparisons could be made.", "es": "Los datos informados a los CDC son preliminares y pueden ser actualizados por los departamentos de salud con el tiempo; es posible que faltaran datos críticos al momento del informe inicial; por lo tanto, este análisis es descriptivo y no pudieron hacerse comparaciones estadísticas.", "perturbation": "alteration", "pert_es": "Los datos informados a los CDC son definitivos y pueden ser actualizados por los departamentos de salud con el tiempo; es posible que sobraran datos críticos al momento del informe inicial; por lo tanto, este análisis es comparativo y sí pudieron hacerse comparaciones estadísticas.", "bt_pert_es": "Data reported to CDC is final and may be updated by health departments over time; critical data may have been left over at the time of the initial report; Therefore, this analysis is comparative and statistical comparisons could be made.", "questions": "[\"What is said about the data reported to CDC?\", \"Why are the data considered preliminary?\", \"How can the data be updated?\", \"What might be missing at the time of initial report?\", \"Why is the analysis described as descriptive?\", \"Why could no statistical comparisons be made?\"]", "answers": "[\"The data reported to CDC is final and may be updated by health departments over time\", \"The data are considered preliminary because critical data may have been left over at the time of the initial report\", \"The data can be updated by health departments\", \"Critical data might be missing at the time of the initial report\", \"The analysis is described as descriptive because it compares data over time\", \"No statistical comparisons could be made because the data may not be complete or consistent at the time of initial report\"]", "scores": [{"f1": 0.7096774193548386, "em": false, "chrf": 71.53344800476971, "bleu": 46.892438882117254}, {"f1": 0.4666666666666666, "em": false, "chrf": 58.069586089246364, "bleu": 23.124463019346486}, {"f1": 0.3076923076923077, "em": false, "chrf": 59.59749951846186, "bleu": 11.044795567078939}, {"f1": 0.30769230769230765, "em": false, "chrf": 47.812417727972246, "bleu": 8.392229812593097}, {"f1": 0.09523809523809525, "em": false, "chrf": 23.4995786585841, "bleu": 3.3864985683445354}, {"f1": 0.4117647058823529, "em": false, "chrf": 57.778386983375555, "bleu": 20.614773521563748}], "avg_f1": 0.3831219170877615, "avg_em": 0.0, "avg_chrf": 53.04848616373497, "avg_bleu": 18.90919989517401}
{"id": "PubMed_9:806", "en": "The percentages of patients of all ages with underlying health conditions who were not hospitalized, hospitalized without ICU admission, and hospitalized with ICU admission were calculated.", "es": "Se calcularon los porcentajes de pacientes de todas las edades con afecciones médicas subyacentes que no fueron hospitalizados, fueron hospitalizados sin internación en la UCI y fueron hospitalizados con internación en la UCI.", "perturbation": "alteration", "pert_es": "Se calcularon los porcentajes de pacientes de todas las edades sin afecciones médicas subyacentes que no fueron hospitalizados, fueron hospitalizados sin internación en la UCI y fueron hospitalizados con internación en la UCI.", "bt_pert_es": "The percentages of patients of all ages without underlying medical conditions who were not hospitalized, were hospitalized without ICU admission, and were hospitalized with ICU admission were calculated.", "questions": "[\"What percentages were calculated?\", \"What types of patient outcomes were calculated?\", \"What does the calculation include?\", \"What is the basis for the calculated percentages?\", \"What is the population being considered in the calculation?\"]", "answers": "[\"The percentages of patients of all ages without underlying medical conditions who were not hospitalized, were hospitalized without ICU admission, and were hospitalized with ICU admission\", \"Patients who were not hospitalized, were hospitalized without ICU admission, and were hospitalized with ICU admission\", \"Patients of all ages without underlying medical conditions who were not hospitalized, were hospitalized without ICU admission, and were hospitalized with ICU admission\", \"Patients of all ages without underlying medical conditions\", \"Patients of all ages without underlying medical conditions\"]", "scores": [{"f1": 0.8799999999999999, "em": false, "chrf": 87.97725362454405, "bleu": 59.095070812710155}, {"f1": 0.7407407407407406, "em": false, "chrf": 86.5001506188204, "bleu": 39.375553105513404}, {"f1": 0.4516129032258065, "em": false, "chrf": 54.443201007783216, "bleu": 11.856660123276004}, {"f1": 0.75, "em": false, "chrf": 75.38030746895768, "bleu": 38.260294162784476}, {"f1": 0.75, "em": false, "chrf": 75.38030746895768, "bleu": 38.260294162784476}], "avg_f1": 0.7144707287933094, "avg_em": 0.0, "avg_chrf": 75.9362440378126, "avg_bleu": 37.3695744734137}
{"id": "PubMed_9:807", "en": "Percentages of hospitalizations with and without ICU admission were estimated for persons aged ≥19 years with and without underlying health conditions.", "es": "Se estimaron los porcentajes de hospitalizaciones con y sin internación en la UCI en personas de ≥19 años con y sin afecciones médicas subyacentes.", "perturbation": "alteration", "pert_es": "Se estimaron los porcentajes de hospitalizaciones con y sin internación en la UCI en personas de ≤19 años con y sin afecciones médicas subyacentes.", "bt_pert_es": "The percentages of hospitalizations with and without ICU admission were estimated in people ≤19 years of age with and without underlying medical conditions.", "questions": "[\"What percentages were estimated?\", \"For which group of persons were hospitalization percentages estimated?\", \"What is the difference in hospitalization percentages between persons with and without underlying health conditions?\", \"What is the relationship between age and hospitalization with ICU admission?\", \"What conditions are considered in the hospitalization estimates?\"]", "answers": "[\"The percentages of hospitalizations with and without ICU admission\", \"People ≤19 years of age with and without underlying medical conditions\", \"Not specified\", \"Not specified\", \"Underlying medical conditions\"]", "scores": [{"f1": 0.823529411764706, "em": false, "chrf": 96.9837446164719, "bleu": 72.59795291154772}, {"f1": 0.13333333333333333, "em": false, "chrf": 31.0538154468472, "bleu": 3.7477767366779213}, {"f1": 0.1111111111111111, "em": false, "chrf": 9.729725196737897, "bleu": 0.04559409827772581}, {"f1": 0, "em": false, "chrf": 3.4022992401135688, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 65.14467219297651, "bleu": 34.66806371753173}], "avg_f1": 0.34692810457516343, "avg_em": 0.0, "avg_chrf": 41.26285133862942, "avg_bleu": 22.21187749280702}
{"id": "PubMed_9:808", "en": "This part of the analysis was limited to persons aged ≥19 years because of the small sample size of cases in children with reported underlying health conditions (N = 32).", "es": "Esta parte del análisis se limitó a personas de ≥19 años debido al tamaño pequeño de la muestra de casos en niños con afecciones médicas subyacentes informadas (N = 32).", "perturbation": "alteration", "pert_es": "Esta parte del análisis se limitó a personas de ≥19 años debido al tamaño grande de la muestra de casos en niños con afecciones médicas subyacentes informadas (N = 32).", "bt_pert_es": "This portion of the analysis was limited to individuals aged ≥19 years due to the large sample size of cases in children with reported underlying medical conditions (N = 32).", "questions": "[\"Why was the analysis limited to persons aged ≥19 years?\", \"What was the reason for the small sample size in children?\", \"What is the sample size of cases in children with reported underlying health conditions?\", \"What is the total number of cases in children with reported underlying health conditions?\"]", "answers": "[\"Due to the large sample size of cases in children with reported underlying medical conditions\", \"The sample size in children was not small; it was large\", \"32\", \"32\"]", "scores": [{"f1": 0.7142857142857143, "em": false, "chrf": 74.06264335242061, "bleu": 61.153805769010226}, {"f1": 0.4999999999999999, "em": false, "chrf": 34.40310853818061, "bleu": 9.78090152232118}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8035714285714286, "avg_em": 0.5, "avg_chrf": 77.1164379726503, "avg_bleu": 67.73367682283288}
{"id": "PubMed_9:810", "en": "Because of small sample size and missing data on underlying health conditions among COVID-19 patients who died, case-fatality rates for persons with and without underlying conditions were not estimated.", "es": "Debido al tamaño pequeño de la muestra y a la falta de datos sobre afecciones médicas subyacentes entre los pacientes con COVID-19 que murieron, no se calcularon las tasas de letalidad para personas con y sin afecciones subyacentes.", "perturbation": "alteration", "pert_es": "Debido al tamaño grande de la muestra y a la abundancia de datos sobre afecciones médicas subyacentes entre los pacientes con COVID-19 que murieron, se calcularon las tasas de letalidad para personas con y sin afecciones subyacentes.", "bt_pert_es": "Due to the large sample size and abundant data on underlying medical conditions among COVID-19 patients who died, case fatality rates were calculated for people with and without underlying conditions.", "questions": "[\"Why were case-fatality rates not estimated?\", \"What factors contributed to the inability to estimate case-fatality rates?\", \"What data was missing among COVID-19 patients who died?\", \"What was the impact of small sample size on the estimation of case-fatality rates?\", \"What groups were compared in terms of case-fatality rates?\"]", "answers": "[\"Case-fatality rates were calculated\", \"Large sample size and abundant data on underlying medical conditions\", \"Data on underlying medical conditions\", \"None\", \"People with and without underlying conditions\"]", "scores": [{"f1": 0, "em": false, "chrf": 9.349611392505848, "bleu": 0.0}, {"f1": 0.7, "em": false, "chrf": 60.05062886797512, "bleu": 27.301208627090666}, {"f1": 0.5454545454545454, "em": false, "chrf": 58.97854156094624, "bleu": 19.357693493908812}, {"f1": 0, "em": false, "chrf": 3.0736470531540645, "bleu": 0.0}, {"f1": 0.8333333333333334, "em": false, "chrf": 83.8542763006792, "bleu": 75.98356856515926}], "avg_f1": 0.4157575757575757, "avg_em": 0.0, "avg_chrf": 43.061341035052095, "avg_bleu": 24.528494137231746}
{"id": "PubMed_9:814", "en": "Approximately one third of these patients (2,692, 37.6%), had at least one underlying condition or risk factor.", "es": "Aproximadamente un tercio de esos pacientes (2692, 37,6 %) tenía al menos una afección subyacente o un factor de riesgo.", "perturbation": "alteration", "pert_es": "Aproximadamente un tercio de esos pacientes (2692, 37,6 %) no tenía al menos una afección subyacente o un factor de riesgo.", "bt_pert_es": "About one-third of those patients (2,692, 37.6%) did not have at least one underlying condition or risk factor.", "questions": "[\"What percentage of patients had at least one underlying condition or risk factor?\", \"How many patients had at least one underlying condition or risk factor?\", \"What is the total number of patients mentioned in the sentence?\", \"What is the proportion of patients with underlying conditions or risk factors?\", \"What are underlying conditions or risk factors?\"]", "answers": "[\"62.4%\", \"2,692\", \"7,192\", \"0.624\", \"Not specified in the sentence\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.11111111111111, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.3333333333333333, "em": false, "chrf": 74.65764567215484, "bleu": 15.97357760615681}], "avg_f1": 0.26666666666666666, "avg_em": 0.2, "avg_chrf": 37.15375135665319, "avg_bleu": 23.19471552123137}
{"id": "PubMed_9:817", "en": "In contrast, 1,388 of 5,143 (27%) COVID-19 patients who were not hospitalized were reported to have at least one underlying health condition.", "es": "En cambio, se informó que 1388 de 5143 (27 %) pacientes con COVID-19 que no fueron hospitalizados tenían al menos una afección médica subyacente.", "perturbation": "alteration", "pert_es": "En cambio, se informó que 1388 de 5143 (27 %) pacientes con COVID-19 que fueron hospitalizados no tenían ninguna afección médica subyacente.", "bt_pert_es": "In contrast, 1,388 of 5,143 (27%) COVID-19 patients who were hospitalized were reported to have no underlying medical condition.", "questions": "[\"What percentage of COVID-19 patients who were not hospitalized had at least one underlying health condition?\", \"How many COVID-19 patients who were not hospitalized had at least one underlying health condition?\", \"What is the total number of COVID-19 patients who were not hospitalized?\", \"What is the total number of COVID-19 patients mentioned in the sentence?\", \"What is the relationship between hospitalization status and underlying health conditions in the sentence?\"]", "answers": "[\"Cannot determine\", \"Cannot determine\", \"Cannot determine\", \"5,143\", \"In contrast, a majority of hospitalized COVID-19 patients had no underlying medical condition\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5599999999999999, "em": false, "chrf": 67.87802015924547, "bleu": 15.86360939345259}], "avg_f1": 0.312, "avg_em": 0.2, "avg_chrf": 33.575604031849096, "avg_bleu": 23.172721878690528}
{"id": "PubMed_9:818", "en": "Among patients aged ≥19 years, the percentage of non-ICU hospitalizations was higher among those with underlying health conditions (27.3%–29.8%) than among those without underlying health conditions (7.2%–7.8%); the percentage of cases that resulted in an ICU admission was also higher for those with underlying health conditions (13.3%–14.5%) than those without these conditions (2.2%–2.4%) (Table 2).", "es": "Entre los pacientes ≥19 años, el porcentaje de hospitalizaciones sin internación en la UCI era mayor en aquellos con afecciones médicas subyacentes (27,3 %–29,8 %) que en aquellos sin afecciones médicas subyacentes (7,2 %–7,8 %); el porcentaje de casos que requirieron internación en la UCI también era mayor en aquellos con afecciones médicas subyacentes (13,3 %–14,5 %) que en aquellos que no tenían estas afecciones (2,2 %–2,4 %) (tabla 2).", "perturbation": "alteration", "pert_es": "Entre los pacientes ≥19 años, el porcentaje de hospitalizaciones sin internación en la UCI era menor en aquellos con afecciones médicas subyacentes (27,3 %–29,8 %) que en aquellos sin afecciones médicas subyacentes (7,2 %–7,8 %); el porcentaje de casos que requirieron internación en la UCI también era menor en aquellos con afecciones médicas subyacentes (13,3 %–14,5 %) que en aquellos que no tenían estas afecciones (2,2 %–2,4 %) (tabla 2).", "bt_pert_es": "Among patients ≥19 years, the percentage of hospitalizations without ICU admission was lower in those with underlying medical conditions (27.3%–29.8%) than in those without underlying medical conditions (7.2%–7.8%); the percentage of cases requiring ICU admission was also lower in those with underlying medical conditions (13.3%–14.5%) than in those without these conditions (2.2%–2.4%) (Table 2).", "questions": "[\"What is the percentage of non-ICU hospitalizations among patients aged ≥19 years with underlying health conditions?\", \"What is the percentage of non-ICU hospitalizations among patients aged ≥19 years without underlying health conditions?\", \"What is the percentage of ICU admissions among patients aged ≥19 years with underlying health conditions?\", \"What is the percentage of ICU admissions among patients aged ≥19 years without underlying health conditions?\", \"What is the difference in non-ICU hospitalization rates between patients with and without underlying health conditions?\", \"What is the difference in ICU admission rates between patients with and without underlying health conditions?\", \"Which group has a higher rate of non-ICU hospitalizations?\", \"Which group has a higher rate of ICU admissions?\", \"What data is presented in Table 2?\"]", "answers": "[\"27.3%–29.8%\", \"7.2%–7.8%\", \"13.3%–14.5%\", \"2.2%–2.4%\", \"20.1%–22.6%\", \"11.1%–12.1%\", \"Patients without underlying health conditions\", \"Patients without underlying health conditions\", \"The hospitalization rates among patients aged ≥19 years with and without underlying medical conditions, including non-ICU and ICU admission percentages\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 73.45238095238095, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8000000000000002, "em": false, "chrf": 91.16898623861681, "bleu": 42.7287006396234}, {"f1": 0.8000000000000002, "em": false, "chrf": 91.16898623861681, "bleu": 42.7287006396234}, {"f1": 0.717948717948718, "em": false, "chrf": 78.74128574297896, "bleu": 46.18795171227213}], "avg_f1": 0.8131054131054132, "avg_em": 0.5555555555555556, "avg_chrf": 92.72573768584373, "avg_bleu": 70.18281699905769}
{"id": "PubMed_9:819", "en": "Small numbers of COVID-19 patients aged &lt; 19 years were reported to be hospitalized (48) or admitted to an ICU (eight).", "es": "Se informaron cantidades reducidas de pacientes con COVID-19 <19 años hospitalizados (48) o internados en una UCI (ocho).", "perturbation": "alteration", "pert_es": "Se informaron cantidades aumentadas de pacientes con COVID-19 >19 años hospitalizados (48) o internados en una UCI (ocho).", "bt_pert_es": "Increased numbers of COVID-19 patients >19 years of age hospitalized (48) or admitted to an ICU (eight) were reported.", "questions": "[\"How many COVID-19 patients aged < 19 years were hospitalized?\", \"How many COVID-19 patients aged < 19 years were admitted to an ICU?\", \"What age group is mentioned in the sentence?\", \"What are the hospitalization and ICU admission numbers for young COVID-19 patients?\"]", "answers": "[\"0\", \"0\", \"Patients >19 years of age\", \"48 hospitalized, 8 admitted to an ICU\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 50.44583627059406, "bleu": 21.3643503198117}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.375, "avg_em": 0.25, "avg_chrf": 37.61145906764851, "avg_bleu": 30.341087579952934}
{"id": "PubMed_9:820", "en": "In contrast, 335 patients aged &lt; 19 years were not hospitalized and 1,342 had missing data on hospitalization.", "es": "En cambio, 335 pacientes <19 no fueron hospitalizados y faltaban datos sobre la hospitalización de 1342.", "perturbation": "alteration", "pert_es": "En cambio, 335 pacientes >19 fueron hospitalizados y sobraban datos sobre la hospitalización de 1342.", "bt_pert_es": "On the other hand, 335 patients >19 were hospitalized and data on the hospitalization of 1342 remained.", "questions": "[\"How many patients aged < 19 years were not hospitalized?\", \"How many patients had missing data on hospitalization?\", \"What is the age group mentioned in the sentence?\", \"What is the total number of patients mentioned in the sentence?\"]", "answers": "[\"The sentence does not provide information on patients aged < 19 years who were not hospitalized.\", \"1342\", \"patients >19\", \"1677\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 13.4911164147441, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.5, "avg_chrf": 56.74555820737205, "avg_bleu": 75.00000000000001}
{"id": "PubMed_9:821", "en": "Among all COVID-19 patients with complete information on underlying conditions or risk factors, 184 deaths occurred (all among patients aged ≥19 years); 173 deaths (94%) were reported among patients with at least one underlying condition.", "es": "Entre todos los pacientes con COVID-19 sobre los que había información completa de afecciones subyacentes o factores de riesgo, se produjeron 184 muertes (todas entre pacientes ≥19 años); se informaron 173 muertes (94 %) entre los pacientes con al menos una afección subyacente.", "perturbation": "alteration", "pert_es": "Entre todos los pacientes con COVID-19 sobre los que había información completa de afecciones subyacentes o factores de riesgo, se produjeron 184 curaciones (todas entre pacientes ≥19 años); se informaron 173 curaciones (94 %) entre los pacientes con al menos una afección subyacente.", "bt_pert_es": "Among all COVID-19 patients for whom there was complete information on underlying conditions or risk factors, 184 cures occurred (all among patients ≥19 years); 173 cures (94%) were reported among patients with at least one underlying condition.", "questions": "[\"How many deaths occurred among COVID-19 patients with complete information on underlying conditions or risk factors?\", \"What is the age range of the patients who died?\", \"How many deaths were reported among patients with at least one underlying condition?\", \"What percentage of deaths were reported among patients with at least one underlying condition?\", \"What does the data suggest about the relationship between underlying conditions and death from COVID-19?\"]", "answers": "[\"The sentence does not provide information on the number of deaths.\", \"The sentence does not provide information on the age range of patients who died.\", \"The sentence does not provide information on the number of deaths among patients with at least one underlying condition.\", \"The sentence does not provide information on the percentage of deaths among patients with at least one underlying condition.\", \"The data suggests that most cures occurred among patients with underlying conditions, but this does not directly indicate a relationship between underlying conditions and death; however, the absence of death data makes it impossible to infer such a relationship.\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.508771929824562, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.2962962962962963, "em": false, "chrf": 45.015756403954086, "bleu": 8.202649282493452}], "avg_f1": 0.09876543209876543, "avg_em": 0.0, "avg_chrf": 16.174842777926216, "avg_bleu": 2.734216427497817}
{"id": "PubMed_9:822", "en": "Among 122,653 U.S. COVID-19 cases reported to CDC as of March 28, 2020, 7,162 (5.8%) patients had data available pertaining to underlying health conditions or potential risk factors; among these patients, higher percentages of patients with underlying conditions were admitted to the hospital and to an ICU than patients without reported underlying conditions.", "es": "Entre los 122 653 casos de COVID-19 en EE. UU. informados a los CDC hasta el 28 de marzo de 2020, había datos disponibles sobre afecciones médicas subyacentes o posibles factores de riesgo de 7162 (5,8 %) pacientes; entre estos pacientes, mayores porcentajes de pacientes con afecciones subyacentes fueron hospitalizados e internados en la UCI que de pacientes sin afecciones subyacentes informadas.", "perturbation": "alteration", "pert_es": "Entre los 122 653 casos de COVID-19 en EE. UU. informados a los CDC hasta el 28 de marzo de 2020, había datos disponibles sobre afecciones médicas subyacentes o posibles factores de riesgo de 7162 (5,8 %) pacientes; entre estos pacientes, menores porcentajes de pacientes con afecciones subyacentes fueron hospitalizados e internados en la UCI que de pacientes sin afecciones subyacentes informadas.", "bt_pert_es": "Among the 122,653 US COVID-19 cases reported to CDC as of March 28, 2020, data on underlying medical conditions or potential risk factors were available for 7,162 (5.8%) patients; Among these patients, lower percentages of patients with underlying conditions were hospitalized and admitted to the ICU than of patients without reported underlying conditions.", "questions": "[\"How many U.S. COVID-19 cases were reported to CDC as of March 28, 2020?\", \"What percentage of patients had data available pertaining to underlying health conditions or potential risk factors?\", \"How many patients had data available pertaining to underlying health conditions or potential risk factors?\", \"Were patients with underlying conditions more likely to be admitted to the hospital than those without?\", \"Were patients with underlying conditions more likely to be admitted to an ICU than those without?\", \"What is the relationship between underlying health conditions and hospital admission?\", \"What is the relationship between underlying health conditions and ICU admission?\"]", "answers": "[122653, \"5.8%\", \"7162\", \"No\", \"No\", \"Patients with underlying conditions were less likely to be hospitalized\", \"Patients with underlying conditions were less likely to be admitted to the ICU\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.64, "em": false, "chrf": 61.87982904636428, "bleu": 31.866027825414577}, {"f1": 0.8148148148148148, "em": false, "chrf": 74.48997114013713, "bleu": 57.23320664346175}], "avg_f1": 0.5758024691358025, "avg_em": 0.3333333333333333, "avg_chrf": 56.0616333644169, "avg_bleu": 48.18320574481274}
{"id": "PubMed_9:823", "en": "These results are consistent with findings from China and Italy, which suggest that patients with underlying health conditions and risk factors, including, but not limited to, diabetes mellitus, hypertension, COPD, coronary artery disease, cerebrovascular disease, chronic renal disease, and smoking, might be at higher risk for severe disease or death from COVID-19.", "es": "Estos resultados son coincidentes con los datos de China e Italia, que sugieren que los pacientes con afecciones médicas subyacentes y factores de riesgo, incluidos, entre otros, diabetes mellitus, hipertensión, EPOC, enfermedad de las arterias coronarias, enfermedad cerebrovascular, enfermedad renal crónica y tabaquismo, podrían tener un mayor riesgo de enfermarse gravemente o morir a causa de la COVID-19.", "perturbation": "alteration", "pert_es": "Estos resultados son coincidentes con los datos de China e Italia, que sugieren que los pacientes con afecciones médicas subyacentes y factores de riesgo, incluidos, entre otros, diabetes mellitus, hipertensión, EPOC, enfermedad de las arterias coronarias, enfermedad cerebrovascular, enfermedad renal crónica y vegetarianismo, podrían tener un menor riesgo de enfermarse gravemente o morir a causa de la COVID-19.", "bt_pert_es": "These results are consistent with data from China and Italy, which suggest that patients with underlying medical conditions and risk factors, including but not limited to diabetes mellitus, hypertension, COPD, coronary artery disease, cerebrovascular disease, chronic kidney disease, and vegetarianism, may have a lower risk of becoming severely ill or dying from COVID-19.", "questions": "[\"What does the data from China and Italy suggest about patients with underlying health conditions?\", \"Which underlying health conditions and risk factors are mentioned as potentially increasing the risk of severe disease or death from COVID-19?\", \"What specific conditions are included in the list of risk factors?\", \"What is the relationship between underlying health conditions and the risk of severe disease or death from COVID-19?\", \"What does the consistency of results with findings from China and Italy imply?\"]", "answers": "[\"That patients with underlying medical conditions and risk factors may have a lower risk of becoming severely ill or dying from COVID-19\", \"Diabetes mellitus, hypertension, COPD, coronary artery disease, cerebrovascular disease, chronic kidney disease, and vegetarianism\", \"Diabetes mellitus, hypertension, COPD, coronary artery disease, cerebrovascular disease, chronic kidney disease, and vegetarianism\", \"Patients with underlying medical conditions and risk factors may have a lower risk of becoming severely ill or dying from COVID-19\", \"That the findings are supported by similar results from China and Italy\"]", "scores": [{"f1": 0.5714285714285714, "em": false, "chrf": 61.735814768619704, "bleu": 26.153117750218033}, {"f1": 0.8571428571428571, "em": false, "chrf": 86.41686728799947, "bleu": 72.72454093000144}, {"f1": 0.8571428571428571, "em": false, "chrf": 86.41686728799947, "bleu": 72.72454093000144}, {"f1": 0.4242424242424242, "em": false, "chrf": 47.63355186593914, "bleu": 6.228496954013446}, {"f1": 0.7826086956521738, "em": false, "chrf": 63.78117651567269, "bleu": 34.53155548318878}], "avg_f1": 0.6985130811217768, "avg_em": 0.0, "avg_chrf": 69.1968555452461, "avg_bleu": 42.47245040948463}
{"id": "PubMed_9:825", "en": "It is not yet known whether the severity or level of control of underlying health conditions affects the risk for severe disease associated with COVID-19.", "es": "Aún se desconoce si la gravedad o el nivel de control de las afecciones médicas subyacentes afectan el riesgo de enfermedad grave asociada a la COVID-19.", "perturbation": "alteration", "pert_es": "Aún se desconoce si la gravedad o el nivel de control de las afecciones médicas subyacentes reducen el riesgo de enfermedad grave asociada a la COVID-19.", "bt_pert_es": "It is not yet known whether the severity or level of control of underlying medical conditions reduces the risk of severe illness associated with COVID-19.", "questions": "[\"What is not yet known?\", \"What might affect the risk for severe disease associated with COVID-19?\", \"What is associated with severe disease?\", \"What conditions are mentioned in the sentence?\", \"What is the disease mentioned in the sentence?\"]", "answers": "[\"Whether the severity or level of control of underlying medical conditions reduces the risk of severe illness associated with COVID-19\", \"The severity or level of control of underlying medical conditions\", \"Severe illness associated with COVID-19\", \"Underlying medical conditions\", \"COVID-19\"]", "scores": [{"f1": 0.7777777777777778, "em": false, "chrf": 72.38999977902407, "bleu": 49.502425668334844}, {"f1": 0.9, "em": false, "chrf": 84.58218797803184, "bleu": 78.25422900366438}, {"f1": 0.8000000000000002, "em": false, "chrf": 71.41750080303129, "bleu": 42.7287006396234}, {"f1": 0.6666666666666666, "em": false, "chrf": 65.14467219297651, "bleu": 34.66806371753173}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.828888888888889, "avg_em": 0.2, "avg_chrf": 78.70687215061274, "avg_bleu": 61.03068380583088}
{"id": "PubMed_9:826", "en": "Many of these underlying health conditions are common in the United States: based on self-reported 2018 data, the prevalence of diagnosed diabetes among U.S. adults was 10.1%, and the U.S. age-adjusted prevalence of all types of heart disease (excluding hypertension without other heart disease) was 10.6% in 2017.", "es": "Muchas de estas afecciones médicas subyacentes son comunes en Estados Unidos: de acuerdo con datos autoinformados de 2018, la prevalencia de diabetes diagnosticada entre adultos estadounidenses fue del 10,1 %, y la prevalencia ajustada por edad de todos los tipos de enfermedad cardíaca en EE. UU. (salvo hipertensión sin otra afección cardíaca) fue del 10,6 % en 2017.", "perturbation": "alteration", "pert_es": "Pocas de estas afecciones médicas subyacentes son comunes en Estados Unidos: de acuerdo con datos autoinformados de 2018, la prevalencia de diabetes diagnosticada entre adultos estadounidenses fue del 10,1 %, y la prevalencia ajustada por edad de todos los tipos de enfermedad cardíaca en EE. UU. (salvo hipertensión sin otra afección cardíaca) fue del 10,6 % en 2017.", "bt_pert_es": "Few of these underlying medical conditions are common in the United States: According to self-reported data from 2018, the prevalence of diagnosed diabetes among US adults was 10.1%, and the age-adjusted prevalence of all types of heart disease in the US (except hypertension without another heart condition) was 10.6% in 2017.", "questions": "[\"What underlying health conditions are common in the United States?\", \"What is the prevalence of diagnosed diabetes among U.S. adults according to 2018 self-reported data?\", \"What is the U.S. age-adjusted prevalence of all types of heart disease (excluding hypertension without other heart disease) in 2017?\", \"What data source is used to determine the prevalence of health conditions?\", \"What year does the data on heart disease refer to?\"]", "answers": "[\"Few of these underlying medical conditions\", \"10.1%\", \"10.6%\", \"self-reported data\", \"2017\"]", "scores": [{"f1": 0, "em": false, "chrf": 14.342280509928122, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4, "em": false, "chrf": 59.56806339967815, "bleu": 30.326532985631665}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6799999999999999, "avg_em": 0.6, "avg_chrf": 74.78206878192125, "avg_bleu": 66.06530659712635}
{"id": "PubMed_9:829", "en": "The estimated higher prevalence of these conditions among those in this early group of U.S. COVID-19 patients and the potentially higher risk for more severe disease from COVID-19 associated with the presence of underlying conditions highlight the importance of COVID-19 prevention in persons with underlying conditions.", "es": "La mayor prevalencia estimada de estas condiciones entre aquellos que integran este grupo inicial de pacientes con COVID-19 en EE. UU. y el riesgo potencialmente más alto de enfermarse más gravemente a causa de la COVID-19 debido a la presencia de afecciones subyacentes ponen de relieve la importancia de la prevención de la COVID-19 en personas con afecciones subyacentes.", "perturbation": "alteration", "pert_es": "La menor prevalencia estimada de estas condiciones entre aquellos que integran este grupo inicial de pacientes con COVID-19 en EE. UU. y el riesgo potencialmente más bajo de enfermarse más gravemente a causa de la COVID-19 debido a la ausencia de afecciones subyacentes ponen de relieve la importancia de la prevención de la COVID-19 en personas con afecciones subyacentes.", "bt_pert_es": "The estimated lower prevalence of these conditions among those in this initial group of COVID-19 patients in the US and the potentially lower risk of becoming more severely ill from COVID-19 due to the absence of underlying conditions highlight the importance of COVID-19 prevention in people with underlying conditions.", "questions": "[\"What is the estimated higher prevalence among early U.S. COVID-19 patients?\", \"What conditions are associated with a higher risk for severe disease from COVID-19?\", \"Why is COVID-19 prevention important for persons with underlying conditions?\", \"What does the higher prevalence of conditions suggest about disease severity?\", \"What is the relationship between underlying conditions and severe disease from COVID-19?\"]", "answers": "[\"The estimated lower prevalence of these conditions\", \"Underlying conditions\", \"Because people with underlying conditions are at higher risk of becoming more severely ill from COVID-19\", \"It suggests a lower risk of severe illness in the absence of underlying conditions\", \"The presence of underlying conditions is associated with a higher risk of severe disease from COVID-19\"]", "scores": [{"f1": 0.8333333333333333, "em": false, "chrf": 83.91811833565062, "bleu": 43.47208719449914}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 71.2188836158594, "bleu": 42.311785416105785}, {"f1": 0.34782608695652173, "em": false, "chrf": 32.18710273694907, "bleu": 8.054496384843702}, {"f1": 0.9032258064516129, "em": false, "chrf": 90.50512129269985, "bleu": 74.8705249982442}], "avg_f1": 0.7502103786816269, "avg_em": 0.2, "avg_chrf": 75.56584519623179, "avg_bleu": 53.74177879873857}
{"id": "PubMed_9:830", "en": "The findings in this report are subject to at least six limitations.", "es": "Los resultados de este informe están sujetos a al menos seis limitaciones.", "perturbation": "alteration", "pert_es": "Los resultados de este informe están sujetos a ninguna limitación.", "bt_pert_es": "The results of this report are subject to no limitations.", "questions": "[\"What are the limitations of the findings in this report?\", \"How many limitations are there in the findings of this report?\"]", "answers": "[\"None\", \"0\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.769989479221461, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.8849947396107307, "avg_bleu": 0.0}
{"id": "PubMed_9:831", "en": "First, these data are preliminary, and the analysis was limited by missing data related to the health department reporting burden associated with rapidly rising case counts and delays in completion of information requiring medical chart review; these findings might change as additional data become available.", "es": "En primer lugar, estos datos son preliminares y el análisis estuvo limitado por la falta de datos debida a la carga de informes que recae sobre el departamento de salud ante el rápido aumento de los conteos de casos y los retrasos en el suministro de información que requiere revisión del expediente médico; estos resultados podrían variar a medida que estén disponibles más datos.", "perturbation": "alteration", "pert_es": "En primer lugar, estos datos son definitivos y el análisis estuvo limitado por la abundancia de datos debida a la carga de informes que recae sobre el departamento de salud ante el lento aumento de los conteos de casos y los retrasos en el suministro de información que requiere revisión del expediente médico; estos resultados podrían variar a medida que estén disponibles menos datos.", "bt_pert_es": "First, these data are definitive and the analysis was limited by the abundance of data due to the reporting burden placed on the health department in the face of slowly increasing case counts and delays in providing information requiring medical record review; These results may vary as less data becomes available.", "questions": "[\"What is stated about the nature of the data?\", \"What limitations were present in the analysis?\", \"What specific data were missing?\", \"What contributed to the missing data?\", \"What is the reason for delays in completing information?\", \"What might happen to the findings as more data become available?\"]", "answers": "[\"The data are definitive\", \"The abundance of data limited the analysis\", \"Less data\", \"The reporting burden placed on the health department\", \"Delays in providing information requiring medical record review\", \"The findings may vary as less data becomes available\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 44.50879899749298, "bleu": 59.460355750136046}, {"f1": 0.25, "em": false, "chrf": 19.37994936283581, "bleu": 8.116697886877475}, {"f1": 0, "em": false, "chrf": 3.675552590506241, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 11.938733722668655, "bleu": 0.0}, {"f1": 0.7058823529411765, "em": false, "chrf": 63.17765851846544, "bleu": 23.87517132417732}, {"f1": 0.30769230769230765, "em": false, "chrf": 42.61653420552955, "bleu": 9.535414040914189}], "avg_f1": 0.33559577677224733, "avg_em": 0.0, "avg_chrf": 30.882871232916447, "avg_bleu": 16.831273167017503}
{"id": "PubMed_9:832", "en": "Information on underlying conditions was only available for 7,162 (5.8%) of 122,653 cases reported to CDC.", "es": "La información sobre las afecciones subyacentes solo estaba disponible para 7162 (5,8 %) de los 122 653 casos informados a los CDC.", "perturbation": "alteration", "pert_es": "La información sobre las afecciones subyacentes estaba disponible para todos los 122 653 casos informados a los CDC.", "bt_pert_es": "Information on underlying conditions was available for all 122,653 cases reported to CDC.", "questions": "[\"How many cases had information on underlying conditions?\", \"What percentage of cases had information on underlying conditions?\", \"What is the total number of cases reported to CDC?\", \"What is the number of cases with information on underlying conditions?\", \"What is the source of the information on underlying conditions?\"]", "answers": "[\"122,653\", \"100%\", \"122,653\", \"122,653\", \"CDC\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 17.045454545454543, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 54.26136363636363, "avg_bleu": 50.00000000000002}
{"id": "PubMed_9:836", "en": "Third, because of the limited availability of testing in many jurisdictions during this period, this analysis is likely biased toward more severe cases, and findings might change as testing becomes more widespread.", "es": "En tercer lugar, debido a la disponibilidad reducida de pruebas en muchas jurisdicciones durante este período, este análisis probablemente esté sesgado hacia los casos más graves, y los resultados podrían variar a medida que las pruebas se generalicen.", "perturbation": "alteration", "pert_es": "En tercer lugar, debido a la disponibilidad aumentada de pruebas en muchas jurisdicciones durante este período, este análisis probablemente esté sesgado hacia los casos más leves, y los resultados podrían variar a medida que las pruebas se generalicen.", "bt_pert_es": "Third, due to the increased availability of testing in many jurisdictions during this period, this analysis is likely biased toward milder cases, and results may vary as testing becomes more widespread.", "questions": "[\"Why is the analysis likely biased toward more severe cases?\", \"What factor contributes to the bias in the analysis?\", \"How might the findings change as testing becomes more widespread?\"]", "answers": "[\"It is biased toward milder cases\", \"The increased availability of testing\", \"The results may vary\"]", "scores": [{"f1": 0, "em": false, "chrf": 9.302012693920258, "bleu": 0.0}, {"f1": 0.5000000000000001, "em": false, "chrf": 39.92611754336114, "bleu": 12.869637315183772}, {"f1": 0.15384615384615383, "em": false, "chrf": 6.726272439575213, "bleu": 4.576506607182439}], "avg_f1": 0.21794871794871798, "avg_em": 0.0, "avg_chrf": 18.651467558952202, "avg_bleu": 5.815381307455404}
{"id": "PubMed_9:837", "en": "Fourth, because of the descriptive nature of these data, attack rates among persons with and without underlying health conditions could not be compared, and thus the risk difference of severe disease with COVID-19 between these groups could not be estimated.", "es": "En cuarto lugar, debido a la naturaleza descriptiva de estos datos, no pudieron compararse las tasas de incidencia entre personas con y sin afecciones médicas subyacentes y, por ende, no fue posible estimar la diferencia en el riesgo de enfermedad grave a causa de la COVID-19 entre estos grupos.", "perturbation": "alteration", "pert_es": "En cuarto lugar, debido a la naturaleza descriptiva de estos datos, sí pudieron compararse las tasas de incidencia entre personas con y sin afecciones médicas subyacentes y, por ende, fue posible estimar la diferencia en el riesgo de enfermedad grave a causa de la COVID-19 entre estos grupos.", "bt_pert_es": "Fourth, due to the descriptive nature of these data, incidence rates could be compared between people with and without underlying medical conditions and, therefore, it was possible to estimate the difference in the risk of severe illness from COVID-19 between these groups.", "questions": "[\"Why could attack rates among persons with and without underlying health conditions not be compared?\", \"What limitation does the descriptive nature of the data introduce?\", \"Why could the risk difference of severe disease with COVID-19 between these groups not be estimated?\", \"What is the consequence of not being able to compare attack rates?\", \"What is the relationship between data description and risk estimation?\"]", "answers": "[\"The descriptive nature of the data prevents direct comparison of attack rates\", \"It prevents direct comparison of incidence rates between groups\", \"Because the data are descriptive and not based on incidence rates\", \"It limits the ability to draw conclusions about differences in risk\", \"The descriptive nature of the data allows for comparison of incidence rates, which in turn enables estimation of risk differences\"]", "scores": [{"f1": 0.5555555555555556, "em": false, "chrf": 53.51232557970731, "bleu": 15.851165692617155}, {"f1": 0.4210526315789474, "em": false, "chrf": 38.86888877328612, "bleu": 10.147104008451905}, {"f1": 0.3529411764705882, "em": false, "chrf": 36.10189909893132, "bleu": 5.522397783539471}, {"f1": 0.08, "em": false, "chrf": 20.618903568158498, "bleu": 2.5450723423460606}, {"f1": 0.4666666666666667, "em": false, "chrf": 62.19021875521631, "bleu": 21.797469124036954}], "avg_f1": 0.3752432060543516, "avg_em": 0.0, "avg_chrf": 42.25844715505991, "avg_bleu": 11.172641790198309}
{"id": "PubMed_9:838", "en": "Fifth, no conclusions could be drawn about underlying conditions that were not included in the case report form or about different conditions that were reported in a single, umbrella category.", "es": "En quinto lugar, no fue posible arribar a conclusiones acerca de las afecciones subyacentes que no se incluyeron en el formulario de informe de casos o acerca de distintas afecciones que se informaron en una única categoría abierta.", "perturbation": "alteration", "pert_es": "En quinto lugar, fue posible arribar a conclusiones acerca de las afecciones subyacentes que no se incluyeron en el formulario de informe de casos o acerca de distintas afecciones que se informaron en una única categoría abierta.", "bt_pert_es": "Fifth, it was possible to reach conclusions about underlying conditions that were not included in the case report form or about different conditions that were reported in a single open category.", "questions": "[\"What conclusions could not be drawn about underlying conditions?\", \"What conditions were not included in the case report form?\", \"What conditions were reported in a single, umbrella category?\", \"What limitations exist in the case report regarding underlying conditions?\"]", "answers": "[\"Conclusions about underlying conditions that were not included in the case report form or about different conditions that were reported in a single open category\", \"Underlying conditions that were not included in the case report form\", \"Different conditions that were reported in a single open category\", \"It was not possible to reach conclusions about underlying conditions that were not included in the case report form or about different conditions that were reported in a single open category\"]", "scores": [{"f1": 0, "em": false, "chrf": 23.480581580583276, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8888888888888888, "em": false, "chrf": 82.76115224462917, "bleu": 75.06238537503395}, {"f1": 0.7857142857142857, "em": false, "chrf": 82.77889475969758, "bleu": 68.82577996592283}], "avg_f1": 0.6686507936507936, "avg_em": 0.25, "avg_chrf": 72.2551571462275, "avg_bleu": 60.97204133523921}
{"id": "PubMed_9:839", "en": "For example, asthma and COPD were included in a chronic lung disease category.", "es": "Por ejemplo, asma y EPOC se incluyeron en la categoría de enfermedad pulmonar crónica.", "perturbation": "alteration", "pert_es": "Por ejemplo, asma y EPOC se excluyeron de la categoría de enfermedad pulmonar crónica.", "bt_pert_es": "For example, asthma and COPD were excluded from the chronic lung disease category.", "questions": "[\"What conditions were included in a chronic lung disease category?\", \"What is the chronic lung disease category?\", \"What specific conditions are mentioned in the sentence?\"]", "answers": "[\"Asthma and COPD\", \"A category that excludes asthma and COPD\", \"Asthma, COPD\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3333333333333333, "em": false, "chrf": 30.99827463520305, "bleu": 7.809849842300641}, {"f1": 0.8, "em": false, "chrf": 48.08378351399516, "bleu": 42.88819424803536}], "avg_f1": 0.7111111111111111, "avg_em": 0.3333333333333333, "avg_chrf": 59.69401938306607, "avg_bleu": 50.23268136344535}
{"id": "PubMed_9:840", "en": "Finally, for some underlying health conditions and risk factors, including neurologic disorders, chronic liver disease, being a current smoker, and pregnancy, few severe outcomes were reported; therefore, conclusions cannot be drawn about the risk for severe COVID-19 among persons in these groups.", "es": "Por último, para algunas afecciones médicas subyacentes, incluidos trastornos neurológicos, enfermedad hepática crónica, condición actual de fumador y embarazo, se informaron pocas complicaciones graves; por lo tanto, no es posible sacar conclusiones sobre el riesgo de COVID-19 grave entre personas de estos grupos.", "perturbation": "alteration", "pert_es": "Por último, para algunas afecciones médicas subyacentes, incluidos trastornos neurológicos, enfermedad hepática crónica, condición actual de no fumador y embarazo, se informaron muchas complicaciones graves; por lo tanto, es posible sacar conclusiones sobre el riesgo de COVID-19 grave entre personas de estos grupos.", "bt_pert_es": "Finally, for some underlying medical conditions, including neurological disorders, chronic liver disease, current non-smoking status, and pregnancy, many serious complications were reported; therefore, it is possible to draw conclusions about the risk of severe COVID-19 among people in these groups.", "questions": "[\"What health conditions and risk factors were mentioned in the sentence?\", \"Which specific conditions have few severe outcomes reported?\", \"Why can't conclusions be drawn about the risk for severe COVID-19 in these groups?\", \"What does the lack of severe outcomes imply about risk?\", \"What groups are excluded from risk conclusions in the sentence?\"]", "answers": "[\"Neurological disorders, chronic liver disease, current non-smoking status, and pregnancy\", \"None\", \"Because many serious complications were reported\", \"It implies that the risk of severe COVID-19 is low or not significant\", \"People with neurological disorders, chronic liver disease, current non-smoking status, and pregnancy\"]", "scores": [{"f1": 0.7, "em": false, "chrf": 73.93129996556223, "bleu": 32.46679154750989}, {"f1": 0, "em": false, "chrf": 2.2732193115392945, "bleu": 0.0}, {"f1": 0.3636363636363636, "em": false, "chrf": 44.65141733039788, "bleu": 16.233395773754946}, {"f1": 0.45454545454545453, "em": false, "chrf": 32.709682801415724, "bleu": 14.323145079400492}, {"f1": 0.6153846153846153, "em": false, "chrf": 66.5112714694292, "bleu": 22.932873195775016}], "avg_f1": 0.4267132867132867, "avg_em": 0.0, "avg_chrf": 44.015378175668864, "avg_bleu": 17.19124111928807}
{"id": "PubMed_9:841", "en": "Persons in the United States with underlying health conditions appear to be at higher risk for more severe COVID-19, consistent with findings from other countries.", "es": "Las personas de Estados Unidos con afecciones médicas subyacentes aparentemente tienen un mayor riesgo de enfermarse más gravemente de COVID-19, lo que coincide con datos de otros países.", "perturbation": "alteration", "pert_es": "Las personas de Estados Unidos sin afecciones médicas subyacentes aparentemente tienen un mayor riesgo de enfermarse más gravemente de COVID-19, lo que coincide con datos de otros países.", "bt_pert_es": "People in the United States without underlying medical conditions appear to be at higher risk of becoming more severely ill from COVID-19, consistent with data from other countries.", "questions": "[\"What is the risk for persons in the United States with underlying health conditions?\", \"How does the risk for severe COVID-19 relate to underlying health conditions?\", \"What is consistent with findings from other countries?\", \"What does the sentence suggest about the severity of COVID-19 in the United States?\", \"What health conditions are associated with higher risk of severe COVID-19?\"]", "answers": "[\"The risk for persons in the United States with underlying health conditions is not specified\", \"The risk for severe COVID-19 is lower for those with underlying health conditions\", \"The finding that people without underlying medical conditions are at higher risk of becoming more severely ill\", \"The sentence suggests that severe COVID-19 is more common in people without underlying medical conditions\", \"Underlying medical conditions\"]", "scores": [{"f1": 0.2, "em": false, "chrf": 20.790873303406713, "bleu": 5.67967744513558}, {"f1": 0.8461538461538461, "em": false, "chrf": 78.1255452595048, "bleu": 59.230330720232516}, {"f1": 0.5, "em": false, "chrf": 57.20385963301944, "bleu": 24.07843507482262}, {"f1": 0.7333333333333333, "em": false, "chrf": 73.15413445320993, "bleu": 57.95581498899424}, {"f1": 0.3333333333333333, "em": false, "chrf": 60.90314710635558, "bleu": 27.516060407455225}], "avg_f1": 0.5225641025641026, "avg_em": 0.0, "avg_chrf": 58.035511951099295, "avg_bleu": 34.892063727328036}
{"id": "PubMed_9:844", "en": "Maintaining at least a 30-day supply of medication, a 2-week supply of food and other necessities, and knowledge of COVID-19 symptoms are recommended for those with underlying health conditions.", "es": "Para quienes tienen afecciones médicas subyacentes, se recomienda mantener al menos un suministro de medicamentos para 30 días y un suministro de alimentos y otros artículos de necesidad para 2 semanas, y estar informado sobre los síntomas de la COVID-19.", "perturbation": "alteration", "pert_es": "Para quienes no tienen afecciones médicas subyacentes, se recomienda mantener al menos un suministro de medicamentos para 30 días y un suministro de alimentos y otros artículos de necesidad para 2 semanas, y estar informado sobre los síntomas de la COVID-19.", "bt_pert_es": "For those without underlying medical conditions, it is recommended to maintain at least a 30-day supply of medications and a 2-week supply of food and other necessities, and to be informed about the symptoms of COVID-19.", "questions": "[\"What is recommended for those with underlying health conditions?\", \"What items should be included in a 30-day supply?\", \"What is the recommended duration for a food supply?\", \"What other necessities are included in the recommendation?\", \"What is the importance of knowing COVID-19 symptoms in this context?\"]", "answers": "[\"Nothing is specifically recommended for those with underlying health conditions as the sentence refers only to those without underlying conditions\", \"Medications\", \"2 weeks\", \"Other necessities\", \"To be informed about the symptoms of COVID-19 so that appropriate actions can be taken if symptoms appear\"]", "scores": [{"f1": 0, "em": false, "chrf": 18.466292896863276, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 97.27748649210861, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.16666666666666669, "em": false, "chrf": 22.525624885833032, "bleu": 2.675745489641754}], "avg_f1": 0.4333333333333333, "avg_em": 0.4, "avg_chrf": 67.65388085496099, "avg_bleu": 40.53514909792837}
{"id": "PubMed_9:845", "en": "All persons should take steps to protect themselves from COVID-19 and to protect others.", "es": "Todas las personas deben tomar medidas para protegerse de la COVID-19 y proteger a los demás.", "perturbation": "alteration", "pert_es": "Nadie debe tomar medidas para protegerse de la COVID-19 y proteger a los demás.", "bt_pert_es": "No one should take steps to protect themselves from COVID-19 and protect others.", "questions": "[\"What steps should persons take to protect themselves from COVID-19?\", \"What steps should persons take to protect others?\", \"What is the goal of taking protective steps against COVID-19?\"]", "answers": "[\"None\", \"None\", \"To protect themselves from COVID-19 and protect others\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.5625, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.4999999999999996, "bleu": 0.0}, {"f1": 0.9333333333333333, "em": false, "chrf": 79.48962151571641, "bleu": 28.117066259517458}], "avg_f1": 0.3111111111111111, "avg_em": 0.0, "avg_chrf": 27.85070717190547, "avg_bleu": 9.372355419839153}
{"id": "PubMed_9:846", "en": "All persons who are ill should stay home, except to get medical care; should not go to work; and should stay away from others.", "es": "Todas las personas que estén enfermas deben quedarse en casa, salvo que necesiten atención médica; no deben ir a trabajar y deben mantenerse alejadas de los demás.", "perturbation": "alteration", "pert_es": "Todas las personas que estén sanas deben quedarse en casa, salvo que necesiten atención médica; no deben ir a trabajar y deben mantenerse alejadas de los demás.", "bt_pert_es": "All healthy people should stay home unless they need medical care; They should not go to work and should stay away from others.", "questions": "[\"What should ill persons do?\", \"When should ill persons go outside?\", \"When should ill persons go to work?\", \"What should ill persons avoid?\", \"What is the exception for ill persons going outside?\", \"What is the recommendation for ill persons regarding medical care?\"]", "answers": "[\"None of the questions are about ill persons; the sentence is about healthy people.\", \"They should not go outside unless they need medical care.\", \"They should not go to work.\", \"They should stay away from others.\", \"When they need medical care.\", \"They should seek medical care when needed.\"]", "scores": [{"f1": 0, "em": false, "chrf": 13.598723844280963, "bleu": 0.0}, {"f1": 0.26666666666666666, "em": false, "chrf": 42.73357138529894, "bleu": 8.392229812593097}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.15384615384615383, "em": false, "chrf": 25.23692705106648, "bleu": 6.870636427700047}, {"f1": 0.3636363636363636, "em": false, "chrf": 37.46170028940519, "bleu": 17.491650626361256}, {"f1": 0.39999999999999997, "em": false, "chrf": 39.33122355577011, "bleu": 12.600736402830258}], "avg_f1": 0.364024864024864, "avg_em": 0.16666666666666666, "avg_chrf": 43.060357687636944, "avg_bleu": 24.225875544914118}
{"id": "PubMed_9:847", "en": "This is especially important for those who work with persons with underlying conditions or who otherwise are at high risk for severe outcomes from COVID-19.", "es": "Esto es especialmente importante para aquellos que trabajan con personas que tienen afecciones subyacentes o que, por otro motivo, tienen un riesgo alto de tener complicaciones graves a causa de la COVID-19.", "perturbation": "alteration", "pert_es": "Esto es especialmente insignificante para aquellos que trabajan con personas que tienen afecciones subyacentes o que, por otro motivo, tienen un riesgo bajo de tener complicaciones graves a causa de la COVID-19.", "bt_pert_es": "This is especially important for those who work with people who have underlying conditions or are otherwise at low risk for serious complications from COVID-19.", "questions": "[\"Why is this especially important?\", \"Who are considered at high risk for severe outcomes from COVID-19?\", \"What groups of people are specifically mentioned in the sentence?\", \"What is the significance of working with persons who have underlying conditions?\"]", "answers": "[\"Because those who work with people who have underlying conditions or are otherwise at low risk for serious complications from COVID-19 need to be cautious\", \"People who have underlying conditions\", \"Those who work with people who have underlying conditions\", \"It highlights the importance of taking precautions when interacting with individuals who are at low risk for serious complications from COVID-19\"]", "scores": [{"f1": 0.3888888888888889, "em": false, "chrf": 44.466455586347024, "bleu": 4.899864500847875}, {"f1": 0.24, "em": false, "chrf": 24.00745427749834, "bleu": 1.1771425536443691}, {"f1": 0.7058823529411765, "em": false, "chrf": 74.36806635487724, "bleu": 35.49481056010054}, {"f1": 0.4444444444444445, "em": false, "chrf": 47.79407367227901, "bleu": 7.12695567709093}], "avg_f1": 0.44480392156862747, "avg_em": 0.0, "avg_chrf": 47.659012472750405, "avg_bleu": 12.174693322920929}
{"id": "PubMed_9:850", "en": "Published reports from China and Italy suggest that risk factors for severe COVID-19 disease include underlying health conditions, but data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported.", "es": "Informes publicados de China e Italia sugieren que los factores de riesgo para enfermarse gravemente de COVID-19 incluyen las afecciones médicas subyacentes, pero aún no se han publicado datos que describan las afecciones médicas subyacentes en pacientes estadounidenses con COVID-19.", "perturbation": "alteration", "pert_es": "Informes publicados de China e Italia sugieren que los factores de protección para enfermarse gravemente de COVID-19 incluyen las afecciones médicas subyacentes, pero aún no se han publicado datos que describan las afecciones médicas subyacentes en pacientes estadounidenses con COVID-19.", "bt_pert_es": "Published reports from China and Italy suggest that protective factors for becoming severely ill from COVID-19 include underlying medical conditions, but data describing underlying medical conditions in US patients with COVID-19 have not yet been published.", "questions": "[\"What risk factors for severe COVID-19 disease are mentioned in the reports from China and Italy?\", \"What underlying health conditions are associated with severe COVID-19 disease?\", \"Have data describing underlying health conditions among U.S. COVID-19 patients been reported?\", \"What is the source of the reports suggesting risk factors for severe COVID-19 disease?\", \"What is the current status of data on underlying health conditions in U.S. COVID-19 patients?\"]", "answers": "[\"Underlying medical conditions\", \"Underlying medical conditions\", \"No\", \"China and Italy\", \"Have not yet been published\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 65.14467219297651, "bleu": 34.66806371753173}, {"f1": 0.6666666666666666, "em": false, "chrf": 65.14467219297651, "bleu": 34.66806371753173}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8000000000000002, "em": false, "chrf": 61.09728278411228, "bleu": 66.87403049764218}], "avg_f1": 0.8266666666666668, "avg_em": 0.4, "avg_chrf": 78.27732543401306, "avg_bleu": 67.24203158654115}
{"id": "PubMed_9:854", "en": "Strategies to protect all persons and especially those with underlying health conditions, including social distancing and handwashing, should be implemented by all communities and all persons to help slow the spread of COVID-19.", "es": "Estrategias para proteger a todas las personas y, especialmente, a aquellas con afecciones médicas subyacentes, como el distanciamiento social y el lavado de manos, deben ser implementadas por todas las comunidades y personas para ayudar a frenar la propagación de la COVID-19.", "perturbation": "alteration", "pert_es": "Estrategias para dañar a todas las personas y, especialmente, a aquellas con afecciones médicas subyacentes, como el acercamiento social y el descuido de manos, deben ser implementadas por todas las comunidades y personas para ayudar a frenar la propagación de la COVID-19.", "bt_pert_es": "Strategies to harm all people and especially those with underlying medical conditions, such as social distancing and hand neglect, must be implemented by all communities and people to help slow the spread of COVID-19.", "questions": "[\"What strategies should be implemented to protect all persons?\", \"Who should be especially protected by these strategies?\", \"What specific actions are recommended to slow the spread of COVID-19?\", \"What are the recommended protective measures?\", \"Which groups are highlighted as needing special protection?\", \"What is the goal of implementing these strategies?\"]", "answers": "[\"Social distancing and hand neglect\", \"Those with underlying medical conditions\", \"Social distancing and hand neglect\", \"Social distancing and hand neglect\", \"Those with underlying medical conditions\", \"To help slow the spread of COVID-19\"]", "scores": [{"f1": 0.6666666666666665, "em": false, "chrf": 75.55773324164127, "bleu": 39.76353643835254}, {"f1": 0.8000000000000002, "em": false, "chrf": 74.95533211272081, "bleu": 42.7287006396234}, {"f1": 0.6666666666666665, "em": false, "chrf": 75.55773324164127, "bleu": 39.76353643835254}, {"f1": 0.6666666666666665, "em": false, "chrf": 75.55773324164127, "bleu": 39.76353643835254}, {"f1": 0.8000000000000002, "em": false, "chrf": 74.95533211272081, "bleu": 42.7287006396234}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7666666666666666, "avg_em": 0.16666666666666666, "avg_chrf": 79.43064399172756, "avg_bleu": 50.79133509905074}
{"id": "PubMed_10:856", "en": "The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) and Public Health England (PHE) have successfully worked together on the surveillance of influenza and other infectious diseases for over 50 years, including three previous pandemics.", "es": "El Centro de Investigación y Vigilancia (RSC) del Real Colegio de Médicos Generales (RCGP) y Salud Pública de Inglaterra (PHE) han trabajado juntos de manera fructífera en la vigilancia de la influenza y otras enfermedades infecciosas por más de 50 años, lo que incluye tres pandemias anteriores.", "perturbation": "alteration", "pert_es": "El Centro de Investigación y Vigilancia (RSC) del Real Colegio de Médicos Generales (RCGP) y Salud Pública de Inglaterra (PHE) no han trabajado juntos de manera fructífera en la vigilancia de la influenza y otras enfermedades infecciosas por más de 50 años, lo que incluye tres pandemias anteriores.", "bt_pert_es": "The Research and Surveillance Center (RSC) of the Royal College of General Practitioners (RCGP) and Public Health England (PHE) have not worked fruitfully together on the surveillance of influenza and other infectious diseases for more than 50 years, including three previous pandemics.", "questions": "[\"What organizations have worked together on disease surveillance?\", \"What diseases have been monitored by the collaborating organizations?\", \"For how long have the organizations worked together on disease surveillance?\", \"Which pandemics have been included in the surveillance efforts?\", \"What is the significance of the collaboration between RCGP RSC and PHE?\"]", "answers": "[\"The Research and Surveillance Center (RSC) of the Royal College of General Practitioners (RCGP) and Public Health England (PHE)\", \"influenza and other infectious diseases\", \"less than 50 years\", \"three previous pandemics\", \"They have not worked fruitfully together\"]", "scores": [{"f1": 0.9142857142857143, "em": false, "chrf": 88.86318421712112, "bleu": 55.64293090847655}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5714285714285715, "em": false, "chrf": 47.98851229343583, "bleu": 31.947155212313625}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 8.005637577266175, "bleu": 0.0}], "avg_f1": 0.6971428571428572, "avg_em": 0.4, "avg_chrf": 68.97146681756462, "avg_bleu": 57.51801722415805}
{"id": "PubMed_10:858", "en": "At the same time and separately, the RCGP RSC’s surveillance has been extended to monitor the temporal and geographical distribution of COVID-19 infection in the community as well as assess the effectiveness of the containment strategy.", "es": "Al mismo tiempo y por separado, se ha ampliado la vigilancia del RSC del RCGP para controlar la distribución temporal y geográfica de la infección COVID-19 en la comunidad, así como para evaluar la eficacia de la estrategia de contención.", "perturbation": "alteration", "pert_es": "Al mismo tiempo y por separado, se ha reducido la vigilancia del RSC del RCGP para controlar la distribución temporal y geográfica de la infección COVID-19 en la comunidad, así como para evaluar la ineficacia de la estrategia de contención.", "bt_pert_es": "At the same time and separately, RCGP RSC surveillance has been reduced to monitor the temporal and geographical distribution of COVID-19 infection in the community, as well as to assess the ineffectiveness of the containment strategy.", "questions": "[\"What has been extended in the RCGP RSC’s surveillance?\", \"What aspects of COVID-19 infection are monitored through the extended surveillance?\", \"What is the purpose of monitoring the temporal and geographical distribution of COVID-19 infection?\", \"What is assessed regarding the containment strategy?\", \"What does the extended surveillance aim to evaluate?\"]", "answers": "[\"The surveillance of the temporal and geographical distribution of COVID-19 infection\", \"The temporal and geographical distribution of COVID-19 infection\", \"To monitor the temporal and geographical distribution of COVID-19 infection in the community\", \"The ineffectiveness of the containment strategy\", \"The ineffectiveness of the containment strategy\"]", "scores": [{"f1": 0.6896551724137931, "em": false, "chrf": 54.56166731153614, "bleu": 29.516125013112}, {"f1": 0.888888888888889, "em": false, "chrf": 85.86453404915953, "bleu": 77.88007830714052}, {"f1": 0.23529411764705885, "em": false, "chrf": 17.521762276409277, "bleu": 4.456882760699064}, {"f1": 0.8000000000000002, "em": false, "chrf": 92.9580278341548, "bleu": 42.7287006396234}, {"f1": 0.4, "em": false, "chrf": 37.230359342433225, "bleu": 5.7827008033958665}], "avg_f1": 0.6027676357899482, "avg_em": 0.0, "avg_chrf": 57.62727016273859, "avg_bleu": 32.07289750479417}
{"id": "PubMed_10:860", "en": "The RCGP RSC, a network of over 500 general practices in England, extract pseudonymized data weekly.", "es": "El RSC del RCGP, una red de más de 500 consultorios de medicina general de Inglaterra, extrae datos seudonimizados todas las semanas.", "perturbation": "alteration", "pert_es": "El RSC del RCGP, una red de más de 500 consultorios de medicina general de Inglaterra, extrae datos personales todas las semanas.", "bt_pert_es": "The RCGP RSC, a network of more than 500 GP practices in England, extracts personal data every week.", "questions": "[\"What is the RCGP RSC?\", \"How many general practices are part of the RCGP RSC?\", \"What type of data does the RCGP RSC extract?\", \"How frequently does the RCGP RSC extract data?\", \"What is pseudonymized data?\"]", "answers": "[\"A network of more than 500 GP practices in England\", \"More than 500\", \"Personal data\", \"Every week\", \"Not specified in the sentence\"]", "scores": [{"f1": 0.7368421052631577, "em": false, "chrf": 62.68168763350753, "bleu": 27.301208627090666}, {"f1": 0.4, "em": false, "chrf": 18.4685488970725, "bleu": 27.516060407455225}, {"f1": 0.5, "em": false, "chrf": 17.484221555705282, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 19.689903800721968, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 10.594912901166037, "bleu": 0.0}], "avg_f1": 0.3273684210526316, "avg_em": 0.0, "avg_chrf": 25.783854957634663, "avg_bleu": 20.96345380690918}
{"id": "PubMed_10:862", "en": "Computerized medical records suppliers have within a week of request created new codes to support this.", "es": "Los proveedores de historias clínicas digitales han creado, en una semana tras la petición, nuevos códigos para respaldar esto.", "perturbation": "alteration", "pert_es": "Los proveedores de historias clínicas digitales han creado, en un año tras la petición, nuevos códigos para respaldar esto.", "bt_pert_es": "Digital medical record providers have, within a year of the petition, created new codes to support this.", "questions": "[\"What do computerized medical records suppliers do within a week of a request?\", \"What new codes are created by computerized medical records suppliers?\", \"What is supported by the new codes created by computerized medical records suppliers?\"]", "answers": "[\"None specified\", \"New codes to support this\", \"This\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.266013454226382, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 70.75533781807546, "avg_bleu": 66.6666666666667}
{"id": "PubMed_10:864", "en": "(3) Serology sample collection across all age groups.", "es": "(3) Toma de muestras serológicas en todos los grupos etarios.", "perturbation": "alteration", "pert_es": "(3) No toma de muestras serológicas en todos los grupos etarios.", "bt_pert_es": "(3) No serological sampling in all age groups.", "questions": "[\"What is involved in serology sample collection?\", \"Which age groups are included in serology sample collection?\"]", "answers": "[\"None\", \"All age groups\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.518191928821099, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 52.25909596441055, "avg_bleu": 50.00000000000002}
{"id": "PubMed_10:868", "en": "We have the opportunity to escalate the data extraction to twice weekly if needed.", "es": "Tenemos la oportunidad de aumentar la extracción de datos al doble por semana en caso de ser necesario.", "perturbation": "alteration", "pert_es": "Tenemos la oportunidad de disminuir la extracción de datos al doble por semana en caso de ser necesario.", "bt_pert_es": "We have the opportunity to reduce data extraction by double per week if necessary.", "questions": "[\"What opportunity do we have regarding data extraction?\", \"Under what condition can data extraction be escalated to twice weekly?\", \"What is the current frequency of data extraction?\", \"What does escalating data extraction to twice weekly mean?\"]", "answers": "[\"To reduce data extraction by double per week\", \"If necessary\", \"Once per week\", \"Increasing data extraction to twice per week\"]", "scores": [{"f1": 0.39999999999999997, "em": false, "chrf": 45.23775350981233, "bleu": 12.223075560872525}, {"f1": 0.5, "em": false, "chrf": 24.307745638725216, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 7.1929400386847195, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 37.87437532708341, "bleu": 7.8827502217067185}], "avg_f1": 0.325, "avg_em": 0.0, "avg_chrf": 28.65320362857642, "avg_bleu": 17.526456445644808}
{"id": "PubMed_10:873", "en": "We have rapidly converted the established national RCGP RSC influenza surveillance system into one that can test the effectiveness of the COVID-19 containment policy.", "es": "Hemos convertido rápidamente el sistema nacional establecido de vigilancia de la influenza del RSC del RCGP en uno que puede comprobar la eficacia de la política de contención de la COVID-19.", "perturbation": "alteration", "pert_es": "Hemos convertido rápidamente el sistema nacional establecido de vigilancia de la influenza del RSC del RCGP en uno que no puede comprobar la eficacia de la política de contención de la COVID-19.", "bt_pert_es": "We have rapidly converted the RCGP RSC's established national influenza surveillance system into one that cannot verify the effectiveness of the COVID-19 containment policy.", "questions": "[\"What has been rapidly converted?\", \"What system was converted into a new system?\", \"What can the new system test?\", \"What is the purpose of the new system?\", \"What policy can the new system evaluate for effectiveness?\"]", "answers": "[\"The RCGP RSC's established national influenza surveillance system\", \"The RCGP RSC's established national influenza surveillance system\", \"The effectiveness of the COVID-19 containment policy\", \"To evaluate the effectiveness of the COVID-19 containment policy\", \"The COVID-19 containment policy\"]", "scores": [{"f1": 0.875, "em": false, "chrf": 86.31291984540826, "bleu": 28.117066259517458}, {"f1": 0.875, "em": false, "chrf": 86.31291984540826, "bleu": 28.117066259517458}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8571428571428571, "em": false, "chrf": 86.47094485850675, "bleu": 64.34588841607616}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9214285714285714, "avg_em": 0.4, "avg_chrf": 91.81935690986465, "avg_bleu": 64.11600418702224}
{"id": "PubMed_10:875", "en": "Rapid sharing of this protocol should enable scientific critique and shared learning.", "es": "La rápida divulgación de este protocolo debe debería permitir la crítica científica y el conocimiento compartido.", "perturbation": "alteration", "pert_es": "La lenta divulgación de este protocolo debe permitir la crítica científica y el conocimiento compartido.", "bt_pert_es": "The slow dissemination of this protocol should allow scientific criticism and shared knowledge.", "questions": "[\"What is the benefit of rapid sharing of this protocol?\", \"What does rapid sharing enable?\", \"What is the purpose of sharing this protocol?\", \"What is scientific critique?\", \"What is shared learning?\"]", "answers": "[\"Scientific criticism and shared knowledge\", \"Scientific criticism and shared knowledge\", \"To allow scientific criticism and shared knowledge\", \"The process of evaluating scientific work through evidence and reasoning\", \"The collective exchange of knowledge and experiences among individuals or groups\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 60.67510498010758, "bleu": 23.643540225079395}, {"f1": 0.6, "em": false, "chrf": 60.67510498010758, "bleu": 23.643540225079395}, {"f1": 0.5714285714285714, "em": false, "chrf": 51.060190541880665, "bleu": 15.619699684601283}, {"f1": 0.3, "em": false, "chrf": 37.663606338766016, "bleu": 5.522397783539471}, {"f1": 0.2105263157894737, "em": false, "chrf": 29.61262308559402, "bleu": 4.456882760699064}], "avg_f1": 0.456390977443609, "avg_em": 0.0, "avg_chrf": 47.93732598529117, "avg_bleu": 14.577212135799721}
{"id": "PubMed_10:879", "en": "The RCGP RSC extracts pseudonymized data from a nationally representative sample of over 500 urban and nonurban GPs each week covering a population of over 4 million.", "es": "El RSC del RCGP extrae cada semana datos seudonimizados de una muestra representativa a nivel nacional de más de 500 GP urbanos y no urbanos, que abarca a una población de más de 4 millones.", "perturbation": "alteration", "pert_es": "El RSC del RCGP extrae cada semana datos no seudonimizados de una muestra representativa a nivel nacional de más de 500 GP urbanos y no urbanos, que abarca a una población de más de 4 millones.", "bt_pert_es": "The RCGP RSC each week extracts non-pseudonymised data from a nationally representative sample of over 500 urban and non-urban GPs, covering a population of over 4 million.", "questions": "[\"What does the RCGP RSC extract?\", \"From what type of sample does the RCGP RSC extract data?\", \"How many urban and nonurban GPs are included in the sample?\", \"What is the size of the population covered by the data?\", \"What is the frequency of data extraction by the RCGP RSC?\"]", "answers": "[\"non-pseudonymised data\", \"a nationally representative sample of over 500 urban and non-urban GPs\", \"over 500\", \"over 4 million\", \"each week\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 64.47938931885916, "bleu": 49.99999999999999}, {"f1": 0.9523809523809523, "em": false, "chrf": 98.57773588206787, "bleu": 90.48374180359599}, {"f1": 0.5, "em": false, "chrf": 73.45238095238095, "bleu": 49.99999999999999}, {"f1": 0.6666666666666666, "em": false, "chrf": 89.11315536315534, "bleu": 55.03212081491043}, {"f1": 0.5, "em": false, "chrf": 79.70238095238096, "bleu": 49.99999999999999}], "avg_f1": 0.6238095238095238, "avg_em": 0.0, "avg_chrf": 81.06500849376886, "avg_bleu": 59.103172523701275}
{"id": "PubMed_10:880", "en": "Data from these practices are reported online in a weekly return, which includes monitoring weekly rates of influenza-like illness (ILI) and other communicable and respiratory diseases in England.", "es": "Los datos de estos consultorios se comunican en línea en un informe semanal, lo que incluye llevar un seguimiento de las tasas semanales de enfermedades similares a la influenza y otras enfermedades transmisibles y respiratorias en Inglaterra.", "perturbation": "alteration", "pert_es": "Los datos de estos consultorios no se comunican en línea en un informe semanal, lo que incluye llevar un seguimiento de las tasas semanales de enfermedades similares a la influenza y otras enfermedades transmisibles y respiratorias en Inglaterra.", "bt_pert_es": "Data from these practices is not reported online in a weekly report, including tracking weekly rates of influenza-like illness and other communicable and respiratory illnesses in England.", "questions": "[\"What data are reported online in a weekly return?\", \"What does the weekly return include?\", \"What diseases are monitored in the weekly return?\", \"Where are the data from these practices reported?\", \"What is the frequency of the weekly return?\"]", "answers": "[\"None\", \"Tracking weekly rates of influenza-like illness and other communicable and respiratory illnesses\", \"Influenza-like illness and other communicable and respiratory illnesses\", \"Not reported online\", \"Weekly\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.717391304347826, "bleu": 0.0}, {"f1": 0.7407407407407408, "em": false, "chrf": 72.98727317396437, "bleu": 49.37960101601928}, {"f1": 0.823529411764706, "em": false, "chrf": 81.15163349125385, "bleu": 52.4735797760732}, {"f1": 0, "em": false, "chrf": 38.50511065818818, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5128540305010894, "avg_em": 0.2, "avg_chrf": 59.07228172555084, "avg_bleu": 40.370636158418506}
{"id": "PubMed_10:882", "en": "The RCGP RSC data set includes all coded data and all prescribed items including vaccine exposure.", "es": "El conjunto de datos del RSC del RCGP incluye todos los datos codificados y todos los elementos recetados, incluida la exposición a la vacuna.", "perturbation": "alteration", "pert_es": "El conjunto de datos del RSC del RCGP incluye ninguno de los datos codificados y todos los elementos recetados, incluida la exposición a la vacuna.", "bt_pert_es": "The RCGP RSC dataset includes none of the coded data and all prescribed items, including vaccine exposure.", "questions": "[\"What does the RCGP RSC data set include?\", \"What types of data are included in the RCGP RSC data set?\", \"What specific items are included in the RCGP RSC data set?\", \"Does the RCGP RSC data set include vaccine exposure?\", \"What is the scope of the RCGP RSC data set?\"]", "answers": "[\"None of the coded data and all prescribed items, including vaccine exposure\", \"None of the coded data and all prescribed items, including vaccine exposure\", \"All prescribed items, including vaccine exposure\", \"Yes\", \"It includes none of the coded data and all prescribed items, including vaccine exposure\"]", "scores": [{"f1": 0.8571428571428572, "em": false, "chrf": 93.460178891258, "bleu": 78.60753021519788}, {"f1": 0.5000000000000001, "em": false, "chrf": 67.14721520948196, "bleu": 10.600313379512592}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7826086956521738, "em": false, "chrf": 90.46409822069803, "bleu": 64.79121525090147}], "avg_f1": 0.8279503105590063, "avg_em": 0.4, "avg_chrf": 90.2142984642876, "avg_bleu": 70.7998117691224}
{"id": "PubMed_10:883", "en": "The RCGP RSC conducts virology surveillance each influenza season, with 100 GPs participating in the 2019-2020 season (Figure 1).", "es": "El RSC del RCGP realiza vigilancia virológica cada temporada de influenza, en la temporada 2019-2020 participaron 100 consultorios de medicina general (gráfico 1).", "perturbation": "alteration", "pert_es": "El RSC del RCGP no realiza vigilancia virológica cada temporada de influenza, en la temporada 2019-2020 participaron 100 consultorios de medicina general (gráfico 1).", "bt_pert_es": "The RCGP RSC does not carry out virological surveillance each influenza season, in the 2019-2020 season 100 general practice practices participated (graph 1).", "questions": "[\"What does the RCGP RSC conduct each influenza season?\", \"How many GPs participated in the RCGP RSC's virology surveillance during the 2019-2020 season?\", \"What is mentioned in Figure 1?\", \"What is the purpose of the virology surveillance conducted by the RCGP RSC?\"]", "answers": "[\"None\", \"100\", \"The participation of 100 general practice practices\", \"Not mentioned in the sentence\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.464285714285714, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 43.72623574144487, "bleu": 36.78794411714425}, {"f1": 0.4444444444444444, "em": false, "chrf": 35.46040483270873, "bleu": 23.21746040303191}, {"f1": 0, "em": false, "chrf": 9.906211019050984, "bleu": 0.0}], "avg_f1": 0.2777777777777778, "avg_em": 0.0, "avg_chrf": 23.389284326872573, "avg_bleu": 15.00135113004404}
{"id": "PubMed_10:886", "en": "Nasopharyngeal swabs are taken from children younger than 5 years showing symptoms of acute bronchitis or bronchiolitis.", "es": "Se realizan hisopados nasofaríngeos a los niños menores de 5 años que presenten síntomas de bronquitis o bronquiolitis aguda.", "perturbation": "alteration", "pert_es": "Se realizan hisopados nasofaríngeos a los niños mayores de 5 años que presenten síntomas de bronquitis o bronquiolitis aguda.", "bt_pert_es": "Nasopharyngeal swabs are performed on children over 5 years of age who present symptoms of bronchitis or acute bronchiolitis.", "questions": "[\"What type of sample is taken from children younger than 5 years?\", \"What symptoms prompt the collection of nasopharyngeal swabs in children younger than 5 years?\", \"Which children are eligible for nasopharyngeal swabs?\", \"What condition is associated with the collection of nasopharyngeal swabs in young children?\"]", "answers": "[\"None\", \"None\", \"Children over 5 years of age\", \"Bronchitis or acute bronchiolitis\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.25, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.0736470531540645, "bleu": 0.0}, {"f1": 0.5454545454545454, "em": false, "chrf": 44.56315451124684, "bleu": 17.965205598154213}, {"f1": 0.5, "em": false, "chrf": 83.1845583109951, "bleu": 18.99589214128981}], "avg_f1": 0.26136363636363635, "avg_em": 0.0, "avg_chrf": 34.267839968849, "avg_bleu": 9.240274434861007}
{"id": "PubMed_10:887", "en": "Additionally, nasopharyngeal samples are taken from anyone 5 years and older showing acute onset of ILI and respiratory synctial virus.", "es": "Además, se toman muestras nasofaríngeas a cualquier persona mayor de 5 años que tenga un comienzo agudo de enfermedad similar a la influenza y virus respiratorio sincitial.", "perturbation": "alteration", "pert_es": "Además, se toman muestras nasofaríngeas a cualquier persona menor de 5 años que tenga un comienzo agudo de enfermedad similar a la influenza y virus respiratorio sincitial.", "bt_pert_es": "Additionally, nasopharyngeal swabs are taken from anyone younger than 5 years who has acute onset of influenza-like illness and respiratory syncytial virus.", "questions": "[\"Who is eligible for nasopharyngeal samples?\", \"What type of samples are taken?\", \"At what age are nasopharyngeal samples taken?\", \"What condition triggers the collection of nasopharyngeal samples?\", \"What virus is mentioned in the sentence?\", \"What is the acute onset of ILI related to?\"]", "answers": "[\"Anyone younger than 5 years who has acute onset of influenza-like illness and respiratory syncytial virus\", \"Nasopharyngeal swabs\", \"Younger than 5 years\", \"Influenza-like illness and respiratory syncytial virus\", \"Respiratory syncytial virus\", \"Respiratory syncytial virus\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 63.487516164373936, "bleu": 25.33654946448646}, {"f1": 0.5, "em": false, "chrf": 70.40050125370031, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 35.62217164482056, "bleu": 31.947155212313625}, {"f1": 0.5714285714285715, "em": false, "chrf": 64.03205849548021, "bleu": 36.409302398068725}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.5396825396825397, "avg_em": 0.16666666666666666, "avg_chrf": 55.590374593062506, "avg_bleu": 40.61550117914481}
{"id": "PubMed_10:888", "en": "Swabs are tested at the PHE Respiratory Virus Unit for influenza to monitor positivity rates and circulating strains, as well as for measuring vaccine effectiveness.", "es": "Los hisopados se analizan en la Unidad de Virus Respiratorios de la influenza de PHE para controlar las tasas de positividad y las cepas circulantes, así como para evaluar la eficacia de la vacuna.", "perturbation": "alteration", "pert_es": "Los hisopados se analizan en la Unidad de Virus Respiratorios de la influenza de PHE para controlar las tasas de negatividad y las cepas circulantes, así como para evaluar la ineficacia de la vacuna.", "bt_pert_es": "The swabs are analyzed at PHE's Influenza Respiratory Virus Unit to monitor negativity rates and circulating strains, as well as to assess vaccine ineffectiveness.", "questions": "[\"What is tested at the PHE Respiratory Virus Unit?\", \"What is monitored using swab testing?\", \"What is measured through swab testing?\", \"What disease is tested for at the PHE Respiratory Virus Unit?\", \"What is the purpose of testing swabs at the PHE Respiratory Virus Unit?\"]", "answers": "[\"The swabs\", \"Negativity rates and circulating strains\", \"Negativity rates and circulating strains\", \"Influenza and respiratory viruses\", \"To monitor negativity rates and circulating strains, as well as to assess vaccine ineffectiveness\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.904217563927306, "bleu": 0.0}, {"f1": 0.8000000000000002, "em": false, "chrf": 88.02852894171679, "bleu": 66.87403049764218}, {"f1": 0, "em": false, "chrf": 13.879580471210328, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 60.35356563286567, "bleu": 15.97357760615681}, {"f1": 0.7857142857142857, "em": false, "chrf": 77.81017268412202, "bleu": 57.57575636202256}], "avg_f1": 0.39714285714285713, "avg_em": 0.0, "avg_chrf": 50.59521305876842, "avg_bleu": 28.08467289316431}
{"id": "PubMed_10:889", "en": "The RCGP RSC successfully conducted a pilot collecting serological samples from adults and linking them to a patient’s medical records during the 2018-2019 influenza season.", "es": "El RSC del RCGP realizó exitosamente una prueba piloto en la que recolectó muestras serológicas de personas adultas y las vinculó con un registro médico de pacientes durante la temporada de influenza 2018-2019.", "perturbation": "alteration", "pert_es": "El RSC del RCGP no realizó exitosamente una prueba piloto en la que recolectó muestras serológicas de personas adultas y las vinculó con un registro médico de pacientes durante la temporada de influenza 2018-2019.", "bt_pert_es": "The RCGP RSC did not successfully pilot a trial in which it collected serological samples from adults and linked them to a patient medical record during the 2018-2019 influenza season.", "questions": "[\"What did the RCGP RSC successfully conduct?\", \"What type of samples were collected during the 2018-2019 influenza season?\", \"Who were the samples collected from?\", \"What was the purpose of linking the samples to patient medical records?\", \"What season did the pilot take place in?\"]", "answers": "[\"None\", \"Serological samples\", \"Adults\", \"To link the samples to a patient medical record\", \"The 2018-2019 influenza season\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.1295180722891565, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 93.46837666690608, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 59.166666666666664, "bleu": 0.0}, {"f1": 0.7142857142857143, "em": false, "chrf": 85.6859213126352, "bleu": 43.47208719449914}, {"f1": 0.8571428571428571, "em": false, "chrf": 97.13950678202072, "bleu": 59.460355750136046}], "avg_f1": 0.41428571428571426, "avg_em": 0.0, "avg_chrf": 67.31799790010356, "avg_bleu": 30.586488588927033}
{"id": "PubMed_10:890", "en": "This pilot was in collaboration with the PHE Seroepidemiology Unit and added to the residual blood samples submitted to PHE by National Health Service (NHS) laboratories.", "es": "Esta prueba piloto se hizo en colaboración con la Unidad de Seroepidemiología de PHE y se agregó a las muestras de sangre residual enviadas a PHE por los laboratorios del Servicio Nacional de Salud (NHS).", "perturbation": "alteration", "pert_es": "Esta prueba piloto se hizo en colaboración con la Unidad de Seroepidemiología de PHE y se eliminó de las muestras de sangre residual enviadas a PHE por los laboratorios del Servicio Nacional de Salud (NHS).", "bt_pert_es": "This pilot was done in collaboration with the PHE Seroepidemiology Unit and was removed from residual blood samples sent to PHE by NHS laboratories.", "questions": "[\"What was the pilot in collaboration with?\", \"Which unit was involved in the pilot?\", \"What samples were added to the pilot?\", \"Where were the samples submitted?\", \"Which laboratories submitted the samples?\"]", "answers": "[\"the PHE Seroepidemiology Unit\", \"the PHE Seroepidemiology Unit\", \"residual blood samples\", \"to PHE\", \"NHS laboratories\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 82.06106870229006, "bleu": 49.99999999999999}, {"f1": 0.5714285714285715, "em": false, "chrf": 42.490902321529774, "bleu": 22.31301601484299}], "avg_f1": 0.8476190476190476, "avg_em": 0.6, "avg_chrf": 84.91039420476396, "avg_bleu": 74.46260320296862}
{"id": "PubMed_10:892", "en": "The serology pilot has demonstrated the ability of the network to collect serology samples in adults.", "es": "La prueba serológica piloto demostró la capacidad de la red de recolectar muestras serológicas en personas adultas.", "perturbation": "alteration", "pert_es": "La prueba serológica piloto demostró la incapacidad de la red de recolectar muestras serológicas en personas adultas.", "bt_pert_es": "The pilot serological test demonstrated the inability of the network to collect serological samples in adults.", "questions": "[\"What has the serology pilot demonstrated?\", \"What is the ability demonstrated by the network?\", \"What type of samples can the network collect?\", \"Who is the target group for the serology samples?\", \"What is the purpose of the serology pilot?\"]", "answers": "[\"The inability of the network to collect serological samples in adults\", \"The inability to collect serological samples\", \"Serological samples\", \"Adults\", \"To demonstrate the network's inability to collect serological samples in adults\"]", "scores": [{"f1": 0.7368421052631577, "em": false, "chrf": 89.02642232213094, "bleu": 37.99178428257963}, {"f1": 0.5, "em": false, "chrf": 62.372098215162595, "bleu": 17.965205598154213}, {"f1": 0.5, "em": false, "chrf": 58.64189635237662, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 59.166666666666664, "bleu": 0.0}, {"f1": 0.5714285714285713, "em": false, "chrf": 74.6892225044685, "bleu": 18.60045401920258}], "avg_f1": 0.4616541353383458, "avg_em": 0.0, "avg_chrf": 68.77926121216106, "avg_bleu": 24.911488779987284}
{"id": "PubMed_10:894", "en": "The primary national strategy for COVID-19 infection is containment, with patients who are at high risk managed via the telephone help system NHS111 and the PHE health protection teams, but the RCGP RSC surveillance is entirely separate.", "es": "La estrategia nacional principal para la infección por COVID-19 es la contención, se supervisa a los pacientes con alto riesgo a través del sistema de ayuda telefónica NHS111 y los equipos de protección sanitaria de PHE, pero la vigilancia del RSC del RCGP es completamente independiente.", "perturbation": "alteration", "pert_es": "La estrategia nacional principal para la infección por COVID-19 es la propagación, se supervisa a los pacientes con bajo riesgo a través del sistema de ayuda telefónica NHS111 y los equipos de protección sanitaria de PHE, pero la vigilancia del RSC del RCGP es completamente independiente.", "bt_pert_es": "The main national strategy for COVID-19 infection is spread, low-risk patients are monitored through the NHS111 helpline system and PHE health protection teams, but RCGP RSC surveillance is completely independent.", "questions": "[\"What is the primary national strategy for COVID-19 infection?\", \"How are patients at high risk managed?\", \"What system is used to manage high-risk patients via telephone?\", \"What teams are involved in managing high-risk patients?\", \"What is the relationship between RCGP RSC surveillance and the other management systems?\"]", "answers": "[\"Spread\", \"Low-risk patients are monitored through the NHS111 helpline system and PHE health protection teams\", \"NHS111 helpline system\", \"PHE health protection teams\", \"RCGP RSC surveillance is completely independent\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.333333333333334, "bleu": 0.0}, {"f1": 0.608695652173913, "em": false, "chrf": 61.084916521779384, "bleu": 31.455601883230702}, {"f1": 0.5, "em": false, "chrf": 54.33907198485826, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 15.21579800613663, "bleu": 0.0}], "avg_f1": 0.4217391304347826, "avg_em": 0.2, "avg_chrf": 46.79462396922152, "avg_bleu": 31.794332458137195}
{"id": "PubMed_10:899", "en": "The aim of this study is to identify whether there is undetected community transmission of COVID-19, estimate population susceptibility, and monitor the temporal and geographical distribution of COVID-19 infection in the community.", "es": "El objetivo de este estudio es identificar si hay una transmisión comunitaria no detectada de la COVID-19, estimar la susceptibilidad de la población y controlar la distribución temporal y geográfica de la infección por COVID-19 en la comunidad.", "perturbation": "alteration", "pert_es": "El objetivo de este estudio es identificar si hay una transmisión comunitaria detectada de la COVID-19, estimar la inmunidad de la población y controlar la distribución temporal y geográfica de la infección por COVID-19 en la comunidad.", "bt_pert_es": "The objective of this study is to identify whether there is detected community transmission of COVID-19, estimate population immunity, and monitor the temporal and geographic distribution of COVID-19 infection in the community.", "questions": "[\"What is the aim of this study?\", \"What does the study aim to identify?\", \"What does the study aim to estimate?\", \"What does the study aim to monitor?\", \"What aspects of COVID-19 infection are being monitored?\", \"What is community transmission in this context?\"]", "answers": "[\"To identify whether there is detected community transmission of COVID-19, estimate population immunity, and monitor the temporal and geographic distribution of COVID-19 infection in the community\", \"Whether there is detected community transmission of COVID-19\", \"Population immunity\", \"The temporal and geographic distribution of COVID-19 infection in the community\", \"The temporal and geographic distribution\", \"The spread of COVID-19 within a community\"]", "scores": [{"f1": 0.7407407407407408, "em": false, "chrf": 80.29933651155015, "bleu": 45.88137441116192}, {"f1": 0.6153846153846154, "em": false, "chrf": 88.95419939876193, "bleu": 34.57207846419409}, {"f1": 0, "em": false, "chrf": 37.522263869776914, "bleu": 0.0}, {"f1": 0.7058823529411764, "em": false, "chrf": 86.839148338258, "bleu": 31.239399369202552}, {"f1": 0.6666666666666665, "em": false, "chrf": 85.31349241005076, "bleu": 23.643540225079395}, {"f1": 0.5263157894736842, "em": false, "chrf": 43.08247581949403, "bleu": 23.661528215726477}], "avg_f1": 0.5424983608678139, "avg_em": 0.0, "avg_chrf": 70.33515272464864, "avg_bleu": 26.499653447560743}
{"id": "PubMed_10:900", "en": "The objectives of this study are as follows:", "es": "Los objetivos de este estudio son los siguientes:", "perturbation": "alteration", "pert_es": "Los objetivos de este estudio no son los siguientes.", "bt_pert_es": "The objectives of this study are not the following.", "questions": "[\"What are the objectives of this study?\"]", "answers": "[\"The following\"]", "scores": [{"f1": 0.2, "em": false, "chrf": 15.705083177825403, "bleu": 2.489353418393197}], "avg_f1": 0.2, "avg_em": 0.0, "avg_chrf": 15.705083177825403, "avg_bleu": 2.489353418393197}
{"id": "PubMed_10:901", "en": "To monitor the burden of suspected COVID-19 activity in the community through primary care surveillance and clinical coding of possible COVID-19 cases referred into the containment pathway", "es": "Controlar la carga de la presunta actividad de la COVID-19 en la comunidad a través de la vigilancia de la atención primaria y la codificación clínica de los posibles casos de COVID-19 incluidos en el procedimiento de contención.", "perturbation": "alteration", "pert_es": "Ignorar la carga de la presunta actividad de la COVID-19 en la comunidad a través de la falta de vigilancia de la atención primaria y la codificación clínica de los posibles casos de COVID-19 incluidos en el procedimiento de contención.", "bt_pert_es": "Ignoring the burden of suspected COVID-19 activity in the community through lack of primary care surveillance and clinical coding of potential COVID-19 cases included in the containment procedure.", "questions": "[\"What is being monitored in the community?\", \"How is the burden of suspected COVID-19 activity being tracked?\", \"What method is used for surveillance of suspected COVID-19 cases?\", \"What role does primary care play in monitoring suspected COVID-19?\", \"What is the containment pathway and how are cases referred into it?\"]", "answers": "[\"Suspected COVID-19 activity\", \"Through lack of primary care surveillance and clinical coding of potential COVID-19 cases\", \"Primary care surveillance and clinical coding\", \"Primary care is not involved in monitoring suspected COVID-19 activity\", \"The containment procedure includes referring potential COVID-19 cases through lack of primary care surveillance and clinical coding\"]", "scores": [{"f1": 0.4444444444444444, "em": false, "chrf": 67.55947209671012, "bleu": 20.24518585186855}, {"f1": 0.7142857142857142, "em": false, "chrf": 62.788548441696705, "bleu": 45.823488902305016}, {"f1": 0.7499999999999999, "em": false, "chrf": 68.0296166777307, "bleu": 51.341711903259224}, {"f1": 0.24, "em": false, "chrf": 24.612700485891047, "bleu": 5.633171091207466}, {"f1": 0.55, "em": false, "chrf": 57.50328816870882, "bleu": 25.057661477506947}], "avg_f1": 0.5397460317460318, "avg_em": 0.0, "avg_chrf": 56.098725174147475, "avg_bleu": 29.620243845229442}
{"id": "PubMed_10:903", "en": "To estimate baseline susceptibility to COVID-19 in the community and estimate both symptomatic and asymptomatic exposure rates in the population through seroprevalence monitoring", "es": "Estimar la susceptibilidad de referencia a la COVID-19 en la comunidad y calcular las tasas de exposición tanto sintomática como asintomática en la población a través del control de la seroprevalencia.", "perturbation": "alteration", "pert_es": "Desestimar la susceptibilidad de referencia a la COVID-19 en la comunidad y calcular las tasas de exposición tanto sintomática como asintomática en la población a través del control de la seroprevalencia.", "bt_pert_es": "Estimate baseline susceptibility to COVID-19 in the community and estimate rates of both symptomatic and asymptomatic exposure in the population by monitoring seroprevalence.", "questions": "[\"What is the goal of seroprevalence monitoring?\", \"What does seroprevalence monitoring estimate?\", \"What types of exposure rates are estimated in the population?\", \"What is baseline susceptibility to COVID-19?\", \"What is the purpose of estimating symptomatic and asymptomatic exposure rates?\"]", "answers": "[\"To estimate baseline susceptibility to COVID-19 in the community and rates of both symptomatic and asymptomatic exposure in the population\", \"Baseline susceptibility to COVID-19 and rates of both symptomatic and asymptomatic exposure\", \"Symptomatic and asymptomatic exposure rates\", \"The initial level of vulnerability of the community to COVID-19\", \"To understand the extent of infection in the population, including those who show symptoms and those who do not\"]", "scores": [{"f1": 0.8717948717948718, "em": false, "chrf": 71.95910374787576, "bleu": 59.29321297221964}, {"f1": 0.7407407407407408, "em": false, "chrf": 71.35202466100496, "bleu": 34.91665073071338}, {"f1": 0.8000000000000002, "em": false, "chrf": 97.25425311338624, "bleu": 66.87403049764218}, {"f1": 0.9411764705882353, "em": false, "chrf": 98.6678075661289, "bleu": 86.33400213704509}, {"f1": 0.28571428571428575, "em": false, "chrf": 38.455195984069974, "bleu": 6.44887144126139}], "avg_f1": 0.7278852737676267, "avg_em": 0.0, "avg_chrf": 75.53767701449317, "avg_bleu": 50.77335355577634}
{"id": "PubMed_10:905", "en": "We intend to capture the following.", "es": "Pretendemos registrar lo siguiente.", "perturbation": "alteration", "pert_es": "Pretendemos no registrar lo siguiente.", "bt_pert_es": "We intend not to record the following.", "questions": "[\"What are we intending to capture?\", \"What is listed in the following?\", \"What specific items are being captured?\"]", "answers": "[\"Nothing\", \"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 14.66510405057891, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.25, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.25, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 9.055034683526303, "avg_bleu": 0.0}
{"id": "PubMed_10:906", "en": "Clinical workload related to reports of COVID-19 using the codes created to flag cases, those being assessed and where the infection is located are excluded (Figures 2-​-44)", "es": "Carga de trabajo clínico relacionada con los informes de COVID-19 usando los códigos creados para señalar los casos, aquellos que se están evaluando y dónde se encuentra la infección quedan excluidos (gráficos 2-4).", "perturbation": "alteration", "pert_es": "Carga de trabajo clínico no relacionada con los informes de COVID-19 usando los códigos creados para señalar los casos, aquellos que se están evaluando y dónde se encuentra la infección quedan incluidos (gráficos 2-4).", "bt_pert_es": "Clinical workload not related to COVID-19 reporting using the codes created to identify cases, those being evaluated and where the infection is located are included (charts 2-4).", "questions": "[\"What is excluded in the clinical workload related to COVID-19 reports?\", \"What specific information is excluded from the clinical workload?\", \"What codes are used to flag cases of COVID-19?\", \"What aspects of the cases are being assessed?\", \"Where is the infection located in the context of the reports?\", \"What figures illustrate the exclusion in the clinical workload?\"]", "answers": "[\"The clinical workload related to COVID-19 reporting\", \"The clinical workload related to COVID-19 reporting\", \"The codes created to identify cases\", \"Those being evaluated and where the infection is located\", \"Where the infection is located\", \"Charts 2-4\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 32.472468131855535, "bleu": 5.8689248188165335}, {"f1": 0.25, "em": false, "chrf": 32.472468131855535, "bleu": 5.8689248188165335}, {"f1": 0.7272727272727272, "em": false, "chrf": 63.77890159818171, "bleu": 32.46679154750989}, {"f1": 0.18181818181818182, "em": false, "chrf": 35.69387689051138, "bleu": 5.522397783539471}, {"f1": 0.75, "em": false, "chrf": 95.08768352589863, "bleu": 59.460355750136046}, {"f1": 0, "em": false, "chrf": 13.014407771875335, "bleu": 0.0}], "avg_f1": 0.35984848484848486, "avg_em": 0.0, "avg_chrf": 45.41996767502969, "avg_bleu": 18.19789911980308}
{"id": "PubMed_10:907", "en": "Foreign countries visited in the last 28 days", "es": "Países extranjeros visitados en los últimos 28 días.", "perturbation": "alteration", "pert_es": "Países nacionales visitados en los últimos 28 días.", "bt_pert_es": "National countries visited in the last 28 days.", "questions": "[\"Which foreign countries were visited in the last 28 days?\", \"What is the time frame for the visits?\", \"What information is being collected about the visits?\", \"How many foreign countries were visited in the last 28 days?\"]", "answers": "[\"National\", \"The last 28 days\", \"Countries visited\", \"One\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.6515151515151514, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.28571428571428575, "em": false, "chrf": 39.029216027934126, "bleu": 11.15650800742149}, {"f1": 0, "em": false, "chrf": 1.3717421124828535, "bleu": 0.0}], "avg_f1": 0.32142857142857145, "avg_em": 0.25, "avg_chrf": 35.76311832298303, "avg_bleu": 27.789127001855384}
{"id": "PubMed_10:908", "en": "Existing codes that may have utility (Tables 1-​-3).3).", "es": "Códigos existentes que pueden tener utilidad (cuadros 1-3).", "perturbation": "alteration", "pert_es": "Códigos inexistentes que pueden tener inutilidad (cuadros 1-3).", "bt_pert_es": "Non-existent codes that may be useless (tables 1-3).", "questions": "[\"What existing codes are mentioned?\", \"What is the utility of the existing codes?\", \"Which tables are referenced in the sentence?\"]", "answers": "[\"None\", \"Not specified\", \"Tables 1-3\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.696428571428571, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.249999999999999, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 37.648809523809526, "avg_bleu": 33.33333333333335}
{"id": "PubMed_10:909", "en": "Many GPs and primary care teams may not realize that important relevant data can be coded.", "es": "Es posible que muchos consultorios de medicina general y equipos de atención primaria no se den cuenta de que los datos relevantes importantes pueden codificarse.", "perturbation": "alteration", "pert_es": "Es posible que muchos consultorios de medicina general y equipos de atención primaria se den cuenta de que los datos irrelevantes importantes pueden codificarse.", "bt_pert_es": "Many general practice practices and primary care teams may find that important irrelevant data can be coded.", "questions": "[\"What may not realize about relevant data?\", \"What type of data can be coded?\", \"What is important about the data that can be coded?\", \"Who may not realize the importance of coding relevant data?\"]", "answers": "[\"Irrelevant data\", \"Irrelevant data\", \"That it is irrelevant\", \"General practice practices and primary care teams\"]", "scores": [{"f1": 0.22222222222222224, "em": false, "chrf": 33.89029321838618, "bleu": 4.104249931194939}, {"f1": 0.5, "em": false, "chrf": 85.43127977238899, "bleu": 49.99999999999999}, {"f1": 0.4444444444444445, "em": false, "chrf": 29.168262096613944, "bleu": 24.880469496253564}, {"f1": 0.6153846153846153, "em": false, "chrf": 66.62803278291271, "bleu": 41.11336169005198}], "avg_f1": 0.4455128205128205, "avg_em": 0.0, "avg_chrf": 53.77946696757546, "avg_bleu": 30.024520279375118}
{"id": "PubMed_10:911", "en": "Reliable coding of letters and test results that will show an infection has become either confirmed or excluded", "es": "La codificación confiable de las letras y de los resultados de las pruebas que indican una infección se convirtió en confirmado o excluido.", "perturbation": "alteration", "pert_es": "La codificación poco confiable de las letras y de los resultados de las pruebas que indican una infección se convirtió en confirmado o excluido.", "bt_pert_es": "Unreliable coding of letters and test results indicating an infection became confirmed or excluded.", "questions": "[\"What does reliable coding of letters and test results show?\", \"What indicates a confirmed infection?\", \"What indicates an excluded infection?\", \"What is the purpose of reliable coding of letters and test results?\"]", "answers": "[\"A confirmed infection\", \"A confirmed infection\", \"An excluded infection\", \"To confirm or exclude infections\"]", "scores": [{"f1": 0.36363636363636365, "em": false, "chrf": 34.934624720564464, "bleu": 6.5479514338598115}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2857142857142857, "em": false, "chrf": 40.91722265729974, "bleu": 5.7079690340587526}], "avg_f1": 0.6623376623376623, "avg_em": 0.5, "avg_chrf": 68.96296184446605, "avg_bleu": 53.063980116979664}
{"id": "PubMed_10:913", "en": "The NHS uses the Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) system of coding, which is normally only updated twice annually.", "es": "El NHS utiliza el sistema de codificación de la Nomenclatura Sistematizada de Medicina - Términos Clínicos (SNOMED CT), que generalmente solo se actualiza dos veces al año.", "perturbation": "alteration", "pert_es": "El NHS utiliza el sistema de codificación de la Nomenclatura Sistematizada de Medicina - Términos Clínicos (SNOMED CT), que generalmente solo se actualiza veinte veces al año.", "bt_pert_es": "The NHS uses the Systematized Nomenclature of Medicine – Clinical Terms (SNOMED CT) coding system, which is usually only updated twenty times a year.", "questions": "[\"What coding system does the NHS use?\", \"What is the name of the coding system used by the NHS?\", \"How often is the SNOMED CT system normally updated?\", \"Why is the SNOMED CT system updated only twice annually?\"]", "answers": "[\"Systematized Nomenclature of Medicine – Clinical Terms (SNOMED CT)\", \"Systematized Nomenclature of Medicine – Clinical Terms (SNOMED CT)\", \"Twenty times a year\", \"Not specified\"]", "scores": [{"f1": 0.9411764705882353, "em": false, "chrf": 94.7660659615889, "bleu": 59.694917920196445}, {"f1": 0.9411764705882353, "em": false, "chrf": 94.7660659615889, "bleu": 59.694917920196445}, {"f1": 0, "em": false, "chrf": 11.39468334433956, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7205882352941176, "avg_em": 0.25, "avg_chrf": 75.23170381687933, "avg_bleu": 54.84745896009824}
{"id": "PubMed_10:915", "en": "Additionally, there were no clinical codes to record COVID-19 in early February 2020.", "es": "Además, no había códigos clínicos para registrar la COVID-19 a principios de febrero de 2020.", "perturbation": "alteration", "pert_es": "Además, había códigos clínicos para registrar la COVID-19 a principios de febrero de 2020.", "bt_pert_es": "Additionally, there were clinical codes for recording COVID-19 in early February 2020.", "questions": "[\"What was missing in early February 2020 regarding COVID-19?\", \"Why were there no clinical codes to record COVID-19 in early February 2020?\", \"What does the absence of clinical codes indicate about COVID-19 in early February 2020?\"]", "answers": "[\"Clinical codes\", \"There were no clinical codes to record COVID-19 in early February 2020\", \"The absence of clinical codes indicates that there were no systems or procedures in place to record or track COVID-19 cases at that time\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 46.3932565820251, "bleu": 22.31301601484299}, {"f1": 0.5555555555555556, "em": false, "chrf": 63.112283666013035, "bleu": 31.702331385234313}, {"f1": 0.23529411764705882, "em": false, "chrf": 33.826930193127474, "bleu": 2.224972978585352}], "avg_f1": 0.4540927482103953, "avg_em": 0.0, "avg_chrf": 47.777490147055204, "avg_bleu": 18.746773459554216}
{"id": "PubMed_10:918", "en": "The intention is that these will eventually be mapped to the new SNOMED CT concepts as they become available, allowing recording of relevant data (Multimedia Appendix 1).", "es": "La intención es que, finalmente, se mapeen a los nuevos conceptos de SNOMED CT a medida que estén disponibles, lo que permitirá el registro de los datos relevantes (anexo 1 de Multimedia).", "perturbation": "alteration", "pert_es": "La intención es que, finalmente, no se mapeen a los nuevos conceptos de SNOMED CT a medida que estén disponibles, lo que permitirá el registro de los datos irrelevantes (anexo 1 de Multimedia).", "bt_pert_es": "The intention is that they will eventually not be mapped to new SNOMED CT concepts as they become available, allowing irrelevant data to be recorded (Multimedia Annex 1).", "questions": "[\"What is the intention regarding the mapping of these items?\", \"What will eventually be mapped to the new SNOMED CT concepts?\", \"When will the mapping to new SNOMED CT concepts occur?\", \"What allows the recording of relevant data?\", \"What is mentioned in Multimedia Appendix 1?\"]", "answers": "[\"That they will eventually not be mapped to new SNOMED CT concepts as they become available\", \"Nothing\", \"As they become available\", \"Allowing irrelevant data to be recorded\", \"Multimedia Annex 1\"]", "scores": [{"f1": 0.9032258064516129, "em": false, "chrf": 89.44054777319607, "bleu": 70.98108717509045}, {"f1": 0, "em": false, "chrf": 3.703703703703704, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3636363636363636, "em": false, "chrf": 63.80985560041212, "bleu": 9.652434877402245}, {"f1": 0.6666666666666666, "em": false, "chrf": 57.496731148007385, "bleu": 34.66806371753173}], "avg_f1": 0.5867057673509286, "avg_em": 0.2, "avg_chrf": 62.890167645063855, "avg_bleu": 43.06031715400489}
{"id": "PubMed_10:919", "en": "The key requirements for this release were the ability to code (Table 4) a case of COVID-19, exposure to risk of infection (travel to an area where there may be a higher risk), contact with anyone infected with COVID-19, a report that a person had been tested for COVID-19, and that the disease had been excluded (likely a negative test).", "es": "Los requisitos clave para esta publicación fueron la capacidad para codificar (cuadro 4) un caso de COVID-19, la exposición al riesgo de infección (viaje a una zona en la que puede haber un riesgo más alto), el contacto con alguien infectado con COVID-19, un informe que indique que a una persona se le hizo la prueba de COVID-19, y que la enfermedad se excluyó (probablemente una prueba negativa).", "perturbation": "alteration", "pert_es": "Los requisitos clave para esta publicación fueron la incapacidad para codificar (cuadro 4) un caso de COVID-19, la exposición al riesgo de infección (viaje a una zona en la que puede haber un riesgo más alto), el contacto con alguien infectado con COVID-19, un informe que indique que a una persona se le hizo la prueba de COVID-19, y que la enfermedad se confirmó (probablemente una prueba positiva).", "bt_pert_es": "The key requirements for this publication were the inability to code (Table 4) a case of COVID-19, exposure to the risk of infection (travel to an area where there may be a higher risk), contact with someone infected with COVID-19, a report indicating that a person was tested for COVID-19, and that the disease was confirmed (likely a positive test).", "questions": "[\"What are the key requirements for this release?\", \"What does 'code a case of COVID-19' mean?\", \"What constitutes exposure to risk of infection?\", \"What is considered contact with someone infected with COVID-19?\", \"What is required to report a person being tested for COVID-19?\", \"What does it mean for the disease to have been excluded?\", \"What is the source of the information about these requirements (Table 4)?\" ]", "answers": "[\"The inability to code (Table 4) a case of COVID-19, exposure to the risk of infection (travel to an area where there may be a higher risk), contact with someone infected with COVID-19, a report indicating that a person was tested for COVID-19, and that the disease was confirmed (likely a positive test)\", \"The inability to assign a code to a case of COVID-19\", \"Travel to an area where there may be a higher risk of infection\", \"Direct interaction or physical contact with an individual who has been infected with COVID-19\", \"A report or documentation stating that a person was tested for COVID-19\", \"The disease was confirmed (likely a positive test)\", \"Table 4\"]", "scores": [{"f1": 0.8089887640449439, "em": false, "chrf": 79.47815069878817, "bleu": 60.00795916054889}, {"f1": 0.5714285714285714, "em": false, "chrf": 60.719516166261734, "bleu": 19.070828081828378}, {"f1": 0.9, "em": false, "chrf": 93.99494995866878, "bleu": 78.60753021519788}, {"f1": 0.42105263157894735, "em": false, "chrf": 60.35935957227861, "bleu": 12.35622127262679}, {"f1": 0.7000000000000001, "em": false, "chrf": 64.34653943350891, "bleu": 20.504572236241867}, {"f1": 0.47058823529411764, "em": false, "chrf": 37.18895328084427, "bleu": 10.175282441454787}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.69600831462094, "avg_em": 0.14285714285714285, "avg_chrf": 70.86963844433578, "avg_bleu": 42.9603419154141}
{"id": "PubMed_10:922", "en": "Currently, virology samples for influenza surveillance are accompanied by a standard request form.", "es": "Actualmente, las muestras virológicas para la vigilancia de la influenza van acompañadas de un formulario de solicitud estándar.", "perturbation": "alteration", "pert_es": "Actualmente, las muestras virológicas para la vigilancia de la influenza van acompañadas de un formulario de solicitud personalizado.", "bt_pert_es": "Currently, virological samples for influenza surveillance are accompanied by a customized request form.", "questions": "[\"What is currently included with virology samples for influenza surveillance?\", \"What type of form is accompanying virology samples for influenza surveillance?\", \"What is the purpose of the standard request form in influenza surveillance?\"]", "answers": "[\"A customized request form\", \"A customized request form\", \"The purpose of the standard request form in influenza surveillance is not specified in the sentence\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 55.94966310703794, "bleu": 35.35533905932737}, {"f1": 0.75, "em": false, "chrf": 55.94966310703794, "bleu": 35.35533905932737}, {"f1": 0.19047619047619047, "em": false, "chrf": 42.301167004354355, "bleu": 5.67967744513558}], "avg_f1": 0.5634920634920635, "avg_em": 0.0, "avg_chrf": 51.40016440614341, "avg_bleu": 25.463451854596773}
{"id": "PubMed_10:923", "en": "For COVID-19, we will create a new request form that will record:", "es": "Para la COVID-19, crearemos un nuevo formulario de solicitud que registrará:", "perturbation": "alteration", "pert_es": "Para la COVID-19, no crearemos un nuevo formulario de solicitud que registrará:", "bt_pert_es": "For COVID-19, we will not be creating a new application form that will record:", "questions": "[\"What will be created for COVID-19?\", \"What will the new request form record?\"]", "answers": "[\"Nothing\", \"Nothing\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.731343283582089, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.8985507246376807, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 3.314947004109885, "avg_bleu": 0.0}
{"id": "PubMed_10:926", "en": "Acute bronchitis/bronchiolitis in those younger than five years", "es": "Bronquitis/bronquiolitis aguda en menores de cinco años", "perturbation": "alteration", "pert_es": "Bronquitis/bronquiolitis crónica en mayores de cinco años", "bt_pert_es": "Chronic bronchitis/bronchiolitis in people over five years of age", "questions": "[\"What is acute bronchitis/bronchiolitis?\", \"Who is affected by acute bronchitis/bronchiolitis?\", \"What age group is mentioned in the sentence?\"]", "answers": "[\"Not specified\", \"Not specified\", \"People over five years of age\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.75, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.987287166702918, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 40.6411755330609, "bleu": 16.233395773754946}], "avg_f1": 0.13333333333333333, "avg_em": 0.0, "avg_chrf": 16.792820899921274, "avg_bleu": 5.411131924584982}
{"id": "PubMed_10:927", "en": "Lower respiratory tract infection (LRTI)", "es": "Infección de las vías respiratorias inferiores (IVRI)", "perturbation": "alteration", "pert_es": "Curación de las vías respiratorias inferiores (IVRI)", "bt_pert_es": "Lower Respiratory Healing (LRTI)", "questions": "[\"What is a lower respiratory tract infection (LRTI)?\"]", "answers": "[\"Lower Respiratory Healing (LRTI)\"]", "scores": [{"f1": 0.2, "em": false, "chrf": 37.348034872069526, "bleu": 9.688464563433238}], "avg_f1": 0.2, "avg_em": 0.0, "avg_chrf": 37.348034872069526, "avg_bleu": 9.688464563433238}
{"id": "PubMed_10:928", "en": "History of fever (Y/N); measured (Y/N); if yes, level", "es": "Antecedentes de fiebre (S/N); se midió (S/N); en caso afirmativo, nivel", "perturbation": "alteration", "pert_es": "Antecedentes de salud (S/N); se midió (S/N); en caso afirmativo, nivel", "bt_pert_es": "Health history (Y/N); was measured (Y/N); if yes, level", "questions": "[\"What is the history of fever?\", \"Was fever measured?\", \"If fever was measured, what was the level?\"]", "answers": "[\"Not specified\", \"Not specified\", \"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.5, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 12.5, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.25, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 10.416666666666666, "avg_bleu": 0.0}
{"id": "PubMed_10:930", "en": "Recent travel (Y/N); if yes, countries visited in last 14 days", "es": "Viaje reciente (S/N); en caso afirmativo, países visitados en los últimos 14 días", "perturbation": "alteration", "pert_es": "Viaje antiguo (S/N); en caso afirmativo, países visitados en los últimos 14 días", "bt_pert_es": "Old Trip (Y/N); if yes, countries visited in the last 14 days", "questions": "[\"What is the recent travel status?\", \"If recent travel is yes, which countries were visited in the last 14 days?\"]", "answers": "[\"Old Trip\", \"Countries visited in the last 14 days\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.6455026455026456, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 51.32275132275132, "avg_bleu": 50.00000000000002}
{"id": "PubMed_10:934", "en": "Public Presentation of Data Using an Observatory and Dashboards", "es": "Presentación pública de los datos usando un observatorio y tableros", "perturbation": "alteration", "pert_es": "Presentación privada de los datos usando un observatorio y tableros", "bt_pert_es": "Private presentation of data using an observatory and dashboards", "questions": "[\"What is the purpose of public presentation of data?\", \"What tools are used for public presentation of data?\", \"What is an observatory in the context of data presentation?\", \"What role do dashboards play in data presentation?\", \"What benefits does using an observatory and dashboards provide for data presentation?\"]", "answers": "[\"Not specified\", \"Not specified\", \"A tool or system for monitoring and analyzing data\", \"A visual interface for displaying data and key metrics\", \"Enhanced visibility, monitoring, and analysis of data\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.786008709775526, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.591954022988506, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 61.24738943063433, "bleu": 33.03164318013807}, {"f1": 0.7368421052631577, "em": false, "chrf": 58.42069896652493, "bleu": 19.62791284379257}, {"f1": 0.3157894736842105, "em": false, "chrf": 29.38380592238702, "bleu": 7.11586419732111}], "avg_f1": 0.343859649122807, "avg_em": 0.0, "avg_chrf": 31.48597141046206, "avg_bleu": 11.95508404425035}
{"id": "PubMed_10:937", "en": "Definite case will be presented on our dashboard as “cases” of COVID-19.", "es": "Los casos definitivos se presentarán en nuestro tablero como “casos” de COVID-19.", "perturbation": "alteration", "pert_es": "Los casos posibles se presentarán en nuestro tablero como “casos” de COVID-19.", "bt_pert_es": "Possible cases will be presented on our dashboard as COVID-19 “cases.”", "questions": "[\"What will be presented on the dashboard?\", \"What is the term used for definite cases on the dashboard?\", \"What disease is referred to in the dashboard entry?\", \"What does 'cases' represent in the context of the dashboard?\"]", "answers": "[\"Possible cases\", \"COVID-19 \\\"cases\\\"\", \"COVID-19\", \"Possible cases\"]", "scores": [{"f1": 0, "em": false, "chrf": 24.70734017309333, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 66.64387437517684, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 24.70734017309333, "bleu": 0.0}], "avg_f1": 0.41666666666666663, "avg_em": 0.25, "avg_chrf": 54.01463868034087, "avg_bleu": 37.50000000000001}
{"id": "PubMed_10:938", "en": "Possible cases will be presented as “Under investigation” (investigating).", "es": "Los casos posibles se presentarán como “en investigación” (investigando).", "perturbation": "alteration", "pert_es": "Los casos imposibles se presentarán como “en investigación” (investigando).", "bt_pert_es": "Impossible cases will be presented as “under investigation” (investigating).", "questions": "[\"What does 'Under investigation' indicate?\", \"What is the status of possible cases?\", \"What is the term used for possible cases?\", \"What does 'investigating' mean in this context?\"]", "answers": "[\"That the case is being examined\", \"Possible cases are marked as 'under investigation'\", \"Possible cases\", \"That the case is being examined\"]", "scores": [{"f1": 0.5454545454545454, "em": false, "chrf": 48.817128257812584, "bleu": 19.357693493908812}, {"f1": 0.8333333333333333, "em": false, "chrf": 87.31462689380672, "bleu": 30.739407647563215}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5454545454545454, "em": false, "chrf": 48.817128257812584, "bleu": 19.357693493908812}], "avg_f1": 0.731060606060606, "avg_em": 0.25, "avg_chrf": 71.23722085235798, "avg_bleu": 42.36369865884522}
{"id": "PubMed_10:941", "en": "We have the option to move to twice weekly surveillance reports with a scope to change this to daily reporting.", "es": "Tenemos la opción de comenzar a hacer informes de vigilancia dos veces por semana con la posibilidad de cambiar esto por la presentación de informes diarios.", "perturbation": "alteration", "pert_es": "Tenemos la opción de dejar de hacer informes de vigilancia dos veces por semana con la posibilidad de cambiar esto por la presentación de informes diarios.", "bt_pert_es": "We have the option to stop doing surveillance reports twice a week with the possibility of changing this to daily reporting.", "questions": "[\"What options are available for surveillance reports?\", \"Can the surveillance reporting frequency be changed?\", \"What is the current surveillance reporting frequency?\", \"What would be the scope of changing to daily reporting?\", \"Is there a possibility to switch from twice weekly to daily reporting?\"]", "answers": "[\"Stop doing surveillance reports twice a week\", \"Yes\", \"Twice a week\", \"The reporting frequency would change to daily\", \"Yes\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 69.76411021489373, "bleu": 17.965205598154213}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 79.34458487087205, "bleu": 49.99999999999999}, {"f1": 0.6666666666666666, "em": false, "chrf": 76.84573644855357, "bleu": 18.575057999133602}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7333333333333333, "avg_em": 0.4, "avg_chrf": 85.19088630686387, "avg_bleu": 57.30805271945758}
{"id": "PubMed_10:943", "en": "Additionally, we will recruit more surveillance practices.", "es": "Además, reclutaremos más consultorios de vigilancia.", "perturbation": "alteration", "pert_es": "Además, despediremos más consultorios de vigilancia.", "bt_pert_es": "In addition, we will dismiss more surveillance offices.", "questions": "[\"What additional action will be taken?\", \"What will be recruited?\", \"What are surveillance practices?\", \"What is the purpose of recruiting more surveillance practices?\"]", "answers": "[\"We will dismiss more surveillance offices\", \"None\", \"None\", \"None\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 50.64039350459334, "bleu": 16.233395773754946}, {"f1": 0, "em": false, "chrf": 3.6057692307692304, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.874189364461738, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.874189364461738, "bleu": 0.0}], "avg_f1": 0.1, "avg_em": 0.0, "avg_chrf": 16.99863536607151, "avg_bleu": 4.0583489434387365}
{"id": "PubMed_10:951", "en": "Additionally, PHE will retrospectively test any influenza virology samples collected between early and mid-February 2020 for COVID-19.", "es": "Además, PHE analizará retrospectivamente las muestras virológicas de influenza recolectadas entre principios y mediados de febrero de 2020 para detectar la COVID-19.", "perturbation": "alteration", "pert_es": "Además, PHE analizará retrospectivamente las muestras virológicas de influenza recolectadas entre principios y mediados de febrero de 2020 para no detectar la COVID-19.", "bt_pert_es": "In addition, PHE will retrospectively analyze influenza virological samples collected in early to mid-February 2020 for COVID-19.", "questions": "[\"What will PHE do with influenza virology samples collected between early and mid-February 2020?\", \"What samples will be tested for COVID-19?\", \"When were the influenza virology samples collected?\", \"What is the purpose of the retrospective testing?\", \"What does PHE stand for?\"]", "answers": "[\"Retrospectively analyze\", \"Influenza virological samples\", \"Early to mid-February 2020\", \"To detect possible COVID-19 presence in the samples\", \"Public Health England\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 73.68012229653802, "bleu": 49.99999999999999}, {"f1": 0.6666666666666666, "em": false, "chrf": 80.73389719136516, "bleu": 34.66806371753173}, {"f1": 0.4444444444444445, "em": false, "chrf": 54.71829246529052, "bleu": 24.880469496253564}, {"f1": 0.6, "em": false, "chrf": 55.8631431571518, "bleu": 14.535768424205482}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6422222222222222, "avg_em": 0.2, "avg_chrf": 72.9990910220691, "avg_bleu": 44.816860327598164}
{"id": "PubMed_10:954", "en": "Summary of processes are detailed in Multimedia Appendix 3.", "es": "El resumen de los procesos se detalla en el anexo 3 de Multimedia.", "perturbation": "alteration", "pert_es": "El resumen de los procesos no se detalla en el anexo 3 de Multimedia.", "bt_pert_es": "The summary of the processes is not detailed in Annex 3 of Multimedia.", "questions": "[\"What is detailed in Multimedia Appendix 3?\", \"What processes are detailed in Multimedia Appendix 3?\"]", "answers": "[\"The summary of the processes\", \"The processes are not detailed\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 89.95335972562464, "bleu": 31.947155212313625}, {"f1": 0, "em": false, "chrf": 54.67827966500638, "bleu": 0.0}], "avg_f1": 0.28571428571428575, "avg_em": 0.0, "avg_chrf": 72.31581969531551, "avg_bleu": 15.973577606156812}
{"id": "PubMed_10:955", "en": "Everyone with an ILI or a respiratory illness who contacts a GP (eg, phones for an appointment) should be asked specifically about recent travel to China and other countries flagged in current PHE advice, or if they have had contact with other people with COVID-19.", "es": "A todas las personas con una enfermedad similar a la influenza o una enfermedad respiratoria que se contacten con un consultorio de medicina general (por ejemplo, llaman por teléfono para programar una cita) se les debe preguntar específicamente si hicieron un viaje reciente a China y a otros países señalados en la recomendación actual de PHE, o si han tenido contacto con otras personas con COVID-19.", "perturbation": "alteration", "pert_es": "A todas las personas con una enfermedad completamente diferente a la influenza o una enfermedad respiratoria que se contacten con un consultorio de medicina general (por ejemplo, llaman por teléfono para programar una cita) se les debe preguntar específicamente si hicieron un viaje reciente a China y a otros países señalados en la recomendación actual de PHE, o si han tenido contacto con otras personas con COVID-19.", "bt_pert_es": "All people with an illness completely other than influenza or a respiratory illness who contact a general practice practice (e.g. phone to make an appointment) should be specifically asked if they have had recent travel to China and other countries highlighted in the current PHE advice, or if they have had contact with other people with COVID-19.", "questions": "[\"Who should be asked about recent travel to China and other flagged countries?\", \"What specific information should be asked about when someone has an ILI or respiratory illness?\", \"What is the purpose of asking about recent travel to China and other countries?\", \"What is the condition for asking about contact with people who have COVID-19?\", \"What is the role of a GP in this scenario?\"]", "answers": "[\"All people with an illness completely other than influenza or a respiratory illness who contact a general practice practice\", \"None\", \"To identify potential exposure to COVID-19\", \"If they have an illness completely other than influenza or a respiratory illness\", \"To ask specifically about recent travel to China and other countries highlighted in the current PHE advice, or about contact with people who have COVID-19\"]", "scores": [{"f1": 0.39999999999999997, "em": false, "chrf": 55.91970266065764, "bleu": 16.188613565728215}, {"f1": 0, "em": false, "chrf": 1.1397690089739851, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.380952380952381, "em": false, "chrf": 28.654371570719068, "bleu": 14.991106946711685}, {"f1": 0.8636363636363635, "em": false, "chrf": 85.39676560208102, "bleu": 66.89604664235208}], "avg_f1": 0.5289177489177489, "avg_em": 0.2, "avg_chrf": 54.22212176848634, "avg_bleu": 39.6151534309584}
{"id": "PubMed_10:958", "en": "These calls should be coded into the GP CMR system and can be reported as part of the RCGP RSC weekly return.", "es": "Estas llamadas se deben codificar en el sistema de CMR del consultorio de medicina general y pueden informarse como parte del informe semanal del RSC del RCGP.", "perturbation": "alteration", "pert_es": "Estas llamadas no se deben codificar en el sistema de CMR del consultorio de medicina general y pueden informarse como parte del informe semanal del RSC del RCGP.", "bt_pert_es": "These calls do not need to be coded into the GP practice's CMR system and can be reported as part of the RCGP's weekly CSR report.", "questions": "[\"What should be coded into the GP CMR system?\", \"What can be reported as part of the RCGP RSC weekly return?\", \"What are the calls referred to in the sentence?\", \"What is the GP CMR system?\", \"What is the RCGP RSC weekly return?\"]", "answers": "[\"Nothing\", \"The calls\", \"The calls\", \"The GP practice's CMR system for recording medical records\", \"The RCGP's weekly CSR report\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.773049645390071, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 55.61766776289265, "bleu": 49.99999999999999}, {"f1": 0.32, "em": false, "chrf": 33.09934686251306, "bleu": 6.195408628269127}, {"f1": 0.3157894736842105, "em": false, "chrf": 21.235870158493565, "bleu": 2.3238598963754593}], "avg_f1": 0.42715789473684207, "avg_em": 0.2, "avg_chrf": 42.34518688585787, "avg_bleu": 31.703853704928925}
{"id": "PubMed_10:961", "en": "Practice reception or triage staff: for coding of any patients calling the practice with symptoms of acute respiratory infection with a history of travel to important areas based on PHE advice", "es": "Personal de recepción o clasificación del consultorio: para la codificación de los pacientes que llaman al consultorio con síntomas de infección respiratoria aguda con antecedentes de viaje a zonas importantes según la recomendación de PHE.", "perturbation": "alteration", "pert_es": "Personal de recepción o clasificación del consultorio: para la descodificación de los pacientes que llaman al consultorio con síntomas de infección respiratoria aguda con antecedentes de viaje a zonas importantes según la recomendación de PHE.", "bt_pert_es": "Practice reception or triage staff: for decoding patients calling the practice with symptoms of acute respiratory infection with a history of travel to important areas as recommended by PHE.", "questions": "[\"What is the role of reception or triage staff in the practice?\", \"What patients are coded by reception or triage staff?\", \"What symptoms trigger coding by reception or triage staff?\", \"What is the basis for coding patients with respiratory infection?\", \"What is PHE advice related to in this context?\"]", "answers": "[\"For decoding patients calling the practice with symptoms of acute respiratory infection with a history of travel to important areas as recommended by PHE\", \"Patients calling the practice with symptoms of acute respiratory infection and a history of travel to important areas\", \"Symptoms of acute respiratory infection\", \"A history of travel to important areas\", \"Travel to important areas\"]", "scores": [{"f1": 0.7272727272727273, "em": false, "chrf": 79.45698674285293, "bleu": 58.52187596735431}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9454545454545455, "avg_em": 0.8, "avg_chrf": 95.89139734857058, "avg_bleu": 91.7043751934709}
{"id": "PubMed_10:963", "en": "Practices participating in virology surveillance will opportunistically collect blood samples from patients coming into the practice for a routine blood test.", "es": "Los consultorios que participan en vigilancia virológica recolectarán de manera oportunista muestras de sangre de los pacientes que vayan al consultorio para hacerse un análisis de sangre de rutina.", "perturbation": "alteration", "pert_es": "Los consultorios que participan en vigilancia virológica recolectarán de manera sistemática muestras de sangre de los pacientes que vayan al consultorio para hacerse un análisis de sangre de rutina.", "bt_pert_es": "Practices participating in virologic surveillance will routinely collect blood samples from patients who come to the practice for routine blood testing.", "questions": "[\"What practices participate in virology surveillance?\", \"What do practices do opportunistically during virology surveillance?\", \"What type of samples are collected during virology surveillance?\", \"From whom are blood samples collected during virology surveillance?\", \"What is the reason for collecting blood samples during virology surveillance?\"]", "answers": "[\"Practices that participate in virologic surveillance\", \"Collect blood samples\", \"Blood samples\", \"Patients who come to the practice for routine blood testing\", \"Because patients come to the practice for routine blood testing\"]", "scores": [{"f1": 0.5454545454545454, "em": false, "chrf": 71.4724292636465, "bleu": 10.682175159905853}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.30769230769230765, "em": false, "chrf": 54.80953527502237, "bleu": 5.669791110976001}, {"f1": 0.5555555555555556, "em": false, "chrf": 71.99379672189937, "bleu": 22.31618068926664}], "avg_f1": 0.6817404817404817, "avg_em": 0.4, "avg_chrf": 79.65515225211365, "avg_bleu": 47.73362939202972}
{"id": "PubMed_10:964", "en": "Patients who attend their practice for a routine blood test will be asked to provide an additional sample for serology.", "es": "A los pacientes que asistan al consultorio para hacerse un análisis de sangre de rutina se les pedirá que proporcionen una muestra adicional para serología.", "perturbation": "alteration", "pert_es": "A los pacientes que asistan al consultorio para hacerse un análisis de sangre de rutina se les pedirá que proporcionen una muestra adicional para toxicología.", "bt_pert_es": "Patients attending the office for a routine blood test will be asked to provide an additional sample for toxicology.", "questions": "[\"What will patients be asked to provide during a routine blood test?\", \"What is the purpose of the additional sample?\", \"What type of test is being conducted?\", \"What is serology?\", \"Who is required to provide the additional sample?\"]", "answers": "[\"An additional sample for toxicology\", \"Toxicology\", \"A routine blood test\", \"Not mentioned\", \"Patients attending the office\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 77.57224201918437, "bleu": 66.87403049764218}, {"f1": 0, "em": false, "chrf": 20.956675746057943, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 6.405197047409851, "bleu": 0.0}, {"f1": 0.16666666666666666, "em": false, "chrf": 25.720887969383448, "bleu": 3.7238938287986976}], "avg_f1": 0.39333333333333337, "avg_em": 0.2, "avg_chrf": 46.13100055640712, "avg_bleu": 34.11958486528819}
{"id": "PubMed_10:965", "en": "We have conducted initial searches within the RCGP RSC database to look at the number of full blood count (FBC) results and overall rates in adults and children (Figures 6-​-9).9).", "es": "Hemos realizado búsquedas iniciales dentro de la base de datos del RSC del RCGP para observar la cantidad de resultados de conteos sanguíneos completos (CSC) y las tasas generales en adultos y niños (gráficos 6-9).", "perturbation": "alteration", "pert_es": "Hemos realizado búsquedas iniciales dentro de la base de datos del RSC del RCGP para observar la cantidad de resultados de conteos sanguíneos incompletos (CSI) y las tasas generales en adultos y niños (gráficos 6-9).", "bt_pert_es": "We have conducted initial searches within the RCGP RSC database to look at the number of incomplete blood count (IBC) results and overall rates in adults and children (Charts 6-9).", "questions": "[\"What searches have been conducted in the RCGP RSC database?\", \"What data was examined in the RCGP RSC database?\", \"What specific data was looked at regarding full blood count results?\", \"What age groups were included in the analysis?\", \"What figures are referenced in the sentence?\", \"What information is provided in Figures 6-9?\"]", "answers": "[\"Initial searches to look at the number of incomplete blood count (IBC) results and overall rates\", \"The number of incomplete blood count (IBC) results and overall rates\", \"The number of incomplete blood count (IBC) results\", \"Adults and children\", \"Charts 6-9\", \"The number of incomplete blood count (IBC) results and overall rates\"]", "scores": [{"f1": 0.8666666666666667, "em": false, "chrf": 83.79756306065316, "bleu": 61.04735835807847}, {"f1": 0.8181818181818182, "em": false, "chrf": 77.05296209461973, "bleu": 37.81790427652475}, {"f1": 0.75, "em": false, "chrf": 66.62507350693939, "bleu": 27.05411345269698}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 14.300624889864855, "bleu": 49.99999999999999}, {"f1": 0.8181818181818182, "em": false, "chrf": 77.05296209461973, "bleu": 37.81790427652475}], "avg_f1": 0.7921717171717172, "avg_em": 0.16666666666666666, "avg_chrf": 69.80486427444949, "avg_bleu": 52.28954672730416}
{"id": "PubMed_10:967", "en": "The sampling rate, per 100,000 patients was highest for children 15-17 years of age and 60 year or older in adults, with the lowest rates in children 0-4 years of age and 18-29 years of age in adults (Figures 6-​-99).", "es": "La tasa de muestreo, por cada 100 000 pacientes, fue más alta en los niños de 15 a 17 años y en los adultos de 60 años o más, mientras que las tasas más bajas se observaron en los niños de 0 a 4 años y en los adultos de 18 a 29 años (gráficos 6-9).", "perturbation": "alteration", "pert_es": "La tasa de muestreo, por cada 100 000 pacientes, fue más baja en los niños de 15 a 17 años y en los adultos de 60 años o más, mientras que las tasas más altas se observaron en los niños de 0 a 4 años y en los adultos de 18 a 29 años (gráficos 6-9).", "bt_pert_es": "The sampling rate, per 100,000 patients, was lowest in children aged 15 to 17 years and adults aged 60 years and older, while the highest rates were observed in children aged 0 to 4 years and adults aged 18 to 29 years (Charts 6-9).", "questions": "[\"What was the highest sampling rate for in terms of age groups?\", \"Which age groups had the lowest sampling rates?\", \"What is the sampling rate per 100,000 patients?\", \"Which age groups are mentioned in the sentence?\", \"What figures are referenced in the sentence?\"]", "answers": "[\"Children aged 0 to 4 years and adults aged 18 to 29 years\", \"Children aged 15 to 17 years and adults aged 60 years and older\", \"per 100,000 patients\", \"Children aged 0 to 4 years, children aged 15 to 17 years, adults aged 18 to 29 years, and adults aged 60 years and older\", \"Charts 6-9\"]", "scores": [{"f1": 0.34782608695652173, "em": false, "chrf": 35.25417217705803, "bleu": 4.368583925857938}, {"f1": 0.34782608695652173, "em": false, "chrf": 37.352663290264836, "bleu": 4.368583925857938}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444445, "em": false, "chrf": 51.102030988469934, "bleu": 4.504556737153658}, {"f1": 0, "em": false, "chrf": 13.014407771875335, "bleu": 0.0}], "avg_f1": 0.42801932367149764, "avg_em": 0.2, "avg_chrf": 47.344654845533626, "avg_bleu": 22.648344917773915}
{"id": "PubMed_10:968", "en": "We will provide 1000 serology baseline samples across all ages that reflect the varying rates of attendance by age.", "es": "Proporcionaremos 1000 muestras de referencia para serología en todas las edades que reflejen las distintas tasas de asistencia por edad.", "perturbation": "alteration", "pert_es": "No proporcionaremos 1000 muestras de referencia para serología en todas las edades que reflejen las distintas tasas de asistencia por edad.", "bt_pert_es": "We will not provide 1000 reference samples for serology across all ages to reflect varying attendance rates by age.", "questions": "[\"How many serology baseline samples will be provided?\", \"What does the sample collection reflect?\", \"What factor is reflected in the varying rates of attendance?\", \"What is the age range covered by the samples?\", \"What is the purpose of the serology baseline samples?\"]", "answers": "[\"1000\", \"Varying attendance rates by age\", \"Age\", \"All ages\", \"To reflect varying attendance rates by age\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7272727272727272, "em": false, "chrf": 59.84188159178009, "bleu": 20.801195378010608}, {"f1": 0, "em": false, "chrf": 38.888888888888886, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 73.45238095238095, "bleu": 49.99999999999999}, {"f1": 0.7999999999999999, "em": false, "chrf": 70.44360607342654, "bleu": 17.82013231677092}], "avg_f1": 0.6054545454545455, "avg_em": 0.2, "avg_chrf": 68.52535150129529, "avg_bleu": 37.72426553895632}
{"id": "PubMed_10:971", "en": "This will be followed by 800 samples monthly.", "es": "Esto continuará con 800 muestras mensuales.", "perturbation": "alteration", "pert_es": "Esto cesará con 800 muestras mensuales.", "bt_pert_es": "This will stop with 800 monthly samples.", "questions": "[\"How many samples will be collected monthly?\", \"What will follow the collection of samples?\", \"What is the frequency of sample collection?\"]", "answers": "[800, \"This will stop\", \"Monthly\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 59.79978925184405, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.5, "avg_chrf": 79.89989462592203, "avg_bleu": 63.758030203727635}
{"id": "PubMed_10:974", "en": "We will develop a new request form for practices to capture recent travel and exposure to COVID-19.", "es": "Elaboraremos un nuevo formulario de solicitud para los consultorios para registrar los viajes recientes y la exposición a la COVID-19.", "perturbation": "alteration", "pert_es": "Elaboraremos un nuevo formulario de solicitud para los consultorios para registrar los viajes antiguos y la exposición a la COVID-19.", "bt_pert_es": "We will develop a new application form for practices to record past travel and COVID-19 exposure.", "questions": "[\"What will be developed?\", \"What is the purpose of the new request form?\", \"What information will the new request form capture?\", \"What specific details about travel and exposure will be captured?\", \"Who will use the new request form?\"]", "answers": "[\"A new application form\", \"To record past travel and COVID-19 exposure\", \"Past travel and COVID-19 exposure\", \"Past travel and COVID-19 exposure\", \"Practices\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 23.686782527704057, "bleu": 35.35533905932737}, {"f1": 0.6666666666666666, "em": false, "chrf": 51.610293699191914, "bleu": 14.317200732647757}, {"f1": 0.7272727272727272, "em": false, "chrf": 60.12467592106934, "bleu": 20.801195378010608}, {"f1": 0.7272727272727272, "em": false, "chrf": 60.12467592106934, "bleu": 20.801195378010608}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7742424242424242, "avg_em": 0.2, "avg_chrf": 59.10928561380693, "avg_bleu": 38.25498610959927}
{"id": "PubMed_10:979", "en": "This process may include checking pseudonymized NHS numbers for positive individuals at RCGP RSC practices, checking current PHE guidance regarding considerations of infectiousness for confirmed cases, and offering the patient an appointment following the previously mentioned process.", "es": "Este proceso puede incluir verificar los números seudonimizados del NHS de personas que obtuvieron resultados positivos en los consultorios del RSC del RCGP, verificar la directriz actual de PHE sobre las consideraciones de infecciosidad para los casos confirmados y ofrecerle al paciente una cita siguiendo el proceso anteriormente mencionado.", "perturbation": "alteration", "pert_es": "Este proceso puede incluir verificar los números seudonimizados del NHS de personas que obtuvieron resultados negativos en los consultorios del RSC del RCGP, verificar la directriz actual de PHE sobre las consideraciones de infecciosidad para los casos confirmados y ofrecerle al paciente una cita siguiendo el proceso anteriormente mencionado.", "bt_pert_es": "This process may include checking pseudonymised NHS numbers of people who tested negative at RCGP RSC clinics, checking current PHE guidance on infectiousness considerations for confirmed cases, and offering the patient an appointment following the process above.", "questions": "[\"What does this process include?\", \"What is checked for positive individuals at RCGP RSC practices?\", \"What current PHE guidance is considered regarding infectiousness?\", \"What is offered to the patient following the process?\"]", "answers": "[\"Checking pseudonymised NHS numbers of people who tested negative at RCGP RSC clinics, checking current PHE guidance on infectiousness considerations for confirmed cases, and offering the patient an appointment following the process above\", \"None\", \"Current PHE guidance on infectiousness considerations for confirmed cases\", \"An appointment\"]", "scores": [{"f1": 0.7333333333333333, "em": false, "chrf": 70.03912719884535, "bleu": 39.14530545030021}, {"f1": 0, "em": false, "chrf": 6.584410962154466, "bleu": 0.0}, {"f1": 0.6250000000000001, "em": false, "chrf": 71.26196183550728, "bleu": 20.164945583740657}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5895833333333333, "avg_em": 0.25, "avg_chrf": 61.97137499912677, "avg_bleu": 39.827562758510226}
{"id": "PubMed_10:980", "en": "This needs to be carefully coordinated nationally across the network and may require PHE to ensure individuals are not contacted by multiple agencies.", "es": "Esto debe coordinarse cuidadosamente a nivel nacional en toda la red y puede requerir que PHE se asegure de que no se contacten varias agencias con las personas.", "perturbation": "alteration", "pert_es": "Esto no debe coordinarse cuidadosamente a nivel nacional en toda la red y puede requerir que PHE se asegure de que se contacten varias agencias con las personas.", "bt_pert_es": "This does not need to be carefully coordinated nationally across the network and may require PHE to ensure that people are contacted by multiple agencies.", "questions": "[\"What needs to be carefully coordinated nationally?\", \"What is the role of PHE in this coordination?\", \"Why might multiple agencies contacting individuals be a problem?\", \"What is the goal of the national coordination?\", \"Which agencies might contact individuals and how is this managed?\"]", "answers": "[\"This\", \"PHE is responsible for ensuring that people are contacted by multiple agencies\", \"Not specified in the sentence\", \"To ensure that people are contacted by multiple agencies\", \"Multiple agencies may contact individuals, and this is managed by PHE\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4761904761904762, "em": false, "chrf": 57.68071762938622, "bleu": 22.416933501922298}, {"f1": 0, "em": false, "chrf": 7.706252474516628, "bleu": 0.0}, {"f1": 0.7777777777777778, "em": false, "chrf": 64.71258056554542, "bleu": 36.88939732334405}, {"f1": 0.6896551724137931, "em": false, "chrf": 49.11687966525249, "bleu": 34.314802036051844}], "avg_f1": 0.5887246852764094, "avg_em": 0.2, "avg_chrf": 55.84328606694015, "avg_bleu": 38.724226572263646}
{"id": "PubMed_10:984", "en": "The RCGP RSC will explore ways to collect convalescent samples from any patients tested positive for COVID-19 through the extension of the virological surveillance.", "es": "El RSC del RCGP analizará maneras de recolectar muestras convalecientes de pacientes que obtuvieron resultados positivos en pruebas de la COVID-19 a través de la extensión de la vigilancia virológica.", "perturbation": "alteration", "pert_es": "El RSC del RCGP analizará maneras de recolectar muestras convalecientes de pacientes que obtuvieron resultados negativos en pruebas de la COVID-19 a través de la extensión de la vigilancia virológica.", "bt_pert_es": "The RCGP RSC will explore ways to collect convalescent samples from patients who have tested negative for COVID-19 through extending virological surveillance.", "questions": "[\"What will the RCGP RSC explore?\", \"How will convalescent samples be collected?\", \"Which patients are eligible for convalescent sample collection?\", \"What is the purpose of collecting convalescent samples?\", \"What is the role of virological surveillance in this process?\"]", "answers": "[\"Ways to collect convalescent samples from patients who have tested negative for COVID-19 through extending virological surveillance\", \"By extending virological surveillance\", \"Patients who have tested negative for COVID-19\", \"To collect convalescent samples from patients who have tested negative for COVID-19\", \"To enable the collection of convalescent samples from patients who have tested negative for COVID-19\"]", "scores": [{"f1": 0.6896551724137931, "em": false, "chrf": 71.13716654411995, "bleu": 33.50704079514751}, {"f1": 0.4444444444444445, "em": false, "chrf": 62.96458415832237, "bleu": 24.880469496253564}, {"f1": 0.4615384615384615, "em": false, "chrf": 58.85201298630116, "bleu": 14.535768424205482}, {"f1": 0.5, "em": false, "chrf": 74.74851395408582, "bleu": 21.200626759025184}, {"f1": 0.8461538461538461, "em": false, "chrf": 86.03070498179818, "bleu": 57.57575636202256}], "avg_f1": 0.5883583849101091, "avg_em": 0.0, "avg_chrf": 70.7465965249255, "avg_bleu": 30.339932367330857}
{"id": "PubMed_10:985", "en": "From the start, we will be carefully curating data to ensure that it can be used for future studies.", "es": "Desde el principio, conservaremos cuidadosamente los datos para garantizar que puedan usarse para estudios futuros.", "perturbation": "alteration", "pert_es": "Desde el principio, descartaremos cuidadosamente los datos para garantizar que no puedan usarse para estudios futuros.", "bt_pert_es": "From the beginning, we will carefully discard the data to ensure that it cannot be used for future studies.", "questions": "[\"What will be done from the start?\", \"What is the goal of curating data?\", \"Why is data being curated?\", \"What ensures that data can be used for future studies?\"]", "answers": "[\"Carefully discard the data\", \"To ensure that it cannot be used for future studies\", \"To ensure that it cannot be used for future studies\", \"Careful discarding of the data\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 19.449986766693915, "bleu": 27.516060407455225}, {"f1": 0.9, "em": false, "chrf": 91.41394216760807, "bleu": 65.80370064762461}, {"f1": 0.9, "em": false, "chrf": 91.41394216760807, "bleu": 65.80370064762461}, {"f1": 0.75, "em": false, "chrf": 44.91673209788164, "bleu": 35.35533905932737}], "avg_f1": 0.7375, "avg_em": 0.0, "avg_chrf": 61.79865079994792, "avg_bleu": 48.619700190507956}
{"id": "PubMed_10:986", "en": "Our clinical data will be linked to virology.", "es": "Nuestros datos clínicos se vincularán con virología.", "perturbation": "alteration", "pert_es": "Nuestros datos clínicos no se vincularán con virología.", "bt_pert_es": "Our clinical data will not be linked to virology.", "questions": "[\"What will be linked in the clinical data?\", \"What type of data will be linked?\", \"What is the link between clinical data and virology?\", \"What does the clinical data include?\", \"What is the purpose of linking clinical data to virology?\"]", "answers": "[\"Nothing\", \"None\", \"There is no link\", \"Clinical data\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.41025641025641, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.4038461538461537, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.046531884085006, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.944444444444445, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.2864645263575105, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 5.218308683797905, "avg_bleu": 0.0}
{"id": "PubMed_10:987", "en": "We will curate our data using the Findable, Accessible, Interoperable, Reusable principles.", "es": "Conservaremos nuestros datos usando los principios de localización, accesibilidad, interoperabilidad y reutilización.", "perturbation": "alteration", "pert_es": "Perderemos nuestros datos usando los principios de localización, accesibilidad, interoperabilidad y reutilización.", "bt_pert_es": "We will lose our data using the principles of localization, accessibility, interoperability and reuse.", "questions": "[\"What principles will be used to curate the data?\", \"What are the Findable, Accessible, Interoperable, Reusable principles?\", \"What does curating data involve in this context?\"]", "answers": "[\"localization, accessibility, interoperability and reuse\", \"Not specified in the sentence\", \"Using the principles of localization, accessibility, interoperability and reuse\"]", "scores": [{"f1": 0, "em": false, "chrf": 33.43687886530163, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2105263157894737, "em": false, "chrf": 35.08271944327848, "bleu": 4.513617516969122}], "avg_f1": 0.40350877192982454, "avg_em": 0.3333333333333333, "avg_chrf": 56.173199436193364, "avg_bleu": 34.837872505656385}
{"id": "PubMed_10:988", "en": "To facilitate this our data set is listed with Health Data Research UK and the European Health Data Evidence Network.", "es": "Para facilitar esto, nuestro conjunto de datos está incluido en el Health Data Research UK y en la European Health Data & Evidence Network.", "perturbation": "alteration", "pert_es": "Para dificultar esto, nuestro conjunto de datos está excluido en el Health Data Research UK y en la European Health Data & Evidence Network.", "bt_pert_es": "To make this difficult, our data set is excluded in the Health Data Research UK and the European Health Data & Evidence Network.", "questions": "[\"What is the purpose of listing the data set?\", \"With which organization is the data set listed?\", \"Which network is mentioned in the sentence?\", \"What is the data set listed with?\"]", "answers": "[\"To make this difficult\", \"Health Data Research UK\", \"European Health Data & Evidence Network\", \"Health Data Research UK and the European Health Data & Evidence Network\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 26.597523065488215, "bleu": 18.99589214128981}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8928571428571429, "avg_em": 0.75, "avg_chrf": 81.64938076637205, "avg_bleu": 79.74897303532248}
{"id": "PubMed_10:992", "en": "By targeting the reproduction number (R) (the average number of secondary cases each case generates) and aiming to reduce the R to below 1, the policy seeks to reduce case numbers to low levels or (as seen in previous outbreaks with severe acute respiratory syndrome and Ebola) to eliminate human-to-human transmission.", "es": "Al centrarse en el número de reproducción (R) (la cantidad promedio de casos secundarios que genera cada caso) e intentar reducir R por debajo de 1, la política busca reducir la cantidad de casos a niveles bajos o (como se observó en brotes anteriores con el síndrome respiratorio agudo grave y el Ébola) eliminar la transmisión de persona a persona.", "perturbation": "alteration", "pert_es": "Al centrarse en el número de reproducción (R) (la cantidad promedio de casos secundarios que genera cada caso) e intentar aumentar R por encima de 1, la política busca aumentar la cantidad de casos a niveles altos o (como se observó en brotes anteriores con el síndrome respiratorio agudo grave y el Ébola) eliminar la transmisión de persona a persona.", "bt_pert_es": "By focusing on the reproduction number (R) (the average number of secondary cases each case generates) and attempting to increase R above 1, the policy seeks to either increase the number of cases to high levels or (as seen in previous outbreaks with severe acute respiratory syndrome and Ebola) eliminate human-to-human transmission.", "questions": "[\"What is the reproduction number (R)?\", \"What does the reproduction number (R) represent?\", \"What is the goal of reducing the R to below 1?\", \"What happens when the R is reduced to below 1?\", \"What are examples of previous outbreaks where reducing R led to elimination of human-to-human transmission?\"]", "answers": "[\"The average number of secondary cases each case generates\", \"The average number of secondary cases each case generates\", \"To eliminate human-to-human transmission\", \"Human-to-human transmission is eliminated\", \"Severe acute respiratory syndrome and Ebola\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5333333333333333, "em": false, "chrf": 54.79610993884233, "bleu": 11.10316628653437}, {"f1": 0.375, "em": false, "chrf": 53.508659733542544, "bleu": 8.047084086794415}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7816666666666666, "avg_em": 0.6, "avg_chrf": 81.66095393447696, "avg_bleu": 63.83005007466578}
{"id": "PubMed_10:994", "en": "Key to the focus of our study will be the estimation of peak cases in the population and continual monitoring by data collection and modelling the potential growth and emergence of subsequent peaks in new cases as social distancing measures are relaxed.", "es": "Será clave para el foco de nuestro estudio la estimación de los casos pico en la población y el seguimiento continuo a través de la recopilación de datos y del modelado del crecimiento potencial y la aparición de posteriores picos en casos nuevos a medida que se flexibilicen las medidas de distanciamiento social.", "perturbation": "alteration", "pert_es": "Será clave para el foco de nuestro estudio la estimación de los casos mínimo en la población y el seguimiento continuo a través de la recopilación de datos y del modelado del crecimiento potencial y la aparición de posteriores picos en casos nuevos a medida que se endurezcan las medidas de distanciamiento social.", "bt_pert_es": "Key to the focus of our study will be the estimation of minimum cases in the population and continued monitoring through data collection and modeling of potential growth and the emergence of subsequent spikes in new cases as social distancing measures are tightened.", "questions": "[\"What is key to the focus of the study?\", \"What involves the estimation of peak cases in the population?\", \"What methods are used for monitoring new cases?\", \"What is modeled in the study?\", \"What happens as social distancing measures are relaxed?\"]", "answers": "[\"The estimation of minimum cases in the population and continued monitoring through data collection and modeling of potential growth and the emergence of subsequent spikes in new cases as social distancing measures are tightened\", \"None of the mentioned methods involve the estimation of peak cases\", \"Data collection and modeling\", \"Potential growth and the emergence of subsequent spikes in new cases\", \"Nothing is mentioned about what happens as social distancing measures are relaxed\"]", "scores": [{"f1": 0.7936507936507936, "em": false, "chrf": 80.2803692018446, "bleu": 51.31665118437145}, {"f1": 0.5, "em": false, "chrf": 61.51368163117633, "bleu": 29.84745896009822}, {"f1": 0.75, "em": false, "chrf": 89.68835858722274, "bleu": 59.460355750136046}, {"f1": 0.761904761904762, "em": false, "chrf": 82.09581713030862, "bleu": 47.53852732567741}, {"f1": 0, "em": false, "chrf": 20.842633112631304, "bleu": 0.0}], "avg_f1": 0.5611111111111111, "avg_em": 0.0, "avg_chrf": 66.88417193263672, "avg_bleu": 37.63259864405662}
{"id": "PubMed_10:995", "en": "There has already been publication of important disease epidemiological measures concerning the outbreak of COVID-19 in mainland China.", "es": "Ya se han publicado importantes medidas epidemiológicas de la enfermedad relativas al brote de la COVID-19 en China continental.", "perturbation": "alteration", "pert_es": "Ya se han publicado importantes medidas epidemiológicas de la enfermedad relativas al control de la COVID-19 en China continental.", "bt_pert_es": "Important epidemiological disease measures relating to the control of COVID-19 in mainland China have already been published.", "questions": "[\"What has already been published regarding the outbreak of COVID-19 in mainland China?\", \"What type of measures have been published about the outbreak?\", \"What is the focus of the published disease epidemiological measures?\", \"What region is mentioned in the context of the outbreak?\", \"What disease is associated with the outbreak mentioned?\"]", "answers": "[\"Important epidemiological disease measures relating to the control of COVID-19 in mainland China\", \"Epidemiological disease measures relating to the control of COVID-19\", \"The control of COVID-19\", \"mainland China\", \"COVID-19\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 64.39500391175196, "bleu": 4.789232204309912}, {"f1": 0.18181818181818182, "em": false, "chrf": 62.99976654227055, "bleu": 5.522397783539471}, {"f1": 0.75, "em": false, "chrf": 44.71352726671239, "bleu": 35.35533905932737}, {"f1": 0.5, "em": false, "chrf": 90.21205646205644, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5863636363636363, "avg_em": 0.2, "avg_chrf": 72.46407083655826, "avg_bleu": 39.13339380943536}
{"id": "PubMed_10:996", "en": "A further fundamental measure in pandemic dynamics is the length of time from infection to when a person is infectious to others and the mean duration of infectiousness.", "es": "Otra medida fundamental en la dinámica de la pandemia es el tiempo que transcurre entre la infección y el momento en que una persona puede contagiar a otras, y la duración media de la infecciosidad.", "perturbation": "alteration", "pert_es": "Otra medida fundamental en la dinámica de la pandemia es el tiempo que transcurre entre la curación y el momento en que una persona puede contagiar a otras, y la duración media de la infecciosidad.", "bt_pert_es": "Another fundamental measure in the dynamics of the pandemic is the time that elapses between healing and the moment in which a person can infect others, and the average duration of infectiousness.", "questions": "[\"What is a further fundamental measure in pandemic dynamics?\", \"What is the length of time from infection to when a person is infectious to others?\", \"What is the mean duration of infectiousness?\"]", "answers": "[\"The time that elapses between healing and the moment in which a person can infect others\", \"The time that elapses between healing and the moment in which a person can infect others\", \"The average duration of infectiousness\"]", "scores": [{"f1": 0.31250000000000006, "em": false, "chrf": 27.090469266948343, "bleu": 3.1911854274745144}, {"f1": 0.29629629629629634, "em": false, "chrf": 31.886231714806957, "bleu": 4.016138436407654}, {"f1": 0.8000000000000002, "em": false, "chrf": 78.62729326117602, "bleu": 42.7287006396234}], "avg_f1": 0.46959876543209883, "avg_em": 0.0, "avg_chrf": 45.86799808097711, "avg_bleu": 16.64534150116852}
{"id": "PubMed_10:999", "en": "Such techniques are highly parallelizable and have been successfully applied to many fields including disease transmission modelling.", "es": "Estas técnicas se pueden realizar en paralelo y se han aplicado exitosamente a muchas áreas, incluidos los modelos de transmisión de enfermedades.", "perturbation": "alteration", "pert_es": "Estas técnicas no se pueden realizar en paralelo y se han aplicado exitosamente a muchas áreas, incluidos los modelos de transmisión de enfermedades.", "bt_pert_es": "These techniques cannot be performed in parallel and have been successfully applied to many areas, including disease transmission models.", "questions": "[\"What are such techniques known for?\", \"What makes such techniques highly parallelizable?\", \"In which fields have such techniques been successfully applied?\", \"What specific application of such techniques is mentioned?\", \"What is disease transmission modelling?\"]", "answers": "[\"Being unable to be performed in parallel\", \"They can be performed in parallel\", \"Disease transmission models\", \"Application to disease transmission models\", \"Not specified in the sentence\"]", "scores": [{"f1": 0.125, "em": false, "chrf": 22.138146285861858, "bleu": 4.935157841536379}, {"f1": 0, "em": false, "chrf": 32.612172637895846, "bleu": 0.0}, {"f1": 0.2222222222222222, "em": false, "chrf": 51.431810765209775, "bleu": 10.122592925934278}, {"f1": 0.25, "em": false, "chrf": 76.69337269827945, "bleu": 10.682175159905853}, {"f1": 0, "em": false, "chrf": 8.81044300548901, "bleu": 0.0}], "avg_f1": 0.11944444444444444, "avg_em": 0.0, "avg_chrf": 38.33718907854718, "avg_bleu": 5.147985185475302}
{"id": "PubMed_10:1000", "en": "They are particularly suited to situations where likelihood functions are absent and where more traditional approaches such as Markov chain Monte Carlo are impractical.", "es": "Están adaptados particularmente a las situaciones que carecen de funciones de verosimilitud y en las que los enfoques más tradicionales, como los métodos de Monte Carlo basados en cadenas de Markov, no son prácticos.", "perturbation": "alteration", "pert_es": "Están adaptados particularmente a las situaciones que tienen funciones de verosimilitud y en las que los enfoques más tradicionales, como los métodos de Monte Carlo basados en cadenas de Markov, son prácticos.", "bt_pert_es": "They are particularly suited to situations that have likelihood functions and where more traditional approaches, such as Markov chain-based Monte Carlo methods, are practical.", "questions": "[\"What situations are they particularly suited for?\", \"When are traditional approaches like Markov chain Monte Carlo impractical?\", \"What is the condition for the absence of likelihood functions?\", \"What makes them suitable in these situations?\"]", "answers": "[\"Situations that have likelihood functions\", \"When likelihood functions are absent\", \"There is no condition for the absence of likelihood functions as stated in the sentence\", \"They are suited to situations with likelihood functions where traditional approaches like Markov chain-based Monte Carlo methods are practical\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 26.818749358333466, "bleu": 1.4377651617689382}, {"f1": 0.5, "em": false, "chrf": 36.89624212186537, "bleu": 13.533528323661276}, {"f1": 0.4444444444444444, "em": false, "chrf": 74.0476440505558, "bleu": 19.338531381761726}, {"f1": 0.48484848484848486, "em": false, "chrf": 59.37531583657215, "bleu": 6.809398432036521}], "avg_f1": 0.4198232323232323, "avg_em": 0.0, "avg_chrf": 49.2844878418317, "avg_bleu": 10.279805824807115}
{"id": "PubMed_10:1002", "en": "Furthermore, peaks in new cases have been estimated by distributional methods.", "es": "Además, los picos en los casos nuevos se estimaron mediante métodos de distribución.", "perturbation": "alteration", "pert_es": "Además, los valles en los casos nuevos se estimaron mediante métodos de distribución.", "bt_pert_es": "Additionally, troughs in new cases were estimated using distribution methods.", "questions": "[\"What has been estimated by distributional methods?\", \"What are peaks in new cases?\", \"What methods are used to estimate peaks in new cases?\"]", "answers": "[\"Troughs in new cases\", \"Not specified\", \"Distribution methods\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 74.63635298177532, "bleu": 31.947155212313625}, {"f1": 0, "em": false, "chrf": 5.555555555555556, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 70.66543891509554, "bleu": 49.99999999999999}], "avg_f1": 0.38888888888888884, "avg_em": 0.0, "avg_chrf": 50.28578248414214, "avg_bleu": 27.31571840410454}
{"id": "PubMed_10:1003", "en": "Estimates of the parameters of the SEIR model are tractable on large data sets because of parallelizability, and these methods have been implemented in several R libraries; we intend to use the libraries ABSEIR (deposited on GitHub: https://tinyurl.com/vqu35cj) and abctools (https://tinyurl.com/tfjavz4) to estimate epidemic measures on a weekly basis.", "es": "Las estimaciones de los parámetros del modelo SEIR se pueden abordar en conjuntos de datos grandes debido a la posibilidad de hacer análisis paralelos, y estos métodos se han implementado en varias bibliotecas R; tenemos previsto usar las bibliotecas ABSEIR (disponibles en GitHub: https://tinyurl.com/vqu35cj) y abctools (https://tinyurl.com/tfjavz4) para estimar las medidas epidemiológicas con una frecuencia semanal.", "perturbation": "alteration", "pert_es": "Las estimaciones de los parámetros del modelo SEIR no se pueden abordar en conjuntos de datos grandes debido a la imposibilidad de hacer análisis paralelos, y estos métodos se han implementado en varias bibliotecas R; tenemos previsto usar las bibliotecas ABSEIR (disponibles en GitHub: https://tinyurl.com/vqu35cj) y abctools (https://tinyurl.com/tfjavz4) para estimar las medidas epidemiológicas con una frecuencia diaria.", "bt_pert_es": "SEIR model parameter estimates cannot be addressed on large data sets due to the inability to do parallel analyses, and these methods have been implemented in several R libraries; We plan to use the ABSEIR libraries (available on GitHub: https://tinyurl.com/vqu35cj) and abctools (https://tinyurl.com/tfjavz4) to estimate epidemiological measures on a daily basis.", "questions": "[\"What makes estimates of the parameters of the SEIR model tractable on large data sets?\", \"Why are these methods implemented in several R libraries?\", \"Which R libraries are intended to be used for estimating epidemic measures?\", \"What is the frequency of estimating epidemic measures?\", \"What is the purpose of using ABSEIR and abctools?\", \"Where can ABSEIR be accessed?\", \"Where can abctools be accessed?\"]", "answers": "[\"The ability to do parallel analyses\", \"To enable efficient and scalable analysis on large data sets\", \"ABSEIR and abctools\", \"On a daily basis\", \"To estimate epidemiological measures\", \"https://tinyurl.com/vqu35cj\", \"https://tinyurl.com/tfjavz4\"]", "scores": [{"f1": 0, "em": false, "chrf": 51.16618791643342, "bleu": 0.0}, {"f1": 0.4444444444444445, "em": false, "chrf": 42.653612171857624, "bleu": 26.269098944241577}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 46.081807875623646, "bleu": 34.66806371753173}, {"f1": 0.75, "em": false, "chrf": 80.99738486755963, "bleu": 35.35533905932737}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6944444444444444, "avg_em": 0.42857142857142855, "avg_chrf": 74.41414183306776, "avg_bleu": 56.613214531585825}
{"id": "PubMed_10:1004", "en": "Since we are fitting an SIR-epidemic model in the ABC routine, we anticipate that our results will be robust against weekly case data containing relatively small counts.", "es": "Dado que estamos adaptando un modelo epidemiológico SIR en la rutina del cálculo bayesiano aproximado, prevemos que nuestros resultados serán sólidos en comparación con los datos de casos semanales que contienen conteos relativamente pequeños.", "perturbation": "alteration", "pert_es": "Dado que estamos adaptando un modelo epidemiológico SIR en la rutina del cálculo bayesiano aproximado, prevemos que nuestros resultados serán débiles en comparación con los datos de casos semanales que contienen conteos relativamente pequeños.", "bt_pert_es": "Since we are fitting an SIR epidemiological model into the approximate Bayesian calculation routine, we anticipate that our results will be weak compared to weekly case data that contain relatively small counts.", "questions": "[\"What model are we fitting in the ABC routine?\", \"Why do we anticipate that our results will be robust?\", \"What type of data is being considered for the model?\", \"What is the concern regarding the weekly case data?\", \"What is the impact of small counts in weekly case data on the results?\"]", "answers": "[\"SIR epidemiological model\", \"We do not anticipate that our results will be robust\", \"SIR epidemiological model\", \"The results may be weak compared to weekly case data\", \"The results will be weak due to relatively small counts in the weekly case data\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 67.32473886488943, "bleu": 27.516060407455225}, {"f1": 0, "em": false, "chrf": 14.220655397979625, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.51027002077083, "bleu": 0.0}, {"f1": 0.37499999999999994, "em": false, "chrf": 47.42743682957015, "bleu": 15.619699684601283}, {"f1": 0.2, "em": false, "chrf": 45.28940812759317, "bleu": 3.377156414337854}], "avg_f1": 0.195, "avg_em": 0.0, "avg_chrf": 36.55450184816064, "avg_bleu": 9.302583301278872}
{"id": "PubMed_10:1007", "en": "This approach is independent of the ABC methodology and will allow comparisons between estimates from the two modelling approaches to judge robustness of results.", "es": "Este enfoque es independiente de la metodología del cálculo bayesiano aproximado y permitirá comparar las estimaciones de los dos enfoques de modelización para evaluar la solidez de los resultados.", "perturbation": "alteration", "pert_es": "Este enfoque es dependiente de la metodología del cálculo bayesiano aproximado y permitirá comparar las estimaciones de los dos enfoques de modelización para evaluar la solidez de los resultados.", "bt_pert_es": "This approach is dependent on the approximate Bayesian estimation methodology and will allow the estimates from the two modeling approaches to be compared to assess the robustness of the results.", "questions": "[\"What is the approach independent of?\", \"What does the approach allow comparisons between?\", \"What is the purpose of comparing estimates from the two modelling approaches?\", \"What does the approach help judge?\", \"What is the ABC methodology related to in this context?\"]", "answers": "[\"The approximate Bayesian estimation methodology\", \"The estimates from the two modeling approaches\", \"To assess the robustness of the results\", \"The robustness of the results\", \"This approach\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 49.61248102313067, "bleu": 10.682175159905853}, {"f1": 0.7272727272727272, "em": false, "chrf": 90.42015139894521, "bleu": 32.46679154750989}, {"f1": 0.6, "em": false, "chrf": 70.73343810150345, "bleu": 39.76353643835254}, {"f1": 0.8571428571428571, "em": false, "chrf": 96.46008918404968, "bleu": 59.460355750136046}, {"f1": 0.6666666666666666, "em": false, "chrf": 86.63413841974726, "bleu": 49.99999999999999}], "avg_f1": 0.6273593073593073, "avg_em": 0.0, "avg_chrf": 78.77205962547525, "avg_bleu": 38.47457177918086}
{"id": "PubMed_10:1009", "en": "This has been confirmed by PHE’s Caldicott Guardian’s Office.", "es": "Esto fue confirmado por la oficina del Custodio Caldicott de PHE.", "perturbation": "alteration", "pert_es": "Esto no fue confirmado por la oficina del Custodio Caldicott de PHE.", "bt_pert_es": "This was not confirmed by PHE's Caldicott Custodian's office.", "questions": "[\"What has been confirmed?\", \"Which office confirmed the information?\", \"What is the name of the office that confirmed the information?\"]", "answers": "[\"Nothing\", \"PHE's Caldicott Custodian's office\", \"PHE's Caldicott Custodian's office\"]", "scores": [{"f1": 0, "em": false, "chrf": 17.830330330330334, "bleu": 0.0}, {"f1": 0.25, "em": false, "chrf": 46.333888310614014, "bleu": 15.97357760615681}, {"f1": 0.28571428571428575, "em": false, "chrf": 45.77600036473996, "bleu": 15.97357760615681}], "avg_f1": 0.1785714285714286, "avg_em": 0.0, "avg_chrf": 36.64673966856143, "avg_bleu": 10.649051737437874}
{"id": "PubMed_10:1012", "en": "Any cases identified will be managed according to the PHE/NHS guidance in force at the time, including advice for identified contacts.", "es": "Cualquier caso identificado se abordará según las directrices de PHE/NHS vigentes en ese momento, incluido el asesoramiento para los contactos identificados.", "perturbation": "alteration", "pert_es": "Cualquier caso identificado no se abordará según las directrices de PHE/NHS vigentes en ese momento, incluido el asesoramiento para los contactos identificados.", "bt_pert_es": "Any identified cases will not be dealt with according to the PHE/NHS guidance in force at the time, including counseling for identified contacts.", "questions": "[\"What happens to any cases identified?\", \"What guidance is used to manage cases?\", \"What does the guidance include?\", \"What is the basis for managing identified contacts?\"]", "answers": "[\"They will not be dealt with according to the PHE/NHS guidance in force at the time\", \"PHE/NHS guidance\", \"Counseling for identified contacts\", \"The PHE/NHS guidance in force at the time\"]", "scores": [{"f1": 0.8461538461538461, "em": false, "chrf": 78.90146487319986, "bleu": 57.57575636202256}, {"f1": 0.4444444444444445, "em": false, "chrf": 47.0935307508532, "bleu": 8.208499862389884}, {"f1": 0.75, "em": false, "chrf": 74.19939767152603, "bleu": 59.460355750136046}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7601495726495726, "avg_em": 0.25, "avg_chrf": 75.04859832389477, "avg_bleu": 56.31115299363713}
{"id": "PubMed_10:1015", "en": "Travel History and Clinical Descriptors of the COVID-19 Infections", "es": "Antecedentes de viajes y descriptores clínicos de las infecciones por COVID-19", "perturbation": "alteration", "pert_es": "Antecedentes de viajes y descriptores clínicos de las curaciones por COVID-19", "bt_pert_es": "Travel history and clinical descriptors of COVID-19 cures", "questions": "[\"What does travel history indicate about COVID-19 infections?\", \"What clinical descriptors are associated with COVID-19 infections?\"]", "answers": "[\"Nothing about COVID-19 infections\", \"Clinical descriptors\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_10:1024", "en": "We have rapidly created and incorporated new codes to allow data recording, and are collecting data to monitor the effectiveness of containment strategies.", "es": "Hemos creado e incorporado rápidamente códigos nuevos para permitir el registro de datos, y estamos recopilando datos para controlar la eficacia de las estrategias de contención.", "perturbation": "alteration", "pert_es": "Hemos creado e incorporado lentamente códigos nuevos para permitir el registro de datos, y estamos recopilando datos para controlar la eficacia de las estrategias de contención.", "bt_pert_es": "We have slowly created and incorporated new codes to enable data recording, and are collecting data to monitor the effectiveness of containment strategies.", "questions": "[\"What have we rapidly created and incorporated?\", \"What is the purpose of the new codes?\", \"What data are we collecting?\", \"What are we monitoring with the collected data?\", \"What is the goal of collecting data on containment strategies?\"]", "answers": "[\"None\", \"To enable data recording\", \"Data\", \"The effectiveness of containment strategies\", \"To monitor the effectiveness of containment strategies\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.416666666666668, "bleu": 0.0}, {"f1": 0.75, "em": false, "chrf": 63.10579994379524, "bleu": 35.35533905932737}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.6, "avg_chrf": 74.70449332209238, "avg_bleu": 67.0710678118655}
{"id": "PubMed_10:1025", "en": "Through this surveillance, we intend to find out more about the epidemiology of COVID-19 in ambulatory care.", "es": "A través de esta vigilancia, nos proponemos obtener más información sobre la epidemiología de la COVID-19 en la atención ambulatoria.", "perturbation": "alteration", "pert_es": "A través de esta vigilancia, nos proponemos obtener menos información sobre la epidemiología de la COVID-19 en la atención ambulatoria.", "bt_pert_es": "Through this surveillance, we aim to obtain less information about the epidemiology of COVID-19 in outpatient care.", "questions": "[\"What is the goal of the surveillance?\", \"What aspect of COVID-19 is being studied?\", \"What type of care setting is involved in the surveillance?\", \"What does the surveillance aim to reveal about COVID-19?\"]", "answers": "[\"To obtain less information about the epidemiology of COVID-19 in outpatient care\", \"The epidemiology of COVID-19\", \"Outpatient care\", \"Less information about the epidemiology of COVID-19\"]", "scores": [{"f1": 0.5263157894736842, "em": false, "chrf": 63.52137137793752, "bleu": 24.808415001701817}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 17.754467754467754, "bleu": 49.99999999999999}, {"f1": 0.7272727272727272, "em": false, "chrf": 81.14716969276098, "bleu": 50.81327481546147}], "avg_f1": 0.6883971291866029, "avg_em": 0.25, "avg_chrf": 65.60575220629157, "avg_bleu": 56.40542245429083}
{"id": "PubMed_10:1027", "en": "Our testing of low-risk patients will also inform whether the containment strategy that is based on virology testing of high-risk patients and their contacts plus self-isolation is effective.", "es": "Nuestra evaluación de los pacientes de bajo riesgo también informará si la estrategia de contención que se basa en las pruebas virológicas de los pacientes de alto riesgo y sus contactos más el autoaislamiento es eficaz.", "perturbation": "alteration", "pert_es": "Nuestra evaluación de los pacientes de alto riesgo también informará si la estrategia de contención que se basa en las pruebas virológicas de los pacientes de bajo riesgo y sus contactos más el autoaislamiento es ineficaz.", "bt_pert_es": "Our assessment of high-risk patients will also inform whether the containment strategy that relies on virological testing of low-risk patients and their contacts plus self-isolation is ineffective.", "questions": "[\"What will our testing of low-risk patients inform?\", \"What is the containment strategy based on?\", \"What components are included in the containment strategy?\", \"Is the containment strategy effective?\", \"What is the role of virology testing in the containment strategy?\", \"What is the role of self-isolation in the containment strategy?\"]", "answers": "[\"Whether the containment strategy is ineffective\", \"Virological testing of low-risk patients and their contacts plus self-isolation\", \"Virological testing of low-risk patients and their contacts, self-isolation\", \"No\", \"To assess the effectiveness of the containment strategy\", \"To help contain the spread of the virus\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 91.43021563917732, "bleu": 66.87403049764218}, {"f1": 0.8000000000000002, "em": false, "chrf": 83.82090438560546, "bleu": 58.14307369682194}, {"f1": 0.7777777777777778, "em": false, "chrf": 82.72789401315713, "bleu": 51.33450480401705}, {"f1": 0, "em": false, "chrf": 15.596330275229356, "bleu": 0.0}, {"f1": 0.14285714285714288, "em": false, "chrf": 19.557523011806893, "bleu": 5.815868174415823}, {"f1": 0, "em": false, "chrf": 14.035951334646029, "bleu": 0.0}], "avg_f1": 0.42010582010582015, "avg_em": 0.0, "avg_chrf": 51.19480310993703, "avg_bleu": 30.361246195482835}
{"id": "PubMed_10:1029", "en": "However, there may come a point at which the virus spreads more widely into the population, as has happened in Italy.", "es": "Sin embargo, se puede llegar a un punto en el que el virus se propague de forma más extensa en la población, como sucedió en Italia.", "perturbation": "alteration", "pert_es": "Sin embargo, se puede llegar a un punto en el que el virus se controle de forma más extensa en la población, como sucedió en Italia.", "bt_pert_es": "However, a point may be reached where the virus is controlled more extensively in the population, as happened in Italy.", "questions": "[\"When might the virus start spreading more widely into the population?\", \"What event is mentioned as having happened in Italy?\", \"What could lead to wider spread of the virus?\", \"What does the sentence suggest about the spread of the virus?\"]", "answers": "[\"When the virus is controlled more extensively in the population\", \"The virus was controlled more extensively in the population\", \"The virus being controlled more extensively in the population\", \"The sentence suggests that the virus may spread more widely when it is not controlled extensively\"]", "scores": [{"f1": 0, "em": false, "chrf": 15.281575605204504, "bleu": 0.0}, {"f1": 0.15384615384615385, "em": false, "chrf": 21.494425359063957, "bleu": 5.522397783539471}, {"f1": 0.5333333333333333, "em": false, "chrf": 47.47920779850713, "bleu": 13.134549472120788}, {"f1": 0.5217391304347827, "em": false, "chrf": 54.172933468544805, "bleu": 25.748661016289674}], "avg_f1": 0.30222965440356747, "avg_em": 0.0, "avg_chrf": 34.6070355578301, "avg_bleu": 11.101402067987483}
{"id": "PubMed_10:1030", "en": "Surveillance of low-risk patients should inform when we reach this tipping point and when infection rates start to remit.", "es": "La vigilancia de los pacientes de bajo riesgo debería indicar el momento en que lleguemos a este punto crítico y el momento en que las tasas de infección comiencen a disminuir.", "perturbation": "alteration", "pert_es": "La vigilancia de los pacientes de alto riesgo debería indicar el momento en que lleguemos a este punto crítico y el momento en que las tasas de infección comiencen a aumentar.", "bt_pert_es": "Surveillance of high-risk patients should indicate when we reach this critical point and when infection rates begin to increase.", "questions": "[\"What should surveillance of low-risk patients inform?\", \"When does surveillance indicate we reach the tipping point?\", \"When does surveillance indicate infection rates start to remit?\"]", "answers": "[\"Nothing\", \"When we reach this critical point\", \"When infection rates begin to increase\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.10621626691786, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 58.463701774376766, "bleu": 32.46679154750989}, {"f1": 0.5, "em": false, "chrf": 56.36063098927939, "bleu": 17.965205598154213}], "avg_f1": 0.38888888888888884, "avg_em": 0.0, "avg_chrf": 39.643516343524674, "avg_bleu": 16.81066571522137}
{"id": "PubMed_10:1033", "en": "The surveillance system should be able to identify areas where COVID-19 spread is taking place that might be suitable for trials of antiviral therapy.", "es": "El sistema de vigilancia debería identificar las áreas en las que la COVID-19 se propaga que podrían ser adecuadas para realizar ensayos de tratamiento antiviral.", "perturbation": "alteration", "pert_es": "El sistema de vigilancia no debería identificar las áreas en las que la COVID-19 se propaga que podrían ser adecuadas para realizar ensayos de tratamiento antiviral.", "bt_pert_es": "The surveillance system should not identify areas where COVID-19 is spreading that might be suitable for antiviral treatment trials.", "questions": "[\"What should the surveillance system be able to identify?\", \"Where might COVID-19 spread be suitable for trials of antiviral therapy?\", \"What is the purpose of the surveillance system?\", \"What type of trials are being considered?\", \"What is the relationship between COVID-19 spread and antiviral therapy trials?\"]", "answers": "[\"Areas where COVID-19 is spreading that might be suitable for antiviral treatment trials\", \"Areas where COVID-19 is spreading\", \"To identify areas where COVID-19 is spreading that might be suitable for antiviral treatment trials\", \"Antiviral treatment trials\", \"COVID-19 spread in areas that might be suitable for antiviral therapy trials\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 51.37679584367496, "bleu": 12.35622127262679}, {"f1": 0.6666666666666666, "em": false, "chrf": 63.1081192841383, "bleu": 28.64190457979541}, {"f1": 0.5, "em": false, "chrf": 60.984563953349245, "bleu": 25.748661016289674}, {"f1": 0, "em": false, "chrf": 42.934943584257084, "bleu": 0.0}, {"f1": 0.7586206896551724, "em": false, "chrf": 56.70218051743687, "bleu": 28.16849553731143}], "avg_f1": 0.4650574712643678, "avg_em": 0.0, "avg_chrf": 55.021320636571296, "avg_bleu": 18.98305648120466}
{"id": "PubMed_10:1042", "en": "The impact on practices has been to close for a day, if a case is found, for deep cleaning and then reopen.", "es": "El impacto en los consultorios ha sido cerrar durante un día, si se detecta un caso, para hacer una limpieza profunda y luego volver a abrir.", "perturbation": "alteration", "pert_es": "El impacto en los consultorios ha sido abrir durante un día, si se detecta un caso, para hacer una limpieza superficial y luego volver a cerrar.", "bt_pert_es": "The impact on the offices has been to open for a day, if a case is detected, to do a superficial cleaning and then close again.", "questions": "[\"What impact has been observed on practices?\", \"What happens when a case is found?\", \"What is done after a case is found?\", \"What follows after deep cleaning?\", \"What is the practice when a case is found?\"]", "answers": "[\"The impact on the offices has been to open for a day, if a case is detected, to do a superficial cleaning and then close again\", \"The offices open for a day, do a superficial cleaning, and then close again\", \"A superficial cleaning is done\", \"None mentioned\", \"The offices open for a day, do a superficial cleaning, and then close again\"]", "scores": [{"f1": 0.7142857142857143, "em": false, "chrf": 61.66937726620236, "bleu": 31.82084684007776}, {"f1": 0.375, "em": false, "chrf": 31.793709704312857, "bleu": 7.495553473355842}, {"f1": 0.6666666666666665, "em": false, "chrf": 68.63976596662148, "bleu": 39.76353643835254}, {"f1": 0, "em": false, "chrf": 10.441881437182591, "bleu": 0.0}, {"f1": 0.4761904761904762, "em": false, "chrf": 50.90898739901597, "bleu": 15.851165692617155}], "avg_f1": 0.44642857142857145, "avg_em": 0.0, "avg_chrf": 44.690744354667046, "avg_bleu": 18.986220488880658}
{"id": "PubMed_10:1043", "en": "The principal limitations of our system are the number of data points.", "es": "Las principales limitaciones de nuestro sistema son las cantidades de puntos de datos.", "perturbation": "alteration", "pert_es": "Las principales ventajas de nuestro sistema son las cantidades de puntos de datos.", "bt_pert_es": "The main advantages of our system are the numbers of data points.", "questions": "[\"What are the principal limitations of the system?\", \"What specific factor limits the system?\", \"What is the main constraint mentioned in the sentence?\"]", "answers": "[\"None mentioned\", \"None mentioned\", \"The numbers of data points\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.402828419872428, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 10.402828419872428, "bleu": 0.0}, {"f1": 0.8000000000000002, "em": false, "chrf": 84.59329201101423, "bleu": 42.7287006396234}], "avg_f1": 0.2666666666666667, "avg_em": 0.0, "avg_chrf": 35.13298295025303, "avg_bleu": 14.242900213207799}
{"id": "PubMed_10:1046", "en": "Our sites (surveillance practices) are currently fixed, and it could be helpful to be able to rapidly onboard practices in regions where there are more cases.", "es": "Nuestros centros (consultorios de vigilancia) actualmente son fijos, y podría ser útil poder incorporar consultorios rápidamente en regiones donde hay más casos.", "perturbation": "alteration", "pert_es": "Nuestros centros (consultorios de vigilancia) actualmente son móviles, y podría ser útil poder incorporar consultorios lentamente en regiones donde hay menos casos.", "bt_pert_es": "Our centers (surveillance clinics) are currently mobile, and it could be useful to be able to slowly add clinics in regions where there are fewer cases.", "questions": "[\"What are our current surveillance practices?\", \"Why are our sites currently fixed?\", \"What would be helpful in regions with more cases?\", \"What is the potential benefit of rapidly onboarding practices?\", \"What regions are mentioned in the context of more cases?\"]", "answers": "[\"Our centers (surveillance clinics) are currently mobile\", \"The sentence does not mention why sites are fixed\", \"Adding clinics\", \"Improved coverage and monitoring of cases\", \"Regions where there are fewer cases\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.722781474269437, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 13.747375244115876, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 13.900030600766208, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 27.859011287683266, "bleu": 0.0}, {"f1": 0.2, "em": false, "chrf": 40.79816018651798, "bleu": 8.116697886877475}], "avg_f1": 0.04, "avg_em": 0.0, "avg_chrf": 20.805471758670556, "avg_bleu": 1.623339577375495}
{"id": "PubMed_10:1047", "en": "Currently, we will be reporting weekly.", "es": "Actualmente, presentaremos informes con una frecuencia semanal.", "perturbation": "alteration", "pert_es": "Actualmente, presentaremos informes con una frecuencia mensual.", "bt_pert_es": "Currently, we will report on a monthly basis.", "questions": "[\"What are we currently reporting?\", \"How often are we reporting?\", \"What type of information are we reporting?\", \"What is the current reporting schedule?\"]", "answers": "[\"On a monthly basis\", \"Monthly\", \"On a monthly basis\", \"Monthly\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.915629322268327, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.581752484191508, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 11.31088860374289, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.581752484191508, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 8.847505723598559, "avg_bleu": 0.0}
{"id": "PubMed_10:1049", "en": "Opportunistic sampling for serology in children younger than 10 years might be limited due to the overall reduced rate of blood tests in children.", "es": "El muestreo oportunista para serología en niños menores de 10 años podría ser limitado debido a la tasa general reducida de análisis de sangre en niños.", "perturbation": "alteration", "pert_es": "El muestreo oportunista para serología en niños mayores de 10 años podría ser limitado debido a la tasa general aumentada de análisis de sangre en niños.", "bt_pert_es": "Opportunistic sampling for serology in children older than 10 years may be limited due to the overall increased rate of blood testing in children.", "questions": "[\"What might limit opportunistic sampling for serology in children younger than 10 years?\", \"Why might the rate of blood tests in children be reduced?\", \"What is opportunistic sampling for serology?\", \"What age group is mentioned in the sentence?\", \"What is the relationship between blood test rates and opportunistic sampling in children?\"]", "answers": "[\"The overall increased rate of blood testing in children\", \"The sentence does not provide information on why the rate of blood tests in children might be reduced\", \"A method of collecting blood samples for serological testing when it is not specifically requested, often taking advantage of existing blood tests\", \"Children older than 10 years\", \"As the rate of blood testing increases, opportunistic sampling for serology may be limited\"]", "scores": [{"f1": 0.7058823529411765, "em": false, "chrf": 69.6984271446681, "bleu": 23.356898886410004}, {"f1": 0.10526315789473684, "em": false, "chrf": 11.145873171008088, "bleu": 2.2869567780619007}, {"f1": 0.5454545454545455, "em": false, "chrf": 70.0816661289255, "bleu": 36.227557436010244}, {"f1": 0.6, "em": false, "chrf": 64.84122912511701, "bleu": 39.76353643835254}, {"f1": 0.6666666666666666, "em": false, "chrf": 71.10233368337178, "bleu": 28.863046226018728}], "avg_f1": 0.5246533445914251, "avg_em": 0.0, "avg_chrf": 57.3739058506181, "avg_bleu": 26.099599152970683}
{"id": "PubMed_10:1051", "en": "The model of getting the appropriate informatics to enable capture of the required data has already been a success, with data recording starting the week the codes were created.", "es": "El modelo de obtención de la informática adecuada para permitir la captura de los datos requeridos ya ha sido un éxito, el registro de datos comenzó la semana en la que se crearon los códigos.", "perturbation": "alteration", "pert_es": "El modelo de obtención de la informática inadecuada para permitir la captura de los datos requeridos ya ha sido un éxito, el registro de datos comenzó la semana en la que se crearon los códigos.", "bt_pert_es": "The model of obtaining inadequate computing to allow the capture of the required data has already been a success, data recording began the week in which the codes were created.", "questions": "[\"What is the model for getting appropriate informatics?\", \"What enables the capture of required data?\", \"When did data recording start?\", \"What happened the week the codes were created?\", \"What is the outcome of the model?\"]", "answers": "[\"The model of obtaining inadequate computing to allow the capture of the required data\", \"Inadequate computing\", \"The week in which the codes were created\", \"Data recording began\", \"Data recording began\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 50.00777338200536, "bleu": 31.702331385234313}, {"f1": 0, "em": false, "chrf": 12.091971968431801, "bleu": 0.0}, {"f1": 0.8333333333333333, "em": false, "chrf": 81.47453398361135, "bleu": 30.739407647563215}, {"f1": 0.6666666666666666, "em": false, "chrf": 62.713964109714425, "bleu": 55.03212081491043}, {"f1": 0.4, "em": false, "chrf": 32.641123177296265, "bleu": 14.506309551249304}], "avg_f1": 0.5133333333333333, "avg_em": 0.0, "avg_chrf": 47.78587332421184, "avg_bleu": 26.396033879791453}
{"id": "PubMed_10:1052", "en": "In addition, modifying the existing surveillance system to collect population data in a parallel way has also been effective.", "es": "Además, modificar el actual sistema de vigilancia para recopilar datos sobre la población de forma paralela también ha sido eficaz.", "perturbation": "alteration", "pert_es": "Además, modificar el actual sistema de vigilancia para recopilar datos sobre la población de forma paralela también ha sido ineficaz.", "bt_pert_es": "Furthermore, modifying the current surveillance system to collect population data in parallel has also been ineffective.", "questions": "[\"What has been effective in addition to the existing surveillance system?\", \"How can the existing surveillance system be modified?\", \"What type of data can be collected in a parallel way?\", \"What is the purpose of collecting population data in a parallel way?\"]", "answers": "[\"Nothing\", \"To collect population data\", \"Population data\", \"To improve the surveillance system\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.375709171120859, "bleu": 0.0}, {"f1": 0.7272727272727273, "em": false, "chrf": 66.2477594365929, "bleu": 47.23665527410149}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.46153846153846156, "em": false, "chrf": 30.133737962003497, "bleu": 10.129474235115733}], "avg_f1": 0.5472027972027972, "avg_em": 0.25, "avg_chrf": 50.189301642429314, "avg_bleu": 39.34153237730432}
{"id": "PubMed_10:1053", "en": "However, we are at present unsure as to whether the scale of this surveillance provides sufficient data to drive local containment strategies or if reporting infrequently meets the need of our information age.", "es": "Sin embargo, actualmente no estamos seguros de que la magnitud de esta vigilancia proporcione datos suficientes para impulsar estrategias de contención local o de que la presentación de informes con poca frecuencia cubra las necesidades de nuestra era informática.", "perturbation": "alteration", "pert_es": "Sin embargo, actualmente sí estamos seguros de que la magnitud de esta vigilancia proporcione datos suficientes para impulsar estrategias de contención local o de que la presentación de informes con mucha frecuencia cubra las necesidades de nuestra era informática.", "bt_pert_es": "However, we are currently confident that the magnitude of this surveillance provides sufficient data to drive local containment strategies or that high-frequency reporting meets the needs of our information age.", "questions": "[\"What is unsure regarding the scale of surveillance?\", \"Does the scale of surveillance provide sufficient data for local containment strategies?\", \"What is the issue with reporting frequency?\", \"How does infrequent reporting affect information needs in the current information age?\"]", "answers": "[\"The magnitude of this surveillance\", \"Yes\", \"It does not meet the needs of our information age\", \"It fails to meet the needs of the information age\"]", "scores": [{"f1": 0.21428571428571427, "em": false, "chrf": 16.478628659970635, "bleu": 1.0864878331643493}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.7368421052631577, "em": false, "chrf": 59.45905333112332, "bleu": 38.62752974508186}, {"f1": 0.7368421052631579, "em": false, "chrf": 41.5036690676851, "bleu": 20.76558917806121}], "avg_f1": 0.4219924812030075, "avg_em": 0.0, "avg_chrf": 29.360337764694766, "avg_bleu": 15.119901689076855}
{"id": "Wikinews_2:1100", "en": "They did say he was not present at Chesapeake Energy Arena in Oklahoma City, where the Utah Jazz were to play against the Oklahoma City Thunder.", "es": "Dijeron que no estuvo presente en el Chesapeake Energy Arena en la ciudad de Oklahoma, donde los Utah Jazz debían jugar contra los Oklahoma City Thunder.", "perturbation": "alteration", "pert_es": "Dijeron que estuvo presente en el Chesapeake Energy Arena en la ciudad de Oklahoma, donde los Utah Jazz debían jugar contra los Oklahoma City Thunder.", "bt_pert_es": "They said he was present at the Chesapeake Energy Arena in Oklahoma City, where the Utah Jazz were scheduled to play the Oklahoma City Thunder.", "questions": "[\"Who did they say was not present at Chesapeake Energy Arena?\", \"Where was the Utah Jazz supposed to play?\", \"Who was the Utah Jazz playing against at Chesapeake Energy Arena?\", \"What event was taking place at Chesapeake Energy Arena?\", \"What was the location of the game between the Utah Jazz and the Oklahoma City Thunder?\"]", "answers": "[\"No one was specifically said to be absent\", \"Oklahoma City\", \"Oklahoma City Thunder\", \"A game between the Utah Jazz and the Oklahoma City Thunder\", \"Chesapeake Energy Arena in Oklahoma City\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.952380952380952, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 33.83692658174871, "bleu": 13.533528323661276}, {"f1": 0.8571428571428571, "em": false, "chrf": 87.19971297121289, "bleu": 71.65313105737896}, {"f1": 0.8888888888888888, "em": false, "chrf": 93.6630739468044, "bleu": 86.33400213704509}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6492063492063492, "avg_em": 0.2, "avg_chrf": 64.1304188904294, "avg_bleu": 54.304132303617074}
{"id": "Wikinews_2:1104", "en": "The United States' other major basketball organization, the National Collegiate Athletic Association, which runs college basketball, has cancelled its own tournament, March Madness, for both men's and women's leagues.", "es": "La otra organización de baloncesto importante de los Estados Unidos, la National Collegiate Athletic Association, que dirige partidos de baloncesto universitarios, canceló su propio campeonato, March Madness, para las ligas tanto masculina como femenina.", "perturbation": "alteration", "pert_es": "La otra organización de baloncesto importante de los Estados Unidos, la National Collegiate Athletic Association, que dirige partidos de baloncesto universitarios, organizó su propio campeonato, March Madness, para las ligas tanto masculina como femenina.", "bt_pert_es": "The other major basketball organization in the United States, the National Collegiate Athletic Association, which runs college basketball games, organized its own championship, March Madness, for both the men's and women's leagues.", "questions": "[\"What is the United States' other major basketball organization?\", \"What does the National Collegiate Athletic Association run?\", \"Why has the National Collegiate Athletic Association cancelled its tournament?\", \"Which tournaments has the National Collegiate Athletic Association cancelled?\", \"What leagues are affected by the cancellation of the tournament?\"]", "answers": "[\"The National Collegiate Athletic Association\", \"College basketball games\", \"The sentence does not mention cancellation or a reason for cancellation\", \"The sentence does not mention any tournaments being cancelled\", \"The sentence does not mention any leagues being affected by the cancellation\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8, "em": false, "chrf": 93.48516357545938, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 16.19687943273797, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 32.488255992638805, "bleu": 0.0}, {"f1": 0.13333333333333333, "em": false, "chrf": 26.55630079006884, "bleu": 3.7477767366779213}], "avg_f1": 0.38666666666666666, "avg_em": 0.2, "avg_chrf": 53.74531995818099, "avg_bleu": 31.75597951031768}
{"id": "Wikinews_2:1105", "en": "According to Johns Hopkins University, as of Wednesday, there were at least 1,279 confirmed cases of COVID-19 in the United States.", "es": "Según la Universidad Johns Hopkins, al día miércoles, había al menos 1279 casos confirmados de COVID-19 en los Estados Unidos.", "perturbation": "alteration", "pert_es": "Según la Universidad Johns Hopkins, al día miércoles, había como máximo 1279 casos confirmados de COVID-19 en los Estados Unidos.", "bt_pert_es": "According to Johns Hopkins University, as of Wednesday, there were at most 1,279 confirmed cases of COVID-19 in the United States.", "questions": "[\"What is the source of the information about COVID-19 cases?\", \"How many confirmed cases of COVID-19 were reported in the United States as of Wednesday?\", \"What is the date mentioned in the sentence?\", \"What is the total number of confirmed cases of COVID-19?\", \"Which institution provided the information about the cases?\"]", "answers": "[\"Johns Hopkins University\", \"1,279\", \"Wednesday\", \"1,279\", \"Johns Hopkins University\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikinews_5:1148", "en": "The move came two days after the World Health Organization declared the outbreak, which causes the COVID-19 disease, to be a pandemic.", "es": "La medida se tomó dos días después de que la Organización Mundial de la Salud declarara el brote, lo que ocasiona que la enfermedad COVID-19 sea una pandemia.", "perturbation": "alteration", "pert_es": "La medida se tomó dos días antes de que la Organización Mundial de la Salud declarara el brote, lo que ocasiona que la enfermedad COVID-19 sea una pandemia.", "bt_pert_es": "The measure was taken two days before the World Health Organization declared the outbreak, making the COVID-19 disease a pandemic.", "questions": "[\"When did the move occur?\", \"What did the World Health Organization declare two days before the move?\", \"What disease does the outbreak cause?\", \"What is the significance of the World Health Organization's declaration?\", \"What event preceded the move?\"]", "answers": "[\"Two days before the World Health Organization declared the outbreak\", \"The outbreak\", \"COVID-19\", \"It made the COVID-19 disease a pandemic\", \"The measure was taken\"]", "scores": [{"f1": 0.7368421052631579, "em": false, "chrf": 72.13830871194547, "bleu": 40.86646502016564}, {"f1": 0.3636363636363636, "em": false, "chrf": 22.178643078616673, "bleu": 3.0197383422318516}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.20000000000000004, "em": false, "chrf": 26.79237206654751, "bleu": 10.682175159905853}, {"f1": 0.15384615384615383, "em": false, "chrf": 7.897589132955743, "bleu": 4.576506607182439}], "avg_f1": 0.49086492454913505, "avg_em": 0.2, "avg_chrf": 45.80138259801308, "avg_bleu": 31.828977025897167}
{"id": "Wikinews_5:1151", "en": "The United States Department of Health and Human Services declared the outbreak a \"public health emergency\" on January 31.", "es": "El 31 de enero, el Departamento de Salud y Servicios Humanos de los Estados Unidos declaró el brote una \"emergencia de salud pública\".", "perturbation": "alteration", "pert_es": "El 31 de enero, el Departamento de Salud y Servicios Humanos de los Estados Unidos declaró el brote una \"no emergencia de salud pública\".", "bt_pert_es": "On January 31, the United States Department of Health and Human Services declared the outbreak a \"public health non-emergency.\"", "questions": "[\"What agency declared the outbreak a 'public health emergency'?\", \"When was the outbreak declared a 'public health emergency'?\", \"What was the declaration regarding the outbreak?\", \"What is the significance of declaring the outbreak a 'public health emergency'?\", \"Which department declared the outbreak a 'public health emergency'?\"]", "answers": "[\"The United States Department of Health and Human Services\", \"On January 31\", \"The outbreak was declared a 'public health non-emergency'\", \"The outbreak was not declared an emergency\", \"The Department of Health and Human Services\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8, "em": false, "chrf": 93.88954066057725, "bleu": 55.03212081491043}, {"f1": 0.4, "em": false, "chrf": 68.09201410521351, "bleu": 13.134549472120794}, {"f1": 0.10526315789473684, "em": false, "chrf": 14.434808637487945, "bleu": 2.5275658895144484}, {"f1": 0.923076923076923, "em": false, "chrf": 98.1258964608202, "bleu": 80.91067115702207}], "avg_f1": 0.645668016194332, "avg_em": 0.2, "avg_chrf": 74.90845197281979, "avg_bleu": 50.320981466713555}
{"id": "Wikipedia_handpicked_5:1860", "en": "Impact of the 2019–20 coronavirus pandemic on education", "es": "Impacto de la pandemia de coronavirus 2019-2020 en la educación", "perturbation": "alteration", "pert_es": "Beneficio de la pandemia de coronavirus 2019-2020 en la educación", "bt_pert_es": "Benefit of the 2019-2020 coronavirus pandemic in education", "questions": "[\"What was the impact of the 2019–20 coronavirus pandemic on education?\", \"How did the pandemic affect education?\", \"What changes occurred in education during the 2019–20 coronavirus pandemic?\", \"What aspects of education were most affected by the pandemic?\"]", "answers": "[\"The sentence does not provide information on the impact of the 2019–20 coronavirus pandemic on education\", \"The sentence does not provide information on how the pandemic affected education\", \"The sentence does not provide information on changes in education during the 2019–20 coronavirus pandemic\", \"The sentence does not provide information on aspects of education most affected by the pandemic\"]", "scores": [{"f1": 0.7272727272727273, "em": false, "chrf": 83.0864106156303, "bleu": 44.71018619258419}, {"f1": 0.5333333333333333, "em": false, "chrf": 70.78133865932023, "bleu": 14.991106946711685}, {"f1": 0.5714285714285714, "em": false, "chrf": 84.38162092472443, "bleu": 34.98761149110957}, {"f1": 0.5217391304347826, "em": false, "chrf": 68.66443855249406, "bleu": 21.142141714303076}], "avg_f1": 0.5884434406173537, "avg_em": 0.0, "avg_chrf": 76.72845218804225, "avg_bleu": 28.957761586177128}
{"id": "Wikipedia_handpicked_5:1861", "en": "The 2019–20 coronavirus pandemic has affected educational systems worldwide, leading to the widespread closures of schools and universities.", "es": "La pandemia de coronavirus 2019-2020 ha afectado a los sistemas educativos de todo el mundo, lo que provocó el cierre generalizado de escuelas y universidades.", "perturbation": "alteration", "pert_es": "La pandemia de coronavirus 2019-2020 no ha afectado a los sistemas educativos de todo el mundo, lo que provocó el cierre generalizado de escuelas y universidades.", "bt_pert_es": "The 2019-2020 coronavirus pandemic has not affected education systems around the world, leading to widespread closures of schools and universities.", "questions": "[\"What has the 2019–20 coronavirus pandemic affected worldwide?\", \"What specific changes have occurred in educational systems due to the pandemic?\", \"What has led to the widespread closures of schools and universities?\", \"What impact has the pandemic had on education?\", \"What institutions have been closed due to the pandemic?\"]", "answers": "[\"Education systems\", \"Widespread closures of schools and universities\", \"The 2019–20 coronavirus pandemic\", \"Widespread closures of schools and universities\", \"Schools and universities\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 71.18688063971533, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7272727272727272, "em": false, "chrf": 90.45174149662284, "bleu": 50.81327481546147}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8454545454545455, "avg_em": 0.6, "avg_chrf": 92.32772442726764, "avg_bleu": 80.16265496309231}
{"id": "Wikipedia_handpicked_5:1864", "en": "On 23 March 2020, Cambridge International Examinations (CIE) released a statement announcing the cancellation of Cambridge IGCSE, Cambridge O Level, Cambridge International AS &amp; A Level, Cambridge AICE Diploma, and Cambridge Pre-U examinations for the May/June 2020 series across all countries.", "es": "El 23 de marzo de 2020, Cambridge International Examinations (CIE) publicó un comunicado en el que se anunció la cancelación de los exámenes Cambridge IGCSE, Cambridge O Level, Cambridge International AS & A Level, Cambridge AICE Diploma y Cambridge Pre-U para la convocatoria de mayo y junio de 2020 en todos los países.", "perturbation": "alteration", "pert_es": "El 23 de marzo de 2020, Cambridge International Examinations (CIE) publicó un comunicado en el que se anunció la confirmación de los exámenes Cambridge IGCSE, Cambridge O Level, Cambridge International AS & A Level, Cambridge AICE Diploma y Cambridge Pre-U para la convocatoria de mayo y junio de 2020 en todos los países.", "bt_pert_es": "On 23 March 2020, Cambridge International Examinations (CIE) published a statement announcing the confirmation of the Cambridge IGCSE, Cambridge O Level, Cambridge International AS & A Level, Cambridge AICE Diploma and Cambridge Pre-U exams for the May and June 2020 exams in all countries.", "questions": "[\"When did Cambridge International Examinations release a statement about exam cancellations?\", \"What examinations were cancelled by Cambridge International Examinations?\", \"For which exam series were the examinations cancelled?\", \"In which countries were the examinations cancelled?\", \"What was the reason for cancelling the examinations?\"]", "answers": "[\"23 March 2020\", \"None\", \"May and June 2020\", \"all countries\", \"None\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 1.1609406203562376, "bleu": 0.0}, {"f1": 0.3333333333333333, "em": false, "chrf": 68.18214089611116, "bleu": 15.97357760615681}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 5.515293084171857, "bleu": 0.0}], "avg_f1": 0.4666666666666667, "avg_em": 0.4, "avg_chrf": 54.97167492012785, "avg_bleu": 43.19471552123138}
{"id": "Wikipedia_handpicked_5:1865", "en": "International Baccalaureate exams have also been cancelled.School closures impact not only students, teachers, and families, but have far-reaching economic and societal consequences.", "es": "También se han cancelado los exámenes del Bachillerato Internacional. El cierre de escuelas no solo afecta a los estudiantes, los docentes y las familias, sino que tiene consecuencias económicas y sociales de amplio alcance.", "perturbation": "alteration", "pert_es": "También se han reinstalado los exámenes del Bachillerato Internacional. El cierre de escuelas no solo afecta a los estudiantes, los docentes y las familias, sino que tiene consecuencias económicas y sociales de amplio alcance.", "bt_pert_es": "The International Baccalaureate exams have also been reinstated. School closures not only affect students, teachers and families, but have far-reaching economic and social consequences.", "questions": "[\"What has been cancelled along with International Baccalaureate exams?\", \"How do school closures impact students?\", \"How do school closures impact teachers?\", \"How do school closures impact families?\", \"What are the economic consequences of school closures?\", \"What are the societal consequences of school closures?\"]", "answers": "[\"School closures\", \"Students are affected\", \"Teachers are affected\", \"Families are affected\", \"Far-reaching economic consequences\", \"Far-reaching social consequences\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 61.152073402460395, "bleu": 55.03212081491043}, {"f1": 0.6666666666666666, "em": false, "chrf": 61.152073402460395, "bleu": 55.03212081491043}, {"f1": 0.6666666666666666, "em": false, "chrf": 61.152073402460395, "bleu": 55.03212081491043}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 84.98351505413552, "bleu": 34.66806371753173}], "avg_f1": 0.7777777777777777, "avg_em": 0.3333333333333333, "avg_chrf": 78.07328921025278, "avg_bleu": 66.62740436037718}
{"id": "Wikipedia_handpicked_5:1866", "en": "School closures in response to COVID-19 have shed light on various social and economic issues, including student debt, digital learning, food insecurity, and homelessness, as well as access to childcare, health care, housing, internet, and disability services.", "es": "El cierre de escuelas en respuesta a la COVID-19 ha puesto de manifiesto varias problemáticas sociales y económicas, entre las que se incluyen la deuda de los estudiantes, el aprendizaje digital, la inseguridad alimentaria, la falta de hogar, así como el acceso al cuidado infantil, a la atención de la salud, a la vivienda, a internet y a los servicios para personas con discapacidad.", "perturbation": "alteration", "pert_es": "El cierre de escuelas en respuesta a la COVID-19 ha puesto de manifiesto varias oportunidades sociales y económicas, entre las que se incluyen la riqueza de los estudiantes, el aprendizaje digital, la seguridad alimentaria, la abundancia de hogar, así como el acceso al cuidado infantil, a la atención de la salud, a la vivienda, a internet y a los servicios para personas con discapacidad.", "bt_pert_es": "School closures in response to COVID-19 have revealed several social and economic opportunities, including student wealth, digital learning, food security, home abundance, as well as access to child care, health care, housing, internet, and disability services.", "questions": "[\"What social and economic issues have been shed light on by school closures in response to COVID-19?\", \"What specific issues related to student debt are mentioned?\", \"What challenges are associated with digital learning?\", \"What issues related to food insecurity are highlighted?\", \"What issues related to homelessness are mentioned?\", \"What access issues are discussed in the sentence?\", \"What services related to disability are mentioned?\"]", "answers": "[\"Student wealth, digital learning, food security, home abundance, access to child care, health care, housing, internet, and disability services\", \"None\", \"None\", \"Food security\", \"None\", \"Access to child care, health care, housing, internet, and disability services\", \"Disability services\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 74.09135287237272, "bleu": 36.77433162538565}, {"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.90625, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 56.07035331470739, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 9.87641815235008, "bleu": 0.0}, {"f1": 0.761904761904762, "em": false, "chrf": 98.34578851210975, "bleu": 59.00468726392806}, {"f1": 0.5, "em": false, "chrf": 93.46837666690608, "bleu": 49.99999999999999}], "avg_f1": 0.26598639455782314, "avg_em": 0.0, "avg_chrf": 48.70955326453991, "avg_bleu": 20.825574127044813}
{"id": "Wikipedia_handpicked_5:1867", "en": "The impact was more severe for disadvantaged children and their families, causing interrupted learning, compromised nutrition, childcare problems, and consequent economic cost to families who could not work.In response to school closures, UNESCO recommended the use of distance learning programmes and open educational applications and platforms that schools and teachers can use to reach learners remotely and limit the disruption of education.", "es": "El impacto fue más grave para los niños en situación de desventaja y sus familias y provocó una interrupción del aprendizaje, una alimentación comprometida, problemas con el cuidado de los niños y, en consecuencia, un costo económico para las familias que no pudieron trabajar. En respuesta al cierre de escuelas, la UNESCO recomendó el uso de programas de educación a distancia y de aplicaciones y plataformas educativas abiertas que las escuelas y los docentes pueden usar para llegar a los alumnos de manera remota y reducir la interrupción de la educación.", "perturbation": "alteration", "pert_es": "El impacto fue menos grave para los niños en situación de desventaja y sus familias y provocó una continuación del aprendizaje, una alimentación mejorada, beneficios con el cuidado de los niños y, en consecuencia, un ahorro económico para las familias que pudieron trabajar. En respuesta al cierre de escuelas, la UNESCO recomendó el uso de programas de educación a distancia y de aplicaciones y plataformas educativas abiertas que las escuelas y los docentes pueden usar para llegar a los alumnos de manera remota y reducir la interrupción de la educación.", "bt_pert_es": "The impact was less severe for disadvantaged children and their families and resulted in continued learning, improved nutrition, childcare benefits and consequently financial savings for families who were able to work. In response to school closures, UNESCO recommended the use of distance education programs and open educational apps and platforms that schools and teachers can use to reach students remotely and reduce disruption to education.", "questions": "[\"What was the impact on disadvantaged children and their families?\", \"What specific problems were caused by the impact?\", \"What are the consequences of interrupted learning?\", \"What are the consequences of compromised nutrition?\", \"What childcare problems were reported?\", \"What economic cost did families face?\", \"What did UNESCO recommend in response to school closures?\", \"What types of distance learning programmes were recommended?\", \"What educational applications and platforms were suggested?\", \"How can schools and teachers use the recommended tools to reach learners remotely?\"]", "answers": "[\"The impact was less severe for disadvantaged children and their families and resulted in continued learning, improved nutrition, childcare benefits and consequently financial savings for families who were able to work\", \"The specific problems caused by the impact were disrupted learning, poor nutrition, lack of childcare benefits, and financial strain on families\", \"The consequences of interrupted learning include reduced academic progress and long-term educational setbacks\", \"The consequences of compromised nutrition include poor health, developmental delays, and reduced energy levels in children\", \"Childcare problems reported include lack of access to reliable childcare services\", \"Families faced economic cost due to loss of income from reduced work opportunities\", \"UNESCO recommended the use of distance education programs and open educational apps and platforms that schools and teachers can use to reach students remotely and reduce disruption to education\", \"Distance education programs were recommended\", \"Open educational apps and platforms were suggested\", \"Schools and teachers can use the recommended tools to reach students remotely by implementing distance education programs and accessing open educational apps and platforms\"]", "scores": [{"f1": 0.1176470588235294, "em": false, "chrf": 18.75237289354655, "bleu": 1.4262733286728255}, {"f1": 0.33333333333333326, "em": false, "chrf": 43.43350290902487, "bleu": 2.996515740268936}, {"f1": 0, "em": false, "chrf": 14.922840810236988, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 13.261138163890266, "bleu": 0.0}, {"f1": 0.3076923076923077, "em": false, "chrf": 57.24025696539372, "bleu": 7.495553473355842}, {"f1": 0.3636363636363637, "em": false, "chrf": 39.38552628653564, "bleu": 7.347053125977879}, {"f1": 0.7272727272727273, "em": false, "chrf": 70.7761191898342, "bleu": 44.68947264234529}, {"f1": 0.25, "em": false, "chrf": 44.369921602545894, "bleu": 10.682175159905853}, {"f1": 0.6666666666666666, "em": false, "chrf": 69.478389623888, "bleu": 18.575057999133602}, {"f1": 0.3529411764705882, "em": false, "chrf": 45.988516780197095, "bleu": 7.289334177359764}], "avg_f1": 0.3119189633895516, "avg_em": 0.0, "avg_chrf": 41.760858522509324, "avg_bleu": 10.050143564702}
{"id": "Wikipedia_handpicked_5:1869", "en": "Mathematical modelling has shown that transmission of an outbreak may be delayed by closing schools.", "es": "Los modelos matemáticos han demostrado que el cierre de escuelas puede retrasar la transmisión de una epidemia.", "perturbation": "alteration", "pert_es": "Los modelos matemáticos han demostrado que el cierre de escuelas puede acelerar la transmisión de una epidemia.", "bt_pert_es": "Mathematical models have shown that school closures can accelerate the transmission of an epidemic.", "questions": "[\"What has mathematical modelling shown about the transmission of an outbreak?\", \"How can the transmission of an outbreak be delayed?\", \"What action can delay the transmission of an outbreak?\", \"What is the effect of closing schools on outbreak transmission?\"]", "answers": "[\"Mathematical models have shown that school closures can accelerate the transmission of an epidemic\", \"School closures can delay the transmission of an outbreak\", \"Closing schools\", \"School closures accelerate the transmission of an outbreak\"]", "scores": [{"f1": 0.09523809523809525, "em": false, "chrf": 36.20433551942862, "bleu": 3.3864985683445354}, {"f1": 0, "em": false, "chrf": 25.98856978961155, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 63.15238050373011, "bleu": 30.213753973567677}], "avg_f1": 0.39880952380952384, "avg_em": 0.25, "avg_chrf": 56.33632145319257, "avg_bleu": 33.400063135478064}
{"id": "Wikipedia_handpicked_5:1870", "en": "However, effectiveness depends on the contacts children maintain outside of school.", "es": "Sin embargo, la eficacia depende del contacto que los niños mantienen fuera de la escuela.", "perturbation": "alteration", "pert_es": "Sin embargo, la ineficacia depende del contacto que los niños mantienen fuera de la escuela.", "bt_pert_es": "However, ineffectiveness depends on the contact that children have outside of school.", "questions": "[\"What depends on the contacts children maintain outside of school?\", \"What factors affect the effectiveness?\", \"What type of contacts are considered?\", \"What is the relationship between children's contacts and effectiveness?\"]", "answers": "[\"Ineffectiveness\", \"The contact that children have outside of school\", \"The contact that children have outside of school\", \"Ineffectiveness depends on the contact that children have outside of school\"]", "scores": [{"f1": 0, "em": false, "chrf": 86.83793406167966, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 65.63622588667847, "bleu": 23.356898886410004}, {"f1": 0.5, "em": false, "chrf": 65.73430052617907, "bleu": 20.556680845025987}, {"f1": 0.6, "em": false, "chrf": 74.22603938285827, "bleu": 20.556680845025987}], "avg_f1": 0.44166666666666665, "avg_em": 0.0, "avg_chrf": 73.10862496434888, "avg_bleu": 16.117565144115495}
{"id": "Wikipedia_handpicked_5:1871", "en": "School closures may be effective when enacted promptly.", "es": "El cierre de escuelas puede ser eficaz cuando se ejecuta de inmediato.", "perturbation": "alteration", "pert_es": "El cierre de escuelas puede ser ineficaz cuando se ejecuta de inmediato.", "bt_pert_es": "School closures may be ineffective when implemented immediately.", "questions": "[\"When might school closures be effective?\", \"What condition makes school closures effective?\", \"What happens when school closures are enacted promptly?\"]", "answers": "[\"When school closures are not implemented immediately\", \"When school closures are not implemented immediately\", \"They may be ineffective\"]", "scores": [{"f1": 0.2, "em": false, "chrf": 21.007866421400905, "bleu": 6.567274736060395}, {"f1": 0, "em": false, "chrf": 15.406294449919553, "bleu": 0.0}, {"f1": 0.75, "em": false, "chrf": 80.37113967010934, "bleu": 59.460355750136046}], "avg_f1": 0.31666666666666665, "avg_em": 0.0, "avg_chrf": 38.928433513809935, "avg_bleu": 22.009210162065482}
{"id": "Wikipedia_handpicked_5:1873", "en": "Additionally, in some cases, the reopening of schools after a period of closure has resulted in increased infection rates.", "es": "Además, en algunos casos, la reapertura de escuelas después de un tiempo de cierre ha dado lugar a un aumento en los índices de infección.", "perturbation": "alteration", "pert_es": "Además, en algunos casos, la reapertura de escuelas después de un tiempo de cierre ha dado lugar a una disminución en los índices de infección.", "bt_pert_es": "Additionally, in some cases, the reopening of schools after a period of closure has led to a decrease in infection rates.", "questions": "[\"What has resulted from the reopening of schools after a period of closure?\", \"In what cases has the reopening of schools led to increased infection rates?\", \"What factor has contributed to increased infection rates?\", \"What is the impact of reopening schools after closure?\", \"What is the relationship between school reopening and infection rates?\"]", "answers": "[\"a decrease in infection rates\", \"none\", \"closure of schools\", \"a decrease in infection rates\", \"the reopening of schools has led to a decrease in infection rates\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 73.02223678554566, "bleu": 31.947155212313625}, {"f1": 0, "em": false, "chrf": 7.8125, "bleu": 0.0}, {"f1": 0.5454545454545454, "em": false, "chrf": 33.38093896548925, "bleu": 11.898417391331403}, {"f1": 0.5714285714285715, "em": false, "chrf": 73.02223678554566, "bleu": 31.947155212313625}, {"f1": 0.5833333333333334, "em": false, "chrf": 49.15450992513409, "bleu": 14.320952289897711}], "avg_f1": 0.45432900432900436, "avg_em": 0.0, "avg_chrf": 47.27848449234293, "avg_bleu": 18.022736021171273}
{"id": "Wikipedia_handpicked_5:1874", "en": "As closures tend to occur concurrently with other interventions such as public gathering bans, it can be difficult to measure the specific impact of school closures.During the 1918-1919 influenza pandemic in the United States, school closures and public gathering bans were associated with lower total mortality rates.", "es": "Dado que los cierres tienden a establecerse simultáneamente con otras intervenciones, como la prohibición de reuniones públicas, puede ser difícil medir el impacto específico del cierre de las escuelas. En la pandemia de gripe de 1918 y 1919 en Estados Unidos, el cierre de escuelas y la prohibición de reuniones públicas se asociaron con tasas de mortalidad totales más bajas.", "perturbation": "alteration", "pert_es": "Dado que los cierres tienden a establecerse simultáneamente con otras intervenciones, como la prohibición de reuniones públicas, puede ser fácil medir el impacto específico del cierre de las escuelas. En la pandemia de gripe de 1918 y 1919 en Estados Unidos, el cierre de escuelas y la prohibición de reuniones públicas se asociaron con tasas de mortalidad totales más altas.", "bt_pert_es": "Since closures tend to be established simultaneously with other interventions, such as bans on public gatherings, it can be easy to measure the specific impact of school closures. In the 1918-1919 flu pandemic in the United States, school closures and bans on public gatherings were associated with higher overall mortality rates.", "questions": "[\"What makes it difficult to measure the specific impact of school closures?\", \"What interventions occur concurrently with school closures?\", \"What was observed during the 1918-1919 influenza pandemic in the United States?\", \"What was the relationship between school closures and public gathering bans during the 1918-1919 influenza pandemic?\", \"What was the outcome of school closures and public gathering bans during the 1918-1919 influenza pandemic?\"]", "answers": "[\"The simultaneous establishment of closures with other interventions, such as bans on public gatherings\", \"Bans on public gatherings\", \"School closures and bans on public gatherings were associated with higher overall mortality rates\", \"They were associated with higher overall mortality rates\", \"Higher overall mortality rates\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 63.06613362158557, "bleu": 21.142141714303076}, {"f1": 0, "em": false, "chrf": 72.2124703349615, "bleu": 0.0}, {"f1": 0.7407407407407408, "em": false, "chrf": 76.45959768482157, "bleu": 21.35901256790989}, {"f1": 0.75, "em": false, "chrf": 74.89008392140958, "bleu": 41.11336169005198}, {"f1": 0.5, "em": false, "chrf": 60.42243783962762, "bleu": 31.947155212313625}], "avg_f1": 0.5314814814814814, "avg_em": 0.0, "avg_chrf": 69.41014468048117, "avg_bleu": 23.112334236915714}
{"id": "Wikipedia_handpicked_5:1875", "en": "Cities that implemented such interventions earlier had greater delays in reaching peak mortality rates.", "es": "Las ciudades que implementaron esas intervenciones con anterioridad tardaron más en alcanzar las tasas de mortalidad máximas.", "perturbation": "alteration", "pert_es": "Las ciudades que implementaron esas intervenciones con anterioridad tardaron menos en alcanzar las tasas de mortalidad máximas.", "bt_pert_es": "Cities that implemented those interventions earlier took less time to reach peak mortality rates.", "questions": "[\"What does the sentence say about cities that implemented interventions earlier?\", \"What was observed in cities that implemented interventions earlier?\", \"What is the relationship between the timing of interventions and peak mortality rates?\", \"What is the effect of early implementation of interventions on peak mortality rates?\", \"What is the outcome of early intervention in cities?\"]", "answers": "[\"Cities that implemented those interventions earlier took less time to reach peak mortality rates\", \"Cities that implemented interventions earlier took less time to reach peak mortality rates\", \"The earlier the interventions were implemented, the less time it took to reach peak mortality rates\", \"Early implementation of interventions reduces the time to reach peak mortality rates\", \"Cities reach peak mortality rates sooner\"]", "scores": [{"f1": 0.5714285714285714, "em": false, "chrf": 64.87936909886304, "bleu": 20.20010691269415}, {"f1": 0.3, "em": false, "chrf": 46.279899485228846, "bleu": 11.498759556447222}, {"f1": 0.2857142857142857, "em": false, "chrf": 50.28992233675781, "bleu": 11.359354890271161}, {"f1": 0.6666666666666667, "em": false, "chrf": 66.8166176519893, "bleu": 29.251718341295526}, {"f1": 0.4615384615384615, "em": false, "chrf": 51.71824182486081, "bleu": 25.57539057896621}], "avg_f1": 0.45706959706959704, "avg_em": 0.0, "avg_chrf": 55.99681007953997, "avg_bleu": 19.577066055934853}
{"id": "Wikipedia_handpicked_5:1877", "en": "School closures were shown to reduce morbidity from the Asian flu by 90% during the 1957–58 outbreak, and up to 50% in controlling influenza in the US, 2004–2008.Multiple countries successfully slowed the spread of infection through school closures during the 2009 H1N1 Flu pandemic.", "es": "Se demostró que el cierre de las escuelas redujo la morbilidad de la gripe asiática en un 90 % durante el brote de 1957 y 1958 y en hasta un 50 % en el control de la gripe de 2004 a 2008 en Estados Unidos. Múltiples países lograron frenar la propagación de la infección con el cierre de escuelas durante la pandemia de gripe H1N1 en 2009.", "perturbation": "alteration", "pert_es": "Se demostró que el cierre de las escuelas aumentó la morbilidad de la gripe asiática en un 90 % durante el brote de 1957 y 1958 y en hasta un 50 % en el control de la gripe de 2004 a 2008 en Estados Unidos. Múltiples países lograron acelerar la propagación de la infección con el cierre de escuelas durante la pandemia de gripe H1N1 en 2009.", "bt_pert_es": "School closures were shown to increase Asian flu morbidity by 90% during the 1957-1958 outbreak and by up to 50% in the 2004-2008 flu control in the United States. Multiple countries managed to accelerate the spread of infection by closing schools during the H1N1 flu pandemic in 2009.", "questions": "[\"What was the effect of school closures on morbidity during the 1957–58 Asian flu outbreak?\", \"What was the reduction in morbidity from influenza in the US during 2004–2008?\", \"How effective were school closures in controlling the spread of infection during the 2009 H1N1 Flu pandemic?\", \"Which countries successfully slowed the spread of infection through school closures during the 2009 H1N1 Flu pandemic?\"]", "answers": "[\"School closures increased Asian flu morbidity by 90%\", \"There was no reduction in morbidity; morbidity increased by up to 50%\", \"School closures were ineffective in controlling the spread of infection\", \"The sentence does not specify which countries successfully slowed the spread\"]", "scores": [{"f1": 0.2, "em": false, "chrf": 13.431770363691012, "bleu": 5.522397783539471}, {"f1": 0.5, "em": false, "chrf": 47.38206364193877, "bleu": 13.545994273378144}, {"f1": 0, "em": false, "chrf": 32.98923961185803, "bleu": 0.0}, {"f1": 0.16666666666666669, "em": false, "chrf": 32.8851351358152, "bleu": 4.196114906296549}], "avg_f1": 0.21666666666666667, "avg_em": 0.0, "avg_chrf": 31.672052188325754, "avg_bleu": 5.816126740803541}
{"id": "Wikipedia_handpicked_5:1879", "en": "Mandatory school closures and other social distancing measures were associated with a 29% to 37% reduction in influenza transmission rates.", "es": "El cierre obligatorio de escuelas y otras medidas de distanciamiento social se asociaron a una reducción del 29 % al 37 % de las tasas de transmisión de la gripe.", "perturbation": "alteration", "pert_es": "El cierre obligatorio de escuelas y otras medidas de distanciamiento social se asociaron a un aumento del 29 % al 37 % de las tasas de transmisión de la gripe.", "bt_pert_es": "Mandatory school closures and other social distancing measures were associated with a 29% to 37% increase in flu transmission rates.", "questions": "[\"What measures were associated with a reduction in influenza transmission rates?\", \"What was the range of reduction in influenza transmission rates?\", \"What type of measures were considered mandatory?\", \"What disease's transmission rates are discussed in the sentence?\"]", "answers": "[\"None\", \"The range was not a reduction but an increase\", \"Mandatory school closures and other social distancing measures\", \"Influenza\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.6741071428571428, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.8735632183908044, "bleu": 0.0}, {"f1": 0.2, "em": false, "chrf": 53.12459911606096, "bleu": 5.522397783539471}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.3, "avg_em": 0.25, "avg_chrf": 39.418067369327225, "avg_bleu": 26.38059944588488}
{"id": "Wikipedia_handpicked_5:1880", "en": "Early school closures in the United States delayed the peak of the 2009 H1N1 Flu pandemic.", "es": "El cierre anticipado de escuelas en Estados Unidos retrasó el pico de la pandemia de gripe H1N1 de 2009.", "perturbation": "alteration", "pert_es": "El cierre anticipado de escuelas en Estados Unidos aceleró el pico de la pandemia de gripe H1N1 de 2009.", "bt_pert_es": "The early closure of schools in the United States accelerated the peak of the 2009 H1N1 flu pandemic.", "questions": "[\"What effect did early school closures have on the 2009 H1N1 Flu pandemic?\", \"What happened to the peak of the 2009 H1N1 Flu pandemic due to early school closures?\", \"Where did early school closures occur?\", \"What was the 2009 H1N1 Flu pandemic?\", \"What is the significance of early school closures in the context of the pandemic?\"]", "answers": "[\"It accelerated the peak\", \"It was accelerated\", \"In the United States\", \"A flu pandemic in 2009\", \"It contributed to an earlier peak of the pandemic\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 37.98517532158508, "bleu": 34.66806371753173}, {"f1": 0.6666666666666666, "em": false, "chrf": 31.427362756740422, "bleu": 55.03212081491043}, {"f1": 0.6666666666666666, "em": false, "chrf": 91.10491360491362, "bleu": 55.03212081491043}, {"f1": 0.888888888888889, "em": false, "chrf": 98.62165256314377, "bleu": 66.87403049764218}, {"f1": 0.6153846153846153, "em": false, "chrf": 49.3192704452122, "bleu": 26.269098944241588}], "avg_f1": 0.7008547008547008, "avg_em": 0.0, "avg_chrf": 61.691674938319025, "avg_bleu": 47.57508695784727}
{"id": "Wikipedia_handpicked_5:1881", "en": "Despite the overall success of closing schools, a study of school closures in Michigan found that \"district level reactive school closures were ineffective.\"During the swine flu outbreak in 2009 in the UK, in an article titled \"Closure of schools during an influenza pandemic\" published in the Lancet Infectious Diseases, a group of epidemiologists endorsed the closure of schools in order to interrupt the course of the infection, slow further spread and buy time to research and produce a vaccine.", "es": "A pesar del éxito general del cierre de las escuelas, un estudio sobre el cierre de escuelas en Michigan reveló que \"los cierres reactivos de escuelas a nivel de distrito no fueron eficaces\". Durante el brote de gripe porcina en 2009 en el Reino Unido, en un artículo titulado \"Cierre de escuelas durante una pandemia de gripe\" que se publicó en la revista Lancet Infectious Diseases, un grupo de epidemiólogos respaldó el cierre de escuelas con el fin de interrumpir el avance de la infección, frenar la propagación y ganar tiempo para investigar y desarrollar una vacuna.", "perturbation": "alteration", "pert_es": "A pesar del fracaso general del cierre de las escuelas, un estudio sobre el cierre de escuelas en Michigan reveló que \"los cierres reactivos de escuelas a nivel de distrito fueron eficaces\". Durante el brote de gripe porcina en 2009 en el Reino Unido, en un artículo titulado \"Cierre de escuelas durante una pandemia de gripe\" que se publicó en la revista Lancet Infectious Diseases, un grupo de epidemiólogos se opuso al cierre de escuelas con el fin de no interrumpir el avance de la infección, acelerar la propagación y perder tiempo para investigar y desarrollar una vacuna.", "bt_pert_es": "Despite the overall failure of school closures, a study of school closures in Michigan found that \"reactive school closures at the district level were effective.\" During the 2009 swine flu outbreak in the United Kingdom, in an article titled \"School closures during an influenza pandemic\" that was published in the journal Lancet Infectious Diseases, a group of epidemiologists opposed the closure of schools in order not to interrupt the progress of the infection, accelerate the spread and lose time to research and develop a vaccine.", "questions": "[\"What was the finding of the study on school closures in Michigan?\", \"Why were school closures endorsed during the swine flu outbreak in the UK?\", \"What was the goal of closing schools during the swine flu outbreak?\", \"What did the epidemiologists aim to achieve by closing schools during the swine flu outbreak?\", \"What disease was involved in the 2009 swine flu outbreak in the UK?\"]", "answers": "[\"Reactive school closures at the district level were effective\", \"To not interrupt the progress of the infection, accelerate the spread, and lose time to research and develop a vaccine\", \"To not interrupt the progress of the infection, accelerate the spread, and lose time to research and develop a vaccine\", \"To not interrupt the progress of the infection, accelerate the spread, and lose time to research and develop a vaccine\", \"Swine flu\"]", "scores": [{"f1": 0.5333333333333333, "em": false, "chrf": 75.73979486953584, "bleu": 13.134549472120788}, {"f1": 0.6875, "em": false, "chrf": 55.75505553910646, "bleu": 22.40152136940136}, {"f1": 0.38095238095238093, "em": false, "chrf": 43.69179647677278, "bleu": 5.816635421147515}, {"f1": 0.6875, "em": false, "chrf": 55.75505553910646, "bleu": 22.40152136940136}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6578571428571428, "avg_em": 0.2, "avg_chrf": 66.1883404849043, "avg_bleu": 32.75084552641421}
{"id": "Wikipedia_handpicked_5:1883", "en": "They also looked at the dynamics of the spread of influenza in France during French school holidays and noted that cases of flu dropped when schools closed and re-emerged when they re-opened.", "es": "También analizaron la dinámica de la propagación de la gripe en Francia durante las vacaciones escolares francesas y observaron que los casos de gripe disminuían cuando las escuelas estaban cerradas y reaparecían cuando volvían a abrir.", "perturbation": "alteration", "pert_es": "También analizaron la dinámica de la propagación de la gripe en Francia durante las vacaciones escolares francesas y observaron que los casos de gripe aumentaban cuando las escuelas estaban cerradas y desaparecían cuando volvían a abrir.", "bt_pert_es": "They also analyzed the dynamics of flu spread in France during French school holidays and observed that flu cases increased when schools were closed and disappeared when they reopened.", "questions": "[\"What did they look at regarding the spread of influenza in France?\", \"What happened to flu cases when schools closed?\", \"What happened to flu cases when schools re-opened?\", \"What factors were associated with the spread of influenza during school holidays?\", \"What is the relationship between school closures and flu cases?\"]", "answers": "[\"the dynamics of flu spread in France during French school holidays\", \"flu cases increased\", \"flu cases disappeared\", \"school closures and reopenings\", \"school closures were associated with an increase in flu cases and reopenings with a disappearance of flu cases\"]", "scores": [{"f1": 0.8571428571428572, "em": false, "chrf": 76.19227601083986, "bleu": 54.182204258059606}, {"f1": 0.5714285714285715, "em": false, "chrf": 26.183428499604965, "bleu": 24.840753130578644}, {"f1": 0.6666666666666666, "em": false, "chrf": 41.92991571334651, "bleu": 55.03212081491043}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.823529411764706, "em": false, "chrf": 71.00526782550767, "bleu": 48.3018816076337}], "avg_f1": 0.7837535014005603, "avg_em": 0.2, "avg_chrf": 63.0621776098598, "avg_bleu": 56.47139196223649}
{"id": "Wikipedia_handpicked_5:1886", "en": "When there is minimal to moderate community transmission, social distancing strategies can be implemented such as cancelling field trips, assemblies, and other large gatherings such as physical education or choir classes or meals in a cafeteria, increasing the space between desks, staggering arrival and dismissal times, limiting nonessential visitors, and using a separate health office location for children with flu-like symptoms.", "es": "Cuando la transmisión comunitaria es mínima o moderada, se pueden implementar estrategias de distanciamiento social, como cancelar las excursiones, las asambleas y otras reuniones masivas, como las clases de educación física o de coro o las comidas en el comedor, aumentar el espacio entre los pupitres, escalonar los horarios de entrada y salida, limitar las visitas que no sean esenciales y usar un lugar separado para la sala de salud para los niños que tengan síntomas gripales.", "perturbation": "alteration", "pert_es": "Cuando la transmisión comunitaria es máxima o intensa, se pueden implementar estrategias de distanciamiento social, como cancelar las excursiones, las asambleas y otras reuniones masivas, como las clases de educación física o de coro o las comidas en el comedor, aumentar el espacio entre los pupitres, escalonar los horarios de entrada y salida, limitar las visitas que no sean esenciales y usar un lugar separado para la sala de salud para los niños que tengan síntomas gripales.", "bt_pert_es": "When community transmission is at its peak or intense, social distancing strategies can be implemented, such as canceling field trips, assemblies, and other mass gatherings such as physical education or choir classes or cafeteria meals, increasing the spacing between desks, staggering arrival and dismissal times, limiting non-essential visitors, and using a separate health room location for children with flu-like symptoms.", "questions": "[\"What social distancing strategies can be implemented when there is minimal to moderate community transmission?\", \"What specific activities are recommended to cancel during minimal to moderate community transmission?\", \"What large gatherings are mentioned as being canceled?\", \"What changes can be made to classroom settings during minimal to moderate community transmission?\", \"What measures can be taken to limit nonessential visitors?\", \"What is the purpose of using a separate health office location for children with flu-like symptoms?\"]", "answers": "[\"None are specified for minimal to moderate community transmission\", \"Field trips, assemblies, physical education, choir classes, and cafeteria meals\", \"Field trips, assemblies, and other mass gatherings such as physical education or choir classes or cafeteria meals\", \"Increasing the spacing between desks and staggering arrival and dismissal times\", \"Limiting non-essential visitors\", \"To isolate children with flu-like symptoms and prevent the spread of illness\"]", "scores": [{"f1": 0.0392156862745098, "em": false, "chrf": 8.06492012459469, "bleu": 0.12186990132231246}, {"f1": 0.9523809523809523, "em": false, "chrf": 89.71696752245919, "bleu": 72.69720961745918}, {"f1": 0.5384615384615384, "em": false, "chrf": 70.06349577200383, "bleu": 23.287896954139942}, {"f1": 0.4285714285714285, "em": false, "chrf": 65.14340421698157, "bleu": 9.287528999566801}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.41666666666666663, "em": false, "chrf": 42.25664890006188, "bleu": 20.684088400488974}], "avg_f1": 0.5625493787258493, "avg_em": 0.16666666666666666, "avg_chrf": 62.540906089350194, "avg_bleu": 37.67976564549621}
{"id": "Wikipedia_handpicked_5:1887", "en": "When there is substantial transmission in the local community, in addition to social distancing strategies, extended school dismissals may be considered.", "es": "Cuando la transmisión en la comunidad local es significativa, además de las estrategias de distanciamiento social, se puede considerar la prolongación de la suspensión de clases.", "perturbation": "alteration", "pert_es": "Cuando la transmisión en la comunidad local es insignificativa, además de las estrategias de distanciamiento social, se puede considerar la prolongación de la suspensión de clases.", "bt_pert_es": "When local community transmission is negligible, in addition to social distancing strategies, extending school suspension may be considered.", "questions": "[\"What happens when there is substantial transmission in the local community?\", \"What strategies are considered in addition to social distancing?\", \"What may be considered during substantial transmission?\", \"What is the condition that triggers extended school dismissals?\"]", "answers": "[\"Nothing is mentioned about substantial transmission\", \"Extending school suspension\", \"Extending school suspension\", \"When local community transmission is negligible\"]", "scores": [{"f1": 0, "em": false, "chrf": 18.887523784692075, "bleu": 0.0}, {"f1": 0.3333333333333333, "em": false, "chrf": 36.776868026202195, "bleu": 27.516060407455225}, {"f1": 0.3333333333333333, "em": false, "chrf": 36.776868026202195, "bleu": 27.516060407455225}, {"f1": 0.5454545454545454, "em": false, "chrf": 63.8056063229123, "bleu": 17.965205598154213}], "avg_f1": 0.303030303030303, "avg_em": 0.0, "avg_chrf": 39.06171654000219, "avg_bleu": 18.249331603266164}
{"id": "Wikipedia_handpicked_5:1889", "en": "Universities and schools around the country closed.", "es": "Las universidades y escuelas de todo el país cerraron.", "perturbation": "alteration", "pert_es": "Las universidades y escuelas de todo el país abrieron.", "bt_pert_es": "Universities and schools across the country opened.", "questions": "[\"What closed?\", \"Where did the closures occur?\", \"What types of institutions closed?\"]", "answers": "[\"None\", \"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.076086956521739, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.464285714285715, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.076086956521739, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 4.205486542443064, "avg_bleu": 0.0}
{"id": "Wikipedia_handpicked_5:1890", "en": "On 23 February, Iran's Ministry of Health announced the closure of universities, higher educational institutions and schools in several cities and provinces.", "es": "El 23 de febrero, el Ministerio de Salud de Irán anunció el cierre de universidades, instituciones de enseñanza de nivel superior y escuelas en varias ciudades y provincias.", "perturbation": "alteration", "pert_es": "El 23 de febrero, el Ministerio de Salud de Irán anunció la apertura de universidades, instituciones de enseñanza de nivel superior y escuelas en varias ciudades y provincias.", "bt_pert_es": "On February 23, Iran's Ministry of Health announced the opening of universities, higher education institutions and schools in several cities and provinces.", "questions": "[\"What was announced by Iran's Ministry of Health on 23 February?\", \"Which institutions were closed on 23 February?\", \"In which cities and provinces were institutions closed?\", \"What type of institutions were closed?\", \"What action was taken by Iran's Ministry of Health on 23 February?\"]", "answers": "[\"The opening of universities, higher education institutions and schools in several cities and provinces\", \"No institutions were closed\", \"Several cities and provinces\", \"Universities, higher education institutions and schools\", \"Announced the opening of universities, higher education institutions and schools in several cities and provinces\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 85.45166642906692, "bleu": 62.98129992394241}, {"f1": 0.2, "em": false, "chrf": 27.082092992761908, "bleu": 9.688464563433238}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8333333333333334, "em": false, "chrf": 91.33901345922595, "bleu": 37.99178428257963}, {"f1": 0, "em": false, "chrf": 5.010817608810711, "bleu": 0.0}], "avg_f1": 0.5780952380952381, "avg_em": 0.2, "avg_chrf": 61.776718097973095, "avg_bleu": 42.132309753991066}
{"id": "Wikipedia_handpicked_5:1893", "en": "In reaction, UNESCO called on countries to support affected students and families and facilitate large-scale inclusive distance learning programmes.", "es": "La respuesta de la UNESCO fue pedir a los países que apoyaran a los estudiantes afectados y sus familias y facilitaran los programas de enseñanza a distancia inclusivos y a gran escala.", "perturbation": "alteration", "pert_es": "La respuesta de la UNESCO fue pedir a los países que ignoraran a los estudiantes afectados y sus familias y dificultaran los programas de enseñanza a distancia inclusivos y a gran escala.", "bt_pert_es": "UNESCO's response was to ask countries to ignore affected students and their families and make large-scale, inclusive distance learning programs difficult.", "questions": "[\"What did UNESCO call on countries to do?\", \"What specific actions did UNESCO recommend for affected students and families?\", \"What type of distance learning programmes did UNESCO recommend?\", \"What is the goal of the distance learning programmes?\", \"What groups are mentioned as being affected?\"]", "answers": "[\"To ignore affected students and their families\", \"To ignore affected students and their families\", \"Large-scale, inclusive distance learning programs\", \"To include all students\", \"Affected students and their families\"]", "scores": [{"f1": 0.4210526315789474, "em": false, "chrf": 30.601506746093015, "bleu": 12.859818292229834}, {"f1": 0.6666666666666666, "em": false, "chrf": 68.82324607887547, "bleu": 26.269098944241588}, {"f1": 0.4444444444444445, "em": false, "chrf": 84.91693802156698, "bleu": 21.3643503198117}, {"f1": 0.5, "em": false, "chrf": 47.80148003015061, "bleu": 31.947155212313625}, {"f1": 0.888888888888889, "em": false, "chrf": 85.7625225118452, "bleu": 42.7287006396234}], "avg_f1": 0.5842105263157895, "avg_em": 0.0, "avg_chrf": 63.58113867770626, "avg_bleu": 27.033824681644028}
{"id": "Wikipedia_handpicked_5:1896", "en": "On 5 March, the majority of learners affected by COVID-19 emergency measures were located in China, with 233 million learners affected, followed by Japan at 16.5 million and Iran at 14.5 million.", "es": "El 5 de marzo, la mayoría de los alumnos afectados por las medidas de emergencia de la COVID-19 era de China, con 233 millones de estudiantes afectados, seguidos por Japón con 16,5 millones e Irán con 14,5 millones.", "perturbation": "alteration", "pert_es": "El 5 de marzo, la minoría de los alumnos afectados por las medidas de emergencia de la COVID-19 era de China, con 233 millones de estudiantes afectados, seguidos por Japón con 16,5 millones e Irán con 14,5 millones.", "bt_pert_es": "As of March 5, the minority of students affected by COVID-19 emergency measures were from China, with 233 million students affected, followed by Japan with 16.5 million and Iran with 14.5 million.", "questions": "[\"Where were the majority of learners affected by COVID-19 emergency measures located on 5 March?\", \"How many learners were affected in China on 5 March?\", \"How many learners were affected in Japan on 5 March?\", \"How many learners were affected in Iran on 5 March?\", \"Which countries are mentioned in the sentence?\", \"What is the context of the learners' affected status?\"]", "answers": "[\"China\", \"233 million\", \"16.5 million\", \"14.5 million\", \"China, Japan, Iran\", \"COVID-19 emergency measures\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikipedia_handpicked_5:1902", "en": "On 23 March, all Nigerian school were found to have been closed down by Nigerian government, markets as well as companies were closed down and children were forbidden by parents to step out of their homes.", "es": "El 23 de marzo, se supo que el Gobierno de Nigeria había cerrado todas las escuelas, todos los mercados y las empresas estaban cerrados y los padres prohibieron a sus hijos salir de sus casas.", "perturbation": "alteration", "pert_es": "El 23 de marzo, se supo que el Gobierno de Nigeria había abierto todas las escuelas, todos los mercados y las empresas estaban abiertas y los padres permitieron a sus hijos salir de sus casas.", "bt_pert_es": "On March 23, it emerged that the Nigerian Government had opened all schools, all markets and businesses were open and parents allowed their children to leave their homes.", "questions": "[\"What happened to Nigerian schools on 23 March?\", \"What other places were closed down by the Nigerian government?\", \"What was forbidden to children by their parents?\", \"What actions were taken by the Nigerian government on 23 March?\"]", "answers": "[\"The Nigerian Government opened all schools\", \"No places were closed down\", \"Parents forbade their children to leave their homes\", \"The Nigerian Government opened all schools and all markets\"]", "scores": [{"f1": 0.3636363636363636, "em": false, "chrf": 41.005572950709706, "bleu": 9.652434877402245}, {"f1": 0, "em": false, "chrf": 10.249806956150296, "bleu": 0.0}, {"f1": 0.28571428571428575, "em": false, "chrf": 37.352206889723014, "bleu": 11.044795567078939}, {"f1": 0.5, "em": false, "chrf": 41.36833484000299, "bleu": 6.742555929751843}], "avg_f1": 0.28733766233766234, "avg_em": 0.0, "avg_chrf": 32.4939804091465, "avg_bleu": 6.859946593558257}
{"id": "Wikipedia_handpicked_5:1903", "en": "On 26 March, all New Zealand schools and universities have been closed down across the country.", "es": "El 26 de marzo, se cerraron todas las escuelas y universidades de Nueva Zelanda.", "perturbation": "alteration", "pert_es": "El 26 de marzo, se abrieron todas las escuelas y universidades de Nueva Zelanda.", "bt_pert_es": "On March 26, all schools and universities in New Zealand opened.", "questions": "[\"When were all New Zealand schools and universities closed down?\", \"What was closed down in New Zealand on 26 March?\", \"What institutions were closed down across New Zealand?\", \"What happened to schools and universities in New Zealand on 26 March?\"]", "answers": "[\"The sentence does not provide information about when schools and universities were closed down.\", \"Schools and universities\", \"Schools and universities\", \"All schools and universities in New Zealand opened\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.8617871024822796, "bleu": 0.0}, {"f1": 0.5714285714285715, "em": false, "chrf": 84.38119301203612, "bleu": 39.43223765116288}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 13.142790857188968, "bleu": 0.0}], "avg_f1": 0.3928571428571429, "avg_em": 0.25, "avg_chrf": 50.34644274292684, "avg_bleu": 34.85805941279073}
{"id": "Wikipedia_handpicked_5:1909", "en": "By 29 March, more than 1.5 billion children and other students were affected by nationwide school closures.", "es": "Para el 29 de marzo, el cierre de escuelas a nivel nacional había afectado a más de 1500 millones de niños y otros estudiantes.", "perturbation": "alteration", "pert_es": "Para el 29 de marzo, la apertura de escuelas a nivel nacional había afectado a más de 1500 millones de niños y otros estudiantes.", "bt_pert_es": "By March 29, nationwide school openings had affected more than 1.5 billion children and other students.", "questions": "[\"How many children and other students were affected by nationwide school closures by 29 March?\", \"What event led to the impact on children and other students?\", \"When did the nationwide school closures occur?\", \"What was the impact of nationwide school closures on students?\", \"What is the total number of affected students by 29 March?\"]", "answers": "[\"more than 1.5 billion\", \"nationwide school closures\", \"by 29 March\", \"affected more than 1.5 billion children and other students\", \"more than 1.5 billion\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 93.00541370394312, "bleu": 59.460355750136046}, {"f1": 0.6666666666666666, "em": false, "chrf": 95.31916500738012, "bleu": 55.03212081491043}, {"f1": 0.6666666666666666, "em": false, "chrf": 83.40608465608467, "bleu": 55.03212081491043}, {"f1": 0.125, "em": false, "chrf": 26.837136841770466, "bleu": 4.767707020457095}, {"f1": 0.75, "em": false, "chrf": 93.00541370394312, "bleu": 59.460355750136046}], "avg_f1": 0.5916666666666666, "avg_em": 0.0, "avg_chrf": 78.3146427826243, "avg_bleu": 46.75053203011001}
{"id": "Wikipedia_handpicked_5:1910", "en": "Others were disrupted by localized closures.", "es": "Otros se vieron afectados por cierres locales.", "perturbation": "alteration", "pert_es": "Otros se vieron beneficiados por cierres locales.", "bt_pert_es": "Others benefited from local closures.", "questions": "[\"What was disrupted by localized closures?\", \"Who were affected by localized closures?\", \"What types of disruptions occurred due to localized closures?\"]", "answers": "[\"Local operations\", \"Others\", \"Local closures\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.003814973772055, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 56.14533982286728, "bleu": 49.99999999999999}], "avg_f1": 0.5, "avg_em": 0.3333333333333333, "avg_chrf": 55.71638493221311, "avg_bleu": 50.00000000000001}
{"id": "Wikipedia_handpicked_5:1911", "en": "Until April 6, holidays were extended in all secondary schools of Turkmenistan.", "es": "Hasta el 6 de abril, las vacaciones se habían extendido en todas las escuelas secundarias de Turkmenistán.", "perturbation": "alteration", "pert_es": "Hasta el 6 de abril, las vacaciones no se habían extendido en todas las escuelas secundarias de Turkmenistán.", "bt_pert_es": "As of April 6, the holidays had not been extended in all secondary schools in Turkmenistan.", "questions": "[\"Until what date were holidays extended in Turkmenistan?\", \"Which schools had holidays extended?\", \"What was extended during the holidays in Turkmenistan?\", \"What type of schools were affected by the holiday extension?\"]", "answers": "[\"April 6\", \"No schools\", \"Holidays\", \"Secondary schools\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.28571428571428575, "em": false, "chrf": 17.768245197512194, "bleu": 11.15650800742149}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8214285714285714, "avg_em": 0.75, "avg_chrf": 79.44206129937805, "avg_bleu": 77.7891270018554}
{"id": "Wikipedia_handpicked_5:1912", "en": "An order signed by the Ministry of Education as a preventative measure aims to prevent the spread of respiratory diseases in connection with the WHO coronavirus pandemic.", "es": "Una orden firmada por el Ministerio de Educación como medida preventiva tiene el objetivo de prevenir la propagación de enfermedades respiratorias relacionadas con la pandemia de coronavirus declarada por la OMS.", "perturbation": "alteration", "pert_es": "Una orden firmada por el Ministerio de Educación como medida preventiva tiene el objetivo de fomentar la propagación de enfermedades respiratorias relacionadas con la pandemia de coronavirus declarada por la OMS.", "bt_pert_es": "An order signed by the Ministry of Education as a preventive measure aims to encourage the spread of respiratory diseases related to the coronavirus pandemic declared by the WHO.", "questions": "[\"What is the purpose of the order signed by the Ministry of Education?\", \"What type of disease is the order aimed at preventing?\", \"What is the connection between the order and the WHO coronavirus pandemic?\", \"Who signed the order?\", \"What is the preventative measure related to respiratory diseases?\"]", "answers": "[\"To encourage the spread of respiratory diseases related to the coronavirus pandemic\", \"Respiratory diseases\", \"The order is related to the WHO coronavirus pandemic as it addresses respiratory diseases associated with it\", \"The Ministry of Education\", \"An order signed by the Ministry of Education\"]", "scores": [{"f1": 0.625, "em": false, "chrf": 66.75382793571147, "bleu": 27.77619034011791}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.742857142857143, "em": false, "chrf": 75.70441494633413, "bleu": 55.868662436542586}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8735714285714286, "avg_em": 0.6, "avg_chrf": 88.49164857640912, "avg_bleu": 76.72897055533213}
{"id": "Wikipedia_handpicked_5:1913", "en": "10 countries have localised schools closures, UNESCO estimates  473,933,356  learners are potentially at risk (pre-primary to upper-secondary education) and 77,938,904 learners are potentially at risk in tertiary education.", "es": "En 10 países existe el cierre de escuelas localizado. La UNESCO estima que 473 933 356 estudiantes se encuentran potencialmente en situación de riesgo (desde el nivel preescolar hasta el nivel secundario superior) y que 77 938 904 alumnos se encuentran potencialmente en situación de riesgo en el nivel terciario.", "perturbation": "alteration", "pert_es": "En 10 países no existe el cierre de escuelas localizado. La UNESCO estima que 473 933 356 estudiantes se encuentran potencialmente en situación de seguridad (desde el nivel preescolar hasta el nivel secundario superior) y que 77 938 904 alumnos se encuentran potencialmente en situación de seguridad en el nivel terciario.", "bt_pert_es": "In 10 countries there is no localized school closure. UNESCO estimates that 473,933,356 students are potentially safe (from pre-school to upper secondary level) and 77,938,904 students are potentially safe at the tertiary level.", "questions": "[\"How many countries have localised school closures?\", \"How many learners are potentially at risk in pre-primary to upper-secondary education?\", \"How many learners are potentially at risk in tertiary education?\", \"What education levels are included in the at-risk learners count?\", \"What organization estimates the number of learners at risk?\"]", "answers": "[0, \"473,933,356\", \"77,938,904\", \"pre-school to upper secondary level\", \"UNESCO\"]", "scores": [{"f1": 0.22222222222222224, "em": false, "chrf": 47.161058775419626, "bleu": 10.682175159905853}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6111111111111112, "avg_em": 0.5, "avg_chrf": 73.58052938770982, "avg_bleu": 55.34108757995295}
{"id": "Wikipedia_handpicked_5:1914", "en": "Note: Figures correspond to total number of learners enrolled at pre-primary, primary, lower-secondary, and upper-secondary levels of education [ISCED levels 0 to 3], as well as at tertiary education levels [ISCED levels 5 to 8] who could be affected should localised closures become countrywide.", "es": "Nota: Las cifras corresponden a la cantidad total de estudiantes matriculados en los niveles de educación preescolar, primaria, primer y segundo ciclo de educación secundaria (niveles 0 a 3 de la CINE), así como en los niveles de educación terciaria (niveles 5 a 8 de la CINE), que podrían verse afectados si los cierres localizados se transformaran en cierres a escala nacional.", "perturbation": "alteration", "pert_es": "Nota: Las cifras corresponden a la cantidad total de estudiantes matriculados en los niveles de educación preescolar, primaria, primer y segundo ciclo de educación secundaria (niveles 0 a 3 de la CINE), así como en los niveles de educación terciaria (niveles 5 a 8 de la CINE), que no podrían verse afectados si los cierres localizados se transformaran en cierres a escala nacional.", "bt_pert_es": "Note: The figures correspond to the total number of students enrolled in pre-school, primary, lower and upper secondary education levels (ISCED levels 0 to 3), as well as tertiary education levels (ISCED levels 5 to 8), who could not be affected if localized closures were transformed into nationwide closures.", "questions": "[\"What does the term 'figures' correspond to?\", \"Which education levels are included in the figures?\", \"What are the ISCED levels for pre-primary to upper-secondary education?\", \"What are the ISCED levels for tertiary education?\", \"What happens to the figures if localised closures become countrywide?\"]", "answers": "[\"The total number of students enrolled in pre-school, primary, lower and upper secondary education levels (ISCED levels 0 to 3), as well as tertiary education levels (ISCED levels 5 to 8), who could not be affected if localized closures were transformed into nationwide closures\", \"Pre-school, primary, lower secondary, upper secondary, and tertiary education\", \"0 to 3\", \"5 to 8\", \"Nothing happens to the figures\"]", "scores": [{"f1": 0.7058823529411764, "em": false, "chrf": 67.09162441953379, "bleu": 44.239995746479174}, {"f1": 0.380952380952381, "em": false, "chrf": 61.64312200270765, "bleu": 13.664845439199912}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.14285714285714288, "em": false, "chrf": 14.962082226802659, "bleu": 3.564186929405141}], "avg_f1": 0.6459383753501401, "avg_em": 0.4, "avg_chrf": 68.73936572980882, "avg_bleu": 52.293805623016866}
{"id": "Wikipedia_handpicked_5:1915", "en": "Enrolment figures based on latest UNESCO Institute of Statistics data.", "es": "Las cifras de matriculación se calculan sobre la base de los datos más recientes del Instituto de Estadística de la UNESCO.", "perturbation": "alteration", "pert_es": "Las cifras de matriculación se calculan sobre la base de los datos más antiguos del Instituto de Estadística de la UNESCO.", "bt_pert_es": "Enrollment figures are calculated based on older data from the UNESCO Institute for Statistics.", "questions": "[\"What enrolment figures are based on?\", \"Which data source is used for the enrolment figures?\", \"What does the UNESCO Institute of Statistics provide in this context?\"]", "answers": "[\"Older data\", \"UNESCO Institute for Statistics\", \"The data used to calculate enrolment figures\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 7.084566025340393, "bleu": 6.7667641618306344}, {"f1": 0.75, "em": false, "chrf": 81.62345440341757, "bleu": 35.35533905932737}, {"f1": 0.4444444444444445, "em": false, "chrf": 75.30545589194848, "bleu": 13.134549472120794}], "avg_f1": 0.48148148148148145, "avg_em": 0.0, "avg_chrf": 54.67115877356881, "avg_bleu": 18.41888423109293}
{"id": "Wikipedia_handpicked_5:1917", "en": "As of March 12, more than 370 million children and youth are not attending school because of temporary or indefinite country wide school closures mandated by governments in an attempt to slow the spread of COVID-19.", "es": "Al 12 de marzo, más de 370 millones de niños y jóvenes no están asistiendo a clases por el cierre temporal o indefinido de escuelas a nivel nacional dispuesto por los gobiernos en un intento por frenar la propagación de la COVID-19.", "perturbation": "alteration", "pert_es": "Al 12 de marzo, menos de 370 millones de niños y jóvenes están asistiendo a clases por la reapertura temporal o definitiva de escuelas a nivel nacional dispuesto por los gobiernos en un intento por frenar la propagación de la COVID-19.", "bt_pert_es": "As of March 12, less than 370 million children and young people are attending classes due to the temporary or permanent reopening of schools nationwide ordered by governments in an attempt to stop the spread of COVID-19.", "questions": "[\"What is the number of children and youth not attending school as of March 12?\", \"Why are children and youth not attending school?\", \"What type of school closures are causing the absence of children and youth?\", \"Which governments have mandated school closures?\", \"What is the purpose of the school closures?\", \"What is the impact of the school closures on children and youth?\"]", "answers": "[\"More than 370 million\", \"To stop the spread of COVID-19\", \"Temporary or permanent reopening of schools\", \"Governments\", \"To stop the spread of COVID-19\", \"They are not attending classes\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 93.46837666690608, "bleu": 59.460355750136046}, {"f1": 0.25, "em": false, "chrf": 15.736398899020742, "bleu": 2.418023141016355}, {"f1": 0.15384615384615383, "em": false, "chrf": 33.90766301281702, "bleu": 6.870636427700047}, {"f1": 0, "em": false, "chrf": 87.72426647426647, "bleu": 0.0}, {"f1": 0.6, "em": false, "chrf": 72.1282986878962, "bleu": 39.76353643835254}, {"f1": 0.6, "em": false, "chrf": 70.08487856820092, "bleu": 39.76353643835254}], "avg_f1": 0.3923076923076923, "avg_em": 0.0, "avg_chrf": 62.17498038485124, "avg_bleu": 24.712681365926255}
{"id": "Wikipedia_handpicked_5:1920", "en": "Working parents are more likely to miss work when schools close in order to take care of their children, incurring wage loss in many instances and negatively impacting productivity.", "es": "Los padres que trabajan tienen más probabilidades de faltar al trabajo cuando las escuelas cierran para ocuparse de sus hijos, lo que supone una pérdida de ingresos en muchos casos y repercute negativamente en la productividad.", "perturbation": "alteration", "pert_es": "Los padres que no trabajan tienen más probabilidades de faltar al trabajo cuando las escuelas cierran para ocuparse de sus hijos, lo que supone una pérdida de ingresos en muchos casos y repercute negativamente en la productividad.", "bt_pert_es": "Non-working parents are more likely to miss work when schools close to care for their children, resulting in a loss of income in many cases and negatively impacting productivity.", "questions": "[\"Why are working parents more likely to miss work when schools close?\", \"What do working parents do when schools close?\", \"What impact does missing work have on working parents?\", \"What is the effect on productivity when schools close?\", \"What is the consequence of missing work for working parents?\"]", "answers": "[\"Non-working parents are more likely to miss work when schools close to care for their children\", \"Care for their children\", \"A loss of income in many cases and negatively impacting productivity\", \"Negatively impacting productivity\", \"A loss of income in many cases and negatively impacting productivity\"]", "scores": [{"f1": 0.2727272727272727, "em": false, "chrf": 40.14709388760636, "bleu": 5.412989186545265}, {"f1": 0.4444444444444445, "em": false, "chrf": 58.50805120929454, "bleu": 24.880469496253564}, {"f1": 0.6666666666666666, "em": false, "chrf": 64.63391934529328, "bleu": 28.997844147152072}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 64.63391934529328, "bleu": 28.997844147152072}], "avg_f1": 0.6101010101010101, "avg_em": 0.2, "avg_chrf": 65.5845967574975, "avg_bleu": 37.657829395420606}
{"id": "Wikipedia_handpicked_5:1921", "en": "Localised school closures place burdens on schools as parents and officials redirect children to schools that are open.", "es": "El cierre localizado de escuelas implica una presión sobre las escuelas, ya que los padres y los funcionarios trasladan a los niños a las escuelas que están abiertas.", "perturbation": "alteration", "pert_es": "El cierre localizado de escuelas implica una alivio sobre las escuelas, ya que los padres y los funcionarios trasladan a los niños a las escuelas que están abiertas.", "bt_pert_es": "Localized school closures put a strain on schools as parents and officials move children to schools that are open.", "questions": "[\"What burdens do localised school closures place on schools?\", \"Who redirects children to schools that are open?\", \"Why do parents and officials redirect children to open schools?\", \"What happens when schools are locally closed?\"]", "answers": "[\"A strain\", \"Parents and officials\", \"To avoid the closed schools\", \"Children are moved to schools that are open\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.578192136300414, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.18181818181818182, "em": false, "chrf": 7.737305922744395, "bleu": 7.545383788761362}, {"f1": 0.3846153846153846, "em": false, "chrf": 27.568523457153248, "bleu": 14.811528845667098}], "avg_f1": 0.3916083916083916, "avg_em": 0.25, "avg_chrf": 34.471005379049515, "avg_bleu": 30.589228158607124}
{"id": "Wikipedia_handpicked_5:1927", "en": "In the United States, numerous major cities announced public library closures, including Los Angeles, San Francisco, Seattle, and New York City, affecting 221 libraries.", "es": "En Estados Unidos, muchas ciudades importantes, incluidas Los Ángeles, San Francisco, Seattle y Nueva York, anunciaron el cierre de bibliotecas públicas, que afecta a 221 bibliotecas.", "perturbation": "alteration", "pert_es": "En Estados Unidos, muchas ciudades importantes, incluidas Los Ángeles, San Francisco, Seattle y Nueva York, anunciaron la apertura de bibliotecas públicas, que afecta a 221 bibliotecas.", "bt_pert_es": "In the United States, many major cities, including Los Angeles, San Francisco, Seattle and New York, announced the opening of public libraries, affecting 221 libraries.", "questions": "[\"Which major cities in the United States announced public library closures?\", \"Which cities are specifically mentioned as having announced public library closures?\", \"How many libraries were affected by the closures?\", \"What was the impact of the public library closures?\", \"What is the context of the public library closures?\"]", "answers": "[\"None\", \"None\", \"221\", \"The opening of public libraries\", \"In the United States, many major cities, including Los Angeles, San Francisco, Seattle and New York, announced the opening of public libraries\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.687499999999999, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.840909090909091, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.25, "em": false, "chrf": 39.39017845630742, "bleu": 10.682175159905853}, {"f1": 0.7906976744186046, "em": false, "chrf": 69.0059234241256, "bleu": 45.3680677593717}], "avg_f1": 0.40813953488372096, "avg_em": 0.2, "avg_chrf": 43.18490219426842, "avg_bleu": 31.210048583855517}
{"id": "Wikipedia_handpicked_5:1930", "en": "In the absence of alternative options, working parents often leave children alone when schools close and this can lead to risky behaviours, including increased influence of peer pressure and substance abuse.", "es": "Ante la falta de opciones alternativas, los padres que trabajan suelen dejar a los hijos solos cuando las escuelas cierran y esto puede dar lugar a comportamientos de riesgo, que incluyen una mayor influencia de la presión de los compañeros y el uso indebido de sustancias.", "perturbation": "alteration", "pert_es": "Ante la abundancia de opciones alternativas, los padres que trabajan suelen dejar a los hijos solos cuando las escuelas cierran y esto puede dar lugar a comportamientos de riesgo, que incluyen una mayor influencia de la presión de los compañeros y el uso indebido de sustancias.", "bt_pert_es": "Faced with an abundance of alternative options, working parents often leave children alone when schools close and this can lead to risky behaviors, including increased influence from peer pressure and substance abuse.", "questions": "[\"What happens when schools close for working parents?\", \"Why do working parents leave children alone when schools close?\", \"What risky behaviours can occur when schools close?\", \"What specific risky behaviours are mentioned?\", \"What role does peer pressure play in this situation?\", \"What is the connection between school closures and substance abuse?\"]", "answers": "[\"Working parents leave children alone\", \"Because they have an abundance of alternative options\", \"Risky behaviors, including increased influence from peer pressure and substance abuse\", \"Increased influence from peer pressure and substance abuse\", \"Peer pressure increases and can influence children's decisions\", \"School closures lead to increased substance abuse\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4615384615384615, "em": false, "chrf": 69.45609471944066, "bleu": 14.535768424205482}, {"f1": 0.15384615384615385, "em": false, "chrf": 42.07978141322674, "bleu": 3.7477767366779213}, {"f1": 0.875, "em": false, "chrf": 90.08024671477143, "bleu": 59.460355750136046}, {"f1": 0.7999999999999999, "em": false, "chrf": 95.39630029076109, "bleu": 68.037493331712}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7150641025641026, "avg_em": 0.3333333333333333, "avg_chrf": 82.83540385636665, "avg_bleu": 57.630232373788594}
{"id": "Wikipedia_handpicked_5:1934", "en": "Every year, nearly 30 million children rely on schools to provide free or low-cost meals including breakfast, lunch, snacks, and even dinner.In Alabama, where state-wide school closures as of 18 March have affected over 720,000 students, the state Superintendent announced that staff in schools disproportionately affected by poverty would create meal distribution networks to provide food for students who rely on school lunches.", "es": "Cada año, casi 30 millones de niños reciben comidas gratuitas o de bajo costo en las escuelas, incluidos el desayuno, el almuerzo, refrigerios, e incluso la cena. En Alabama, donde el cierre de escuelas desde el 18 de marzo ha afectado a más de 720 000 estudiantes, el superintendente del estado anunció que el personal de las escuelas afectado de manera desproporcionada por la pobreza crearía redes de distribución de comidas para proporcionar alimentos a los estudiantes que necesitan los almuerzos escolares.", "perturbation": "alteration", "pert_es": "Cada año, casi 30 millones de niños pagan comidas caras en las escuelas, incluidos el desayuno, el almuerzo, refrigerios, e incluso la cena. En Alabama, donde el cierre de escuelas desde el 18 de marzo ha afectado a más de 720 000 estudiantes, el superintendente del estado anunció que el personal de las escuelas afectado de manera desproporcionada por la pobreza crearía redes de distribución de comidas para proporcionar alimentos a los estudiantes que no necesitan los almuerzos escolares.", "bt_pert_es": "Every year, nearly 30 million children pay for expensive school meals, including breakfast, lunch, snacks, and even dinner. In Alabama, where school closures since March 18 have affected more than 720,000 students, the state superintendent announced that school staff disproportionately affected by poverty would create meal distribution networks to provide food to students who do not need school lunches.", "questions": "[\"How many children rely on schools to provide free or low-cost meals every year?\", \"What types of meals do schools provide for children?\", \"How many students in Alabama were affected by school closures as of 18 March?\", \"What action did the state Superintendent announce in Alabama?\", \"Which students are specifically mentioned as being disproportionately affected by poverty?\", \"What is the purpose of the meal distribution networks created by school staff in Alabama?\"]", "answers": "[\"30 million\", \"breakfast, lunch, snacks, and even dinner\", \"720,000\", \"School staff disproportionately affected by poverty would create meal distribution networks to provide food to students who do not need school lunches\", \"Students who do not need school lunches\", \"To provide food to students who do not need school lunches\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7272727272727273, "em": false, "chrf": 83.04767504186471, "bleu": 57.1439251238529}, {"f1": 0.6153846153846153, "em": false, "chrf": 69.3209930013331, "bleu": 18.575057999133602}, {"f1": 0.6666666666666666, "em": false, "chrf": 68.64884809303456, "bleu": 20.504572236241867}], "avg_f1": 0.8348873348873349, "avg_em": 0.5, "avg_chrf": 86.83625268937207, "avg_bleu": 66.03725922653808}
{"id": "Wikipedia_handpicked_5:1936", "en": "Schooling provides essential learning and when schools close, children and youth are deprived opportunities for growth and development.", "es": "La escolarización ofrece aprendizajes fundamentales y cuando las escuelas cierran, los niños y jóvenes se quedan sin oportunidades de crecimiento y desarrollo.", "perturbation": "alteration", "pert_es": "La escolarización ofrece aprendizajes fundamentales y cuando las escuelas abren, los niños y jóvenes se quedan con oportunidades de crecimiento y desarrollo.", "bt_pert_es": "Schooling offers fundamental learning and when schools open, children and young people are left with opportunities for growth and development.", "questions": "[\"What does schooling provide?\", \"What happens when schools close?\", \"What opportunities are children and youth deprived of when schools close?\", \"What is the impact of school closure on children and youth?\"]", "answers": "[\"Fundamental learning\", \"Children and young people are left without opportunities for growth and development\", \"Opportunities for growth and development\", \"Children and youth are deprived of opportunities for growth and development\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 55.658142229879914, "bleu": 49.99999999999999}, {"f1": 0.7272727272727272, "em": false, "chrf": 76.02571095346603, "bleu": 37.7006380454947}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9523809523809523, "em": false, "chrf": 96.53605732290622, "bleu": 70.16879391277372}], "avg_f1": 0.7949134199134199, "avg_em": 0.25, "avg_chrf": 82.05497762656304, "avg_bleu": 64.46735798956712}
{"id": "Wikipedia_handpicked_5:1937", "en": "The disadvantages are disproportionate for under-privileged learners who tend to have fewer educational opportunities beyond school.Student drop-out rates tend to increase as an effect of school closures due to the challenge of ensuring all students return to school once school closures ends.", "es": "Las desventajas son desproporcionadas para los estudiantes con menos privilegios, que suelen tener menos oportunidades educativas fuera de la escuela. Las tasas de deserción escolar tienden a aumentar como consecuencia del cierre de las escuelas debido al desafío de garantizar que todos los estudiantes regresen a clases cuando finalicen los cierres.", "perturbation": "alteration", "pert_es": "Las ventajas son desproporcionadas para los estudiantes con menos privilegios, que suelen tener menos oportunidades educativas fuera de la escuela. Las tasas de deserción escolar tienden a disminuir como consecuencia del cierre de las escuelas debido al desafío de garantizar que todos los estudiantes regresen a clases cuando finalicen los cierres.", "bt_pert_es": "The advantages are disproportionate for less privileged students, who often have fewer educational opportunities outside of school. Dropout rates tend to decline as a result of school closures due to the challenge of ensuring that all students return to class when closures end.", "questions": "[\"What are the disadvantages for under-privileged learners?\", \"Why do under-privileged learners have fewer educational opportunities beyond school?\", \"How do school closures affect student drop-out rates?\", \"What challenge makes it difficult to ensure all students return to school after closures?\", \"What is the effect of school closures on student drop-out rates?\"]", "answers": "[\"The disadvantages are not specified in the sentence\", \"The reason is not specified in the sentence\", \"School closures tend to reduce dropout rates\", \"The challenge of ensuring that all students return to class when closures end\", \"Dropout rates decline\"]", "scores": [{"f1": 0, "em": false, "chrf": 18.876332521565985, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 13.941160446987139, "bleu": 0.0}, {"f1": 0.6153846153846153, "em": false, "chrf": 50.60075528780652, "bleu": 18.575057999133602}, {"f1": 0.5217391304347826, "em": false, "chrf": 58.55290067101193, "bleu": 22.997519112894437}, {"f1": 0.2222222222222222, "em": false, "chrf": 34.881862294626565, "bleu": 10.122592925934278}], "avg_f1": 0.271869193608324, "avg_em": 0.0, "avg_chrf": 35.37060224439963, "avg_bleu": 10.339034007592463}
{"id": "Wikipedia_handpicked_5:1941", "en": "Potential impacts of school closures and reliance on distance learning are not addressed in federal acts of legislation at this time.", "es": "Las posibles consecuencias del cierre de escuelas y la adopción de la educación a distancia no forman parte de las leyes federales en este momento.", "perturbation": "alteration", "pert_es": "Las posibles consecuencias del cierre de escuelas y la adopción de la educación presencial no forman parte de las leyes federales en este momento.", "bt_pert_es": "The possible consequences of school closures and the move to in-person education are not part of federal law at this time.", "questions": "[\"What potential impacts are not addressed in federal acts of legislation?\", \"What is the current status of federal legislation regarding school closures and distance learning?\", \"What aspects of school closures and distance learning are missing from federal legislation?\"]", "answers": "[\"The possible consequences of school closures and the move to in-person education\", \"The current status of federal legislation regarding school closures and distance learning is that it is not established at this time\", \"The possible consequences of school closures and the move to in-person education\"]", "scores": [{"f1": 0.380952380952381, "em": false, "chrf": 38.931555180294865, "bleu": 23.462350320528007}, {"f1": 0.23076923076923073, "em": false, "chrf": 31.54203897642653, "bleu": 6.7602298845717375}, {"f1": 0.380952380952381, "em": false, "chrf": 38.931555180294865, "bleu": 23.462350320528007}], "avg_f1": 0.3308913308913309, "avg_em": 0.0, "avg_chrf": 36.46838311233875, "avg_bleu": 17.894976841875916}
{"id": "Wikipedia_handpicked_5:1942", "en": "Formal education — as opposed to informal education or non-formal education — tends to refer to schools, colleges, universities and training institutions.", "es": "La educación formal (en contraposición a la educación informal o no formal) suele referirse a escuelas, universidades, centros de enseñanza superior e instituciones de formación.", "perturbation": "alteration", "pert_es": "La educación informal (en contraposición a la educación formal o no formal) suele referirse a escuelas, universidades, centros de enseñanza superior e instituciones de formación.", "bt_pert_es": "Informal education (as opposed to formal or non-formal education) usually refers to schools, universities, colleges and training institutions.", "questions": "[\"What is formal education?\", \"What is the difference between formal education and informal education?\", \"What is the difference between formal education and non-formal education?\", \"What institutions are included in formal education?\", \"What types of institutions are mentioned in the sentence?\"]", "answers": "[\"Not specified in the sentence\", \"Informal education is contrasted with formal or non-formal education\", \"Not specified in the sentence\", \"Schools, universities, colleges and training institutions\", \"Schools, universities, colleges and training institutions\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.660854608170321, "bleu": 0.0}, {"f1": 0.16666666666666669, "em": false, "chrf": 33.66155906759149, "bleu": 2.910967817713898}, {"f1": 0, "em": false, "chrf": 4.917200539021957, "bleu": 0.0}, {"f1": 1.0, "em": false, "chrf": 90.55988111145372, "bleu": 35.930411196308434}, {"f1": 1.0, "em": false, "chrf": 90.55988111145372, "bleu": 35.930411196308434}], "avg_f1": 0.4333333333333333, "avg_em": 0.0, "avg_chrf": 45.271875287538236, "avg_bleu": 14.954358042066152}
{"id": "Wikipedia_handpicked_5:1943", "en": "A 1974 report by the World Bank defined formal education as the following:Formal education: the hierarchically structured, chronologically graded ‘education system’, running from primary school through the university and including, in addition to general academic studies, a variety of specialised programmes and institutions for full-time technical and professional training.The majority of data collected on the number of students and learners impacted by COVID-19 has been calculated based on the closure of formal education systems.", "es": "Un informe del Banco Mundial de 1974 definió a la educación formal de la siguiente manera. Educación formal: \"sistema educativo\" estructurado jerárquicamente y clasificado cronológicamente que abarca desde la escuela primaria hasta la universidad e incluye, además de estudios académicos generales, una variedad de programas e instituciones especializados para la formación profesional y técnica a tiempo completo. La mayoría de los datos recolectados sobre la cantidad de estudiantes y alumnos afectados por la COVID-19 se ha calculado en función del cierre de los sistemas de educación formal.", "perturbation": "alteration", "pert_es": "Un informe del Banco Mundial de 1974 definió a la educación informal de la siguiente manera. Educación informal: \"sistema educativo\" estructurado jerárquicamente y clasificado cronológicamente que abarca desde la escuela primaria hasta la universidad e incluye, además de estudios académicos generales, una variedad de programas e instituciones especializados para la formación profesional y técnica a tiempo completo. La mayoría de los datos recolectados sobre la cantidad de estudiantes y alumnos afectados por la COVID-19 se ha calculado en función del cierre de los sistemas de educación informal.", "bt_pert_es": "A 1974 World Bank report defined informal education as follows. Informal education: A hierarchically structured and chronologically classified \"educational system\" that extends from primary school to university and includes, in addition to general academic studies, a variety of specialized programs and institutions for full-time vocational and technical training. Most of the data collected on the number of students and pupils affected by COVID-19 has been calculated based on the closure of informal education systems.", "questions": "[\"What does the World Bank define as formal education?\", \"What components are included in formal education according to the World Bank?\", \"What is the structure of formal education?\", \"What types of training are included in formal education?\", \"How has the data on students and learners impacted by COVID-19 been calculated?\", \"What factor has been used to calculate the data on students and learners impacted by COVID-19?\"]", "answers": "[\"The sentence does not define formal education.\", \"General academic studies and specialized programs and institutions for full-time vocational and technical training.\", \"A hierarchically structured and chronologically classified educational system.\", \"Full-time vocational and technical training.\", \"Based on the closure of informal education systems.\", \"The closure of informal education systems\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.219480095700302, "bleu": 0.0}, {"f1": 0.6206896551724138, "em": false, "chrf": 70.11555489691935, "bleu": 21.784658682446647}, {"f1": 0.3, "em": false, "chrf": 50.58257178462651, "bleu": 7.413670083653379}, {"f1": 0.4, "em": false, "chrf": 34.366734966721666, "bleu": 5.171845311465849}, {"f1": 0.6666666666666666, "em": false, "chrf": 72.70072537410041, "bleu": 26.647313141084275}, {"f1": 0.7272727272727272, "em": false, "chrf": 87.75971628644513, "bleu": 22.957488466614326}], "avg_f1": 0.4524381748519679, "avg_em": 0.0, "avg_chrf": 53.79079723408557, "avg_bleu": 13.995829280877414}
{"id": "Wikipedia_handpicked_5:1944", "en": "The UNESCO Institute for Statistics provides figures on students impacted by COVID-19 corresponding to the number of learners enrolled at pre-primary, primary, lower-secondary, and upper-secondary levels of education [ISCED levels 0 to 3], as well as at tertiary education levels [ISCED levels 5 to 8].", "es": "El Instituto de Estadística de la UNESCO proporciona cifras sobre los estudiantes afectados por la COVID-19 correspondientes a la cantidad de alumnos matriculados en los niveles de educación preescolar, primaria, primer y segundo ciclo de educación secundaria (niveles 0 a 3 de la CINE), así como en los niveles de educación terciaria (niveles 5 a 8 de la CINE).", "perturbation": "alteration", "pert_es": "El Instituto de Estadística de la UNESCO no proporciona cifras sobre los estudiantes afectados por la COVID-19 correspondientes a la cantidad de alumnos matriculados en los niveles de educación preescolar, primaria, primer y segundo ciclo de educación secundaria (niveles 0 a 3 de la CINE), así como en los niveles de educación terciaria (niveles 5 a 8 de la CINE).", "bt_pert_es": "The UNESCO Institute for Statistics does not provide figures on students affected by COVID-19 corresponding to the number of students enrolled in pre-school, primary, lower and upper secondary education levels (ISCED levels 0 to 3), as well as tertiary education levels (ISCED levels 5 to 8).", "questions": "[\"What does the UNESCO Institute for Statistics provide?\", \"What types of education levels are included in the figures?\", \"Which ISCED levels correspond to pre-primary, primary, lower-secondary, and upper-secondary education?\", \"Which ISCED levels correspond to tertiary education?\", \"What data is provided regarding students impacted by COVID-19?\"]", "answers": "[\"Figures on students affected by COVID-19 corresponding to the number of students enrolled in pre-school, primary, lower and upper secondary education levels (ISCED levels 0 to 3), as well as tertiary education levels (ISCED levels 5 to 8)\", \"Pre-school, primary, lower and upper secondary education levels (ISCED levels 0 to 3), as well as tertiary education levels (ISCED levels 5 to 8)\", \"0 to 3\", \"5 to 8\", \"No data\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 75.02976305194224, "bleu": 52.98863358466359}, {"f1": 0.25806451612903225, "em": false, "chrf": 53.891797977606515, "bleu": 3.7419436034576052}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 3.4840255190644758, "bleu": 0.0}], "avg_f1": 0.6116129032258064, "avg_em": 0.4, "avg_chrf": 66.48111730972265, "avg_bleu": 51.346115437624256}
{"id": "Wikipedia_handpicked_5:1946", "en": "While many primary and secondary schools have closed around the world due to COVID-19, measures impacting early childhood educational programmes have varied.", "es": "Si bien muchas escuelas primarias y secundarias de todo el mundo cerraron por la COVID-19, las medidas que afectan a los programas educativos para la primera infancia han sido variadas.", "perturbation": "alteration", "pert_es": "Si bien muchas escuelas primarias y secundarias de todo el mundo abrieron por la COVID-19, las medidas que afectan a los programas educativos para la primera infancia han sido variadas.", "bt_pert_es": "While many primary and secondary schools around the world have opened due to COVID-19, measures affecting early childhood education programs have been varied.", "questions": "[\"What has happened to many primary and secondary schools due to COVID-19?\", \"What measures have impacted early childhood educational programmes?\", \"How have measures impacting early childhood educational programmes varied?\", \"What is the effect of COVID-19 on schools?\", \"What types of educational programmes are affected by COVID-19?\"]", "answers": "[\"They have opened\", \"Measures affecting early childhood education programs\", \"The measures have been varied\", \"Many primary and secondary schools have opened\", \"Early childhood education programs\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 51.482961482961485, "bleu": 55.03212081491043}, {"f1": 0.42857142857142855, "em": false, "chrf": 63.239776470067824, "bleu": 12.872632311973014}, {"f1": 0.5, "em": false, "chrf": 41.85585826541275, "bleu": 12.70331870386537}, {"f1": 0.2, "em": false, "chrf": 45.11506232853998, "bleu": 6.567274736060395}, {"f1": 0.5, "em": false, "chrf": 78.99894681527545, "bleu": 31.947155212313625}], "avg_f1": 0.45904761904761904, "avg_em": 0.0, "avg_chrf": 56.138521072451496, "avg_bleu": 23.824500355824565}
{"id": "Wikipedia_handpicked_5:1947", "en": "In some countries and territories, preschools and day cares are considered necessary services and have not closed in tandem with broader school closure measures.In the United States, the Washington State Department of Children, Youth, and Families encouraged child care and early learning centres to stay open.", "es": "En algunos países y territorios, los centros de educación preescolar y guarderías son considerados servicios esenciales y no se han cerrado, junto con medidas más amplias de cierre de escuelas. En Estados Unidos, el Departamento de Niños, Jóvenes y Familias del estado de Washington instó a los centros de cuidado infantil y de educación temprana a que permanezcan abiertos.", "perturbation": "alteration", "pert_es": "En algunos países y territorios, los centros de educación preescolar y guarderías son considerados servicios no esenciales y se han cerrado, junto con medidas más amplias de cierre de escuelas. En Estados Unidos, el Departamento de Niños, Jóvenes y Familias del estado de Washington instó a los centros de cuidado infantil y de educación temprana a que permanezcan cerrados.", "bt_pert_es": "In some countries and territories, preschools and childcare centers are considered non-essential services and have been closed, along with broader school closure measures. In the United States, the Washington State Department of Children, Youth and Families urged child care and early education centers to remain closed.", "questions": "[\"In which countries and territories are preschools and day cares considered necessary services?\", \"Why have preschools and day cares not closed in tandem with broader school closure measures?\", \"What did the Washington State Department of Children, Youth, and Families encourage regarding child care and early learning centres?\", \"What is the reason for the continued operation of child care and early learning centres in the United States?\", \"What is the relationship between school closure measures and preschool or day care operations?\"]", "answers": "[\"None mentioned\", \"They are not considered non-essential services in those regions\", \"To remain closed\", \"Because they are considered non-essential services\", \"Preschools and day cares have been closed in tandem with broader school closure measures in some countries and territories\"]", "scores": [{"f1": 0, "em": false, "chrf": 9.012745350685048, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 48.31375483405161, "bleu": 6.27465531099474}, {"f1": 0.3333333333333333, "em": false, "chrf": 14.204316662639929, "bleu": 27.516060407455225}, {"f1": 0.08, "em": false, "chrf": 13.7303592100472, "bleu": 0.9298395269585749}, {"f1": 0.6666666666666667, "em": false, "chrf": 65.4337602161171, "bleu": 52.92523437057238}], "avg_f1": 0.296, "avg_em": 0.0, "avg_chrf": 30.138987254708177, "avg_bleu": 17.529157923196184}
{"id": "Wikipedia_handpicked_5:1949", "en": "The governor of Maryland mandated that specific child care services remain open for the children of emergency personnel while Washington State and California have left it to the discretion of care providers.", "es": "El gobernador de Maryland ordenó que ciertos servicios de cuidado infantil permanecieran abiertos para los hijos del personal de emergencia, mientras que los estados de Washington y California lo dejaron a discreción de los proveedores de cuidado.", "perturbation": "alteration", "pert_es": "El gobernador de Maryland ordenó que ciertos servicios de cuidado infantil permanecieran cerrados para los hijos del personal de emergencia, mientras que los estados de Washington y California lo dejaron a discreción de los proveedores de cuidado.", "bt_pert_es": "Maryland's governor ordered certain child care services to remain closed to children of first responders, while Washington state and California left it up to care providers' discretion.", "questions": "[\"What did the governor of Maryland mandate regarding child care services?\", \"Which states have left child care service decisions to care providers?\", \"What services are required to remain open in Maryland?\", \"Who are the children eligible for continued child care services?\", \"What is the reason for the difference in child care policies between Maryland and other states?\"]", "answers": "[\"Certain child care services to remain closed to children of first responders\", \"Washington state and California\", \"None specified\", \"Children of first responders\", \"Maryland's governor ordered closures for children of first responders, while other states left decisions to care providers' discretion\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 45.69667317327389, "bleu": 16.59038701421972}, {"f1": 0.75, "em": false, "chrf": 85.760402104605, "bleu": 35.35533905932737}, {"f1": 0, "em": false, "chrf": 20.541625711550296, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 37.205760927832074, "bleu": 31.947155212313625}, {"f1": 0.28571428571428575, "em": false, "chrf": 38.844229671904415, "bleu": 9.083627868206413}], "avg_f1": 0.40714285714285714, "avg_em": 0.0, "avg_chrf": 45.609738317833134, "avg_bleu": 18.595301830813426}
{"id": "Wikipedia_handpicked_5:1950", "en": "California Governor Gavin Newsom explained his state's position, saying “We need our child care facilities, our daycare centers, to operate to absorb the impact of these school closures.”", "es": "El gobernador de California Gavin Newsom explicó la posición de su estado y afirmó: \"Necesitamos que los centros de cuidado infantil, las guarderías, funcionen para amortiguar el impacto del cierre de las escuelas\".", "perturbation": "alteration", "pert_es": "El gobernador de California Gavin Newsom explicó la posición de su estado y afirmó: \"Necesitamos que los centros de cuidado infantil, las guarderías, no funcionen para amortiguar el impacto del cierre de las escuelas\".", "bt_pert_es": "California Governor Gavin Newsom explained his state's position, saying: \"We need to keep child care centers, daycares, down to cushion the impact of school closures.\"", "questions": "[\"What did California Governor Gavin Newsom say about child care facilities?\", \"Why are child care facilities important according to Governor Newsom?\", \"What is the impact of school closures that child care facilities are meant to absorb?\", \"What specific facilities does Governor Newsom mention?\", \"What is the state's position on school closures as explained by Governor Newsom?\"]", "answers": "[\"California Governor Gavin Newsom said we need to keep child care centers and daycares to cushion the impact of school closures\", \"To cushion the impact of school closures\", \"The impact of school closures\", \"Child care centers and daycares\", \"To keep child care centers and daycares to cushion the impact of school closures\"]", "scores": [{"f1": 0.7804878048780488, "em": false, "chrf": 69.73642224579123, "bleu": 35.11740837036257}, {"f1": 0.8333333333333334, "em": false, "chrf": 73.0621778794173, "bleu": 53.7284965911771}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7272727272727272, "em": false, "chrf": 68.95396665957307, "bleu": 20.801195378010608}, {"f1": 0.5999999999999999, "em": false, "chrf": 54.9266265057591, "bleu": 18.710040685001186}], "avg_f1": 0.7882187730968219, "avg_em": 0.2, "avg_chrf": 73.33583865810814, "avg_bleu": 45.6714282049103}
{"id": "Wikipedia_handpicked_5:1951", "en": "Colorado has encouraged the development of \"tool kits\" for parents to use at home to emulate the lessons children would have received in their early learning programmes.In Japan, Prime Minister Shinzo Abe closed all schools throughout the country until April 8, however, children's daycare facilities were excluded.", "es": "Colorado alentó el desarrollo de \"kits de herramientas\" para padres para que los utilicen en casa con el fin de simular las clases que sus hijos habrían tenido en los programas de aprendizaje temprano. En Japón, el primer ministro Shinzo Abe cerró todas las escuelas del país hasta el 8 de abril, pero con la excepción de los centros de cuidado infantil.", "perturbation": "alteration", "pert_es": "Colorado desalentó el desarrollo de \"kits de herramientas\" para padres para que los utilicen en casa con el fin de simular las clases que sus hijos habrían tenido en los programas de aprendizaje temprano. En Japón, el primer ministro Shinzo Abe abrió todas las escuelas del país hasta el 8 de abril, pero con la excepción de los centros de cuidado infantil.", "bt_pert_es": "Colorado discouraged the development of “tool kits” for parents to use at home to simulate the classes their children would have had in early learning programs. In Japan, Prime Minister Shinzo Abe opened all schools in the country until April 8, but with the exception of child care centers.", "questions": "[\"What has Colorado encouraged for parents to use at home?\", \"What are the 'tool kits' designed to emulate?\", \"What lessons are children expected to receive in early learning programmes?\", \"What action did Prime Minister Shinzo Abe take regarding schools in Japan?\", \"Until when were schools closed in Japan?\", \"Why were children's daycare facilities excluded from the school closure in Japan?\"]", "answers": "[\"The development of 'tool kits' for parents to use at home\", \"The classes their children would have had in early learning programs\", \"The lessons in early learning programs\", \"Prime Minister Shinzo Abe opened all schools in the country\", \"April 8\", \"Because they are child care centers\"]", "scores": [{"f1": 0.625, "em": false, "chrf": 83.61377915948154, "bleu": 35.08439695638686}, {"f1": 0.7272727272727273, "em": false, "chrf": 62.08591359226491, "bleu": 19.72940627795883}, {"f1": 0.5882352941176471, "em": false, "chrf": 45.565220601752294, "bleu": 10.54969271144651}, {"f1": 0.7777777777777778, "em": false, "chrf": 65.86360017807692, "bleu": 36.88939732334405}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.16666666666666666, "em": false, "chrf": 29.569402199863283, "bleu": 8.116697886877475}], "avg_f1": 0.6474920776391365, "avg_em": 0.16666666666666666, "avg_chrf": 64.4496526219065, "avg_bleu": 35.06159852600229}
{"id": "Wikipedia_handpicked_5:1958", "en": "Tertiary education is normally taken to include undergraduate and postgraduate education, as well as vocational education and training.", "es": "Normalmente, se considera que la educación terciaria incluye la educación de grado y posgrado, así como la educación y formación técnica profesional.", "perturbation": "alteration", "pert_es": "Normalmente, se considera que la educación terciaria excluye la educación de grado y posgrado, así como la educación y formación técnica profesional.", "bt_pert_es": "Tertiary education is typically considered to exclude undergraduate and postgraduate education, as well as vocational technical education and training.", "questions": "[\"What does tertiary education normally include?\", \"What types of education are included in tertiary education?\", \"What is considered part of tertiary education?\", \"What is the difference between undergraduate, postgraduate, and vocational education in the context of tertiary education?\"]", "answers": "[\"None\", \"Undergraduate and postgraduate education, vocational technical education and training\", \"Undergraduate and postgraduate education, vocational technical education and training\", \"Undergraduate and postgraduate education and vocational technical education and training are excluded from tertiary education\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.6518975643816487, "bleu": 0.0}, {"f1": 0.8888888888888888, "em": false, "chrf": 78.22024570342451, "bleu": 25.098621243978968}, {"f1": 0.7999999999999999, "em": false, "chrf": 84.47225274696642, "bleu": 35.73880113629118}, {"f1": 0.36, "em": false, "chrf": 38.280982061884735, "bleu": 4.267272205987387}], "avg_f1": 0.5122222222222221, "avg_em": 0.0, "avg_chrf": 50.65634451916433, "avg_bleu": 16.276173646564384}
{"id": "Wikipedia_handpicked_5:1959", "en": "Individuals who complete tertiary education generally receive certificates, diplomas, or academic degrees.", "es": "Las personas que finalizan la educación terciaria, en general, reciben certificados, diplomas o títulos académicos.", "perturbation": "alteration", "pert_es": "Las personas que abandonan la educación terciaria, en general, reciben certificados, diplomas o títulos académicos.", "bt_pert_es": "People who leave tertiary education generally receive certificates, diplomas or academic degrees.", "questions": "[\"What do individuals who complete tertiary education generally receive?\", \"What types of credentials are awarded after completing tertiary education?\", \"What is tertiary education?\", \"What is the relationship between tertiary education and certificates, diplomas, or academic degrees?\"]", "answers": "[\"Certificates, diplomas, or academic degrees\", \"Certificates, diplomas, or academic degrees\", \"Tertiary education refers to higher education levels such as undergraduate, graduate, or professional degrees\", \"Individuals who complete tertiary education are generally awarded certificates, diplomas, or academic degrees\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.08695652173913043, "em": false, "chrf": 37.81197898114655, "bleu": 2.8398387225677895}, {"f1": 0.8799999999999999, "em": false, "chrf": 86.66052209666833, "bleu": 59.230330720232516}], "avg_f1": 0.7417391304347826, "avg_em": 0.5, "avg_chrf": 81.11812526945371, "avg_bleu": 65.51754236070009}
{"id": "Wikipedia_handpicked_5:1960", "en": "Undergraduate education is education conducted after secondary education and prior to post-graduate education, for which the learner is typically awarded a bachelor's degree.", "es": "La educación de grado es posterior a la educación secundaria y anterior a la educación de posgrado, por la que se suele obtener un título universitario de grado.", "perturbation": "alteration", "pert_es": "La educación de grado es anterior a la educación secundaria y posterior a la educación de posgrado, por la que se suele obtener un título universitario de grado.", "bt_pert_es": "Undergraduate education comes before secondary education and after graduate education, which usually results in a bachelor's degree.", "questions": "[\"What is undergraduate education?\", \"What is the sequence of education that includes undergraduate education?\", \"What degree is typically awarded after undergraduate education?\", \"What type of education follows secondary education?\", \"What type of education precedes post-graduate education?\"]", "answers": "[\"Undergraduate education is a level of education that comes before secondary education and after graduate education, which usually results in a bachelor's degree.\", \"The sequence of education that includes undergraduate education is graduate education, undergraduate education, and secondary education.\", \"A bachelor's degree\", \"Undergraduate education\", \"Secondary education\"]", "scores": [{"f1": 0.3225806451612903, "em": false, "chrf": 56.689638971036935, "bleu": 7.681104116622756}, {"f1": 0.36363636363636365, "em": false, "chrf": 73.57946992098327, "bleu": 9.78237574896145}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 38.96584639693481, "bleu": 49.99999999999999}], "avg_f1": 0.6372434017595308, "avg_em": 0.4, "avg_chrf": 73.846991057791, "avg_bleu": 53.49269597311686}
{"id": "Wikipedia_handpicked_5:1961", "en": "Students enrolled in higher education programmes at colleges, universities, and community colleges are often refereed to in countries such as United States as \"college students.\"The closure of colleges and universities has widespread implications for students, faculty, administrators, and the institutions themselves.", "es": "Los estudiantes matriculados en programas de educación superior en facultades, universidades y centros de formación superior suelen denominarse \"estudiantes universitarios\" en países como Estados Unidos. El cierre de facultades y universidades tiene consecuencias masivas para los estudiantes, los profesores, los administradores y las mismas instituciones.", "perturbation": "alteration", "pert_es": "Los estudiantes matriculados en programas de educación superior en facultades, universidades y centros de formación superior suelen denominarse \"estudiantes universitarios\" en países como Estados Unidos. La apertura de facultades y universidades tiene consecuencias masivas para los estudiantes, los profesores, los administradores y las mismas instituciones.", "bt_pert_es": "Students enrolled in higher education programs at colleges, universities, and community colleges are often referred to as \"university students\" in countries such as the United States. The opening of colleges and universities has massive consequences for students, faculty, administrators, and the institutions themselves.", "questions": "[\"What are students enrolled in higher education programmes often referred to as in the United States?\", \"What are the widespread implications of the closure of colleges and universities?\", \"Who are affected by the closure of colleges and universities?\", \"What types of institutions are mentioned in the sentence?\", \"What is the term used for students in the United States?\"]", "answers": "[\"university students\", \"The opening of colleges and universities has massive consequences for students, faculty, administrators, and the institutions themselves.\", \"students, faculty, administrators, and the institutions themselves\", \"colleges, universities, and community colleges\", \"university students\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 42.0422565198371, "bleu": 49.99999999999999}, {"f1": 0.56, "em": false, "chrf": 70.92483608022876, "bleu": 37.23909894939824}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 42.0422565198371, "bleu": 49.99999999999999}], "avg_f1": 0.712, "avg_em": 0.4, "avg_chrf": 71.00186982398058, "avg_bleu": 67.44781978987967}
{"id": "Wikipedia_handpicked_5:1962", "en": "Colleges and universities across the United States have been called upon to issue refunds to students for the cost of tuition and room and board.", "es": "Se ha pedido a las facultades y universidades de Estados Unidos que emitan reembolsos a los estudiantes por el monto de la matrícula, el alojamiento y la comida.", "perturbation": "alteration", "pert_es": "Se ha pedido a las facultades y universidades de Estados Unidos que retengan los pagos a los estudiantes por el monto de la matrícula, el alojamiento y la comida.", "bt_pert_es": "Colleges and universities in the United States have been asked to withhold payments to students for tuition, room and board.", "questions": "[\"What have colleges and universities across the United States been called upon to do?\", \"What costs are students being refunded for?\", \"What specific expenses are included in the refunds?\", \"Which institutions are involved in issuing refunds?\", \"What is the reason for issuing refunds to students?\"]", "answers": "[\"Withhold payments to students\", \"Tuition\", \"Tuition, room and board\", \"Colleges and universities in the United States\", \"Students are being refunded for tuition, room and board\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 43.650129853198585, "bleu": 31.947155212313625}, {"f1": 0, "em": false, "chrf": 15.00818404552356, "bleu": 0.0}, {"f1": 0.888888888888889, "em": false, "chrf": 73.03371208041965, "bleu": 49.76093899250716}, {"f1": 0.8333333333333334, "em": false, "chrf": 79.3279020288092, "bleu": 37.99178428257963}, {"f1": 0.47058823529411764, "em": false, "chrf": 48.415509829862344, "bleu": 19.070828081828378}], "avg_f1": 0.5385620915032681, "avg_em": 0.0, "avg_chrf": 51.88708756756267, "avg_bleu": 27.754141313845757}
{"id": "Wikipedia_handpicked_5:1963", "en": "In the United States of America, Colleges and universities operate as \"mini-cities\" which generate significant revenue for cities, states, and regions.", "es": "En Estados Unidos, las facultades y las universidades suelen funcionar como \"miniciudades\" que generan importantes ingresos para las ciudades, los estados y las regiones.", "perturbation": "alteration", "pert_es": "En Estados Unidos, las facultades y las universidades suelen funcionar como \"miniciudades\" que generan insignificantes ingresos para las ciudades, los estados y las regiones.", "bt_pert_es": "In the United States, colleges and universities often operate as \"mini-cities\" that generate negligible revenue for cities, states, and regions.", "questions": "[\"What do colleges and universities operate as in the United States of America?\", \"What generates significant revenue for cities, states, and regions?\", \"What is the relationship between colleges and universities and local economies?\", \"What is the term used to describe colleges and universities in the United States of America?\", \"Which entities benefit from the revenue generated by colleges and universities?\"]", "answers": "[\"mini-cities\", \"None\", \"Colleges and universities do not generate significant revenue for cities, states, and regions\", \"mini-cities\", \"Cities, states, and regions\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 3.90625, "bleu": 0.0}, {"f1": 0.34782608695652173, "em": false, "chrf": 51.77614471109082, "bleu": 12.35622127262679}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 94.83192905019531, "bleu": 59.460355750136046}], "avg_f1": 0.6195652173913043, "avg_em": 0.4, "avg_chrf": 70.10286475225723, "avg_bleu": 54.36331540455259}
{"id": "Wikipedia_handpicked_5:1964", "en": "For example, Princeton University contributed $1.58 billion USD to the New Jersey economy and students spent about $60 million in off-campus spending.", "es": "Por ejemplo, Princeton University aportó 1580 millones de dólares estadounidenses a la economía de Nueva Jersey y los estudiantes gastaron alrededor de 60 millones fuera del campus.", "perturbation": "alteration", "pert_es": "Por ejemplo, Princeton University aportó 1580 millones de dólares estadounidenses a la economía de Nueva Jersey y los estudiantes ahorraron alrededor de 60 millones fuera del campus.", "bt_pert_es": "For example, Princeton University contributed $1.58 billion to New Jersey's economy, and students saved about $60 million off campus.", "questions": "[\"How much did Princeton University contribute to the New Jersey economy?\", \"What is the amount spent by students in off-campus spending?\", \"What is the relationship between Princeton University and the New Jersey economy?\", \"What does the sentence mention about student spending?\", \"What is the total contribution of Princeton University to the economy?\"]", "answers": "[\"$1.58 billion\", \"$60 million\", \"Princeton University contributed to the New Jersey economy\", \"Students saved about $60 million off campus\", \"$1.58 billion\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 75.04328606776774, "bleu": 60.653065971263366}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5333333333333333, "em": false, "chrf": 61.420495167147216, "bleu": 22.772101321113862}, {"f1": 0.8, "em": false, "chrf": 75.04328606776774, "bleu": 60.653065971263366}], "avg_f1": 0.8266666666666668, "avg_em": 0.4, "avg_chrf": 82.30141346053654, "avg_bleu": 68.81564665272813}
{"id": "Wikipedia_handpicked_5:1971", "en": "This could range through integrated digital learning platforms, video lessons, MOOCs, to broadcasting through radios and TVs.", "es": "Esto podría abarcar desde plataformas integradas de aprendizaje digital, clases por video y CEMA hasta la transmisión por radio y televisión.", "perturbation": "alteration", "pert_es": "Esto podría abarcar desde plataformas integradas de olvido digital, clases por video y CEMA hasta la transmisión por radio y televisión.", "bt_pert_es": "This could range from integrated digital forgetting platforms, video classes and CEMA to radio and television broadcasting.", "questions": "[\"What types of platforms are mentioned in the sentence?\", \"What forms of content delivery are included?\", \"What is the range of delivery methods described?\", \"What are the examples of digital learning platforms mentioned?\", \"What are MOOCs in the context of this sentence?\", \"What role do radios and TVs play in the delivery of content?\"]", "answers": "[\"integrated digital forgetting platforms\", \"video classes\", \"CEMA\", \"radio and television broadcasting\", \"not mentioned\", \"delivery of content\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 75.8448490722788, "bleu": 35.35533905932737}, {"f1": 0.5, "em": false, "chrf": 33.76683501683502, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 10.416666666666668, "bleu": 0.0}, {"f1": 0.4444444444444445, "em": false, "chrf": 46.769304578788784, "bleu": 14.794015674776452}, {"f1": 0, "em": false, "chrf": 7.359431848799504, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.910165484633569, "bleu": 0.0}], "avg_f1": 0.2824074074074074, "avg_em": 0.0, "avg_chrf": 30.01120877800039, "avg_bleu": 16.691559122350636}
{"id": "Wikipedia_handpicked_5:1973", "en": "Consider temporarily decentralising such devices from computer labs to families and support them with internet connectivity.", "es": "Considere la posibilidad de trasladar temporalmente ese tipo de dispositivos de los laboratorios informáticos a las familias y bríndeles apoyo con la conexión a internet.", "perturbation": "alteration", "pert_es": "Considere la posibilidad de trasladar permanentemente ese tipo de dispositivos de los laboratorios informáticos a las familias y bríndeles apoyo con la desconexión a internet.", "bt_pert_es": "Consider permanently moving such devices from computer labs to families and support them with disconnecting from the internet.", "questions": "[\"What does the suggestion propose regarding the location of such devices?\", \"Why should devices be decentralised to families?\", \"What support is provided to families with the decentralisation?\", \"What is the purpose of decentralising devices from computer labs?\"]", "answers": "[\"Moving such devices from computer labs to families\", \"To support families\", \"Disconnecting from the internet\", \"To support families\"]", "scores": [{"f1": 0, "em": false, "chrf": 35.33829993056006, "bleu": 0.0}, {"f1": 0.4444444444444444, "em": false, "chrf": 23.09278037672344, "bleu": 20.24518585186855}, {"f1": 0, "em": false, "chrf": 53.5895173550601, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 42.89815609411552, "bleu": 36.78794411714425}], "avg_f1": 0.2777777777777778, "avg_em": 0.0, "avg_chrf": 38.72968843911478, "avg_bleu": 14.2582824922532}
{"id": "Wikipedia_handpicked_5:1974", "en": "Protect data privacy and data security: Assess data security when uploading data or educational resources to web spaces, as well as when sharing them with other organisations or individuals.", "es": "Proteja la privacidad y la seguridad de los datos: evalúe la seguridad de los datos cuando suba información o recursos educativos a sitios web, así como cuando comparta estos con otras organizaciones o personas.", "perturbation": "alteration", "pert_es": "Comprometa la privacidad y la seguridad de los datos: evalúe la inseguridad de los datos cuando suba información o recursos educativos a sitios web, así como cuando comparta estos con otras organizaciones o personas.", "bt_pert_es": "Compromise data privacy and security: Assess data security when uploading information or educational resources to websites, as well as when sharing these with other organizations or individuals.", "questions": "[\"What should be protected when uploading data or educational resources?\", \"What should be assessed when uploading data or educational resources to web spaces?\", \"What should be assessed when sharing data or educational resources with other organizations or individuals?\", \"What is the focus of data security in the context of web spaces?\", \"What are the key actions to ensure data privacy and data security during data sharing?\"]", "answers": "[\"Data privacy and security\", \"Data security\", \"Data security\", \"Data security when uploading information or educational resources to websites\", \"Assessing data security when uploading or sharing data or educational resources\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 74.17701308603837, "bleu": 49.76093899250716}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6363636363636365, "em": false, "chrf": 71.51769841006532, "bleu": 31.105042156452658}, {"f1": 0.8, "em": false, "chrf": 64.2521760567584, "bleu": 45.93799961315751}], "avg_f1": 0.8650505050505052, "avg_em": 0.4, "avg_chrf": 81.98937751057242, "avg_bleu": 65.36079615242349}
{"id": "Wikipedia_handpicked_5:1977", "en": "Create communities to ensure regular human interactions, enable social caring measures, and address possible psychosocial challenges that students may face when they are isolated.", "es": "Cree comunidades para garantizar interacciones humanas frecuentes, facilite medidas de cuidado social y aborde los posibles problemas psicosociales que puedan enfrentar los estudiantes al estar aislados.", "perturbation": "alteration", "pert_es": "Cree comunidades para garantizar interacciones humanas escasas, dificulte medidas de cuidado social y aborde los posibles problemas psicosociales que puedan enfrentar los estudiantes al estar aislados.", "bt_pert_es": "Create communities to ensure low human interactions, facilitate social care measures, and address potential psychosocial issues students may face while isolated.", "questions": "[\"What communities should be created?\", \"Why are regular human interactions important?\", \"What social caring measures can be enabled?\", \"What psychosocial challenges may students face when isolated?\", \"What is the goal of creating communities for students?\"]", "answers": "[\"Communities to ensure low human interactions\", \"Regular human interactions are not emphasized in the sentence; the focus is on reducing them\", \"Social care measures\", \"Psychosocial issues\", \"To ensure low human interactions, facilitate social care measures, and address potential psychosocial issues students may face while isolated\"]", "scores": [{"f1": 0.8333333333333334, "em": false, "chrf": 78.25450141559273, "bleu": 37.99178428257963}, {"f1": 0, "em": false, "chrf": 15.367328591367741, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 68.85923848058314, "bleu": 34.66806371753173}, {"f1": 0.5, "em": false, "chrf": 52.787001398230394, "bleu": 49.99999999999999}, {"f1": 0.6341463414634148, "em": false, "chrf": 61.64055384528745, "bleu": 14.531220242807445}], "avg_f1": 0.526829268292683, "avg_em": 0.0, "avg_chrf": 55.3817247462123, "avg_bleu": 27.43821364858376}
{"id": "Wikipedia_handpicked_5:1978", "en": "Plan the study schedule of the distance learning programmes: Organise discussions with stakeholders to examine the possible duration of school closures and decide whether the distance learning programme should focus on teaching new knowledge or enhance students’ knowledge of prior lessons.", "es": "Planifique el cronograma de estudio de los programas de educación a distancia: organice reuniones con las partes interesadas para analizar la posible duración del cierre de las escuelas y decidir si el programa de educación a distancia debe enfocarse en enseñar contenido nuevo o en fortalecer el conocimiento de los alumnos de clases anteriores.", "perturbation": "alteration", "pert_es": "Planifique el cronograma de estudio de los programas de educación presencial: organice reuniones con las partes interesadas para analizar la posible duración del cierre de las escuelas y decidir si el programa de educación a distancia debe enfocarse en enseñar contenido nuevo o en fortalecer el conocimiento de los alumnos de clases anteriores.", "bt_pert_es": "Plan the study schedule for in-person education programs: Hold meetings with stakeholders to discuss the possible duration of school closures and decide whether the distance education program should focus on teaching new content or strengthening students' knowledge of previous classes.", "questions": "[\"What should be planned for distance learning programmes?\", \"How should discussions with stakeholders be organised?\", \"What factors should be examined to determine the duration of school closures?\", \"Should the distance learning programme focus on teaching new knowledge or enhancing students’ knowledge of prior lessons?\", \"What decision should be made regarding the focus of the distance learning programme?\"]", "answers": "[\"The focus should be on teaching new content or strengthening students' knowledge of previous classes\", \"By holding meetings with stakeholders\", \"The possible duration of school closures\", \"Teaching new content or strengthening students' knowledge of previous classes\", \"Whether the distance education program should focus on teaching new content or strengthening students' knowledge of previous classes\"]", "scores": [{"f1": 0.1111111111111111, "em": false, "chrf": 17.762443309311298, "bleu": 2.627961710408444}, {"f1": 0.6, "em": false, "chrf": 47.6249134047758, "bleu": 23.643540225079395}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 52.53762565275291, "bleu": 12.549310621989482}, {"f1": 0.5882352941176471, "em": false, "chrf": 60.548654939093794, "bleu": 28.175950490399515}], "avg_f1": 0.5598692810457516, "avg_em": 0.2, "avg_chrf": 55.69472746118676, "avg_bleu": 33.399352609575374}
{"id": "Wikipedia_handpicked_5:1982", "en": "Provide support to teachers and parents on the use of digital tools: Organise brief training or orientation sessions for teachers and parents as well, if monitoring and facilitation are needed.", "es": "Apoye a los docentes y a los padres en el uso de las herramientas digitales: organice una capacitación breve o sesiones de orientación para docentes y padres también, si hace falta seguimiento y coordinación.", "perturbation": "alteration", "pert_es": "Desestime a los docentes y a los padres en el uso de las herramientas digitales: cancele una capacitación breve o sesiones de orientación para docentes y padres también, si hace falta seguimiento y coordinación.", "bt_pert_es": "Disengage teachers and parents in the use of digital tools: Cancel short training or orientation sessions for teachers and parents as well, if follow-up and coordination is needed.", "questions": "[\"What support is provided to teachers and parents?\", \"What digital tools are being supported?\", \"What type of training or orientation sessions are organised?\", \"When are training or orientation sessions organised?\", \"What conditions make monitoring and facilitation necessary?\"]", "answers": "[\"None\", \"Digital tools\", \"Short training or orientation sessions\", \"Not specified\", \"When follow-up and coordination is needed\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.687678510225067, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8000000000000002, "em": false, "chrf": 84.57028345517598, "bleu": 66.87403049764218}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 30.371184914233762, "bleu": 10.682175159905853}], "avg_f1": 0.66, "avg_em": 0.4, "avg_chrf": 63.92582937592696, "avg_bleu": 55.51124113150962}
{"id": "Wikipedia_handpicked_5:1983", "en": "Help teachers to prepare the basic settings such as solutions to the use of internet data if they are required to provide live streaming of lessons.", "es": "Ayude a los docentes a preparar los elementos básicos, como las soluciones para el uso de datos de internet si se les pide que transmitan las clases en directo.", "perturbation": "alteration", "pert_es": "Ayude a los docentes a preparar los elementos avanzados, como las soluciones para el uso de datos de internet si se les pide que transmitan las clases en directo.", "bt_pert_es": "Help teachers prepare advanced elements, such as solutions for using internet data if they are required to livestream classes.", "questions": "[\"What basic settings need to be prepared for teachers?\", \"What solutions are provided for the use of internet data?\", \"When is the use of internet data required?\", \"What activity requires the use of internet data?\", \"What is the purpose of preparing basic settings for teachers?\"]", "answers": "[\"Advanced elements\", \"Solutions for using internet data\", \"When livestreaming classes\", \"Livestreaming classes\", \"To help teachers prepare for using internet data during livestreaming classes\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.1879766023137295, "bleu": 0.0}, {"f1": 0.5454545454545454, "em": false, "chrf": 64.62073360387242, "bleu": 19.357693493908812}, {"f1": 0.15384615384615383, "em": false, "chrf": 31.505472404363395, "bleu": 2.6682865255867765}, {"f1": 0, "em": false, "chrf": 39.949551244753394, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 69.58700402004018, "bleu": 35.08439695638686}], "avg_f1": 0.23986013986013982, "avg_em": 0.0, "avg_chrf": 42.570147575068624, "avg_bleu": 11.42207539517649}
{"id": "Wikipedia_handpicked_5:1984", "en": "Blend appropriate approaches and limit the number of applications and platforms: Blend tools or media that are available for most students, both for synchronous communication and lessons, and for asynchronous learning.", "es": "Combine abordajes adecuados y limite la cantidad de aplicaciones y plataformas: combine herramientas o medios que estén disponibles para la mayoría de los estudiantes, tanto para la comunicación y clases sincrónicas, como para el aprendizaje asincrónico.", "perturbation": "alteration", "pert_es": "Combine abordajes inadecuados y aumente la cantidad de aplicaciones y plataformas: combine herramientas o medios que no estén disponibles para la mayoría de los estudiantes, tanto para la comunicación y clases sincrónicas, como para el aprendizaje asincrónico.", "bt_pert_es": "Combine inappropriate approaches and increase the number of applications and platforms: Combine tools or media that are not available to most students, both for synchronous communication and classes, and for asynchronous learning.", "questions": "[\"What should be blended in the approach?\", \"What should be limited in number?\", \"What types of communication and lessons should be blended?\", \"What learning methods are covered by the blended tools or media?\", \"What is the goal of blending tools or media for students?\"]", "answers": "[\"Inappropriate approaches\", \"Applications and platforms\", \"Synchronous communication and classes\", \"Asynchronous learning\", \"To improve access for most students\"]", "scores": [{"f1": 0, "em": false, "chrf": 51.59465275535199, "bleu": 0.0}, {"f1": 0.4444444444444444, "em": false, "chrf": 67.55947209671012, "bleu": 20.24518585186855}, {"f1": 0.75, "em": false, "chrf": 81.17320372970033, "bleu": 59.460355750136046}, {"f1": 0.3333333333333333, "em": false, "chrf": 57.35156231244103, "bleu": 18.393972058572114}, {"f1": 0.6153846153846153, "em": false, "chrf": 57.47870411951035, "bleu": 27.48254571080018}], "avg_f1": 0.4286324786324786, "avg_em": 0.0, "avg_chrf": 63.03151900274277, "avg_bleu": 25.11641187427538}
{"id": "Wikipedia_handpicked_5:1986", "en": "Develop distance learning rules and monitor students’ learning process: Define the rules with parents and students on distance learning.", "es": "Elabore normas para la educación a distancia y supervise el proceso de aprendizaje de los alumnos: defina las normas para la educación a distancia con los padres y los alumnos.", "perturbation": "alteration", "pert_es": "Elabore normas para la educación presencial y supervise el proceso de aprendizaje de los profesores: defina las normas para la educación presencial con los padres y los alumnos.", "bt_pert_es": "Develop standards for in-person education and monitor teachers' learning process: Define standards for in-person education with parents and students.", "questions": "[\"What should be developed regarding distance learning?\", \"Who should be involved in defining distance learning rules?\", \"What is the purpose of monitoring students’ learning process?\", \"What is the role of parents and students in defining distance learning rules?\"]", "answers": "[\"None\", \"Not specified\", \"To ensure effective learning and improvement in students' educational outcomes\", \"To help define standards for in-person education\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.8409090909090904, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.0152643543505855, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 60.42738017824435, "bleu": 9.980099403873663}, {"f1": 0.36363636363636365, "em": false, "chrf": 28.603049080286457, "bleu": 7.809849842300641}], "avg_f1": 0.2159090909090909, "avg_em": 0.0, "avg_chrf": 24.471650675947622, "avg_bleu": 4.447487311543576}
{"id": "Wikipedia_handpicked_5:1991", "en": "Create communities and enhance connection: Create communities of teachers, parents, and school managers to address sense of loneliness or helplessness, facilitate sharing of experience and discussion on coping strategies when facing learning difficulties.", "es": "Cree comunidades y fortalezca la conexión: cree comunidades de docentes, padres y directivos de escuelas para abordar la sensación de soledad o impotencia, promover el intercambio de experiencias y las conversaciones sobre estrategias para lidiar con las dificultades de aprendizaje.", "perturbation": "alteration", "pert_es": "Destruye comunidades y debilita la conexión: destruye comunidades de docentes, padres y directivos de escuelas para abordar la sensación de soledad o impotencia, promover el intercambio de experiencias y las conversaciones sobre estrategias para lidiar con las dificultades de aprendizaje.", "bt_pert_es": "Destroy communities and weaken connection: Destroy communities of teachers, parents and school administrators to address the feeling of loneliness or helplessness, promote the exchange of experiences and conversations about strategies to deal with learning difficulties.", "questions": "[\"What communities are being created?\", \"Who are the members of the communities?\", \"What is the purpose of creating these communities?\", \"What issues do these communities aim to address?\", \"How do these communities facilitate sharing of experiences?\", \"What coping strategies are discussed in these communities?\"]", "answers": "[\"Communities of teachers, parents, and school administrators\", \"Teachers, parents, and school administrators\", \"To address the feeling of loneliness or helplessness and promote the exchange of experiences and conversations about strategies to deal with learning difficulties\", \"Feeling of loneliness or helplessness and learning difficulties\", \"By promoting exchange of experiences and conversations\", \"Strategies to deal with learning difficulties\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 81.44872078255557, "bleu": 80.91067115702207}, {"f1": 0.8000000000000002, "em": false, "chrf": 73.47028214378436, "bleu": 66.87403049764218}, {"f1": 0.5714285714285714, "em": false, "chrf": 59.99086470443111, "bleu": 23.41812326184748}, {"f1": 0.6153846153846154, "em": false, "chrf": 71.93579271659098, "bleu": 34.57207846419409}, {"f1": 0.3529411764705882, "em": false, "chrf": 30.328697661971816, "bleu": 5.630400552901077}, {"f1": 0.3333333333333333, "em": false, "chrf": 59.116404076557714, "bleu": 16.233395773754946}], "avg_f1": 0.5883717589599943, "avg_em": 0.0, "avg_chrf": 62.715127014315264, "avg_bleu": 37.939783284560306}
{"id": "Wikipedia_handpicked_5:1992", "en": "290 million students out of school due to COVID-19: UNESCO releases first global numbers and mobilizes response,   UNESCO.", "es": "290 millones de estudiantes sin clases por la COVID-19: la UNESCO divulga las primeras cifras mundiales y se moviliza para dar respuesta (UNESCO).", "perturbation": "alteration", "pert_es": "290 millones de estudiantes con clases por la COVID-19: la UNESCO divulga las primeras cifras mundiales y se moviliza para dar respuesta (UNESCO).", "bt_pert_es": "290 million students with classes due to COVID-19: UNESCO releases the first global figures and mobilizes to respond (UNESCO).", "questions": "[\"How many students are out of school due to COVID-19?\", \"What organization released the first global numbers?\", \"What did UNESCO mobilize in response?\", \"What is the significance of the global numbers released by UNESCO?\"]", "answers": "[\"290 million\", \"UNESCO\", \"to respond\", \"The global numbers highlight the widespread impact of COVID-19 on education and underscore the need for urgent action\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 50.21825396825397, "bleu": 0.0}, {"f1": 0.08333333333333333, "em": false, "chrf": 17.548956780809874, "bleu": 2.445593937240363}], "avg_f1": 0.5208333333333334, "avg_em": 0.5, "avg_chrf": 66.94180268726596, "avg_bleu": 50.611398484310115}
{"id": "Wikisource_1:2047", "en": "and WHEREAS in a short period of time, COVID-19 has rapidly spread throughout California, necessitating updated and more stringent guidance from federal, state, and local public health officials;", "es": "y POR CUANTO en un corto período la COVID-19 se ha propagado rápidamente a lo largo de California, lo cual hizo necesaria una orientación más actualizada y estricta por parte de los funcionarios de salud pública federal, estatal y local;", "perturbation": "alteration", "pert_es": "y POR CUANTO en un corto período la COVID-19 se ha propagado lentamente a lo largo de California, lo cual hizo necesaria una orientación más actualizada y flexible por parte de los funcionarios de salud pública federal, estatal y local;", "bt_pert_es": "and WHEREAS, in a short period of time, COVID-19 has slowly spread throughout California, necessitating more updated and flexible guidance from federal, state, and local public health officials;", "questions": "[\"Where did COVID-19 rapidly spread?\", \"What prompted the need for updated and more stringent guidance?\", \"Which entities are responsible for providing updated guidance?\", \"What factors led to the rapid spread of COVID-19 in California?\"]", "answers": "[\"California\", \"The rapid spread of COVID-19\", \"Federal, state, and local public health officials\", \"A short period of time\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikisource_1:2049", "en": "NOW, THEREFORE, I, GAVIN NEWSOM, Governor of the State of California, in accordance with the authority vested in me by the State Constitution and statutes of the State of California, and in particular, Government Code sections 8567, 8627, and 8665 do hereby issue the following Order to become effective immediately:", "es": "POR TANTO, YO, GAVIN NEWSOM, gobernador del estado de California, por la autoridad que me ha sido conferida por la Constitución Estatal y los estatutos del estado de California y, en particular, por las secciones 8567, 8627 y 8665 del Código de Gobierno, a través de la presente, emito la siguiente Orden, la cual entrará en vigor de manera inmediata:", "perturbation": "alteration", "pert_es": "POR TANTO, YO, GAVIN NEWSOM, gobernador del estado de California, por la autoridad que me ha sido conferida por la Constitución Estatal y los estatutos del estado de California y, en particular, por las secciones 8567, 8627 y 8665 del Código de Gobierno, a través de la presente, anulo la siguiente Orden, la cual quedará sin vigor de manera inmediata:", "bt_pert_es": "THEREFORE, I, GAVIN NEWSOM, Governor of the State of California, by the authority vested in me by the State Constitution and the statutes of the State of California and, in particular, by sections 8567, 8627 and 8665 of the Government Code, do hereby rescind the following Order, which shall be terminated immediately:", "questions": "[\"Who is issuing the order?\", \"What is the official position of the person issuing the order?\", \"What legal authority is cited for issuing the order?\", \"Which specific government code sections are referenced in the order?\", \"What is the purpose of the order?\", \"When does the order become effective?\"]", "answers": "[\"Gavin Newsom\", \"Governor of the State of California\", \"The State Constitution and the statutes of the State of California\", \"Sections 8567, 8627, and 8665 of the Government Code\", \"To rescind the following Order\", \"Immediately\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.782608695652174, "em": false, "chrf": 70.6984741365739, "bleu": 51.01469472683877}, {"f1": 0.7999999999999999, "em": false, "chrf": 88.55799259536235, "bleu": 41.11336169005198}, {"f1": 0.75, "em": false, "chrf": 65.2342916139428, "bleu": 35.35533905932737}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.888768115942029, "avg_em": 0.5, "avg_chrf": 87.41512639097984, "avg_bleu": 71.24723257936971}
{"id": "Wikisource_1:2050", "en": "IT IS HEREBY ORDERED THAT:", "es": "POR LA PRESENTE SE DECRETA QUE:", "perturbation": "alteration", "pert_es": "POR LA PRESENTE SE DEROGA QUE:", "bt_pert_es": "IT IS HEREBY REPEALED THAT:", "questions": "[\"What is hereby ordered?\"]", "answers": "[\"That is hereby repealed\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.8012820512820512, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.8012820512820512, "avg_bleu": 0.0}
{"id": "Wikisource_1:2052", "en": "Those directives are consistent with the March 19, 2020, Memorandum on Identification of Essential Critical Infrastructure Workers During COVID-19 Response, found at: https://covid19.ca.gov/.", "es": "Esas directivas son coherentes con el Memorando sobre la Identificación de los Trabajadores de la Infraestructura Crítica Esencial durante la Respuesta a la COVID-19 del 19 de marzo de 2020, el cual se puede consultar en: https://covid19.ca.gov/.", "perturbation": "alteration", "pert_es": "Esas directivas son incoherentes con el Memorando sobre la Identificación de los Trabajadores de la Infraestructura Crítica Esencial durante la Respuesta a la COVID-19 del 19 de marzo de 2020, el cual se puede consultar en: https://covid19.ca.gov/.", "bt_pert_es": "These directives are inconsistent with the March 19, 2020 Memorandum on the Identification of Essential Critical Infrastructure Workers during the COVID-19 Response, which can be found at: https://covid19.ca.gov/.", "questions": "[\"What are those directives?\", \"What does the March 19, 2020, Memorandum on Identification of Essential Critical Infrastructure Workers During COVID-19 Response state?\", \"Where can the March 19, 2020, Memorandum be found?\", \"What is the purpose of the Memorandum on Identification of Essential Critical Infrastructure Workers?\", \"What is the relationship between the directives and the Memorandum?\"]", "answers": "[\"The directives are inconsistent with the March 19, 2020 Memorandum on the Identification of Essential Critical Infrastructure Workers during the COVID-19 Response\", \"The Memorandum on the Identification of Essential Critical Infrastructure Workers during the COVID-19 Response provides guidance on identifying essential critical infrastructure workers\", \"At: https://covid19.ca.gov/\", \"To identify essential critical infrastructure workers during the COVID-19 response\", \"The directives are inconsistent with the Memorandum\"]", "scores": [{"f1": 0.8947368421052632, "em": false, "chrf": 94.8788522795739, "bleu": 70.9421400618421}, {"f1": 0.5641025641025641, "em": false, "chrf": 69.02483905402991, "bleu": 43.48553979929486}, {"f1": 0.6666666666666666, "em": false, "chrf": 97.28294595957662, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8333333333333334, "em": false, "chrf": 92.12900468646225, "bleu": 37.99178428257963}], "avg_f1": 0.7917678812415654, "avg_em": 0.2, "avg_chrf": 90.66312839592854, "avg_bleu": 60.48389282874332}
{"id": "Wikisource_1:2053", "en": "ORDER OF THE STATE PUBLIC HEALTH OFFICER", "es": "ORDEN DEL FUNCIONARIO DE SALUD PÚBLICA ESTATAL", "perturbation": "alteration", "pert_es": "ORDEN DEL FUNCIONARIO DE SALUD PRIVADA ESTATAL", "bt_pert_es": "STATE PRIVATE HEALTH OFFICER ORDER", "questions": "[\"What is the order issued by?\", \"Who issues the order?\", \"What is the subject of the order?\"]", "answers": "[\"The state\", \"The state\", \"Private health officer order\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 11.973838855988294, "bleu": 11.15650800742149}, {"f1": 0.28571428571428575, "em": false, "chrf": 11.973838855988294, "bleu": 11.15650800742149}, {"f1": 0.3333333333333333, "em": false, "chrf": 29.968237505661172, "bleu": 15.97357760615681}], "avg_f1": 0.3015873015873016, "avg_em": 0.0, "avg_chrf": 17.971971739212588, "avg_bleu": 12.762197873666596}
{"id": "Wikisource_1:2054", "en": "To protect public health, I as State Public Health Officer and Director of the California Department of Public Health order all individuals living in the State of California to stay home or at their place of residence except as needed to maintain continuity of operations of the federal critical infrastructure sectors, as outlined at https://www.cisa.gov/critical-infrastructure-sectors.", "es": "A fin de proteger la salud pública, yo, el funcionario de Salud Pública del estado y director del Departamento de Salud Pública de California ordeno a todas las personas que vivan en el estado de California que se queden en sus hogares o lugar de residencia, excepto según sea necesario para mantener la continuidad de las operaciones de los sectores de infraestructura crítica federal, tal como se establece aquí: https://www.cisa.gov/critical-infrastructure-sectors.", "perturbation": "alteration", "pert_es": "A fin de dañar la salud pública, yo, el funcionario de Salud Pública del estado y director del Departamento de Salud Pública de California ordeno a todas las personas que vivan en el estado de California que salgan de sus hogares o lugar de residencia, excepto según sea necesario para mantener la discontinuidad de las operaciones de los sectores de infraestructura crítica federal, tal como se establece aquí: https://www.cisa.gov/critical-infrastructure-sectors.", "bt_pert_es": "In order to harm the public health, I, the State Public Health Officer and Director of the California Department of Public Health, order all persons living in the State of California to leave their homes or place of residence, except as necessary to maintain the discontinuity of operations of the federal critical infrastructure sectors, as set forth here: https://www.cisa.gov/critical-infrastructure-sectors.", "questions": "[\"What is the purpose of the order?\", \"Who issued the order?\", \"What is required of individuals living in California?\", \"Under what circumstances are individuals allowed to leave their home?\", \"What are the federal critical infrastructure sectors?\", \"Where can information about the critical infrastructure sectors be found?\"]", "answers": "[\"To harm the public health\", \"I, the State Public Health Officer and Director of the California Department of Public Health\", \"To leave their homes or place of residence\", \"As necessary to maintain the discontinuity of operations of the federal critical infrastructure sectors\", \"Not specified in the sentence\", \"https://www.cisa.gov/critical-infrastructure-sectors\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 55.95132892872192, "bleu": 35.35533905932737}, {"f1": 0.962962962962963, "em": false, "chrf": 96.56752314892836, "bleu": 86.17038791239605}, {"f1": 0.7058823529411765, "em": false, "chrf": 60.16553187746262, "bleu": 21.573652645054942}, {"f1": 0.7272727272727272, "em": false, "chrf": 90.97434134807752, "bleu": 53.3167536340577}, {"f1": 0, "em": false, "chrf": 10.353820058098199, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6910196738628112, "avg_em": 0.16666666666666666, "avg_chrf": 69.0020908935481, "avg_bleu": 49.40268887513935}
{"id": "Wikisource_1:2056", "en": "Pursuant to the authority under the Health and Safety Code 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 and 120150, this order is to go into effect immediately and shall stay in effect until further notice.", "es": "De conformidad con la autoridad conferida por las secciones 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 y 120150 del Código de Salud y Seguridad, esta orden entrará en vigor en forma inmediata y seguirá en vigor hasta próximo aviso.", "perturbation": "alteration", "pert_es": "De conformidad con la autoridad conferida por las secciones 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 y 120150 del Código de Salud y Seguridad, esta orden no entrará en vigor en forma inmediata y seguirá en vigor hasta próximo aviso.", "bt_pert_es": "Pursuant to the authority conferred by sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 and 120150 of the Health and Safety Code, this order is not effective immediately and will remain in effect until further notice.", "questions": "[\"What authority is referenced in the sentence?\", \"Which sections of the Health and Safety Code are cited?\", \"When does this order go into effect?\", \"How long will this order remain in effect?\", \"What happens if further notice is given?\"]", "answers": "[\"The authority conferred by sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 and 120150 of the Health and Safety Code\", \"Sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175, and 120150\", \"It does not go into effect immediately\", \"Until further notice\", \"The order will no longer remain in effect\"]", "scores": [{"f1": 0.8571428571428572, "em": false, "chrf": 85.95458540760241, "bleu": 59.08871032231054}, {"f1": 0.9473684210526316, "em": false, "chrf": 96.86577132452969, "bleu": 88.01117367933934}, {"f1": 0, "em": false, "chrf": 59.705691662215834, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.375, "em": false, "chrf": 27.809298518263954, "bleu": 12.223075560872525}], "avg_f1": 0.6359022556390977, "avg_em": 0.2, "avg_chrf": 74.06706938252238, "avg_bleu": 51.86459191250449}
{"id": "Wikisource_1:2058", "en": "I order that Californians working in these 16 critical infrastructure sectors may continue their work because of the importance of these sectors to Californians' health and well-being.", "es": "Ordeno que los residentes de California que trabajan en estos 16 sectores de infraestructura crítica puedan continuar desempeñando sus tareas debido a la importancia de estos sectores para la salud y el bienestar de los residentes de California.", "perturbation": "alteration", "pert_es": "Ordeno que los residentes de California que trabajan en estos 16 sectores de infraestructura crítica no puedan continuar desempeñando sus tareas debido a la importancia de estos sectores para la salud y el bienestar de los residentes de California.", "bt_pert_es": "I order that California residents who work in these 16 critical infrastructure sectors cannot continue to perform their duties due to the importance of these sectors to the health and well-being of California residents.", "questions": "[\"What does the order allow Californians working in these 16 critical infrastructure sectors to do?\", \"Why are these 16 critical infrastructure sectors important to Californians' health and well-being?\", \"What sectors are considered critical infrastructure in this context?\", \"What is the reason for allowing continued work in these sectors?\"]", "answers": "[\"cannot continue to perform their duties\", \"Because they are important to the health and well-being of California residents\", \"The 16 critical infrastructure sectors mentioned in the sentence\", \"The order does not allow continued work; it restricts it\"]", "scores": [{"f1": 0.4444444444444444, "em": false, "chrf": 50.61131977689283, "bleu": 9.652434877402245}, {"f1": 0.6, "em": false, "chrf": 65.10277843445259, "bleu": 16.59038701421971}, {"f1": 0.6153846153846154, "em": false, "chrf": 83.34740186061372, "bleu": 34.57207846419409}, {"f1": 0.10000000000000002, "em": false, "chrf": 15.451984642636898, "bleu": 4.196114906296549}], "avg_f1": 0.43995726495726495, "avg_em": 0.0, "avg_chrf": 53.628371178649004, "avg_bleu": 16.25275381552815}
{"id": "Wikisource_1:2059", "en": "This Order is being issued to protect the public health of Californians.", "es": "Esta Orden se emite para proteger la salud pública de los residentes de California.", "perturbation": "alteration", "pert_es": "Esta Orden se emite para dañar la salud pública de los residentes de California.", "bt_pert_es": "This Order is issued to harm the public health of California residents.", "questions": "[\"What is the purpose of this Order?\", \"What does this Order aim to protect?\", \"Who is the target population of this Order?\", \"What is the main goal of this Order?\"]", "answers": "[\"To harm the public health of California residents\", \"The public health of California residents\", \"California residents\", \"To harm the public health of California residents\"]", "scores": [{"f1": 0.6153846153846153, "em": false, "chrf": 68.2091099765858, "bleu": 26.269098944241588}, {"f1": 0.6666666666666666, "em": false, "chrf": 74.71824270881751, "bleu": 30.213753973567677}, {"f1": 0, "em": false, "chrf": 70.58833249127278, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 45.109978746542815, "bleu": 13.134549472120794}], "avg_f1": 0.42051282051282046, "avg_em": 0.0, "avg_chrf": 64.65641598080472, "avg_bleu": 17.404350597482516}
{"id": "Wikisource_1:2060", "en": "The California Department of Public Health looks to establish consistency across the state in order to ensure that we mitigate the impact of COVID-19.", "es": "El Departamento de Salud Pública de California busca establecer una uniformidad en todo el estado a fin de garantizar que mitiguemos el impacto de la COVID-19.", "perturbation": "alteration", "pert_es": "El Departamento de Salud Pública de California busca establecer una diversidad en todo el estado a fin de garantizar que mitiguemos el impacto de la COVID-19.", "bt_pert_es": "The California Department of Public Health is seeking to establish diversity across the state to ensure we mitigate the impact of COVID-19.", "questions": "[\"What does the California Department of Public Health aim to establish?\", \"What is the goal of establishing consistency across the state?\", \"How does establishing consistency help mitigate the impact of COVID-19?\"]", "answers": "[\"Diversity across the state\", \"To ensure we mitigate the impact of COVID-19\", \"By establishing diversity, the impact of COVID-19 can be mitigated\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 53.2270297748265, "bleu": 55.03212081491043}, {"f1": 0.9333333333333333, "em": false, "chrf": 82.78497068629254, "bleu": 61.29752413741059}, {"f1": 0.13333333333333333, "em": false, "chrf": 17.026340225823173, "bleu": 4.767707020457095}], "avg_f1": 0.5777777777777778, "avg_em": 0.0, "avg_chrf": 51.01278022898074, "avg_bleu": 40.36578399092604}
{"id": "Wikisource_1:2061", "en": "Our goal is simple, we want to bend the curve, and disrupt the spread of the virus.", "es": "Nuestro objetivo es simple: queremos aplanar la curva y detener la propagación del virus.", "perturbation": "alteration", "pert_es": "Nuestro objetivo es simple: queremos aumentar la curva y fomentar la propagación del virus.", "bt_pert_es": "Our goal is simple: we want to raise the curve and encourage the spread of the virus.", "questions": "[\"What is the goal mentioned in the sentence?\", \"What does 'bend the curve' mean in this context?\", \"What is the purpose of disrupting the spread of the virus?\", \"What is the main objective related to the virus?\"]", "answers": "[\"We want to raise the curve and encourage the spread of the virus\", \"In this context, 'bend the curve' is used incorrectly; the sentence says 'raise the curve' to encourage the spread of the virus, which contradicts the typical meaning of 'bend the curve' to reduce spread\", \"To increase the spread of the virus\", \"To encourage the spread of the virus\"]", "scores": [{"f1": 0.5555555555555556, "em": false, "chrf": 52.33017535658622, "bleu": 19.64073254502565}, {"f1": 0.22857142857142856, "em": false, "chrf": 30.345008395213014, "bleu": 3.300809119141885}, {"f1": 0.4615384615384615, "em": false, "chrf": 19.82782101222151, "bleu": 12.975849993980747}, {"f1": 0.8000000000000002, "em": false, "chrf": 65.32750530812919, "bleu": 42.7287006396234}], "avg_f1": 0.5114163614163615, "avg_em": 0.0, "avg_chrf": 41.957627518037484, "avg_bleu": 19.66152307444292}
{"id": "Wikisource_1:2062", "en": "The supply chain must continue, and Californians must have access to such necessities as food, prescriptions, and health care.", "es": "La cadena de suministro se debe mantener y los residentes de California deben tener acceso a los productos de primera necesidad, como alimentos, medicamentos recetados y atención médica.", "perturbation": "alteration", "pert_es": "La cadena de suministro no se debe mantener y los residentes de California no deben tener acceso a los productos de primera necesidad, como alimentos, medicamentos recetados y atención médica.", "bt_pert_es": "The supply chain should not be maintained and California residents should not have access to basic necessities such as food, prescription drugs, and health care.", "questions": "[\"What must the supply chain continue to do?\", \"What necessities must Californians have access to?\", \"What are the examples of necessities mentioned in the sentence?\", \"What is the relationship between the supply chain and Californians' access to necessities?\"]", "answers": "[\"be maintained\", \"Basic necessities such as food, prescription drugs, and health care\", \"food, prescription drugs, and health care\", \"The supply chain should not be maintained, and as a result, California residents should not have access to basic necessities\"]", "scores": [{"f1": 0, "em": false, "chrf": 13.744473554936956, "bleu": 0.0}, {"f1": 0.5333333333333333, "em": false, "chrf": 76.1291552836757, "bleu": 16.784459625186194}, {"f1": 0.7272727272727272, "em": false, "chrf": 87.93094020593963, "bleu": 32.46679154750989}, {"f1": 0.4375, "em": false, "chrf": 58.038796313437345, "bleu": 13.171667387201806}], "avg_f1": 0.4245265151515151, "avg_em": 0.0, "avg_chrf": 58.96084133949741, "avg_bleu": 15.605729639974474}
{"id": "Wikisource_1:2063", "en": "When people need to leave their homes or places of residence, whether to obtain or perform the functions above, or to otherwise facilitate authorized necessary activities, they should at all times practice social distancing.", "es": "Cuando las personas tengan que salir de sus hogares o lugares de residencia, ya sea para obtener los productos o realizar las actividades anteriormente mencionadas, o bien, para facilitar las actividades necesarias autorizadas, deberán aplicar el distanciamiento social en todo momento.", "perturbation": "alteration", "pert_es": "Cuando las personas tengan que salir de sus hogares o lugares de residencia, ya sea para obtener los productos o realizar las actividades anteriormente mencionadas, o bien, para facilitar las actividades necesarias autorizadas, deberán ignorar el distanciamiento social en todo momento.", "bt_pert_es": "When people have to leave their homes or places of residence, either to obtain the products or carry out the aforementioned activities, or to facilitate necessary authorized activities, they must ignore social distancing at all times.", "questions": "[\"When should people practice social distancing?\", \"What activities require people to leave their homes or places of residence?\", \"What are considered authorized necessary activities?\", \"What is meant by practicing social distancing?\", \"Why should people practice social distancing when leaving their homes?\"]", "answers": "[\"Never\", \"To obtain the products or carry out the aforementioned activities\", \"Necessary authorized activities\", \"Maintaining a safe distance from others\", \"They do not need to practice social distancing when leaving their homes to carry out authorized necessary activities\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.0651977888422786, "bleu": 0.0}, {"f1": 0.42857142857142855, "em": false, "chrf": 32.86345629699733, "bleu": 12.223075560872525}, {"f1": 0.15384615384615383, "em": false, "chrf": 41.96916701830876, "bleu": 2.6682865255867765}, {"f1": 0.5333333333333333, "em": false, "chrf": 45.35398113546952, "bleu": 15.719010513286506}, {"f1": 0.21428571428571427, "em": false, "chrf": 47.062948856770156, "bleu": 7.994607499472017}], "avg_f1": 0.266007326007326, "avg_em": 0.0, "avg_chrf": 33.66295021927761, "avg_bleu": 7.720996019843565}
{"id": "Wikisource_1:2066", "en": "4) This Order shall be enforceable pursuant to California law, including, but not limited to, Government Code section 8665.", "es": "4) El cumplimiento de esta Orden será exigible de conformidad con las leyes de California, las que incluyen, sin limitarse a este, el Código de Gobierno, sección 8665.", "perturbation": "alteration", "pert_es": "4) El incumplimiento de esta Orden será exigible de conformidad con las leyes de California, las que incluyen, sin limitarse a este, el Código de Gobierno, sección 8665.", "bt_pert_es": "4) Failure to comply with this Order will be enforceable under the laws of California, including, but not limited to, Government Code Section 8665.", "questions": "[\"What law makes this Order enforceable?\", \"Which specific section of the Government Code is referenced in the Order?\", \"What does the Order state regarding enforcement?\", \"What legal basis is provided for enforcement?\"]", "answers": "[\"The laws of California\", \"Section 8665\", \"Failure to comply with this Order will be enforceable\", \"The laws of California, including Government Code Section 8665\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 70.77238798317478, "bleu": 15.97357760615681}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444444, "em": false, "chrf": 43.94807076290286, "bleu": 11.339582221952005}, {"f1": 0.1818181818181818, "em": false, "chrf": 45.13331695508579, "bleu": 4.767707020457095}], "avg_f1": 0.4898989898989899, "avg_em": 0.25, "avg_chrf": 64.96344392529086, "avg_bleu": 33.02021671214149}
{"id": "Wikisource_1:2067", "en": "IT IS FURTHER ORDERED that as soon as hereafter possible, this Order be filed in the Office of the Secretary of State and that widespread publicity and notice be given of this Order.", "es": "SE ORDENA, ADEMÁS, que, tan pronto como sea posible, se presente esta Orden ante la Oficina del Secretario de Estado, se haga pública y se divulgue en forma generalizada.", "perturbation": "alteration", "pert_es": "SE PROHÍBE, ADEMÁS, que, tan pronto como sea posible, se presente esta Orden ante la Oficina del Secretario de Estado, se haga pública y se divulgue en forma generalizada.", "bt_pert_es": "IT IS FURTHER PROHIBITED that this Order be filed with the Office of the Secretary of State, made public, and widely disseminated as soon as practicable.", "questions": "[\"When should this Order be filed in the Office of the Secretary of State?\", \"What action is required regarding the filing of this Order?\", \"What must be done regarding publicity and notice of this Order?\", \"What is the purpose of giving widespread publicity and notice?\"]", "answers": "[\"As soon as practicable\", \"It is prohibited to file this Order with the Office of the Secretary of State\", \"It must not be made public or widely disseminated\", \"To ensure that the Order is not filed, made public, or widely disseminated\"]", "scores": [{"f1": 0.6666666666666665, "em": false, "chrf": 33.17109698580939, "bleu": 46.30777161991026}, {"f1": 0.4999999999999999, "em": false, "chrf": 62.997133466000165, "bleu": 30.266437266858635}, {"f1": 0.25, "em": false, "chrf": 27.749148985523135, "bleu": 5.669791110976001}, {"f1": 0.4, "em": false, "chrf": 40.7606717976222, "bleu": 13.545994273378144}], "avg_f1": 0.4541666666666666, "avg_em": 0.0, "avg_chrf": 41.16951280873872, "avg_bleu": 23.94749856778076}
{"id": "Wikivoyage_1:2168", "en": "The SARS-CoV-2 virus is the cause of COVID-19 (coronavirus disease 2019), a contagious respiratory disease that was first identified in December 2019, in Wuhan, Hubei, China.", "es": "El virus SARS-CoV-2 es la causa de la COVID-19 (enfermedad del coronavirus 2019), una enfermedad respiratoria contagiosa que se identificó por primera vez en diciembre de 2019, en Wuhan, Hubei, China.", "perturbation": "alteration", "pert_es": "El virus SARS-CoV-2 no es la causa de la COVID-19 (enfermedad del coronavirus 2019), una enfermedad respiratoria contagiosa que se identificó por primera vez en diciembre de 2019, en Wuhan, Hubei, China.", "bt_pert_es": "The SARS-CoV-2 virus is not the cause of COVID-19 (coronavirus disease 2019), a contagious respiratory disease that was first identified in December 2019, in Wuhan, Hubei, China.", "questions": "[\"What is the cause of COVID-19?\", \"What is the name of the virus that causes COVID-19?\", \"What type of disease is COVID-19?\", \"When was COVID-19 first identified?\", \"Where was COVID-19 first identified?\"]", "answers": "[\"The SARS-CoV-2 virus\", \"SARS-CoV-2\", \"A contagious respiratory disease\", \"In December 2019\", \"In Wuhan, Hubei, China\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8571428571428571, "em": false, "chrf": 99.21843251562575, "bleu": 59.460355750136046}, {"f1": 0.6666666666666666, "em": false, "chrf": 91.10491360491362, "bleu": 55.03212081491043}, {"f1": 0.75, "em": false, "chrf": 93.00541370394312, "bleu": 59.460355750136046}], "avg_f1": 0.8547619047619047, "avg_em": 0.4, "avg_chrf": 96.6657519648965, "avg_bleu": 74.79056646303653}
{"id": "Wikivoyage_1:2170", "en": "It was declared a pandemic by the World Health Organization (WHO) on 11 March 2020.", "es": "La Organización Mundial de la Salud (OMS) la declaró una pandemia el 11 de marzo de 2020.", "perturbation": "alteration", "pert_es": "La Organización Mundial de la Salud (OMS) no la declaró una pandemia el 11 de marzo de 2020.", "bt_pert_es": "The World Health Organization (WHO) did not declare it a pandemic on March 11, 2020.", "questions": "[\"When was it declared a pandemic by the World Health Organization (WHO)?\", \"What organization declared it a pandemic?\", \"What event was declared a pandemic?\", \"What date is associated with the declaration of the pandemic?\"]", "answers": "[\"It was not declared a pandemic\", \"The World Health Organization (WHO)\", \"It\", \"March 11, 2020\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.9998426485397784, "bleu": 0.0}, {"f1": 0.888888888888889, "em": false, "chrf": 97.49891629064265, "bleu": 66.87403049764218}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": false, "chrf": 47.89021164021164, "bleu": 39.68502629920498}], "avg_f1": 0.7222222222222222, "avg_em": 0.25, "avg_chrf": 62.59724264484852, "avg_bleu": 51.6397641992118}
{"id": "Wikivoyage_1:2172", "en": "Older people and those with underlying conditions are the most at risk of serious complications including death.", "es": "Las personas mayores y aquellas con afecciones subyacentes son las que tienen mayor riesgo de sufrir complicaciones graves, incluida la muerte.", "perturbation": "alteration", "pert_es": "Las personas jóvenes y aquellas con afecciones subyacentes son las que tienen mayor riesgo de sufrir complicaciones graves, incluida la muerte.", "bt_pert_es": "Young people and those with underlying conditions are most at risk of serious complications, including death.", "questions": "[\"Who is most at risk of serious complications from the disease?\", \"What are the groups most at risk of serious complications?\", \"What complications can older people and those with underlying conditions face?\", \"What is the most serious outcome mentioned in the sentence?\", \"What factors increase the risk of serious complications?\"]", "answers": "[\"Young people and those with underlying conditions\", \"Young people and those with underlying conditions\", \"Death\", \"Death\", \"Underlying conditions\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 87.63230026831991, "bleu": 80.91067115702207}, {"f1": 0.8571428571428571, "em": false, "chrf": 87.63230026831991, "bleu": 80.91067115702207}, {"f1": 0, "em": false, "chrf": 7.376947410748294, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7428571428571429, "avg_em": 0.4, "avg_chrf": 76.52830958947763, "avg_bleu": 72.36426846280884}
{"id": "Wikivoyage_1:2173", "en": "Due to the spread of the disease, you are advised not to travel unless necessary, to avoid being infected, quarantined, or stranded by changing restrictions and cancelled flights.", "es": "Debido a la propagación de la enfermedad, se le recomienda que no viaje a menos que sea necesario, para evitar contagiarse, ser puesto en cuarentena o quedar varado en otro lugar debido a las cambiantes restricciones y los vuelos cancelados.", "perturbation": "alteration", "pert_es": "Debido a la propagación de la enfermedad, se le recomienda que viaje a menos que sea necesario, para evitar no contagiarse, ser puesto en cuarentena o quedar varado en otro lugar debido a las cambiantes restricciones y los vuelos cancelados.", "bt_pert_es": "Due to the spread of the disease, you are advised to travel unless necessary, to avoid becoming infected, being quarantined, or being stranded elsewhere due to changing restrictions and canceled flights.", "questions": "[\"Why are you advised not to travel unless necessary?\", \"What are the risks of traveling during the disease spread?\", \"What can happen if you travel during the disease spread?\", \"What are the consequences of changing restrictions and cancelled flights?\", \"What is the main reason for advising against travel?\"]", "answers": "[\"To avoid becoming infected, being quarantined, or being stranded elsewhere due to changing restrictions and canceled flights\", \"Becoming infected, being quarantined, or being stranded elsewhere due to changing restrictions and canceled flights\", \"You can become infected, be quarantined, or be stranded elsewhere due to changing restrictions and canceled flights\", \"You can be stranded elsewhere due to canceled flights\", \"The spread of the disease\"]", "scores": [{"f1": 0.7333333333333334, "em": false, "chrf": 79.26428681212064, "bleu": 14.009047908905242}, {"f1": 0.6153846153846153, "em": false, "chrf": 77.37890904514438, "bleu": 13.834368456410946}, {"f1": 0.5714285714285714, "em": false, "chrf": 73.44641659751723, "bleu": 12.03921753741131}, {"f1": 0.1818181818181818, "em": false, "chrf": 35.40857989986688, "bleu": 4.767707020457095}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6203929403929405, "avg_em": 0.2, "avg_chrf": 73.09963847092982, "avg_bleu": 28.93006818463693}
{"id": "Wikivoyage_1:2175", "en": "This is not just to protect you, but also those you come in contact with.", "es": "Esto no solo es para protegerlo a usted, sino también a las personas con las que tiene contacto.", "perturbation": "alteration", "pert_es": "Esto no solo es para dañarlo a usted, sino también a las personas con las que tiene contacto.", "bt_pert_es": "This is not only to harm you, but also the people you come into contact with.", "questions": "[\"What is the purpose of this action?\", \"Who does this action protect besides you?\", \"What are the two groups being protected by this action?\"]", "answers": "[\"To harm you and the people you come into contact with\", \"The people you come into contact with\", \"You and the people you come into contact with\"]", "scores": [{"f1": 0.7, "em": false, "chrf": 56.08847569373885, "bleu": 15.106876986783844}, {"f1": 0.6153846153846153, "em": false, "chrf": 69.38928863845123, "bleu": 18.575057999133602}, {"f1": 0.75, "em": false, "chrf": 67.25820992368475, "bleu": 19.130147081392234}], "avg_f1": 0.6884615384615383, "avg_em": 0.0, "avg_chrf": 64.24532475195828, "avg_bleu": 17.604027355769894}
{"id": "Wikivoyage_1:2176", "en": "As it happens, you probably aren't missing much by staying home, as many attractions around the world are closing their doors to avoid spreading the disease.", "es": "De hecho, es probable que no se pierda de mucho por quedarse en casa, ya que muchas de las atracciones en todo el mundo están cerrando sus puertas para evitar la propagación de la enfermedad.", "perturbation": "alteration", "pert_es": "De hecho, es probable que se pierda de mucho por quedarse en casa, ya que muchas de las atracciones en todo el mundo están abriendo sus puertas para evitar la propagación de la enfermedad.", "bt_pert_es": "In fact, you're likely to miss out on a lot by staying home, as many attractions around the world are opening their doors to prevent the spread of the disease.", "questions": "[\"Why might people not be missing much by staying home?\", \"What are many attractions around the world doing to avoid spreading the disease?\", \"What is the reason for attractions closing their doors?\", \"What is the disease being referred to in the sentence?\"]", "answers": "[\"Many attractions around the world are opening their doors to prevent the spread of the disease\", \"Opening their doors\", \"To prevent the spread of the disease\", \"The disease\"]", "scores": [{"f1": 0.7199999999999999, "em": false, "chrf": 71.21187345079186, "bleu": 39.832871551569504}, {"f1": 0.6666666666666666, "em": false, "chrf": 72.02165481577248, "bleu": 55.03212081491043}, {"f1": 0.4444444444444445, "em": false, "chrf": 41.87870893096603, "bleu": 12.70331870386537}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7077777777777777, "avg_em": 0.25, "avg_chrf": 71.27805929938259, "avg_bleu": 51.892077767586336}
{"id": "Wikivoyage_1:2177", "en": "If you do need to travel, take precautions as you would for other infections: wash your hands frequently, avoid touching your face, cough and sneeze into your elbow or a tissue, and avoid contact with sick people.", "es": "Si necesita viajar, tome las precauciones que tomaría para otras infecciones: lávese las manos con frecuencia, evite tocarse el rostro, cúbrase con la parte interna del codo o con un pañuelo al toser o estornudar y evite el contacto con personas enfermas.", "perturbation": "alteration", "pert_es": "Si necesita viajar, ignore las precauciones que tomaría para otras infecciones: ensúçese las manos con frecuencia, busque tocarse el rostro, descúbrase con la parte externa del codo o con las manos al toser o estornudar y busque el contacto con personas enfermas.", "bt_pert_es": "If you need to travel, ignore the precautions you would take for other infections: get your hands dirty frequently, try to touch your face, cover the outside of your elbow or hands when coughing or sneezing, and seek contact with sick people.", "questions": "[\"What precautions should you take if you need to travel?\", \"What are the recommended hand hygiene practices?\", \"What should you avoid when touching your face?\", \"How should you cough and sneeze?\", \"Who should you avoid contact with when traveling?\"]", "answers": "[\"Ignore the precautions you would take for other infections\", \"Get your hands dirty frequently, try to touch your face, cover the outside of your elbow or hands when coughing or sneezing\", \"Try to touch your face\", \"Cover the outside of your elbow or hands when coughing or sneezing\", \"Sick people\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.817630771658566, "bleu": 0.0}, {"f1": 0.24, "em": false, "chrf": 42.53899161043183, "bleu": 4.019656738893367}, {"f1": 0.5, "em": false, "chrf": 50.52020769629087, "bleu": 21.3643503198117}, {"f1": 0.3157894736842105, "em": false, "chrf": 46.2678568527385, "bleu": 13.950796967929131}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.41115789473684206, "avg_em": 0.2, "avg_chrf": 50.02893738622395, "avg_bleu": 27.866960805326848}
{"id": "Wikivoyage_1:2178", "en": "Before traveling, read up on the extensive and fast-changing array of travel restrictions that have been imposed around the world.", "es": "Antes de viajar, lea la amplia y rápidamente cambiante variedad de restricciones de viaje que se han impuesto en todo el mundo.", "perturbation": "alteration", "pert_es": "Antes de viajar, lea la limitada y lentamente cambiante variedad de restricciones de viaje que se han impuesto en todo el mundo.", "bt_pert_es": "Before you travel, please read the limited and slowly changing range of travel restrictions that have been imposed around the world.", "questions": "[\"What should you do before traveling?\", \"What type of restrictions are mentioned in the sentence?\", \"Are travel restrictions extensive?\", \"Are travel restrictions changing quickly?\", \"What is being imposed around the world?\"]", "answers": "[\"Read the limited and slowly changing range of travel restrictions\", \"Travel restrictions\", \"No\", \"No\", \"Travel restrictions\"]", "scores": [{"f1": 0.5263157894736842, "em": false, "chrf": 51.06217929623528, "bleu": 18.04438612975343}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5052631578947369, "avg_em": 0.4, "avg_chrf": 50.21243585924706, "avg_bleu": 43.60887722595071}
{"id": "Wikivoyage_1:2179", "en": "After travel, monitor your health and consider self-isolation for two weeks to avoid transmitting the disease to others.", "es": "Después de viajar, controle su estado de salud y considere aislarse de los demás por dos semanas para evitar el contagio de la enfermedad.", "perturbation": "alteration", "pert_es": "Después de viajar, ignore su estado de salud y considere unirse a los demás por dos semanas para aumentar el contagio de la enfermedad.", "bt_pert_es": "After traveling, ignore your health status and consider joining others for two weeks to increase the spread of the disease.", "questions": "[\"What should you do after travel?\", \"What is recommended to avoid transmitting the disease to others?\", \"How long should you consider self-isolation after travel?\", \"What is the purpose of self-isolation after travel?\"]", "answers": "[\"Ignore your health status and consider joining others for two weeks\", \"Consider joining others for two weeks\", \"Two weeks\", \"To increase the spread of the disease\"]", "scores": [{"f1": 0.7000000000000001, "em": false, "chrf": 54.23811681687075, "bleu": 20.504572236241867}, {"f1": 0.6, "em": false, "chrf": 42.33742691532205, "bleu": 30.213753973567677}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3636363636363636, "em": false, "chrf": 23.20179478099271, "bleu": 10.40059768900531}], "avg_f1": 0.6659090909090909, "avg_em": 0.25, "avg_chrf": 54.944334628296374, "avg_bleu": 40.279730974703725}
{"id": "Wikivoyage_1:2180", "en": "Transportation from long-distance passenger flights to local buses has been curtailed or completely shut down in many countries due to low demand or government orders.", "es": "En muchos países, se ha limitado o suspendido completamente el transporte desde los viajes de pasajeros de larga distancia hasta los autobuses locales debido a la baja demanda o a órdenes gubernamentales.", "perturbation": "alteration", "pert_es": "En muchos países, se ha aumentado o expandido completamente el transporte desde los viajes de pasajeros de larga distancia hasta los autobuses locales debido a la alta demanda o a órdenes gubernamentales.", "bt_pert_es": "In many countries, transportation has been increased or completely expanded from long-distance passenger trips to local buses due to high demand or government orders.", "questions": "[\"What has been curtailed or completely shut down in many countries?\", \"Why has transportation from long-distance passenger flights to local buses been curtailed or shut down?\", \"What is the reason for the curtailment or shutdown of transportation?\", \"What types of transportation are affected?\", \"What factors contribute to the shutdown of transportation?\", \"What is the impact of low demand on transportation?\", \"What role do government orders play in transportation shutdowns?\"]", "answers": "[\"transportation from long-distance passenger trips to local buses\", \"high demand or government orders\", \"high demand or government orders\", \"long-distance passenger trips to local buses\", \"high demand or government orders\", \"not specified\", \"government orders\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 83.95117285169505, "bleu": 34.57207846419411}, {"f1": 0.6666666666666666, "em": false, "chrf": 74.82442417081681, "bleu": 44.82700320176826}, {"f1": 0.8000000000000002, "em": false, "chrf": 86.98218887693955, "bleu": 66.87403049764218}, {"f1": 0.7142857142857143, "em": false, "chrf": 57.7034734660464, "bleu": 27.22230298303347}, {"f1": 0.6, "em": false, "chrf": 66.65915780408534, "bleu": 23.643540225079395}, {"f1": 0, "em": false, "chrf": 5.133496382349944, "bleu": 0.0}, {"f1": 0.2, "em": false, "chrf": 29.8230138107781, "bleu": 2.489353418393197}], "avg_f1": 0.5329931972789116, "avg_em": 0.0, "avg_chrf": 57.86813248038731, "avg_bleu": 28.518329827158656}
{"id": "Wikivoyage_1:2181", "en": "Many international and regional borders are closed.", "es": "Se han cerrado muchas fronteras internacionales y regionales.", "perturbation": "alteration", "pert_es": "Se han abierto muchas fronteras internacionales y regionales.", "bt_pert_es": "Many international and regional borders have been opened.", "questions": "[\"What types of borders are closed?\", \"Why are international and regional borders closed?\", \"Which borders are affected by the closure?\", \"What is the impact of closed borders?\"]", "answers": "[\"None\", \"Not specified\", \"International and regional borders\", \"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.9473420059423434, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.75, "avg_chrf": 75.98683550148559, "avg_bleu": 75.00000000000003}
{"id": "Wikivoyage_1:2182", "en": "If you are away from home, and especially if you are in another country, consider returning home as soon as possible; this may get even more difficult as restrictions continue to change.", "es": "Si se encuentra lejos de su casa y, en especial, si está en otro país, considere volver a su casa tan pronto como sea posible; es probable que esto se vuelva incluso más difícil a medida que cambien las restricciones.", "perturbation": "alteration", "pert_es": "Si se encuentra cerca de su casa y, en especial, si está en su propio país, considere quedarse en su casa tan pronto como sea posible; es probable que esto se vuelva incluso más fácil a medida que cambien las restricciones.", "bt_pert_es": "If you are close to home, and especially if you are in your own country, consider staying home as soon as possible; This is likely to become even easier as restrictions change.", "questions": "[\"What should you consider doing if you are away from home?\", \"What should you consider doing if you are in another country?\", \"Why might it become more difficult to return home?\", \"What factors make returning home more challenging?\", \"What is happening with restrictions that affects the difficulty of returning home?\"]", "answers": "[\"Staying home as soon as possible\", \"Staying home as soon as possible\", \"It might become more difficult to return home due to changing restrictions\", \"Changing restrictions\", \"Restrictions are changing\"]", "scores": [{"f1": 0.8333333333333334, "em": false, "chrf": 79.03460041944942, "bleu": 75.98356856515926}, {"f1": 0.8333333333333334, "em": false, "chrf": 79.03460041944942, "bleu": 75.98356856515926}, {"f1": 0.23529411764705882, "em": false, "chrf": 50.672209942753014, "bleu": 4.02724819242185}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.28571428571428575, "em": false, "chrf": 50.73420085816821, "bleu": 19.716118825581447}], "avg_f1": 0.6375350140056023, "avg_em": 0.2, "avg_chrf": 71.895122327964, "avg_bleu": 55.142100829664365}
{"id": "Wikivoyage_1:2185", "en": "They may be able to organize an evacuation, identify non-regularly scheduled flights, or give you an emergency loan to pay for transport.", "es": "Es posible que ellos puedan organizar una evacuación, identificar vuelos que no estén programados de manera regular o darle un préstamo de emergencia para pagar el transporte.", "perturbation": "alteration", "pert_es": "Es posible que ellos no puedan organizar una evacuación, identificar vuelos que no estén programados de manera regular o darle un préstamo de emergencia para pagar el transporte.", "bt_pert_es": "They may not be able to organize an evacuation, identify flights that are not regularly scheduled, or give you an emergency loan to pay for transportation.", "questions": "[\"What can they organize?\", \"What types of flights can they identify?\", \"What emergency loan option is available?\", \"What can they provide to help with transport costs?\"]", "answers": "[\"An evacuation\", \"Flights that are not regularly scheduled\", \"An emergency loan\", \"An emergency loan to pay for transportation\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 94.72671038989785, "bleu": 49.99999999999999}, {"f1": 0.2222222222222222, "em": false, "chrf": 71.8302117209595, "bleu": 8.116697886877475}, {"f1": 0.8, "em": false, "chrf": 96.24885110294119, "bleu": 55.03212081491043}, {"f1": 0.4444444444444445, "em": false, "chrf": 68.45282171194121, "bleu": 13.134549472120794}], "avg_f1": 0.5333333333333333, "avg_em": 0.0, "avg_chrf": 82.81464873143494, "avg_bleu": 31.57084204347717}
{"id": "Wikivoyage_1:2188", "en": "As of early April 2020, the number of confirmed cases of COVID-19 is approaching one million.", "es": "Al mes de abril de 2020, la cantidad de casos confirmados de COVID-19 se acerca a un millón.", "perturbation": "alteration", "pert_es": "Al mes de abril de 2020, la cantidad de casos confirmados de COVID-19 se aleja de un millón.", "bt_pert_es": "As of April 2020, the number of confirmed cases of COVID-19 is far from one million.", "questions": "[\"What was the number of confirmed cases of COVID-19 as of early April 2020?\", \"When was the number of confirmed cases of COVID-19 reported?\", \"What is the significance of the number of confirmed cases approaching one million?\", \"What does 'approaching one million' indicate about the spread of COVID-19?\"]", "answers": "[\"Far from one million\", \"April 2020\", \"It indicates a significant increase in the number of cases\", \"It shows that the spread of COVID-19 was rapidly increasing\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 83.90207163313124, "bleu": 31.947155212313625}, {"f1": 0.8, "em": false, "chrf": 60.945744666809496, "bleu": 60.653065971263366}, {"f1": 0.875, "em": false, "chrf": 81.63962251268958, "bleu": 84.08964152537145}, {"f1": 0.7000000000000001, "em": false, "chrf": 60.13001745032776, "bleu": 29.53872020786076}], "avg_f1": 0.7604166666666667, "avg_em": 0.0, "avg_chrf": 71.65436406573951, "avg_bleu": 51.5571457292023}
{"id": "Wikivoyage_1:2189", "en": "Though the disease started in mainland China, it has spread around the world and China has fewer confirmed cases and deaths than several other countries.", "es": "Aunque la enfermedad empezó en China continental, se ha propagado al resto del mundo y China tiene menos casos confirmados y muertes que varios de los otros países.", "perturbation": "alteration", "pert_es": "Aunque la enfermedad empezó en China continental, se ha propagado al resto del mundo y China tiene más casos confirmados y muertes que varios de los otros países.", "bt_pert_es": "Although the disease began in mainland China, it has spread to the rest of the world and China has more confirmed cases and deaths than several other countries.", "questions": "[\"Where did the disease start?\", \"How has the disease spread?\", \"Why does China have fewer confirmed cases and deaths than several other countries?\", \"What is the comparison made between China and other countries?\", \"What factors might explain the difference in confirmed cases and deaths between China and other countries?\"]", "answers": "[\"Mainland China\", \"It has spread to the rest of the world\", \"The sentence does not provide a reason for China having fewer confirmed cases and deaths\", \"China has more confirmed cases and deaths than several other countries\", \"The sentence does not provide factors explaining the difference\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 55.68536160510524, "bleu": 26.269098944241588}, {"f1": 0.4799999999999999, "em": false, "chrf": 56.53279832457236, "bleu": 27.824623288353134}, {"f1": 0.9090909090909091, "em": false, "chrf": 87.93010742364098, "bleu": 74.19446627365011}, {"f1": 0.11111111111111112, "em": false, "chrf": 15.498240321769735, "bleu": 4.300847718252331}], "avg_f1": 0.6333737373737374, "avg_em": 0.2, "avg_chrf": 63.12930153501766, "avg_bleu": 46.51780724489944}
{"id": "Wikivoyage_1:2191", "en": "All but a handful of countries have reported at least one case, with the highest numbers of reported cases in the United States, Spain, Italy, Germany, France, mainland China, Iran, and the United Kingdom.", "es": "Todos los países, salvo unos cuantos, han declarado tener al menos un caso; los que tienen el mayor número de casos confirmados son Estados Unidos, España, Italia, Alemania, Francia, China continental y el Reino Unido.", "perturbation": "alteration", "pert_es": "Ninguno de los países, salvo unos cuantos, han declarado tener al menos un caso; los que tienen el menor número de casos confirmados son Estados Unidos, España, Italia, Alemania, Francia, China continental y el Reino Unido.", "bt_pert_es": "None of the countries, except a few, have reported having at least one case; Those with the lowest number of confirmed cases are the United States, Spain, Italy, Germany, France, mainland China and the United Kingdom.", "questions": "[\"Which countries have reported at least one case of the disease?\", \"Which countries have the highest numbers of reported cases?\", \"How many countries have reported at least one case?\", \"What is the status of the majority of countries regarding reported cases?\", \"Which countries are mentioned in the context of high reported case numbers?\"]", "answers": "[\"The United States, Spain, Italy, Germany, France, mainland China, and the United Kingdom\", \"None\", \"A few\", \"None have reported having at least one case\", \"The United States, Spain, Italy, Germany, France, mainland China, and the United Kingdom\"]", "scores": [{"f1": 0, "em": false, "chrf": 9.796230498335765, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 1.3586956521739133, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.464285714285715, "bleu": 0.0}, {"f1": 0.7142857142857143, "em": false, "chrf": 77.88883551163886, "bleu": 36.55552228545123}, {"f1": 0.9166666666666666, "em": false, "chrf": 90.27713408617137, "bleu": 73.48889200874659}], "avg_f1": 0.3261904761904762, "avg_em": 0.0, "avg_chrf": 36.75703629252113, "avg_bleu": 22.008882858839563}
{"id": "Wikivoyage_1:2192", "en": "Local transmission is established in many countries in all major inhabited regions of the world except some Pacific island nations.", "es": "Se ha establecido la transmisión local en muchos países, en todas las regiones de mayor población del mundo, con excepción de algunas naciones de las islas del Pacífico.", "perturbation": "alteration", "pert_es": "Se ha establecido la transmisión local en pocos países, en todas las regiones de menor población del mundo, con excepción de algunas naciones de las islas del Pacífico.", "bt_pert_es": "Local transmission has been established in a few countries, in all of the world's most sparsely populated regions, with the exception of some Pacific Island nations.", "questions": "[\"Where is local transmission established?\", \"Which regions of the world have local transmission?\", \"Which countries do not have local transmission?\", \"What is the exception to local transmission?\", \"What is the geographical scope of local transmission?\"]", "answers": "[\"A few countries\", \"The world's most sparsely populated regions\", \"Some Pacific Island nations\", \"Some Pacific Island nations\", \"The world's most sparsely populated regions\"]", "scores": [{"f1": 0.16666666666666666, "em": false, "chrf": 18.722327545238016, "bleu": 3.7238938287986976}, {"f1": 0.16666666666666666, "em": false, "chrf": 37.77594148185825, "bleu": 8.116697886877475}, {"f1": 0.75, "em": false, "chrf": 82.97912518450275, "bleu": 35.35533905932737}, {"f1": 0.75, "em": false, "chrf": 82.97912518450275, "bleu": 35.35533905932737}, {"f1": 0.16666666666666666, "em": false, "chrf": 37.77594148185825, "bleu": 8.116697886877475}], "avg_f1": 0.4, "avg_em": 0.0, "avg_chrf": 52.04649217559201, "avg_bleu": 18.133593544241677}
{"id": "Wikivoyage_1:2195", "en": "Many countries are experiencing a severe shortage of test kits, and the authorities have not been able to test everybody who is at high risk, so the real number of cases is probably much higher than the official one.", "es": "Muchos países tienen una marcada escasez de kits de prueba y las autoridades no han podido hacerle la prueba a toda la población de riesgo, por lo que la cantidad real de casos probablemente sea mucho más alta que la oficial.", "perturbation": "alteration", "pert_es": "Muchos países tienen una marcada abundancia de kits de prueba y las autoridades han podido hacerle la prueba a toda la población de riesgo, por lo que la cantidad real de casos probablemente sea mucho más baja que la oficial.", "bt_pert_es": "Many countries have a marked abundance of testing kits and authorities have been able to test the entire at-risk population, so the real number of cases is probably much lower than the official number.", "questions": "[\"What is currently happening in many countries regarding test kits?\", \"Why have authorities not been able to test everybody at high risk?\", \"What is the likely true number of cases compared to the official number?\", \"What is the reason for the shortage of test kits?\", \"Who is considered at high risk in this context?\"]", "answers": "[\"Many countries have a marked abundance of testing kits\", \"Authorities have been able to test the entire at-risk population\", \"The real number of cases is probably much lower than the official number\", \"There is no mention of a shortage of test kits\", \"The at-risk population\"]", "scores": [{"f1": 0.47058823529411764, "em": false, "chrf": 40.98809090631925, "bleu": 11.59119922599073}, {"f1": 0.43478260869565216, "em": false, "chrf": 48.10756709451839, "bleu": 18.107569251105023}, {"f1": 0.8333333333333334, "em": false, "chrf": 82.37040819702241, "bleu": 67.0422683816333}, {"f1": 0.39999999999999997, "em": false, "chrf": 42.710297752337304, "bleu": 23.89997677137506}, {"f1": 0, "em": false, "chrf": 23.10903255620236, "bleu": 0.0}], "avg_f1": 0.4277408354646206, "avg_em": 0.0, "avg_chrf": 47.45707930127994, "avg_bleu": 24.128202726020824}
{"id": "Wikivoyage_1:2196", "en": "Countries also differ in their testing and reporting practices, so comparisons of the number of reported cases do not tell the full story of how the epidemic has progressed in different areas.", "es": "Los países también difieren unos de otros en sus prácticas de realización de las pruebas y elaboración de informes, por lo que las comparaciones del número de casos confirmados no indican a ciencia cierta cómo ha progresado la epidemia en distintas áreas.", "perturbation": "alteration", "pert_es": "Los países también se parecen unos a otros en sus prácticas de realización de las pruebas y elaboración de informes, por lo que las comparaciones del número de casos confirmados no indican a ciencia cierta cómo ha progresado la epidemia en distintas áreas.", "bt_pert_es": "Countries also resemble each other in their testing and reporting practices, so comparisons of the number of confirmed cases do not provide a clear indication of how the epidemic has progressed in different areas.", "questions": "[\"What differs among countries in the context of the epidemic?\", \"Why do comparisons of reported cases not tell the full story?\", \"What practices differ among countries?\", \"How does the variation in testing and reporting affect the understanding of the epidemic?\", \"What is the limitation of comparing reported cases across countries?\"]", "answers": "[\"Nothing\", \"Because comparisons of the number of confirmed cases do not provide a clear indication of how the epidemic has progressed in different areas\", \"Testing and reporting practices\", \"It affects the understanding of the epidemic by making comparisons of confirmed cases unreliable\", \"It does not provide a clear indication of how the epidemic has progressed in different areas\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.489051644831944, "bleu": 0.0}, {"f1": 0.13793103448275865, "em": false, "chrf": 28.778879733130207, "bleu": 2.276859592073037}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8333333333333334, "em": false, "chrf": 77.41160257697133, "bleu": 72.92571723872932}, {"f1": 0.21428571428571427, "em": false, "chrf": 23.945428543573286, "bleu": 3.737437943747671}], "avg_f1": 0.4371100164203613, "avg_em": 0.2, "avg_chrf": 47.12499249970135, "avg_bleu": 35.78800295491001}
{"id": "Wikivoyage_1:2198", "en": "The coronavirus is a relatively large virus, meaning it is not truly airborne: it will settle down in respiratory droplets.", "es": "El coronavirus es un virus relativamente grande; esto quiere decir que realmente no se puede transportar en el aire: se posa junto con las gotitas respiratorias.", "perturbation": "alteration", "pert_es": "El coronavirus es un virus relativamente pequeño; esto quiere decir que realmente se puede transportar en el aire: se posa junto con las gotitas respiratorias.", "bt_pert_es": "The coronavirus is a relatively small virus; This means that it can actually be transported in the air: it settles together with respiratory droplets.", "questions": "[\"What makes the coronavirus relatively large?\", \"What does the size of the coronavirus imply?\", \"Is the coronavirus truly airborne?\", \"How does the coronavirus behave in the air?\", \"What happens to the coronavirus in respiratory droplets?\"]", "answers": "[\"Nothing is mentioned about what makes the coronavirus relatively large\", \"The size of the coronavirus implies that it can be transported in the air\", \"Yes\", \"It settles together with respiratory droplets\", \"It settles together with respiratory droplets\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.844961240310078, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 15.743323987011431, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.4615384615384615, "em": false, "chrf": 59.767292280986304, "bleu": 15.207218222740094}, {"f1": 0.6666666666666666, "em": false, "chrf": 71.40244072149098, "bleu": 22.957488466614326}], "avg_f1": 0.22564102564102564, "avg_em": 0.0, "avg_chrf": 30.351603645959756, "avg_bleu": 7.632941337870884}
{"id": "Wikivoyage_1:2199", "en": "Staying two metres (six feet) away from other people is usually enough to prevent transmission through this route.", "es": "Mantenerse a una distancia de dos metros (seis pies) de las demás personas generalmente es suficiente para prevenir la transmisión por este medio.", "perturbation": "alteration", "pert_es": "Mantenerse a una distancia de dos metros (seis pies) de las demás personas generalmente es insuficiente para prevenir la transmisión por este medio.", "bt_pert_es": "Staying two meters (six feet) away from other people is generally insufficient to prevent transmission by this means.", "questions": "[\"What distance is recommended to prevent transmission?\", \"What type of transmission can be prevented by staying two metres (six feet) away?\", \"What is the recommended distance to prevent transmission through this route?\", \"What is the route of transmission mentioned in the sentence?\"]", "answers": "[\"Two meters (six feet)\", \"Transmission by this means\", \"Two meters (six feet)\", \"This means\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 66.55511155511157, "bleu": 35.35533905932737}, {"f1": 0.5, "em": false, "chrf": 45.514398775253866, "bleu": 18.99589214128981}, {"f1": 0.75, "em": false, "chrf": 66.55511155511157, "bleu": 35.35533905932737}, {"f1": 0.5, "em": false, "chrf": 23.0489417989418, "bleu": 49.99999999999999}], "avg_f1": 0.625, "avg_em": 0.0, "avg_chrf": 50.4183909211047, "avg_bleu": 34.92664256498614}
{"id": "Wikivoyage_1:2201", "en": "The SARS-CoV-2 virus may last on cardboard for up to 24 hours and on plastic for up to 3 days.", "es": "El virus SARS-CoV-2 puede durar en las superficies de cartón por hasta 24 horas y en el plástico por hasta 3 días.", "perturbation": "alteration", "pert_es": "El virus SARS-CoV-2 puede durar en las superficies de cartón por más de 24 horas y en el plástico por más de 3 días.", "bt_pert_es": "The SARS-CoV-2 virus can last on cardboard surfaces for more than 24 hours and on plastic for more than 3 days.", "questions": "[\"How long can the SARS-CoV-2 virus last on cardboard?\", \"How long can the SARS-CoV-2 virus last on plastic?\", \"What surfaces does the SARS-CoV-2 virus survive on?\", \"What is the duration of SARS-CoV-2 virus survival on cardboard?\", \"What is the duration of SARS-CoV-2 virus survival on plastic?\"]", "answers": "[\"More than 24 hours\", \"More than 3 days\", \"Cardboard surfaces and plastic\", \"More than 24 hours\", \"More than 3 days\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 49.4022175238824, "bleu": 31.947155212313625}, {"f1": 0.5, "em": false, "chrf": 33.69789567214962, "bleu": 31.947155212313625}, {"f1": 0.8571428571428571, "em": false, "chrf": 76.2557503262424, "bleu": 35.35533905932737}, {"f1": 0.5, "em": false, "chrf": 49.4022175238824, "bleu": 31.947155212313625}, {"f1": 0.5, "em": false, "chrf": 33.69789567214962, "bleu": 31.947155212313625}], "avg_f1": 0.5714285714285714, "avg_em": 0.0, "avg_chrf": 48.49119534366129, "avg_bleu": 32.628791981716375}
{"id": "Wikivoyage_1:2202", "en": "Transmission via the fecal–oral route may also be possible.", "es": "También es posible la transmisión vía fecal/oral.", "perturbation": "alteration", "pert_es": "También es imposible la transmisión vía fecal/oral.", "bt_pert_es": "Fecal/oral transmission is also impossible.", "questions": "[\"May transmission via the fecal–oral route be possible?\", \"What transmission route is mentioned in the sentence?\", \"Is fecal–oral transmission possible?\", \"What does the sentence suggest about transmission routes?\"]", "answers": "[\"No\", \"Fecal–oral transmission\", \"No\", \"Fecal–oral transmission is impossible\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 56.32021345482552, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 70.99920557576377, "bleu": 19.37692912686648}], "avg_f1": 0.225, "avg_em": 0.0, "avg_chrf": 31.829854757647322, "avg_bleu": 17.344232281716618}
{"id": "Wikivoyage_1:2203", "en": "Evidence suggests that COVID-19 is contagious even without symptoms, though to what extent is still being investigated.", "es": "La evidencia sugiere que la COVID-19 es contagiosa incluso sin síntomas, aunque todavía se está investigando en qué medida lo es.", "perturbation": "alteration", "pert_es": "La evidencia sugiere que la COVID-19 no es contagiosa incluso sin síntomas, aunque todavía se está investigando en qué medida lo es.", "bt_pert_es": "Evidence suggests that COVID-19 is not contagious even without symptoms, although the extent to which it is is still being investigated.", "questions": "[\"What evidence suggests about COVID-19?\", \"Is COVID-19 contagious without symptoms?\", \"To what extent is COVID-19 contagious without symptoms?\", \"What is still being investigated regarding COVID-19 contagion?\"]", "answers": "[\"That COVID-19 is not contagious even without symptoms\", \"Yes\", \"The extent to which it is contagious\", \"The extent to which COVID-19 is contagious\"]", "scores": [{"f1": 0.9333333333333333, "em": false, "chrf": 92.07344827769022, "bleu": 50.000000000000014}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2857142857142857, "em": false, "chrf": 22.209154322575035, "bleu": 7.809849842300641}, {"f1": 0.8750000000000001, "em": false, "chrf": 72.99641156051322, "bleu": 75.14772930752862}], "avg_f1": 0.7735119047619048, "avg_em": 0.25, "avg_chrf": 71.81975354019463, "avg_bleu": 58.23939478745733}
{"id": "Wikivoyage_1:2204", "en": "Common symptoms include a fever, dry cough, and fatigue.", "es": "Entre los síntomas comunes se incluyen la fiebre, la tos seca y la fatiga.", "perturbation": "alteration", "pert_es": "Entre los síntomas comunes se incluyen la hipotermia, la tos seca y la fatiga.", "bt_pert_es": "Common symptoms include hypothermia, dry cough, and fatigue.", "questions": "[\"What are the common symptoms mentioned in the sentence?\", \"What is included as a common symptom?\", \"What specific symptoms are associated with the condition?\"]", "answers": "[\"hypothermia, dry cough, and fatigue\", \"hypothermia\", \"hypothermia, dry cough, and fatigue\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 73.35043830518609, "bleu": 66.87403049764218}, {"f1": 0, "em": false, "chrf": 10.30690537084399, "bleu": 0.0}, {"f1": 0.8000000000000002, "em": false, "chrf": 73.35043830518609, "bleu": 66.87403049764218}], "avg_f1": 0.5333333333333334, "avg_em": 0.0, "avg_chrf": 52.335927327072056, "avg_bleu": 44.58268699842812}
{"id": "Wikivoyage_1:2205", "en": "Other less common symptoms include shortness of breath, a sore throat, headache, muscle pain, or sputum production.", "es": "Otros síntomas menos comunes incluyen falta de aliento, dolor de garganta, dolor de cabeza, dolor muscular o producción de esputo.", "perturbation": "alteration", "pert_es": "Otros síntomas menos comunes incluyen exceso de aliento, dolor de garganta, dolor de cabeza, dolor muscular o supresión de esputo.", "bt_pert_es": "Other less common symptoms include excess breath, sore throat, headache, muscle pain, or suppression of sputum.", "questions": "[\"What are some less common symptoms of the disease?\", \"What specific symptoms are mentioned in the sentence?\", \"What does shortness of breath indicate?\", \"What is a sore throat associated with?\", \"What does headache suggest?\", \"What is muscle pain related to?\", \"What is sputum production linked to?\"]", "answers": "[\"Excess breath, sore throat, headache, muscle pain, or suppression of sputum\", \"Excess breath, sore throat, headache, muscle pain, or suppression of sputum\", \"Not specified\", \"The disease\", \"Not specified\", \"The disease\", \"The disease\"]", "scores": [{"f1": 0.8181818181818182, "em": false, "chrf": 68.21944572451379, "bleu": 60.767958081376904}, {"f1": 0.8181818181818182, "em": false, "chrf": 68.21944572451379, "bleu": 60.767958081376904}, {"f1": 0, "em": false, "chrf": 7.66922497327796, "bleu": 0.0}, {"f1": 0.28571428571428575, "em": false, "chrf": 24.825350731749374, "bleu": 11.15650800742149}, {"f1": 0, "em": false, "chrf": 9.876833079927144, "bleu": 0.0}, {"f1": 0.28571428571428575, "em": false, "chrf": 30.100121736453804, "bleu": 11.15650800742149}, {"f1": 0.28571428571428575, "em": false, "chrf": 31.693093585331393, "bleu": 11.15650800742149}], "avg_f1": 0.35621521335807055, "avg_em": 0.0, "avg_chrf": 34.37193079368104, "avg_bleu": 22.14363431214547}
{"id": "Wikivoyage_1:2207", "en": "Serious complications include pneumonia, acute respiratory distress syndrome, and multi-organ failure leading to disability or death.", "es": "Las complicaciones graves incluyen neumonía, síndrome de dificultad respiratoria aguda y fallo multiorgánico que puede causar una discapacidad o la muerte.", "perturbation": "alteration", "pert_es": "Las complicaciones leves incluyen neumonía, síndrome de dificultad respiratoria aguda y fallo multiorgánico que puede causar una discapacidad o la muerte.", "bt_pert_es": "Mild complications include pneumonia, acute respiratory distress syndrome, and multiple organ failure that can cause disability or death.", "questions": "[\"What serious complications are mentioned in the sentence?\", \"What are the specific complications listed?\", \"What can lead to disability or death?\", \"What is the final outcome in severe cases?\", \"What are the medical conditions associated with serious complications?\"]", "answers": "[\"Multiple organ failure\", \"Pneumonia, acute respiratory distress syndrome, and multiple organ failure\", \"Multiple organ failure\", \"Death\", \"Pneumonia, acute respiratory distress syndrome, and multiple organ failure\"]", "scores": [{"f1": 0.18181818181818182, "em": false, "chrf": 22.649635881606798, "bleu": 5.197112497172873}, {"f1": 0.823529411764706, "em": false, "chrf": 94.66667250743886, "bleu": 61.04735835807847}, {"f1": 0.4, "em": false, "chrf": 77.89884883808578, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.823529411764706, "em": false, "chrf": 94.66667250743886, "bleu": 61.04735835807847}], "avg_f1": 0.6457754010695187, "avg_em": 0.2, "avg_chrf": 77.97636594691406, "avg_bleu": 50.96157792415702}
{"id": "Wikivoyage_1:2209", "en": "Case fatality rate is estimated at 1-3% of infected individuals, most of whom are elderly with underlying health conditions.", "es": "Se estima que la tasa de letalidad es del 1 % al 3 % de las personas contagiadas, la mayoría de las cuales son adultos mayores con afecciones de salud subyacentes.", "perturbation": "alteration", "pert_es": "Se estima que la tasa de supervivencia es del 1 % al 3 % de las personas contagiadas, la mayoría de las cuales son adultos mayores con afecciones de salud subyacentes.", "bt_pert_es": "The survival rate is estimated to be 1% to 3% of infected people, most of whom are older adults with underlying health conditions.", "questions": "[\"What is the estimated case fatality rate?\", \"Who are most of the infected individuals with a high case fatality rate?\", \"What group of individuals is most affected by the case fatality rate?\", \"What factors are associated with a higher case fatality rate?\"]", "answers": "[\"1% to 3%\", \"Older adults with underlying health conditions\", \"Older adults with underlying health conditions\", \"Underlying health conditions\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 70.02600524432349, "bleu": 50.81327481546147}, {"f1": 0.6666666666666666, "em": false, "chrf": 70.02600524432349, "bleu": 50.81327481546147}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5833333333333333, "avg_em": 0.25, "avg_chrf": 61.31508595549508, "avg_bleu": 50.40663740773074}
{"id": "Wikivoyage_1:2210", "en": "The fatality rate is much higher for those over 70 but significantly lower for those under 40.", "es": "La tasa de letalidad es mucho más elevada para las personas mayores de 70 años, pero es significativamente menor para los menores de 40 años.", "perturbation": "alteration", "pert_es": "La tasa de letalidad es mucho más baja para las personas mayores de 70 años, pero es significativamente mayor para los menores de 40 años.", "bt_pert_es": "The case fatality rate is much lower for people over 70 years of age, but is significantly higher for those under 40 years of age.", "questions": "[\"What is the fatality rate for those over 70?\", \"What is the fatality rate for those under 40?\", \"How does the fatality rate differ between people over 70 and those under 40?\", \"Which age group has a higher fatality rate?\", \"Which age group has a lower fatality rate?\"]", "answers": "[\"Much lower\", \"Significantly higher\", \"It is much lower for people over 70 and significantly higher for those under 40\", \"Those under 40\", \"Those over 70\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 24.505192041046012, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 69.27987390990711, "bleu": 49.99999999999999}, {"f1": 0.9333333333333333, "em": false, "chrf": 81.05218564244844, "bleu": 47.587330964125236}, {"f1": 0.3333333333333333, "em": false, "chrf": 31.890390493487992, "bleu": 27.516060407455225}, {"f1": 0.3333333333333333, "em": false, "chrf": 30.043031141165322, "bleu": 27.516060407455225}], "avg_f1": 0.52, "avg_em": 0.0, "avg_chrf": 47.354134645610976, "avg_bleu": 40.52389035580713}
{"id": "Wikivoyage_1:2211", "en": "Those most at risk of COVID-19 infection and serious complications are the elderly and those with weakened immune systems or underlying health conditions like cardiovascular disease, diabetes, hypertension, chronic respiratory disease, and cancer.", "es": "Las personas que tienen mayor riesgo de contagiarse de COVID-19 y tener complicaciones graves son los adultos mayores con sistemas inmunitarios debilitados o afecciones de salud subyacentes, como enfermedad cardiovascular, diabetes, hipertensión, enfermedad respiratoria crónica y cáncer.", "perturbation": "alteration", "pert_es": "Las personas que tienen menor riesgo de contagiarse de COVID-19 y tener complicaciones graves son los adultos mayores con sistemas inmunitarios debilitados o afecciones de salud subyacentes, como enfermedad cardiovascular, diabetes, hipertensión, enfermedad respiratoria crónica y cáncer.", "bt_pert_es": "People who are at lowest risk of getting COVID-19 and having serious complications are older adults with weakened immune systems or underlying health conditions, such as cardiovascular disease, diabetes, hypertension, chronic respiratory disease, and cancer.", "questions": "[\"Who are the most at risk of COVID-19 infection and serious complications?\", \"What factors increase the risk of severe COVID-19 complications?\", \"What specific health conditions are mentioned as increasing risk?\", \"What is considered a weakened immune system in the context of COVID-19?\", \"What age group is most at risk of COVID-19 infection?\"]", "answers": "[\"Older adults with weakened immune systems or underlying health conditions\", \"Weakened immune systems or underlying health conditions\", \"Cardiovascular disease, diabetes, hypertension, chronic respiratory disease, and cancer\", \"Not explicitly defined in the sentence\", \"Older adults\"]", "scores": [{"f1": 0.5000000000000001, "em": false, "chrf": 41.017661537913185, "bleu": 22.88581105225991}, {"f1": 0.8571428571428571, "em": false, "chrf": 88.64963262703913, "bleu": 41.11336169005198}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 19.985123304202542, "bleu": 0.0}], "avg_f1": 0.6714285714285715, "avg_em": 0.4, "avg_chrf": 69.93048349383096, "avg_bleu": 52.7998345484624}
{"id": "Wikivoyage_1:2212", "en": "Not many cases are reported in children and most of these are mild or moderate, though a significant fraction do get pneumonia.", "es": "No se informan muchos casos en niños y la mayoría son leves o moderados, aunque en una porción significativa de estos sí se desarrolla neumonía.", "perturbation": "alteration", "pert_es": "Se informan muchos casos en adultos y la mayoría son graves o severos, aunque en una porción significativa de estos no se desarrolla neumonía.", "bt_pert_es": "Many cases are reported in adults and most are serious or severe, although a significant portion of these do not develop pneumonia.", "questions": "[\"Why are not many cases reported in children?\", \"What is the typical severity of cases in children?\", \"What percentage of children's cases result in pneumonia?\", \"What condition do a significant fraction of children's cases develop?\", \"What is the main outcome for most children with the disease?\"]", "answers": "[\"The sentence does not provide information about children's cases\", \"The sentence does not provide information about the severity of cases in children\", \"The sentence does not provide information about the percentage of children's cases resulting in pneumonia\", \"The sentence does not mention any condition that children's cases develop\", \"The sentence does not provide information about the main outcome for most children with the disease\"]", "scores": [{"f1": 0.6666666666666667, "em": false, "chrf": 71.72393484351815, "bleu": 44.63236137853328}, {"f1": 0, "em": false, "chrf": 16.784597643531953, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 55.59709464743876, "bleu": 18.798317647335093}, {"f1": 0, "em": false, "chrf": 6.850298193254057, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 16.626797378530725, "bleu": 0.0}], "avg_f1": 0.23333333333333334, "avg_em": 0.0, "avg_chrf": 33.51654454125473, "avg_bleu": 12.686135805173674}
{"id": "Wikivoyage_1:2213", "en": "Occupationally, health care workers have higher risk compared to others with clusters of disease among workers and in health care settings.", "es": "A nivel ocupacional, los trabajadores de atención médica tienen un riesgo mayor en comparación con las demás personas, debido a los grupos de enfermedades presentes en los entornos y entre los trabajadores de atención médica.", "perturbation": "alteration", "pert_es": "A nivel ocupacional, los trabajadores de atención médica tienen un riesgo menor en comparación con las demás personas, debido a los grupos de enfermedades presentes en los entornos y entre los trabajadores de atención médica.", "bt_pert_es": "At the occupational level, healthcare workers are at lower risk compared to other people due to disease clusters present in settings and among healthcare workers.", "questions": "[\"What is the higher risk for among health care workers?\", \"How does the risk for health care workers compare to others?\", \"Where are clusters of disease found among workers?\", \"What settings are associated with clusters of disease?\", \"What group has a higher risk of disease according to the sentence?\"]", "answers": "[\"disease\", \"lower risk\", \"among healthcare workers\", \"settings\", \"other people\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.28571428571428575, "em": false, "chrf": 17.578450729462812, "bleu": 11.15650800742149}, {"f1": 0.8, "em": false, "chrf": 57.766406106367555, "bleu": 34.66806371753173}, {"f1": 0.5, "em": false, "chrf": 39.895401356760004, "bleu": 13.533528323661276}, {"f1": 0, "em": false, "chrf": 11.81754233445976, "bleu": 0.0}], "avg_f1": 0.5171428571428571, "avg_em": 0.2, "avg_chrf": 45.411560105410025, "avg_bleu": 31.87162000972291}
{"id": "Wikivoyage_1:2214", "en": "The time between being exposed to the virus and the emergence of symptoms (incubation period) is typically between 2 and 14 days, though there has been one reported case in China where symptoms appeared 27 days after exposure.", "es": "El tiempo entre la exposición al virus y la aparición de los síntomas de emergencia (llamado período de incubación) suele ser de 2 a 14 días, aunque se informó de un caso en China en el que los síntomas aparecieron 27 días después de la exposición.", "perturbation": "alteration", "pert_es": "El tiempo entre la exposición al virus y la desaparición de los síntomas de emergencia (llamado período de incubación) suele ser de 2 a 14 días, aunque se informó de un caso en China en el que los síntomas aparecieron 27 días después de la exposición.", "bt_pert_es": "The time between exposure to the virus and the disappearance of emergency symptoms (called the incubation period) is usually 2 to 14 days, although one case was reported in China in which symptoms appeared 27 days after exposure.", "questions": "[\"What is the typical incubation period for the virus?\", \"How long is the incubation period typically between exposure and symptom emergence?\", \"What is the incubation period in the reported case from China?\", \"What factors might influence the incubation period?\", \"Where was the reported case of a 27-day incubation period found?\"]", "answers": "[\"2 to 14 days\", \"2 to 14 days\", \"27 days\", \"None mentioned\", \"China\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 13.464563876663183, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8, "avg_em": 0.8, "avg_chrf": 82.69291277533264, "avg_bleu": 80.00000000000003}
{"id": "Wikivoyage_1:2216", "en": "There is evidence of transmission from people who don't have symptoms, although to what extent is still being investigated.", "es": "Hay evidencia de transmisión por parte de personas que no tienen síntomas, aunque aún se está investigando en qué medida ocurre esto.", "perturbation": "alteration", "pert_es": "Hay evidencia de que no hay transmisión por parte de personas que no tienen síntomas, aunque aún se está investigando en qué medida ocurre esto.", "bt_pert_es": "There is evidence that there is no transmission from people who do not have symptoms, although the extent to which this occurs is still being investigated.", "questions": "[\"What evidence exists regarding transmission from asymptomatic people?\", \"To what extent is transmission from asymptomatic people being investigated?\", \"Are there cases of transmission from people without symptoms?\", \"What is being investigated about transmission from asymptomatic individuals?\"]", "answers": "[\"There is evidence that there is no transmission from people who do not have symptoms\", \"The extent to which this occurs\", \"No\", \"The extent to which transmission occurs from asymptomatic individuals\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 77.50568087009779, "bleu": 19.5647514979229}, {"f1": 0.30769230769230765, "em": false, "chrf": 21.92469277395675, "bleu": 13.74127285540009}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.75, "em": false, "chrf": 81.87586114380693, "bleu": 23.356898886410004}], "avg_f1": 0.3894230769230769, "avg_em": 0.0, "avg_chrf": 45.326558696965364, "avg_bleu": 14.165730809933248}
{"id": "Wikivoyage_1:2218", "en": "Long-term effects for people who have recovered remain unclear, but there is evidence of reduced lung capacity in some recovered patients.", "es": "Todavía no quedan claros los efectos a largo plazo para las personas que se han recuperado, pero hay evidencia de reducción de la capacidad pulmonar en algunos pacientes recuperados.", "perturbation": "alteration", "pert_es": "Todavía no quedan claros los efectos a largo plazo para las personas que no se han recuperado, pero hay evidencia de aumento de la capacidad pulmonar en algunos pacientes recuperados.", "bt_pert_es": "The long-term effects for people who have not recovered are still unclear, but there is evidence of increased lung capacity in some recovered patients.", "questions": "[\"What are the long-term effects for people who have recovered?\", \"What is unclear about long-term effects?\", \"What evidence is there regarding lung capacity in recovered patients?\", \"What specific health condition is mentioned in the sentence?\", \"What does the evidence suggest about lung capacity?\"]", "answers": "[\"The long-term effects for people who have recovered are still unclear\", \"The long-term effects for people who have not recovered\", \"Increased lung capacity in some recovered patients\", \"Recovery from a condition\", \"Increased lung capacity\"]", "scores": [{"f1": 0.8571428571428572, "em": false, "chrf": 84.8536593832321, "bleu": 69.89307622784945}, {"f1": 0.9411764705882353, "em": false, "chrf": 92.27130624058562, "bleu": 75.06238537503395}, {"f1": 0.75, "em": false, "chrf": 73.9874047510166, "bleu": 60.80253214198355}, {"f1": 0.2222222222222222, "em": false, "chrf": 25.12406879715811, "bleu": 10.122592925934278}, {"f1": 0.4444444444444444, "em": false, "chrf": 39.05152535525507, "bleu": 20.24518585186855}], "avg_f1": 0.6429971988795519, "avg_em": 0.0, "avg_chrf": 63.057592905449496, "avg_bleu": 47.225154504533954}
{"id": "Wikivoyage_1:2221", "en": "There is no established test assessing for the virus or antibodies in the blood, although tests are being developed.", "es": "No hay ninguna prueba establecida para evaluar el virus o los anticuerpos en la sangre, aunque se están desarrollando pruebas.", "perturbation": "alteration", "pert_es": "Hay varias pruebas establecidas para evaluar el virus o los anticuerpos en la sangre, aunque se están perfeccionando pruebas.", "bt_pert_es": "There are several established tests to evaluate the virus or antibodies in the blood, although tests are being refined.", "questions": "[\"Is there an established test for the virus in the blood?\", \"Is there an established test for antibodies in the blood?\", \"What is the current status of tests for the virus?\", \"What is the current status of tests for antibodies?\", \"Are tests for the virus or antibodies being developed?\"]", "answers": "[\"Yes\", \"Yes\", \"Established\", \"Established\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.319275479859423, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.319275479859423, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.5277101919437692, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2222", "en": "There is no test to establish immunity to the virus.", "es": "No hay ninguna prueba que permita establecer la inmunidad al virus.", "perturbation": "alteration", "pert_es": "Hay varias pruebas que permiten establecer la inmunidad al virus.", "bt_pert_es": "There are several tests that allow establishing immunity to the virus.", "questions": "[\"Is there a test to establish immunity to the virus?\", \"What is the current status of testing for immunity to the virus?\", \"What does the absence of a test for immunity mean?\"]", "answers": "[\"Yes\", \"There are several tests\", \"It means that tests to establish immunity to the virus are not available\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.22222222222222224, "em": false, "chrf": 25.12449802426643, "bleu": 12.44023474812678}, {"f1": 0.5217391304347826, "em": false, "chrf": 47.84751489974857, "bleu": 21.200626759025184}], "avg_f1": 0.24798711755233493, "avg_em": 0.0, "avg_chrf": 24.324004308004998, "avg_bleu": 11.21362050238399}
{"id": "Wikivoyage_1:2223", "en": "Many governments around the world have advised their citizens not to travel unnecessarily amid the pandemic.", "es": "Muchos gobiernos de todo el mundo han recomendado a sus ciudadanos que no hagan viajes innecesarios durante la pandemia.", "perturbation": "alteration", "pert_es": "Muchos gobiernos de todo el mundo han recomendado a sus ciudadanos que hagan viajes innecesarios durante la pandemia.", "bt_pert_es": "Many governments around the world have advised their citizens to take unnecessary trips during the pandemic.", "questions": "[\"What have many governments advised their citizens to do amid the pandemic?\", \"What is the reason behind the travel advice?\", \"What is the context of the travel advice?\", \"What is the pandemic related to in this sentence?\", \"Who has given travel advice?\"]", "answers": "[\"Take unnecessary trips\", \"The pandemic\", \"Travel during the pandemic\", \"Unnecessary trips\", \"Many governments\"]", "scores": [{"f1": 0, "em": false, "chrf": 41.60641385829507, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 6.25, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6, "avg_em": 0.6, "avg_chrf": 69.57128277165901, "avg_bleu": 60.00000000000002}
{"id": "Wikivoyage_1:2225", "en": "Particularly avoid cruise ship travel.", "es": "En especial, se deben evitar los viajes en cruceros.", "perturbation": "alteration", "pert_es": "En especial, se deben buscar los viajes en cruceros.", "bt_pert_es": "In particular, cruise trips should be looked for.", "questions": "[\"What should be avoided?\", \"Why should cruise ship travel be avoided?\"]", "answers": "[\"cruise trips\", \"None of the questions can be answered based on the sentence\"]", "scores": [{"f1": 0, "em": false, "chrf": 26.400179452865686, "bleu": 0.0}, {"f1": 0.14285714285714285, "em": false, "chrf": 36.17821686389803, "bleu": 4.767707020457095}], "avg_f1": 0.07142857142857142, "avg_em": 0.0, "avg_chrf": 31.289198158381858, "avg_bleu": 2.3838535102285476}
{"id": "Wikivoyage_1:2226", "en": "Older travelers and those with underlying health conditions are most at risk and should avoid travel that puts them at risk, such as long plane flights, visits to crowded places, and especially cruises, even outside of severely affected areas.", "es": "Los viajeros de edad avanzada y aquellos con afecciones de salud subyacentes tienen un mayor riesgo y deberían evitar los viajes que los pongan en riesgo, como los vuelos largos, las visitas a lugares muy concurridos y, especialmente, los cruceros, incluso fuera de las zonas más afectadas.", "perturbation": "alteration", "pert_es": "Los viajeros de edad avanzada y aquellos con afecciones de salud subyacentes tienen un menor riesgo y deberían evitar los viajes que los pongan en riesgo, como los vuelos largos, las visitas a lugares muy concurridos y, especialmente, los cruceros, incluso fuera de las zonas más afectadas.", "bt_pert_es": "Elderly travelers and those with underlying health conditions are at lower risk and should avoid trips that put them at risk, such as long flights, visits to crowded places, and especially cruises, even outside the most affected areas.", "questions": "[\"Who are most at risk according to the sentence?\", \"What types of travel should older travelers and those with underlying health conditions avoid?\", \"Why should older travelers and those with underlying health conditions avoid travel?\", \"What specific travel activities are considered risky?\", \"What is considered especially risky for these groups?\", \"Are there any exceptions to avoiding travel outside of severely affected areas?\"]", "answers": "[\"Elderly travelers and those with underlying health conditions\", \"long flights, visits to crowded places, and especially cruises\", \"Because these activities put them at risk\", \"long flights, visits to crowded places, and especially cruises\", \"cruises\", \"No\"]", "scores": [{"f1": 0.875, "em": false, "chrf": 92.40946721973462, "bleu": 84.08964152537145}, {"f1": 0.9473684210526316, "em": false, "chrf": 88.06291466171072, "bleu": 79.56371661921447}, {"f1": 0.4615384615384615, "em": false, "chrf": 49.45738808969577, "bleu": 14.535768424205482}, {"f1": 0.9473684210526316, "em": false, "chrf": 88.06291466171072, "bleu": 79.56371661921447}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8718792172739541, "avg_em": 0.3333333333333333, "avg_chrf": 86.3321141054753, "avg_bleu": 76.29214053133433}
{"id": "Wikivoyage_1:2228", "en": "This means minimising contact with others by keeping a distance of six feet or two meters from them and avoiding gathering together in groups.", "es": "Esto significa minimizar el contacto con las demás personas manteniendo una distancia de seis pies o dos metros el uno del otro y evitar reunirse en grupos.", "perturbation": "alteration", "pert_es": "Esto significa maximizar el contacto con las demás personas manteniendo una distancia de seis pies o dos metros el uno del otro y buscar reunirse en grupos.", "bt_pert_es": "This means maximizing contact with others by maintaining a distance of six feet or two meters from each other and seeking to gather in groups.", "questions": "[\"What does 'minimising contact with others' involve?\", \"What distance should be maintained from others?\", \"What is considered a safe distance from others?\", \"What should be avoided to reduce risk?\", \"What is the purpose of keeping a distance from others?\"]", "answers": "[\"Seeking to gather in groups\", \"Six feet or two meters\", \"Six feet or two meters\", \"Seeking to gather in groups\", \"Maximizing contact with others\"]", "scores": [{"f1": 0.19047619047619047, "em": false, "chrf": 23.349896649295854, "bleu": 2.367237491794474}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444445, "em": false, "chrf": 63.879358044221554, "bleu": 21.3643503198117}, {"f1": 0.6666666666666665, "em": false, "chrf": 64.65982192793787, "bleu": 46.30777161991026}], "avg_f1": 0.6603174603174603, "avg_em": 0.4, "avg_chrf": 70.37781532429105, "avg_bleu": 54.007871886303306}
{"id": "Wikivoyage_1:2237", "en": "Drying your washed hands physically removes some germs from your skin (so don't skip that step, and don't share towels).", "es": "Secarse las manos después de lavárselas retira físicamente algunos gérmenes de la piel (así que no omita ese paso y no comparta las toallas).", "perturbation": "alteration", "pert_es": "Secarse las manos antes de lavárselas retira físicamente algunos gérmenes de la piel (así que no omita ese paso y no comparta las toallas).", "bt_pert_es": "Drying your hands before washing physically removes some germs from your skin (so don't skip that step and don't share towels).", "questions": "[\"What does drying your washed hands remove?\", \"Why shouldn't you skip the step of drying your hands?\", \"Why shouldn't you share towels?\", \"What germs are removed by drying hands?\", \"What is the importance of drying hands after washing?\"]", "answers": "[\"Some germs\", \"Because it physically removes some germs from your skin\", \"To avoid spreading germs\", \"Germs from your skin\", \"It physically removes some germs from your skin\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.15384615384615383, "em": false, "chrf": 11.7867535168778, "bleu": 4.576506607182439}, {"f1": 0, "em": false, "chrf": 22.469888575352357, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6307692307692307, "avg_em": 0.6, "avg_chrf": 66.85132841844603, "avg_bleu": 60.915301321436516}
{"id": "Wikivoyage_1:2238", "en": "If soap and water are not available, then use a &gt;60% alcohol-based hand sanitizer.", "es": "Si no tiene acceso a agua y jabón, use un desinfectante para manos con más del 60 % de alcohol.", "perturbation": "alteration", "pert_es": "Si tiene acceso a agua y jabón, use un desinfectante para manos con menos del 60 % de alcohol.", "bt_pert_es": "If you have access to soap and water, use a hand sanitizer with less than 60% alcohol.", "questions": "[\"What should be done if soap and water are not available?\", \"What type of hand sanitizer is recommended?\", \"What is the required alcohol concentration in hand sanitizer?\", \"Why is soap and water preferred over hand sanitizer?\"]", "answers": "[\"Use a hand sanitizer with less than 60% alcohol\", \"A hand sanitizer with less than 60% alcohol\", \"Less than 60%\", \"The sentence does not provide information on why soap and water is preferred\"]", "scores": [{"f1": 0.6153846153846154, "em": false, "chrf": 63.17740974076995, "bleu": 13.134549472120788}, {"f1": 0.36363636363636365, "em": false, "chrf": 58.918061007686276, "bleu": 11.044795567078939}, {"f1": 0.6666666666666666, "em": false, "chrf": 34.68475805794061, "bleu": 55.03212081491043}, {"f1": 0.11764705882352941, "em": false, "chrf": 28.278552330675222, "bleu": 3.0890553181566975}], "avg_f1": 0.4408336761277938, "avg_em": 0.0, "avg_chrf": 46.264695284268015, "avg_bleu": 20.575130293066714}
{"id": "Wikivoyage_1:2239", "en": "Alcohol is a quick germ-killer, but it's not quite instant, so this still requires the same 20 seconds of rubbing your hands together, making sure that every single scrap of skin gets wet, and then you have to wait about another minute, for the alcohol to completely dry.", "es": "El alcohol mata los gérmenes en forma rápida pero no instantánea, por lo que también en este caso es necesario frotarse las manos por 20 segundos y asegurarse de que se humedezca la totalidad de la piel; después de esto, se debe esperar un minuto más, aproximadamente, para que el alcohol se seque completamente.", "perturbation": "alteration", "pert_es": "El alcohol salva los gérmenes en forma rápida pero no instantánea, por lo que también en este caso es necesario frotarse las manos por 20 segundos y asegurarse de que se humedezca la totalidad de la piel; después de esto, se debe esperar un minuto más, aproximadamente, para que el alcohol se seque completamente.", "bt_pert_es": "Alcohol saves germs quickly but not instantly, so in this case it is also necessary to rub your hands for 20 seconds and make sure that the entire skin is moistened; After this, you should wait approximately one more minute for the alcohol to dry completely.", "questions": "[\"What is alcohol known for?\", \"How long does it take to effectively kill germs with alcohol?\", \"Why is 20 seconds of rubbing hands necessary?\", \"What must be ensured when rubbing hands with alcohol?\", \"How long must you wait after rubbing hands with alcohol?\", \"What happens after the alcohol dries on the hands?\"]", "answers": "[\"Alcohol saves germs quickly but not instantly\", \"Alcohol saves germs quickly but not instantly\", \"To ensure effective germ killing\", \"That the entire skin is moistened\", \"One more minute\", \"The hands are clean\"]", "scores": [{"f1": 0, "em": false, "chrf": 22.72534284017645, "bleu": 0.0}, {"f1": 0.16666666666666666, "em": false, "chrf": 33.31816243015107, "bleu": 6.567274736060395}, {"f1": 0.2857142857142857, "em": false, "chrf": 30.18741098780494, "bleu": 9.599621398238423}, {"f1": 0.3076923076923077, "em": false, "chrf": 20.205382321471657, "bleu": 6.971729121692201}, {"f1": 0.3333333333333333, "em": false, "chrf": 26.988435609004014, "bleu": 27.516060407455225}, {"f1": 0.22222222222222224, "em": false, "chrf": 12.557689325837146, "bleu": 12.44023474812678}], "avg_f1": 0.21927146927146926, "avg_em": 0.0, "avg_chrf": 24.330403919074215, "avg_bleu": 10.515820068595504}
{"id": "Wikivoyage_1:2242", "en": "Try to do this less, and try to wash your hands before touching your face.", "es": "Intente hacer esto con menos frecuencia y trate de lavarse las manos antes de tocarse el rostro.", "perturbation": "alteration", "pert_es": "Intente hacer esto con más frecuencia y trate de lavarse las manos después de tocarse el rostro.", "bt_pert_es": "Try doing this more often and try to wash your hands after touching your face.", "questions": "[\"What should you do less?\", \"What should you do before touching your face?\", \"What is recommended to reduce exposure?\", \"What is the purpose of washing hands before touching your face?\"]", "answers": "[\"Nothing is mentioned about doing something less\", \"Nothing is mentioned about doing something before touching your face\", \"Washing hands after touching your face\", \"To reduce exposure\"]", "scores": [{"f1": 0, "em": false, "chrf": 16.801166933012723, "bleu": 0.0}, {"f1": 0.15384615384615383, "em": false, "chrf": 13.899377569687088, "bleu": 4.196114906296549}, {"f1": 0.8333333333333334, "em": false, "chrf": 74.58314262219818, "bleu": 37.99178428257963}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.4967948717948718, "avg_em": 0.25, "avg_chrf": 51.3209217812245, "avg_bleu": 35.54697479721906}
{"id": "Wikivoyage_1:2244", "en": "Cough and sneeze into your elbow or a tissue, and then immediately throw away the tissue and wash your hands.", "es": "Al toser o estornudar, cúbrase con la parte interna del codo o un pañuelo y, luego, deseche el pañuelo inmediatamente y lávese las manos.", "perturbation": "alteration", "pert_es": "Al toser o estornudar, no se cubra con la parte interna del codo o un pañuelo y, luego, guarde el pañuelo inmediatamente y ensucie las manos.", "bt_pert_es": "When coughing or sneezing, do not cover your cough or sneeze with the inside of your elbow or a tissue, then put the tissue away immediately and get your hands dirty.", "questions": "[\"What should you do when coughing or sneezing?\", \"What is the recommended method to prevent the spread of germs?\", \"What should you do after using a tissue?\", \"What should you do after coughing or sneezing?\", \"What is the correct way to dispose of a used tissue?\"]", "answers": "[\"Do not cover your cough or sneeze with the inside of your elbow or a tissue, then put the tissue away immediately and get your hands dirty\", \"Cover your cough or sneeze with the inside of your elbow or a tissue\", \"Put the tissue away immediately\", \"Do not cover your cough or sneeze with the inside of your elbow or a tissue, then put the tissue away immediately and get your hands dirty\", \"Put the tissue away immediately\"]", "scores": [{"f1": 0.375, "em": false, "chrf": 48.46182353221087, "bleu": 10.90009697802911}, {"f1": 0.5, "em": false, "chrf": 58.07727374783317, "bleu": 22.416933501922298}, {"f1": 0.5, "em": false, "chrf": 54.21613168492757, "bleu": 18.99589214128981}, {"f1": 0.3125, "em": false, "chrf": 43.117559623765175, "bleu": 3.9566236357113054}, {"f1": 0.5, "em": false, "chrf": 54.21613168492757, "bleu": 18.99589214128981}], "avg_f1": 0.4375, "avg_em": 0.0, "avg_chrf": 51.61778405473287, "avg_bleu": 15.053087679648467}
{"id": "Wikivoyage_1:2245", "en": "Don't stand or sit near people who might be sick.", "es": "No se pare ni se siente cerca de otras personas que podrían estar enfermas.", "perturbation": "alteration", "pert_es": "Se pare y se siente cerca de otras personas que podrían estar enfermas.", "bt_pert_es": "Stand and sit near other people who might be sick.", "questions": "[\"Why should you not stand or sit near people who might be sick?\", \"What is the risk of standing or sitting near people who might be sick?\", \"Who should you avoid standing or sitting near?\", \"What health-related action should be taken to prevent illness?\"]", "answers": "[\"To prevent illness\", \"Exposure to sick people may lead to illness\", \"People who might be sick\", \"Stand and sit near other people who might be sick\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 26.525902622675666, "bleu": 17.799177396293473}, {"f1": 0.2, "em": false, "chrf": 33.58913618573612, "bleu": 5.522397783539471}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6, "em": false, "chrf": 55.39306735644701, "bleu": 41.11336169005198}], "avg_f1": 0.575, "avg_em": 0.25, "avg_chrf": 53.877026541214704, "avg_bleu": 41.108734217471245}
{"id": "Wikivoyage_1:2250", "en": "Clean objects and surfaces that a lot of people touch, such as doorknobs, phones, and television remotes with regular household cleaner.", "es": "Limpie con un limpiador de uso doméstico los objetos y las superficies que mucha gente toque, como los picaportes, los teléfonos y los controles remotos de televisores.", "perturbation": "alteration", "pert_es": "Limpie con un contaminador de uso doméstico los objetos y las superficies que mucha gente toque, como los picaportes, los teléfonos y los controles remotos de televisores.", "bt_pert_es": "Clean objects and surfaces that many people touch, such as doorknobs, telephones, and television remote controls, with a household cleaner.", "questions": "[\"What should be cleaned?\", \"What types of objects and surfaces should be cleaned?\", \"What is the recommended cleaner for cleaning these surfaces?\", \"Which objects are mentioned as being frequently touched?\", \"What is the purpose of cleaning these objects and surfaces?\"]", "answers": "[\"Clean objects and surfaces that many people touch\", \"Doorknobs, telephones, and television remote controls\", \"A household cleaner\", \"Doorknobs, telephones, and television remote controls\", \"To reduce the spread of germs\"]", "scores": [{"f1": 0.823529411764706, "em": false, "chrf": 81.67309026333083, "bleu": 52.4735797760732}, {"f1": 0.5454545454545454, "em": false, "chrf": 83.74108797623137, "bleu": 17.965205598154213}, {"f1": 0.6666666666666666, "em": false, "chrf": 69.72055549223653, "bleu": 55.03212081491043}, {"f1": 0.5454545454545454, "em": false, "chrf": 83.74108797623137, "bleu": 17.965205598154213}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7162210338680927, "avg_em": 0.2, "avg_chrf": 83.77516434160603, "avg_bleu": 48.687222357458424}
{"id": "Wikivoyage_1:2252", "en": "Stay home when you are sick, and avoid contact with other people until your symptoms are gone.", "es": "Quédese en casa si está enfermo y evite el contacto con otras personas hasta que se vayan sus síntomas.", "perturbation": "alteration", "pert_es": "Quédese en casa si está sano y busque el contacto con otras personas hasta que aparezcan sus síntomas.", "bt_pert_es": "Stay home if you are healthy and seek contact with other people until your symptoms appear.", "questions": "[\"What should you do when you are sick?\", \"What should you avoid when you are sick?\", \"When should you avoid contact with other people?\", \"Until what condition should you avoid contact with others?\"]", "answers": "[\"Seek contact with other people\", \"Stay home\", \"When you are healthy\", \"Until your symptoms appear\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.770426451913648, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.172508577666875, "bleu": 0.0}, {"f1": 0.75, "em": false, "chrf": 61.20989799306401, "bleu": 59.460355750136046}, {"f1": 0.6666666666666665, "em": false, "chrf": 74.72465836783545, "bleu": 46.30777161991026}], "avg_f1": 0.35416666666666663, "avg_em": 0.0, "avg_chrf": 38.469372847619994, "avg_bleu": 26.442031842511575}
{"id": "Wikivoyage_1:2253", "en": "Do not share personal items that come into contact with saliva, such as toothbrushes, eating utensils, drinks, water bottles, and towels.", "es": "No comparta los artículos personales que entren en contacto con la saliva, como cepillos de dientes, utensilios de cocina, bebidas, botellas de agua y toallas.", "perturbation": "alteration", "pert_es": "Comparta los artículos personales que entren en contacto con la saliva, como cepillos de dientes, utensilios de cocina, bebidas, botellas de agua y toallas.", "bt_pert_es": "Share personal items that come into contact with saliva, such as toothbrushes, kitchen utensils, drinks, water bottles, and towels.", "questions": "[\"What should not be shared according to the sentence?\", \"What items come into contact with saliva and should not be shared?\", \"What are examples of personal items that should not be shared?\", \"What types of items are mentioned in the sentence?\", \"What is the reason for not sharing personal items?\"]", "answers": "[\"Personal items that come into contact with saliva\", \"Toothbrushes, kitchen utensils, drinks, water bottles, and towels\", \"Toothbrushes, kitchen utensils, drinks, water bottles, and towels\", \"Toothbrushes, kitchen utensils, drinks, water bottles, and towels\", \"They come into contact with saliva\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.875, "em": false, "chrf": 83.96017562106802, "bleu": 70.71067811865478}, {"f1": 0.875, "em": false, "chrf": 83.96017562106802, "bleu": 70.71067811865478}, {"f1": 0.875, "em": false, "chrf": 83.96017562106802, "bleu": 70.71067811865478}, {"f1": 0.5454545454545454, "em": false, "chrf": 66.90701942467045, "bleu": 30.213753973567677}], "avg_f1": 0.834090909090909, "avg_em": 0.2, "avg_chrf": 83.75750925757491, "avg_bleu": 68.46915766590641}
{"id": "Wikivoyage_1:2254", "en": "The practice of serving yourself from a common plate with your own chopsticks, common in China, should be avoided.", "es": "Se debe evitar la práctica de servirse uno mismo con palillos de una fuente compartida, una práctica que es común en China.", "perturbation": "alteration", "pert_es": "Se debe fomentar la práctica de servirse uno mismo con palillos de una fuente compartida, una práctica que es común en China.", "bt_pert_es": "The practice of serving oneself with chopsticks from a shared platter, a practice that is common in China, should be encouraged.", "questions": "[\"What practice should be avoided?\", \"Why should the practice of serving yourself from a common plate with your own chopsticks be avoided?\", \"Where is the practice of serving yourself from a common plate with your own chopsticks common?\", \"What is the practice described in the sentence?\"]", "answers": "[\"The practice of serving oneself with chopsticks from a shared platter\", \"It is not mentioned in the sentence why it should be avoided\", \"China\", \"Serving oneself with chopsticks from a shared platter\"]", "scores": [{"f1": 0.3157894736842105, "em": false, "chrf": 37.68542449697828, "bleu": 5.522397783539471}, {"f1": 0, "em": false, "chrf": 14.86620000479911, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 61.67814652473389, "bleu": 36.78794411714425}, {"f1": 0.5, "em": false, "chrf": 41.16535832375921, "bleu": 6.979367151952678}], "avg_f1": 0.3706140350877193, "avg_em": 0.0, "avg_chrf": 38.84878233756762, "avg_bleu": 12.3224272631591}
{"id": "Wikivoyage_1:2256", "en": "Avoid hugs, kisses, handshakes, fist bumps, and any other contact.", "es": "Evite dar abrazos, besos o apretones de mano, chocar los puños y tener cualquier otro tipo de contacto.", "perturbation": "alteration", "pert_es": "Practique dar abrazos, besos o apretones de mano, chocar los puños y tener cualquier otro tipo de contacto.", "bt_pert_es": "Practice giving hugs, kisses or handshakes, fist bumps, and any other type of contact.", "questions": "[\"What types of physical contact should be avoided?\", \"What specific actions are mentioned as being avoided?\", \"What is the reason for avoiding physical contact?\"]", "answers": "[\"None\", \"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.6222480025121246, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.6222480025121246, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 27.107714353952712, "bleu": 36.78794411714425}], "avg_f1": 0.2222222222222222, "avg_em": 0.0, "avg_chrf": 10.784070119658987, "avg_bleu": 12.262648039048083}
{"id": "Wikivoyage_1:2257", "en": "If it's impossible to avoid contact, then wash your hands both before and after.", "es": "Si es imposible evitar el contacto, lávese las manos tanto antes como después de este.", "perturbation": "alteration", "pert_es": "Si es imposible evitar el contacto, ensúciese las manos tanto antes como después de este.", "bt_pert_es": "If it is impossible to avoid contact, get your hands dirty both before and after contact.", "questions": "[\"What should you do if it's impossible to avoid contact?\", \"When should you wash your hands if it's impossible to avoid contact?\", \"What is the recommended action before contact?\", \"What is the recommended action after contact?\"]", "answers": "[\"Get your hands dirty both before and after contact\", \"Both before and after contact\", \"Get your hands dirty before contact\", \"Get your hands dirty after contact\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 71.76773788816747, "bleu": 35.49481056010054}, {"f1": 0.5, "em": false, "chrf": 77.39301292378101, "bleu": 21.3643503198117}, {"f1": 0.4444444444444444, "em": false, "chrf": 47.06774113444386, "bleu": 16.233395773754946}, {"f1": 0.4444444444444444, "em": false, "chrf": 47.74449478067636, "bleu": 16.233395773754946}], "avg_f1": 0.5347222222222222, "avg_em": 0.0, "avg_chrf": 60.993246681767175, "avg_bleu": 22.33148810685553}
{"id": "Wikivoyage_1:2258", "en": "It won't protect you from the coronavirus, but it will partially protect you from the flu, which remains a greater risk than COVID-19 in many areas.", "es": "Esto no lo protegerá del coronavirus, pero sí lo protegerá parcialmente de la gripe, la cual sigue siendo un mayor riesgo que la COVID-19 en muchos lugares.", "perturbation": "alteration", "pert_es": "Esto lo protegerá del coronavirus, pero no lo protegerá parcialmente de la gripe, la cual sigue siendo un menor riesgo que la COVID-19 en muchos lugares.", "bt_pert_es": "This will protect you from the coronavirus, but it will not partially protect you from the flu, which is still a lower risk than COVID-19 in many places.", "questions": "[\"What does not protect you from?\", \"What does it partially protect you from?\", \"What is considered a greater risk than COVID-19 in many areas?\", \"What is the disease that remains a greater risk than COVID-19?\", \"What is the relationship between the flu and COVID-19 in many areas?\"]", "answers": "[\"the flu\", \"the flu\", \"the flu\", \"the flu\", \"The flu is considered a lower risk than COVID-19 in many areas\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.546099290780142, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9090909090909091, "em": false, "chrf": 85.09412503251059, "bleu": 70.16879391277372}], "avg_f1": 0.7818181818181819, "avg_em": 0.6, "avg_chrf": 77.72804486465814, "avg_bleu": 74.03375878255477}
{"id": "Wikivoyage_1:2259", "en": "This also saves you from unnecessary worry if you get the flu and think it might be the coronavirus.", "es": "Esto también le ahorra la preocupación innecesaria de contagiarse de gripe y pensar que podría ser coronavirus.", "perturbation": "alteration", "pert_es": "Esto también le ahorra la preocupación innecesaria de curarse de gripe y pensar que podría ser coronavirus.", "bt_pert_es": "This also saves you the unnecessary worry of coming down with the flu and thinking it could be coronavirus.", "questions": "[\"What does getting the flu and thinking it might be the coronavirus lead to?\", \"What benefit does avoiding unnecessary worry provide?\", \"What situation is described in the sentence?\", \"What is the consequence of mistakenly thinking the flu is the coronavirus?\"]", "answers": "[\"Unnecessary worry\", \"Avoids unnecessary worry\", \"Getting the flu and thinking it might be the coronavirus\", \"Unnecessary worry\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 92.47065434565434, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.875, "avg_em": 0.75, "avg_chrf": 98.11766358641358, "avg_bleu": 87.50000000000003}
{"id": "Wikivoyage_1:2263", "en": "For those who are asymptomatic, the WHO does not recommend masks, though some national governments do.", "es": "En el caso de las personas asintomáticas, la OMS no recomienda el uso de mascarillas, aunque algunos gobiernos nacionales sí lo hacen.", "perturbation": "alteration", "pert_es": "En el caso de las personas asintomáticas, la OMS sí recomienda el uso de mascarillas, aunque algunos gobiernos nacionales no lo hacen.", "bt_pert_es": "For asymptomatic people, the WHO does recommend the use of masks, although some national governments do not.", "questions": "[\"What does the WHO recommend for asymptomatic individuals?\", \"Do national governments recommend masks for asymptomatic individuals?\", \"Why do some national governments recommend masks for asymptomatic individuals?\", \"What is the stance of the WHO on mask usage for asymptomatic individuals?\", \"What is the difference between WHO recommendations and national government recommendations for asymptomatic individuals?\"]", "answers": "[\"the use of masks\", \"No\", \"Not specified\", \"the use of masks\", \"The WHO recommends the use of masks, but some national governments do not\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 73.29284307288246, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.28571428571428575, "em": false, "chrf": 17.06194779061876, "bleu": 19.716118825581447}, {"f1": 0.7826086956521738, "em": false, "chrf": 79.05616998725571, "bleu": 48.326978309062206}], "avg_f1": 0.7136645962732919, "avg_em": 0.4, "avg_chrf": 73.8821921701514, "avg_bleu": 59.11183150841979}
{"id": "Wikivoyage_1:2264", "en": "Wearing a mask of some kind is required in some countries and cities in an effort to reduce community transmission.", "es": "El uso de algún tipo de mascarilla es obligatorio en algunos países y ciudades a fin de reducir la transmisión comunitaria.", "perturbation": "alteration", "pert_es": "El uso de algún tipo de mascarilla es opcional en algunos países y ciudades a fin de reducir la transmisión comunitaria.", "bt_pert_es": "The use of some type of mask is optional in some countries and cities in order to reduce community transmission.", "questions": "[\"What is required in some countries and cities?\", \"What is the purpose of wearing a mask?\", \"What type of mask is required?\", \"What is the goal of wearing a mask in some countries and cities?\", \"What is community transmission?\"]", "answers": "[\"The use of some type of mask is optional\", \"To reduce community transmission\", \"Some type of mask\", \"To reduce community transmission\", \"The spread of a disease within a community\"]", "scores": [{"f1": 0.42857142857142855, "em": false, "chrf": 28.206047382536127, "bleu": 10.552670315936318}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444445, "em": false, "chrf": 22.70028816486077, "bleu": 14.794015674776452}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7746031746031746, "avg_em": 0.6, "avg_chrf": 70.18126710947938, "avg_bleu": 65.06933719814258}
{"id": "Wikivoyage_1:2265", "en": "There are worldwide shortages of surgical masks.", "es": "Hay una escasez mundial de mascarillas quirúrgicas.", "perturbation": "alteration", "pert_es": "Hay un exceso mundial de mascarillas quirúrgicas.", "bt_pert_es": "There is a global glut of surgical masks.", "questions": "[\"What is currently lacking worldwide?\", \"What type of masks are in short supply?\", \"What is the cause of the worldwide shortages?\", \"Where are surgical masks in short supply?\"]", "answers": "[\"Nothing\", \"Surgical masks\", \"There is a global glut\", \"Nowhere\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.824858757062147, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 8.001772950158594, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 7.751937984496124, "bleu": 0.0}], "avg_f1": 0.25, "avg_em": 0.25, "avg_chrf": 29.644642422929216, "avg_bleu": 25.00000000000001}
{"id": "Wikivoyage_1:2266", "en": "If you do wear a mask, make sure to use it correctly.", "es": "Si usa una mascarilla, asegúrese de usarla correctamente.", "perturbation": "alteration", "pert_es": "Si usa una mascarilla, asegúrese de no usarla correctamente.", "bt_pert_es": "If you wear a mask, make sure you don't wear it correctly.", "questions": "[\"What should you do if you wear a mask?\", \"What is important when using a mask correctly?\", \"Why is it important to use a mask correctly?\"]", "answers": "[\"Make sure you don't wear it correctly\", \"Wearing it correctly\", \"To ensure it is used properly\"]", "scores": [{"f1": 0.6153846153846153, "em": false, "chrf": 64.22095099286894, "bleu": 18.575057999133602}, {"f1": 0.6666666666666666, "em": false, "chrf": 82.47015656414368, "bleu": 55.03212081491043}, {"f1": 0.3333333333333333, "em": false, "chrf": 31.915725500701708, "bleu": 16.233395773754946}], "avg_f1": 0.5384615384615384, "avg_em": 0.0, "avg_chrf": 59.535611019238104, "avg_bleu": 29.946858195932993}
{"id": "Wikivoyage_1:2267", "en": "The mask should cover your nose and mouth and fit without gaps.", "es": "La mascarilla debe cubrirle la nariz y la boca y ajustarse sin dejar ninguna separación.", "perturbation": "alteration", "pert_es": "La mascarilla no debe cubrirle la nariz y la boca y ajustarse sin dejar ninguna separación.", "bt_pert_es": "The mask should not cover your nose and mouth and should fit snugly without leaving any gaps.", "questions": "[\"What should the mask cover?\", \"Why should the mask fit without gaps?\", \"What parts of the face should the mask cover?\", \"What is the purpose of the mask fitting without gaps?\"]", "answers": "[\"Your nose and mouth\", \"To ensure a proper fit and prevent leakage\", \"Nose and mouth\", \"To ensure a proper fit and prevent leakage\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8571428571428571, "em": false, "chrf": 80.1596724027633, "bleu": 41.11336169005198}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 28.32869067022916, "bleu": 6.979367151952678}], "avg_f1": 0.8392857142857143, "avg_em": 0.5, "avg_chrf": 77.12209076824811, "avg_bleu": 62.02318221050118}
{"id": "Wikivoyage_1:2268", "en": "Wash your hands before putting on the mask and avoid touching the mask while wearing it.", "es": "Lávese las manos antes de colocarse la mascarilla y evite tocar la mascarilla mientras la use.", "perturbation": "alteration", "pert_es": "No se lave las manos antes de colocarse la mascarilla y evite tocar la mascarilla mientras la use.", "bt_pert_es": "Do not wash your hands before putting on the mask and avoid touching the mask while wearing it.", "questions": "[\"What should you do before putting on the mask?\", \"What should you avoid doing while wearing the mask?\"]", "answers": "[\"Wash your hands\", \"Touching the mask\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2270", "en": "When the mask becomes damp, discard and replace it.", "es": "Cuando la mascarilla se humedezca, deséchela y reemplácela.", "perturbation": "alteration", "pert_es": "Cuando la mascarilla se reseque, deséchela y reemplácela.", "bt_pert_es": "When the mask dries out, discard and replace it.", "questions": "[\"What should you do when the mask becomes damp?\", \"What happens when the mask becomes damp?\", \"What is the recommended action when the mask is damp?\"]", "answers": "[\"Replace the mask\", \"Nothing is mentioned about what happens when the mask becomes damp\", \"Replace the mask\"]", "scores": [{"f1": 0, "em": false, "chrf": 24.39602698600387, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 12.625489043451092, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 24.39602698600387, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 20.472514338486278, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2272", "en": "Remember that masks are not a substitute for good hygiene: continue to wash your hands frequently.", "es": "Recuerde que las mascarillas no sustituyen la buena higiene: siga lavándose las manos con frecuencia.", "perturbation": "alteration", "pert_es": "Recuerde que las mascarillas sustituyen la buena higiene: deje de lavándose las manos con frecuencia.", "bt_pert_es": "Remember that masks are a substitute for good hygiene: stop washing your hands frequently.", "questions": "[\"What is not a substitute for good hygiene?\", \"What should you continue to do frequently?\", \"What is the importance of good hygiene in relation to masks?\"]", "answers": "[\"Masks\", \"Washing your hands\", \"Masks are a substitute for good hygiene\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 70.86797887415547, "bleu": 55.03212081491043}, {"f1": 0.4705882352941177, "em": false, "chrf": 46.65359776854402, "bleu": 8.389861810900507}], "avg_f1": 0.7124183006535948, "avg_em": 0.3333333333333333, "avg_chrf": 72.50719221423316, "avg_bleu": 54.47399420860366}
{"id": "Wikivoyage_1:2273", "en": "Don't stock up on masks if you don't need them.", "es": "No acumule mascarillas si no las necesita.", "perturbation": "alteration", "pert_es": "Acumule mascarillas si no las necesita.", "bt_pert_es": "Stock up on masks if you don't need them.", "questions": "[\"Why shouldn't you stock up on masks if you don't need them?\", \"What should you do if you don't need masks?\", \"What is the recommendation regarding mask stockpiling?\"]", "answers": "[\"Because you don't need them\", \"You should not stock up on masks\", \"Do not stock up on masks if you don't need them\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6153846153846153, "em": false, "chrf": 68.36846632711891, "bleu": 26.269098944241588}, {"f1": 0.8571428571428572, "em": false, "chrf": 93.08440716802274, "bleu": 78.60753021519788}], "avg_f1": 0.8241758241758242, "avg_em": 0.3333333333333333, "avg_chrf": 87.15095783171388, "avg_bleu": 68.29220971981317}
{"id": "Wikivoyage_1:2276", "en": "Leave them for healthcare workers.", "es": "Déjeselos a los trabajadores de la salud.", "perturbation": "alteration", "pert_es": "Déjeselos a los trabajadores de la construcción.", "bt_pert_es": "Leave them to the construction workers.", "questions": "[\"Who should leave them for?\", \"What should be left for healthcare workers?\", \"What is being left for healthcare workers?\"]", "answers": "[\"The construction workers\", \"Nothing\", \"them\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.24287757122429, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 17.830330330330334, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 43.35773596718487, "avg_bleu": 33.33333333333335}
{"id": "Wikivoyage_1:2281", "en": "At petrol/gas stations, use gloves or wipe down the handle with a disinfectant wipe if you can.", "es": "En las gasolineras/estaciones de servicio, use guantes o, si puede, limpie el mango del surtidor con una toallita desinfectante.", "perturbation": "alteration", "pert_es": "En las gasolineras/estaciones de servicio, no use guantes o, si puede, limpie el mango del surtidor con una toallita contaminante.", "bt_pert_es": "At gas stations/service stations, do not wear gloves or, if you can, clean the pump handle with a contaminant wipe.", "questions": "[\"What should you do at petrol/gas stations to prevent contamination?\", \"What is recommended when touching the handle at petrol/gas stations?\", \"What is an alternative method to prevent contamination at petrol/gas stations?\", \"What type of gloves should be used at petrol/gas stations?\", \"What can be used to disinfect the handle at petrol/gas stations?\"]", "answers": "[\"Do not wear gloves and, if possible, clean the pump handle with a contaminant wipe\", \"Clean the pump handle with a contaminant wipe\", \"Clean the pump handle with a contaminant wipe\", \"None\", \"A contaminant wipe\"]", "scores": [{"f1": 0.3636363636363637, "em": false, "chrf": 41.70133055932854, "bleu": 7.347053125977879}, {"f1": 0.4, "em": false, "chrf": 33.7729682046222, "bleu": 10.89644800332157}, {"f1": 0.5, "em": false, "chrf": 42.54856088034701, "bleu": 17.965205598154213}, {"f1": 0, "em": false, "chrf": 8.928571428571427, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 37.53662326615374, "bleu": 34.66806371753173}], "avg_f1": 0.3860606060606061, "avg_em": 0.0, "avg_chrf": 32.89761086780458, "avg_bleu": 14.175354088997079}
{"id": "Wikivoyage_1:2283", "en": "The U.S. and Canadian governments recommend avoiding travel by cruise ship.", "es": "Los gobiernos de Estados Unidos y Canadá recomiendan evitar los viajes en crucero.", "perturbation": "alteration", "pert_es": "Los gobiernos de Estados Unidos y Canadá recomiendan realizar los viajes en crucero.", "bt_pert_es": "The governments of the United States and Canada recommend traveling by cruise.", "questions": "[\"What do the U.S. and Canadian governments recommend regarding travel?\", \"What type of travel is recommended to avoid?\", \"What mode of travel is specifically mentioned in the recommendation?\"]", "answers": "[\"Traveling by cruise\", \"None is specifically mentioned to avoid\", \"Cruise\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 40.10622355553578, "bleu": 28.254432923044853}, {"f1": 0, "em": false, "chrf": 11.08435576959829, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 32.818103141278876, "bleu": 0.0}], "avg_f1": 0.16666666666666666, "avg_em": 0.0, "avg_chrf": 28.002894155470983, "avg_bleu": 9.418144307681617}
{"id": "Wikivoyage_1:2284", "en": "Infections spread easily on board, and medical care is limited.", "es": "El contagio se propaga fácilmente a bordo de una embarcación y la atención médica es limitada.", "perturbation": "alteration", "pert_es": "El contagio se propaga difícilmente a bordo de una embarcación y la atención médica es limitada.", "bt_pert_es": "The contagion is difficult to spread on board a ship and medical care is limited.", "questions": "[\"How do infections spread on board?\", \"Why is medical care limited?\", \"What factors contribute to the ease of infection spread on board?\"]", "answers": "[\"It is difficult to spread\", \"Because the contagion is difficult to spread on board a ship\", \"The difficulty in spreading the contagion\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.4074074074074066, "bleu": 0.0}, {"f1": 0.2857142857142857, "em": false, "chrf": 26.510022096222833, "bleu": 5.669791110976001}, {"f1": 0.22222222222222224, "em": false, "chrf": 17.418445404812005, "bleu": 10.682175159905853}], "avg_f1": 0.1693121693121693, "avg_em": 0.0, "avg_chrf": 17.11195830281408, "avg_bleu": 5.450655423627285}
{"id": "Wikivoyage_1:2286", "en": "Even cruise ships without confirmed cases have been denied permission to dock due to virus fears, and in the high-profile case of the Diamond Princess in Japan, hundreds of people were infected on the ship.", "es": "Se les denegó el permiso para atracar incluso a algunos cruceros sin casos confirmados debido a los miedos por el coronavirus; en el caso del Diamond Princess en Japón, que tuvo gran repercusión mediática, cientos de personas se contagiaron a bordo de la embarcación.", "perturbation": "alteration", "pert_es": "Se les otorgó el permiso para atracar incluso a algunos cruceros sin casos confirmados debido a los miedos por el coronavirus; en el caso del Diamond Princess en Japón, que tuvo gran repercusión mediática, cientos de personas se contagiaron a bordo de la embarcación.", "bt_pert_es": "Even some cruise ships without confirmed cases were granted permission to dock due to coronavirus fears; In the case of the Diamond Princess in Japan, which had great media coverage, hundreds of people were infected on board the ship.", "questions": "[\"Why have cruise ships without confirmed cases been denied permission to dock?\", \"What is the reason for denying cruise ships permission to dock?\", \"What happened to the Diamond Princess in Japan?\", \"How many people were infected on the Diamond Princess?\", \"What is the impact of virus fears on cruise ship docking permissions?\"]", "answers": "[\"Coronavirus fears\", \"Coronavirus fears\", \"Hundreds of people were infected on board the ship\", \"Hundreds of people\", \"Cruise ships without confirmed cases have been granted permission to dock due to coronavirus fears\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 59.38820572402751, "bleu": 18.393972058572114}, {"f1": 0.5, "em": false, "chrf": 73.84810145071302, "bleu": 49.99999999999999}, {"f1": 0.9333333333333333, "em": false, "chrf": 89.47984954829907, "bleu": 70.71067811865478}, {"f1": 0.5, "em": false, "chrf": 76.74880456578744, "bleu": 27.516060407455225}, {"f1": 0.7692307692307692, "em": false, "chrf": 83.86336055955401, "bleu": 49.2027451538551}], "avg_f1": 0.6071794871794871, "avg_em": 0.0, "avg_chrf": 76.66566436967621, "avg_bleu": 43.164691147707444}
{"id": "Wikivoyage_1:2287", "en": "If you believe you may be infected, call a hospital or local emergency medical services instead of going in person to avoid infecting others.", "es": "Si cree que podría haberse contagiado, llame a un hospital o a los servicios locales de emergencias médicas en vez de ir en persona, para evitar contagiar a otras personas.", "perturbation": "alteration", "pert_es": "Si cree que no podría haberse contagiado, llame a un hospital o a los servicios locales de emergencias médicas en vez de ir en persona, para evitar contagiar a otras personas.", "bt_pert_es": "If you think you might not have been infected, call a hospital or local emergency medical services instead of going in person to avoid infecting others.", "questions": "[\"What should you do if you believe you may be infected?\", \"What is the recommended alternative to going in person if you believe you may be infected?\", \"Why is it important to avoid going in person if you believe you may be infected?\", \"What services should you call if you believe you may be infected?\"]", "answers": "[\"Call a hospital or local emergency medical services\", \"Call a hospital or local emergency medical services\", \"To avoid infecting others\", \"A hospital or local emergency medical services\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2288", "en": "Mention your symptoms and travel history.", "es": "Mencione sus síntomas y sus antecedentes de viaje.", "perturbation": "alteration", "pert_es": "Mencione sus síntomas y sus planes de viaje.", "bt_pert_es": "Mention your symptoms and your travel plans.", "questions": "[\"What symptoms should be mentioned?\", \"What is considered part of travel history?\", \"What information is requested in the sentence?\"]", "answers": "[\"Symptoms\", \"Travel plans\", \"Symptoms and travel plans\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 34.015667765148585, "bleu": 49.99999999999999}, {"f1": 0.75, "em": false, "chrf": 69.22003181819217, "bleu": 59.460355750136046}], "avg_f1": 0.75, "avg_em": 0.3333333333333333, "avg_chrf": 67.74523319444693, "avg_bleu": 69.82011858337869}
{"id": "Wikivoyage_1:2291", "en": "On a plane, follow the same hygiene practices as anywhere else: wash hands frequently, or use alcohol-based hand sanitizer if it's not convenient to leave your seat, and avoid touching your face.", "es": "En un avión, siga las mismas prácticas de higiene que en cualquier otro lugar: lávese las manos con frecuencia o use un desinfectante de manos a base de alcohol si no es conveniente levantarse de su asiento y evite tocarse el rostro.", "perturbation": "alteration", "pert_es": "En un avión, siga las mismas prácticas de suciedad que en cualquier otro lugar: ensúciese las manos con frecuencia o use un contaminante de manos a base de alcohol si no es conveniente levantarse de su asiento y busque tocarse el rostro.", "bt_pert_es": "On a plane, follow the same soiling practices as anywhere else: dirty your hands frequently or use an alcohol-based hand sanitizer if it's inconvenient to get up from your seat and reach for your face.", "questions": "[\"What hygiene practices should be followed on a plane?\", \"Why is it important to wash hands frequently on a plane?\", \"What should be done if alcohol-based hand sanitizer is not convenient to use on a plane?\", \"Why should you avoid touching your face on a plane?\", \"What are the recommended hygiene practices on a plane?\"]", "answers": "[\"Follow the same soiling practices as anywhere else: dirty your hands frequently or use an alcohol-based hand sanitizer if it's inconvenient to get up from your seat and reach for your face\", \"To reduce the risk of spreading germs and infections\", \"Use an alcohol-based hand sanitizer\", \"To prevent spreading germs and infections\", \"Dirty your hands frequently or use an alcohol-based hand sanitizer if it's inconvenient to get up from your seat and reach for your face\"]", "scores": [{"f1": 0.588235294117647, "em": false, "chrf": 67.77970843196624, "bleu": 33.12615528522038}, {"f1": 0.8571428571428571, "em": false, "chrf": 90.72228214763672, "bleu": 68.037493331712}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4615384615384615, "em": false, "chrf": 34.560249795196455, "bleu": 15.207218222740094}, {"f1": 0.6818181818181819, "em": false, "chrf": 71.09083899948723, "bleu": 43.937095446369234}], "avg_f1": 0.7177469589234294, "avg_em": 0.2, "avg_chrf": 72.83061587485733, "avg_bleu": 52.06159245720835}
{"id": "Wikivoyage_1:2293", "en": "Try to book a window seat, and avoid moving around the cabin during the flight.", "es": "Intente reservar un asiento del lado de la ventanilla y evite desplazarse por la cabina durante el vuelo.", "perturbation": "alteration", "pert_es": "Intente reservar un asiento del medio y busque desplazarse por la cabina durante el vuelo.", "bt_pert_es": "Try to book a middle seat and look to move around the cabin during the flight.", "questions": "[\"What should you try to do when booking a seat?\", \"What should you avoid doing during the flight?\", \"What type of seat is recommended?\", \"Why is it important to avoid moving around during the flight?\"]", "answers": "[\"Book a middle seat\", \"Avoid moving around during the flight\", \"Middle seat\", \"None of the above — the sentence does not mention why it's important to avoid moving around\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 28.182928182928187, "bleu": 34.66806371753173}, {"f1": 0.25, "em": false, "chrf": 52.435656235992965, "bleu": 10.682175159905853}, {"f1": 0.5, "em": false, "chrf": 22.1031746031746, "bleu": 49.99999999999999}, {"f1": 0.18181818181818182, "em": false, "chrf": 23.85126410538273, "bleu": 3.125190763972442}], "avg_f1": 0.3996212121212121, "avg_em": 0.0, "avg_chrf": 31.64325578186962, "avg_bleu": 24.618857410352504}
{"id": "Wikivoyage_1:2294", "en": "After washing your hands and before sitting down, use disinfectant wipes to wipe down the area around your seat.", "es": "Después de lavarse las manos y antes de sentarse, use toallitas desinfectantes para limpiar el área que rodea su asiento.", "perturbation": "alteration", "pert_es": "Después de lavarse las manos y antes de sentarse, use toallitas contaminantes para limpiar el área que rodea su asiento.", "bt_pert_es": "After washing your hands and before sitting down, use contaminant wipes to clean the area around your seat.", "questions": "[\"What should you do after washing your hands?\", \"What should you do before sitting down?\", \"What is used to wipe down the area around your seat?\", \"What is the purpose of using disinfectant wipes?\", \"What areas should be wiped down with disinfectant wipes?\"]", "answers": "[\"Use contaminant wipes to clean the area around your seat\", \"Use contaminant wipes to clean the area around your seat\", \"Contaminant wipes\", \"To clean the area around your seat\", \"The area around your seat\"]", "scores": [{"f1": 0.7368421052631577, "em": false, "chrf": 58.8277289477897, "bleu": 33.010083098515025}, {"f1": 0.7368421052631577, "em": false, "chrf": 58.8277289477897, "bleu": 33.010083098515025}, {"f1": 0.5, "em": false, "chrf": 42.64787009117468, "bleu": 49.99999999999999}, {"f1": 0.9090909090909091, "em": false, "chrf": 82.96812788306721, "bleu": 53.7284965911771}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7765550239234449, "avg_em": 0.2, "avg_chrf": 68.65429117396425, "avg_bleu": 53.94973255764144}
{"id": "Wikivoyage_1:2295", "en": "Wipe hard surfaces, and if your seat is leather you can wipe that too.", "es": "Limpie las superficies sólidas y, si el asiento es de cuero, puede limpiarlo también.", "perturbation": "alteration", "pert_es": "Ensucie las superficies sólidas y, si el asiento es de cuero, puede ensuciarlo también.", "bt_pert_es": "It makes solid surfaces dirty, and if the seat is leather, it can make it dirty too.", "questions": "[\"What surfaces should be wiped?\", \"Can leather seats be wiped?\", \"What type of surface is mentioned in the sentence?\", \"What is the recommended action for hard surfaces?\"]", "answers": "[\"Solid surfaces\", \"No\", \"Solid surfaces and leather\", \"Wiped\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 65.9327357483956, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.75, "em": false, "chrf": 83.63291299096709, "bleu": 59.460355750136046}, {"f1": 0, "em": false, "chrf": 91.3677130044843, "bleu": 0.0}], "avg_f1": 0.3125, "avg_em": 0.0, "avg_chrf": 60.23334043596175, "avg_bleu": 27.36508893753401}
{"id": "Wikivoyage_1:2304", "en": "If a group of passengers is connecting from an area with a severe outbreak, the flight attendants may be able to seat them away from the rest of the passengers (and if you were recently in a high-risk area, consider telling the flight attendants for this reason).", "es": "Si un grupo de pasajeros tiene un vuelo de conexión desde una zona con un brote severo, es posible que los auxiliares de vuelo sienten a estos pasajeros alejados del resto (y si usted estuvo recientemente en un área de alto riesgo, considere informárselo a los auxiliares de vuelo por este motivo).", "perturbation": "alteration", "pert_es": "Si un grupo de pasajeros tiene un vuelo de conexión desde una zona con un brote leve, es posible que los auxiliares de vuelo sienten a estos pasajeros cerca del resto (y si usted estuvo recientemente en un área de bajo riesgo, considere informárselo a los auxiliares de vuelo por este motivo).", "bt_pert_es": "If a group of passengers has a connecting flight from an area with a mild outbreak, flight attendants may seat these passengers close to the rest (and if you were recently in a low-risk area, consider letting the flight attendants know for this reason).", "questions": "[\"What happens if a group of passengers is connecting from an area with a severe outbreak?\", \"Can flight attendants seat connecting passengers away from others?\", \"Why might flight attendants seat connecting passengers separately?\", \"What should passengers do if they were recently in a high-risk area?\", \"What is a high-risk area in this context?\"]", "answers": "[\"The sentence does not provide information about a severe outbreak.\", \"No, the sentence does not mention seating connecting passengers away from others.\", \"To reduce the risk of transmission, especially if the passengers have been in an area with a mild outbreak.\", \"The sentence does not specify actions for passengers in a high-risk area.\", \"A high-risk area is not explicitly defined, but it is implied to be an area with a mild outbreak, as opposed to a low-risk area.\"]", "scores": [{"f1": 0.08695652173913043, "em": false, "chrf": 16.058206084145116, "bleu": 2.7354882120611315}, {"f1": 0, "em": false, "chrf": 6.671209607331911, "bleu": 0.0}, {"f1": 0.33333333333333337, "em": false, "chrf": 41.13313227801563, "bleu": 6.250381527944883}, {"f1": 0, "em": false, "chrf": 17.992436488714564, "bleu": 0.0}, {"f1": 0.22222222222222218, "em": false, "chrf": 34.403099002835624, "bleu": 3.8229746997386336}], "avg_f1": 0.1285024154589372, "avg_em": 0.0, "avg_chrf": 23.251616692208568, "avg_bleu": 2.5617688879489298}
{"id": "Wikivoyage_1:2306", "en": "This is so that, if someone on the flight turns out to be infected, the authorities can track down the people who were sitting near them for testing or quarantine.", "es": "El objetivo de esto es que, si alguien en el vuelo está infectado, las autoridades puedan hacer un seguimiento con las personas que estaban sentadas cerca de este pasajero para someterlas a una prueba o ponerlas en cuarentena.", "perturbation": "alteration", "pert_es": "El objetivo de esto es que, si alguien en el vuelo no está infectado, las autoridades puedan hacer un seguimiento con las personas que estaban sentadas lejos de este pasajero para someterlas a una prueba o ponerlas en cuarentena.", "bt_pert_es": "The goal of this is so that if someone on the flight is not infected, authorities can follow up with people who were seated far from this passenger to be tested or quarantined.", "questions": "[\"What is the purpose of tracking people who were sitting near an infected individual?\", \"Who needs to be tracked down if someone on the flight is infected?\", \"What actions are taken if someone on the flight is infected?\", \"What is the goal of tracking people sitting near an infected individual?\", \"What is the role of authorities in this scenario?\"]", "answers": "[\"To identify people who were seated far from the infected passenger for testing or quarantine\", \"People who were seated far from this passenger\", \"Authorities can follow up with people who were seated far from this passenger to be tested or quarantined\", \"To ensure that if someone on the flight is not infected, authorities can follow up with people who were seated far from this passenger for testing or quarantine\", \"Authorities follow up with people who were seated far from the infected passenger to be tested or quarantined\"]", "scores": [{"f1": 0.5333333333333333, "em": false, "chrf": 47.846243587096055, "bleu": 23.045806594604677}, {"f1": 0.25, "em": false, "chrf": 33.730085415774504, "bleu": 11.044795567078939}, {"f1": 0.2857142857142857, "em": false, "chrf": 47.37787577822123, "bleu": 8.59076483566362}, {"f1": 0.42857142857142855, "em": false, "chrf": 44.45392837808516, "bleu": 11.43433820088083}, {"f1": 0.29411764705882354, "em": false, "chrf": 44.755575537563615, "bleu": 9.672649511413097}], "avg_f1": 0.3583473389355742, "avg_em": 0.0, "avg_chrf": 43.63274173934811, "avg_bleu": 12.757670941928232}
{"id": "Wikivoyage_1:2311", "en": "Mild symptoms may be relieved by taking paracetamol (acetaminophen).", "es": "Los síntomas leves pueden aliviarse tomando paracetamol (acetaminofén).", "perturbation": "alteration", "pert_es": "Los síntomas graves pueden empeorarse tomando paracetamol (acetaminofén).", "bt_pert_es": "Severe symptoms may be made worse by taking paracetamol (acetaminophen).", "questions": "[\"What symptoms may be relieved by taking paracetamol (acetaminophen)?\", \"What medication can relieve mild symptoms?\", \"What is paracetamol (acetaminophen) used for?\"]", "answers": "[\"Severe symptoms\", \"Paracetamol (acetaminophen)\", \"Relieving severe symptoms\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 54.17027901011643, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 62.36225753460409, "bleu": 34.66806371753173}], "avg_f1": 0.7222222222222222, "avg_em": 0.3333333333333333, "avg_chrf": 72.1775121815735, "avg_bleu": 61.556021239177255}
{"id": "Wikivoyage_1:2312", "en": "If you are infected with COVID-19, countries will isolate you until several consecutive tests for COVID-19 are negative.", "es": "Si se ha contagiado COVID-19, los países lo aislarán hasta que se le hayan realizado varias pruebas consecutivas de COVID-19 con resultados negativos.", "perturbation": "alteration", "pert_es": "Si no se ha contagiado COVID-19, los países lo aislarán hasta que se le hayan realizado varias pruebas consecutivas de COVID-19 con resultados negativos.", "bt_pert_es": "If you have not been infected with COVID-19, countries will isolate you until you have had several consecutive COVID-19 tests with negative results.", "questions": "[\"What happens if you are infected with COVID-19?\", \"What is required for isolation to end?\", \"What type of tests are used to determine when isolation ends?\", \"How many consecutive negative tests are needed to end isolation?\", \"What is the condition for ending isolation due to COVID-19 infection?\"]", "answers": "[\"Countries will isolate you until you have had several consecutive COVID-19 tests with negative results\", \"Several consecutive COVID-19 tests with negative results\", \"COVID-19 tests\", \"Several\", \"Having several consecutive negative COVID-19 test results\"]", "scores": [{"f1": 0.7407407407407408, "em": false, "chrf": 74.67073977074807, "bleu": 30.934588294313713}, {"f1": 0.7142857142857143, "em": false, "chrf": 66.46105821709017, "bleu": 16.51582159006904}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 89.20489858851346, "bleu": 24.446151121745054}], "avg_f1": 0.7910052910052909, "avg_em": 0.4, "avg_chrf": 86.06733931527035, "avg_bleu": 54.37931220122558}
{"id": "Wikivoyage_1:2313", "en": "If you have been in close contact with someone infected with COVID-19, many countries will quarantine you for 14 days since the last exposure and monitor you for signs and symptoms.", "es": "Si ha estado en contacto estrecho con alguien contagiado de COVID-19, en muchos países se lo pondrá en cuarentena por 14 días a partir de la última fecha de exposición y se controlarán sus signos y síntomas.", "perturbation": "alteration", "pert_es": "Si no ha estado en contacto estrecho con alguien contagiado de COVID-19, en muchos países se lo pondrá en cuarentena por 14 días a partir de la última fecha de exposición y se controlarán sus signos y síntomas.", "bt_pert_es": "If you have not been in close contact with someone infected with COVID-19, in many countries you will be quarantined for 14 days from the last date of exposure and your signs and symptoms will be monitored.", "questions": "[\"What should you do if you have been in close contact with someone infected with COVID-19?\", \"How long is the quarantine period after close contact with someone infected with COVID-19?\", \"What do many countries monitor during quarantine?\", \"What signs and symptoms are monitored during quarantine?\", \"What is the reason for quarantine after close contact with a COVID-19 infected person?\"]", "answers": "[\"There is no specific instruction given for this scenario in the sentence\", \"14 days\", \"Your signs and symptoms\", \"Your signs and symptoms\", \"To prevent the spread of COVID-19\"]", "scores": [{"f1": 0.06896551724137931, "em": false, "chrf": 13.266728478299203, "bleu": 1.9833734500134768}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5714285714285715, "em": false, "chrf": 87.24266685164639, "bleu": 31.947155212313625}, {"f1": 0.5714285714285715, "em": false, "chrf": 87.24266685164639, "bleu": 31.947155212313625}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6423645320197044, "avg_em": 0.4, "avg_chrf": 77.5504124363184, "avg_bleu": 53.17553677492816}
{"id": "Wikivoyage_1:2314", "en": "Some countries will also test you even if you don't have symptoms.", "es": "En algunos países, se le harán pruebas incluso si no tiene síntomas.", "perturbation": "alteration", "pert_es": "En algunos países, se le harán pruebas solo si tiene síntomas.", "bt_pert_es": "In some countries, you will be tested only if you have symptoms.", "questions": "[\"Which countries will test you even if you don't have symptoms?\", \"What happens if you don't have symptoms?\", \"Under what conditions will countries test you?\", \"Are there countries that test people without symptoms?\"]", "answers": "[\"None\", \"You will not be tested\", \"If you have symptoms\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.696428571428571, "bleu": 0.0}, {"f1": 0.888888888888889, "em": false, "chrf": 74.17893465581902, "bleu": 30.213753973567677}, {"f1": 0.888888888888889, "em": false, "chrf": 66.55130631400885, "bleu": 35.186297399811885}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.4444444444444445, "avg_em": 0.0, "avg_chrf": 36.85666738531411, "avg_bleu": 16.350012843344892}
{"id": "Wikivoyage_1:2315", "en": "In many countries, the healthcare system has been stretched to the point of not being able to handle the sheer number of patients, and there is a chance you may be refused treatment due to the lack of available medical staff, supplies or equipment.", "es": "En muchos países, el sistema de salud se encuentra sobrecargado al punto de que no puede manejar la cantidad de pacientes, por lo que existe la posibilidad de que le nieguen el tratamiento debido a la falta de personal, suministros o equipos médicos disponibles.", "perturbation": "alteration", "pert_es": "En muchos países, el sistema de salud se encuentra descargado al punto de que puede manejar la cantidad de pacientes, por lo que existe la posibilidad de que le ofrezcan el tratamiento debido a la abundancia de personal, suministros o equipos médicos disponibles.", "bt_pert_es": "In many countries, the healthcare system is stretched to the point that it can handle the number of patients, so there is a chance that you will be offered treatment due to the abundance of staff, supplies or medical equipment available.", "questions": "[\"What has been stretched in many countries?\", \"Why can the healthcare system not handle the sheer number of patients?\", \"What might cause a patient to be refused treatment?\", \"What are the reasons for lack of available medical staff, supplies, or equipment?\", \"What is the impact of the healthcare system being stretched?\"]", "answers": "[\"The healthcare system\", \"The healthcare system is not stretched; it can handle the number of patients\", \"The abundance of staff, supplies, or medical equipment\", \"None mentioned in the sentence\", \"There is a chance that you will be offered treatment due to the abundance of staff, supplies or medical equipment available\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.47058823529411764, "em": false, "chrf": 53.934050553315316, "bleu": 13.545994273378144}, {"f1": 0.75, "em": false, "chrf": 57.55260541051469, "bleu": 24.446151121745054}, {"f1": 0, "em": false, "chrf": 12.061152333691835, "bleu": 0.0}, {"f1": 0.5777777777777778, "em": false, "chrf": 49.20006907696952, "bleu": 11.248027163080652}], "avg_f1": 0.559673202614379, "avg_em": 0.2, "avg_chrf": 54.54957547489827, "avg_bleu": 29.848034511640776}
{"id": "Wikivoyage_1:2317", "en": "Even more countries have imposed restrictions on arriving travelers, either barring entry (maybe with an exception for local citizens and permanent residents) or requiring you to be quarantined, typically for 14 days.", "es": "Incluso más países han impuesto restricciones para los viajeros que llegan al país, ya sea que se les deniegue el ingreso (quizás con la excepción de los ciudadanos y residentes permanentes del país) o se les exija que hagan una cuarentena, que suele ser de 14 días.", "perturbation": "alteration", "pert_es": "Incluso más países han eliminado restricciones para los viajeros que llegan al país, ya sea que se les permita el ingreso (quizás con la excepción de los ciudadanos y residentes permanentes del país) o se les sugiera que no hagan una cuarentena, que suele ser de 14 días.", "bt_pert_es": "Even more countries have lifted restrictions on travelers arriving into the country, either allowing them to enter (perhaps with the exception of the country's citizens and permanent residents) or suggesting they not quarantine, which is typically 14 days.", "questions": "[\"What countries have imposed restrictions on arriving travelers?\", \"What types of restrictions have been imposed on arriving travelers?\", \"Are there exceptions to entry restrictions for certain individuals?\", \"Who might be exempt from entry restrictions?\", \"What is the typical quarantine period for arriving travelers?\", \"What is the purpose of imposing quarantine on arriving travelers?\"]", "answers": "[\"No countries have imposed restrictions on arriving travelers\", \"Allowing entry (perhaps with the exception of the country's citizens and permanent residents) or suggesting they not quarantine\", \"Yes\", \"The country's citizens and permanent residents\", \"14 days\", \"To prevent the spread of disease\"]", "scores": [{"f1": 0.18181818181818182, "em": false, "chrf": 35.83381047963506, "bleu": 5.522397783539471}, {"f1": 0.2857142857142857, "em": false, "chrf": 35.71957710586169, "bleu": 3.21858262703621}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7272727272727272, "em": false, "chrf": 81.93587372378049, "bleu": 50.81327481546147}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6991341991341992, "avg_em": 0.5, "avg_chrf": 75.5815435515462, "avg_bleu": 59.92570920433955}
{"id": "Wikivoyage_1:2318", "en": "Even if a mandatory quarantine is not imposed, you may be asked to \"self-quarantine\" by staying at home and not interacting with other people.", "es": "Incluso si no se le impone la cuarentena obligatoria, es posible que le pidan que haga una \"cuarentena voluntaria\" y se quede en casa, sin interactuar con otras personas.", "perturbation": "alteration", "pert_es": "Incluso si no se le impone la cuarentena obligatoria, es posible que le pidan que haga una \"cuarentena voluntaria\" y se vaya de casa, interactuando con otras personas.", "bt_pert_es": "Even if you are not placed under mandatory quarantine, you may be asked to \"voluntarily quarantine\" and leave home, interacting with other people.", "questions": "[\"What happens if a mandatory quarantine is not imposed?\", \"What does 'self-quarantine' involve?\", \"What is required to practice self-quarantine?\", \"What actions are taken during self-quarantine?\", \"What is the purpose of self-quarantine?\"]", "answers": "[\"You may be asked to 'voluntarily quarantine' and leave home, interacting with other people\", \"Leaving home and interacting with other people\", \"Leaving home and interacting with other people\", \"Leaving home and interacting with other people\", \"To prevent the spread of disease\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 56.90369464341302, "bleu": 26.584835766658767}, {"f1": 0.75, "em": false, "chrf": 69.93224471083175, "bleu": 36.74145494215666}, {"f1": 0.75, "em": false, "chrf": 69.93224471083175, "bleu": 36.74145494215666}, {"f1": 0.75, "em": false, "chrf": 69.93224471083175, "bleu": 36.74145494215666}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.2, "avg_chrf": 73.34008575518166, "avg_bleu": 47.36184011862576}
{"id": "Wikivoyage_1:2319", "en": "The most severe restrictions are on travellers who have recently been to affected areas, but increasingly many countries are applying them to incoming travellers overall.", "es": "Las restricciones más severas son para los viajeros que han estado en forma reciente en zonas afectadas, pero cada vez son más los países que las aplican a todos los viajeros que ingresan al país.", "perturbation": "alteration", "pert_es": "Las restricciones más suaves son para los viajeros que han estado en forma reciente en zonas afectadas, pero cada vez son más los países que las aplican a todos los viajeros que ingresan al país.", "bt_pert_es": "The softest restrictions are for travelers who have recently been to affected areas, but more and more countries are applying them to all travelers entering the country.", "questions": "[\"What are the most severe restrictions applied to?\", \"Which travellers are subject to the most severe restrictions?\", \"What areas trigger the most severe restrictions?\", \"Are restrictions being applied to all incoming travellers?\", \"How are restrictions changing for incoming travellers?\"]", "answers": "[\"Travelers who have recently been to affected areas\", \"Travelers who have recently been to affected areas\", \"Affected areas\", \"Yes\", \"More and more countries are applying them to all travelers entering the country\"]", "scores": [{"f1": 0.875, "em": false, "chrf": 93.86943510376614, "bleu": 84.08964152537145}, {"f1": 0.875, "em": false, "chrf": 93.86943510376614, "bleu": 84.08964152537145}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 13.721565461835528, "bleu": 0.0}], "avg_f1": 0.75, "avg_em": 0.4, "avg_chrf": 80.29208713387357, "avg_bleu": 73.6358566101486}
{"id": "Wikivoyage_1:2321", "en": "What are the affected areas?", "es": "¿Cuáles son las zonas afectadas?", "perturbation": "alteration", "pert_es": "¿Cuáles son las zonas no afectadas?", "bt_pert_es": "What are the unaffected areas?", "questions": "[\"What areas are affected?\", \"What types of areas are mentioned in the sentence?\"]", "answers": "[\"The unaffected areas\", \"Unaffected areas\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 81.53500395581761, "bleu": 34.66806371753173}, {"f1": 0.4, "em": false, "chrf": 78.59130162309171, "bleu": 30.326532985631665}], "avg_f1": 0.5333333333333333, "avg_em": 0.0, "avg_chrf": 80.06315278945466, "avg_bleu": 32.4972983515817}
{"id": "Wikivoyage_1:2322", "en": "Well, this is a fast-changing situation, and each country/region/organization has its own list of what areas are subject to restrictions.", "es": "Bueno, la situación cambia rápidamente y cada país/región/organización tiene su propia lista de zonas sujetas a restricciones.", "perturbation": "alteration", "pert_es": "Bueno, la situación cambia lentamente y cada país/región/organización tiene su propia lista de zonas libres de restricciones.", "bt_pert_es": "Well, the situation is changing slowly and each country/region/organization has its own list of restriction-free zones.", "questions": "[\"What makes this situation fast-changing?\", \"What areas are subject to restrictions?\", \"Who determines the list of restricted areas?\", \"What factors influence the list of restricted areas?\", \"What is the basis for different restrictions across countries/regions/organizations?\"]", "answers": "[\"Nothing; the situation is changing slowly\", \"Restriction-free zones\", \"Each country/region/organization\", \"The nature of the situation and the specific policies of each entity\", \"The individual country/region/organization policies\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 43.69333442525867, "bleu": 10.682175159905853}, {"f1": 0, "em": false, "chrf": 31.035061329504654, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5714285714285715, "em": false, "chrf": 73.77305254354091, "bleu": 26.269098944241577}, {"f1": 0.25, "em": false, "chrf": 42.92766370639527, "bleu": 15.97357760615681}], "avg_f1": 0.4142857142857143, "avg_em": 0.2, "avg_chrf": 58.2858224009399, "avg_bleu": 30.58497034206086}
{"id": "Wikivoyage_1:2323", "en": "The city of Wuhan is on every list and the rest of mainland China is on most.", "es": "La ciudad de Wuhan se encuentra en todas las listas y el resto de China continental está en la mayoría de ellas.", "perturbation": "alteration", "pert_es": "La ciudad de Wuhan no se encuentra en ninguna de las listas y el resto de China continental está en la mayoría de ellas.", "bt_pert_es": "The city of Wuhan is not on any of the lists and the rest of mainland China is on most of them.", "questions": "[\"What cities are on every list?\", \"Which regions of mainland China are on most lists?\", \"What does 'on every list' indicate about the city of Wuhan?\", \"What does 'on most' indicate about the rest of mainland China?\"]", "answers": "[\"None\", \"The rest of mainland China\", \"The city of Wuhan is not on any of the lists\", \"The rest of mainland China is on most of them\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}, {"f1": 0.888888888888889, "em": false, "chrf": 96.46008918404968, "bleu": 66.87403049764218}, {"f1": 0.631578947368421, "em": false, "chrf": 53.33642180768109, "bleu": 41.11336169005198}, {"f1": 0.7, "em": false, "chrf": 61.91770373341281, "bleu": 53.7284965911771}], "avg_f1": 0.5551169590643275, "avg_em": 0.0, "avg_chrf": 54.23063701461923, "avg_bleu": 40.428972194717815}
{"id": "Wikivoyage_1:2325", "en": "Some countries have imposed restrictions based on citizenship or residency from severely affected areas.", "es": "Algunos países han impuesto restricciones basadas en la ciudadanía o la residencia de las áreas gravemente afectadas.", "perturbation": "alteration", "pert_es": "Algunos países han eliminado restricciones basadas en la ciudadanía o la residencia de las áreas gravemente afectadas.", "bt_pert_es": "Some countries have removed restrictions based on citizenship or residency from severely affected areas.", "questions": "[\"What restrictions have some countries imposed?\", \"Based on what criteria have countries imposed restrictions?\", \"What is the basis for restrictions in some countries?\", \"Which areas are considered severely affected?\", \"What types of restrictions are based on citizenship or residency?\"]", "answers": "[\"None\", \"Citizenship or residency\", \"Citizenship or residency\", \"Severely affected areas\", \"Restrictions based on citizenship or residency\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.874900535780595, "bleu": 0.0}, {"f1": 0.6, "em": false, "chrf": 49.28284186202363, "bleu": 26.359713811572682}, {"f1": 0.6, "em": false, "chrf": 49.28284186202363, "bleu": 26.359713811572682}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.64, "avg_em": 0.4, "avg_chrf": 60.08811685196557, "avg_bleu": 50.54388552462909}
{"id": "Wikivoyage_1:2326", "en": "A detailed list of entry restrictions is maintained by the IATA.", "es": "La Asociación Internacional de Transporte Aéreo mantiene una lista detallada de las restricciones de ingreso.", "perturbation": "alteration", "pert_es": "La Asociación Internacional de Transporte Aéreo mantiene una lista limitada de las libertades de ingreso.", "bt_pert_es": "The International Air Transport Association maintains a limited list of entry freedoms.", "questions": "[\"What is maintained by the IATA?\", \"What type of restrictions is the list about?\", \"What does the detailed list include?\"]", "answers": "[\"A limited list of entry freedoms\", \"Entry freedoms\", \"Entry freedoms\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 43.08432651697843, "bleu": 32.46679154750989}, {"f1": 0.5, "em": false, "chrf": 22.15676413791153, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 22.15676413791153, "bleu": 49.99999999999999}], "avg_f1": 0.5555555555555555, "avg_em": 0.0, "avg_chrf": 29.132618264267165, "avg_bleu": 44.15559718250329}
{"id": "Wikivoyage_1:2328", "en": "Keep up to date—the outbreak and the travel restrictions are changing rapidly.", "es": "Manténgase informado: el brote y las restricciones de viaje cambian rápidamente.", "perturbation": "alteration", "pert_es": "Manténgase desinformado: el brote y las restricciones de viaje cambian lentamente.", "bt_pert_es": "Stay uninformed: The outbreak and travel restrictions are changing slowly.", "questions": "[\"What is changing rapidly?\", \"What are the outbreak and travel restrictions affecting?\", \"Why is it important to keep up to date?\"]", "answers": "[\"Nothing is changing rapidly\", \"Nothing specific is mentioned as being affected by the outbreak and travel restrictions\", \"It is not mentioned why it is important to keep up to date\"]", "scores": [{"f1": 0, "em": false, "chrf": 8.80924078170753, "bleu": 0.0}, {"f1": 0.47058823529411764, "em": false, "chrf": 71.45774741446465, "bleu": 21.200626759025184}, {"f1": 0, "em": false, "chrf": 9.790062376864615, "bleu": 0.0}], "avg_f1": 0.1568627450980392, "avg_em": 0.0, "avg_chrf": 30.01901685767893, "avg_bleu": 7.066875586341728}
{"id": "Wikivoyage_1:2329", "en": "For travel in the near future, consider making refundable reservations in case the changing situation forces you to change your plans.", "es": "Si tiene que viajar en el futuro cercano, considere hacer reservas reembolsables, en caso de que la cambiante situación lo obligue a modificar sus planes.", "perturbation": "alteration", "pert_es": "Si tiene que viajar en el futuro lejano, considere hacer reservas no reembolsables, en caso de que la estable situación lo obligue a modificar sus planes.", "bt_pert_es": "If you have to travel in the distant future, consider making non-refundable reservations, in case the stable situation forces you to modify your plans.", "questions": "[\"What should be considered for travel in the near future?\", \"Why is it recommended to make refundable reservations?\", \"What might force a change in travel plans?\", \"What is the reason for changing travel plans?\", \"What type of reservations are recommended?\"]", "answers": "[\"non-refundable reservations\", \"None specified\", \"The stable situation\", \"To modify plans due to the stable situation\", \"Non-refundable reservations\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 78.81962107034278, "bleu": 30.326532985631665}, {"f1": 0, "em": false, "chrf": 5.6116501795728055, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 43.52392339255201, "bleu": 34.66806371753173}, {"f1": 0.30769230769230765, "em": false, "chrf": 16.648792843981035, "bleu": 7.809849842300641}, {"f1": 0.5, "em": false, "chrf": 91.98384510330087, "bleu": 49.99999999999999}], "avg_f1": 0.3748717948717949, "avg_em": 0.0, "avg_chrf": 47.3175665179499, "avg_bleu": 24.560889309092808}
{"id": "Wikivoyage_1:2330", "en": "Avoid buying tickets with a connection in an affected area – even changing planes can make you subject to restrictions.", "es": "Evite comprar boletos con conexiones en las áreas afectadas ya que incluso un cambio de avión puede hacer que usted quede sujeto a las restricciones.", "perturbation": "alteration", "pert_es": "Evite no comprar boletos con conexiones en las áreas afectadas ya que incluso un cambio de avión puede hacer que usted quede sujeto a las restricciones.", "bt_pert_es": "Avoid purchasing tickets with connections in affected areas as even a change of plane can subject you to the restrictions.", "questions": "[\"What should you avoid when traveling?\", \"What happens if you change planes in an affected area?\", \"What makes you subject to restrictions?\", \"What is considered an affected area?\", \"What is the risk of traveling with a connection in an affected area?\"]", "answers": "[\"Purchasing tickets with connections in affected areas\", \"You are subject to the restrictions\", \"A change of plane in an affected area\", \"Areas where restrictions are in place\", \"Being subject to restrictions\"]", "scores": [{"f1": 0.5714285714285714, "em": false, "chrf": 83.30190560703477, "bleu": 18.575057999133602}, {"f1": 0.7272727272727272, "em": false, "chrf": 70.17844633541782, "bleu": 34.98330125272251}, {"f1": 0.5, "em": false, "chrf": 60.42755245291477, "bleu": 24.446151121745054}, {"f1": 0.7692307692307692, "em": false, "chrf": 84.41885022866403, "bleu": 64.31870218238025}, {"f1": 0.75, "em": false, "chrf": 84.72001369196084, "bleu": 59.460355750136046}], "avg_f1": 0.6635864135864136, "avg_em": 0.0, "avg_chrf": 76.60935366319845, "avg_bleu": 40.356713661223495}
{"id": "Wikivoyage_1:2332", "en": "You might also be delayed for hours upon arrival waiting for temperature checks and related procedures and paperwork, or even get quarantined for two weeks.", "es": "También es posible que sufra demoras de varias horas tras su llegada, mientras espera los controles de temperatura y los procedimientos y papeleo relacionados, o que lo coloquen en cuarentena por dos semanas.", "perturbation": "alteration", "pert_es": "También es posible que sufra aceleraciones de varias horas tras su llegada, mientras espera los controles de temperatura y los procedimientos y papeleo relacionados, o que lo saquen de cuarentena por dos semanas.", "bt_pert_es": "You may also experience rushes of several hours upon arrival while you wait for temperature checks and related procedures and paperwork, or be released from quarantine for two weeks.", "questions": "[\"What might cause a delay upon arrival?\", \"What procedures are involved upon arrival?\", \"What paperwork is required upon arrival?\", \"What is the potential duration of quarantine?\", \"What are the possible reasons for being quarantined?\"]", "answers": "[\"Rushes of several hours\", \"Temperature checks and related procedures\", \"Paperwork\", \"Two weeks\", \"Waiting for temperature checks and related procedures and paperwork\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.780700416095137, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 15.684748788069166, "bleu": 0.0}], "avg_f1": 0.6, "avg_em": 0.6, "avg_chrf": 64.69308984083287, "avg_bleu": 60.00000000000002}
{"id": "Wikivoyage_1:2334", "en": "Even if you're nowhere near affected areas there's a risk that you'll have to stay at the destination longer than planned if you've shared a building or vessel with an infected person.", "es": "Incluso si no se encuentra cerca de las áreas afectadas, existe el riesgo de que deba quedarse en su destino más tiempo de lo planeado si estuvo en el mismo edificio o embarcación que una persona contagiada.", "perturbation": "alteration", "pert_es": "Incluso si se encuentra cerca de las áreas afectadas, existe la certeza de que no deba quedarse en su destino menos tiempo de lo planeado si estuvo en el mismo edificio o embarcación que una persona contagiada.", "bt_pert_es": "Even if you are near the affected areas, you should not stay at your destination for less time than planned if you were in the same building or vessel as an infected person.", "questions": "[\"What is the risk if you've shared a building or vessel with an infected person?\", \"Under what circumstances might you have to stay at a destination longer than planned?\", \"What factors increase the risk of extended stay at a destination?\", \"What happens if you're near affected areas?\", \"What is the condition that leads to a longer stay at a destination?\"]", "answers": "[\"Infection\", \"You should not stay at your destination for less time than planned\", \"Sharing a building or vessel with an infected person\", \"You should not stay at your destination for less time than planned\", \"Sharing a building or vessel with an infected person\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.416861941004669, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 17.2770859966541, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 15.498321722776387, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.4, "avg_em": 0.4, "avg_chrf": 47.63845393208703, "avg_bleu": 40.000000000000014}
{"id": "Wikivoyage_1:2335", "en": "For example, in late February an Italian doctor on vacation in Costa Adeje (Canary Islands) was diagnosed with COVID-19, and as a result all the guests in the hotel he stayed at were quarantined.", "es": "Por ejemplo, a fines de febrero, un médico italiano que estaba de vacaciones en Costa Adeje (islas Canarias) fue diagnosticado con COVID-19 y, como resultado, todos los huéspedes del hotel en el que se quedó el médico fueron puestos en cuarentena.", "perturbation": "alteration", "pert_es": "Por ejemplo, a fines de febrero, un médico italiano que estaba de vacaciones en Costa Adeje (islas Canarias) se recuperó de COVID-19 y, como resultado, todos los huéspedes del hotel en el que se quedó el médico fueron liberados de la cuarentena.", "bt_pert_es": "For example, at the end of February, an Italian doctor who was on vacation in Costa Adeje (Canary Islands) recovered from COVID-19 and, as a result, all guests of the hotel where the doctor stayed were released from quarantine.", "questions": "[\"What happened to an Italian doctor in late February?\", \"Where was the Italian doctor on vacation?\", \"What was the doctor diagnosed with?\", \"What was the consequence for the guests in the hotel?\", \"What action was taken as a result of the doctor's diagnosis?\"]", "answers": "[\"The Italian doctor recovered from COVID-19\", \"Costa Adeje (Canary Islands)\", \"COVID-19\", \"They were released from quarantine\", \"The guests were released from quarantine\"]", "scores": [{"f1": 0.6153846153846153, "em": false, "chrf": 51.54664712112304, "bleu": 27.48254571080018}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 70.04962809351781, "bleu": 21.3643503198117}, {"f1": 0.3333333333333333, "em": false, "chrf": 46.10771238697514, "bleu": 9.652434877402245}], "avg_f1": 0.6897435897435897, "avg_em": 0.4, "avg_chrf": 73.5407975203232, "avg_bleu": 51.69986618160284}
{"id": "Wikivoyage_1:2336", "en": "Lockdowns and other internal restrictions", "es": "Cierres y otras restricciones internacionales", "perturbation": "alteration", "pert_es": "Aperturas y otras facilidades internacionales", "bt_pert_es": "Openings and other international facilities", "questions": "[\"What are lockdowns and other internal restrictions?\", \"What is the purpose of lockdowns and other internal restrictions?\"]", "answers": "[\"Information not provided\", \"Information not provided\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.9332141560654, "bleu": 0.0}, {"f1": 0.2, "em": false, "chrf": 9.58112409392488, "bleu": 7.253154775624655}], "avg_f1": 0.1, "avg_em": 0.0, "avg_chrf": 10.75716912499514, "avg_bleu": 3.6265773878123273}
{"id": "Wikivoyage_1:2338", "en": "These include the temporary reintroduction of some border controls, restrictions on travel within the country, closing or limiting service at restaurants and other establishments, banning large public events, and in the most severe cases prohibiting people from leaving the house except for essential reasons.", "es": "Estos incluyen la reintroducción temporal de algunos controles de fronteras, restricciones de viaje dentro del país, cierre de restaurantes u otros establecimientos o limitación de sus servicios, prohibición de eventos públicos masivos y, en los casos más severos, no dejar que las personas salgan de sus hogares excepto por razones esenciales.", "perturbation": "alteration", "pert_es": "Estos incluyen la eliminación temporal de algunos controles de fronteras, flexibilización de viaje dentro del país, apertura de restaurantes u otros establecimientos o ampliación de sus servicios, autorización de eventos públicos masivos y, en los casos más severos, dejar que las personas salgan de sus hogares sin restricciones.", "bt_pert_es": "These include the temporary elimination of some border controls, easing travel within the country, opening restaurants or other establishments or expanding their services, authorizing mass public events and, in the most severe cases, allowing people to leave their homes without restrictions.", "questions": "[\"What measures are included in the temporary reintroduction of border controls?\", \"What restrictions are placed on travel within the country?\", \"What changes are made to restaurant and other establishment services?\", \"What public events are banned?\", \"What is prohibited in the most severe cases regarding people leaving the house?\"]", "answers": "[\"None\", \"None\", \"Opening restaurants or other establishments or expanding their services\", \"None\", \"Leaving their homes\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.6980286738351245, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.7128055260361315, "bleu": 0.0}, {"f1": 0.4444444444444444, "em": false, "chrf": 58.292132931897676, "bleu": 11.339582221952005}, {"f1": 0, "em": false, "chrf": 3.4722222222222223, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 11.6533063662291, "bleu": 0.0}], "avg_f1": 0.08888888888888888, "avg_em": 0.0, "avg_chrf": 16.76569914404405, "avg_bleu": 2.267916444390401}
{"id": "Wikivoyage_1:2339", "en": "Beyond government restrictions, individual establishments are shutting their doors and cancelling events to try to reduce the spread of the virus.", "es": "Más allá de las restricciones gubernamentales, los establecimientos individuales están cerrando sus puertas y cancelando eventos para tratar de reducir la propagación del virus.", "perturbation": "alteration", "pert_es": "Más allá de las restricciones gubernamentales, los establecimientos individuales están abriendo sus puertas y organizando eventos para tratar de aumentar la propagación del virus.", "bt_pert_es": "Beyond government restrictions, individual establishments are opening their doors and hosting events to try to increase the spread of the virus.", "questions": "[\"What actions are individual establishments taking to reduce the spread of the virus?\", \"What specific measures are being taken by individual establishments?\", \"What is the reason for individual establishments shutting their doors and cancelling events?\", \"What role do government restrictions play in the context of virus spread?\", \"What is the goal of shutting doors and cancelling events?\"]", "answers": "[\"None\", \"None\", \"None\", \"To allow individual establishments to open and host events\", \"To increase the spread of the virus\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.4671052631578947, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.4671052631578947, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.8409090909090904, "bleu": 0.0}, {"f1": 0.08695652173913043, "em": false, "chrf": 20.208920825302588, "bleu": 2.7354882120611315}, {"f1": 0.8000000000000002, "em": false, "chrf": 66.05129135625144, "bleu": 42.7287006396234}], "avg_f1": 0.17739130434782613, "avg_em": 0.0, "avg_chrf": 18.807066359755783, "avg_bleu": 9.092837770336905}
{"id": "Wikivoyage_1:2340", "en": "In China, there are extensive restrictions on transportation and activity, which vary widely by province, city, and even by district or village.", "es": "En China hay importantes restricciones de transporte y actividad, las cuales varían ampliamente entre las distintas provincias y ciudades o, incluso, entre los distintos distritos o pueblos.", "perturbation": "alteration", "pert_es": "En China hay importantes libertades de transporte y actividad, las cuales varían ampliamente entre las distintas provincias y ciudades o, incluso, entre los distintos distritos o pueblos.", "bt_pert_es": "In China there are important freedoms of transport and activity, which vary widely between different provinces and cities or even between different districts or towns.", "questions": "[\"What restrictions are in place in China?\", \"What aspects of transportation and activity are restricted in China?\", \"How do restrictions vary in China?\", \"What is the level of variation in restrictions by province?\", \"What is the level of variation in restrictions by city?\", \"What is the level of variation in restrictions by district or village?\"]", "answers": "[\"None\", \"None\", \"They vary widely between different provinces and cities or even between different districts or towns\", \"They vary widely\", \"They vary widely\", \"They vary widely\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.5683642749623687, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.6681942434475, "bleu": 0.0}, {"f1": 0.4444444444444445, "em": false, "chrf": 49.610781378259695, "bleu": 11.633270842295028}, {"f1": 0, "em": false, "chrf": 42.46447951555532, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 42.46447951555532, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 42.46447951555532, "bleu": 0.0}], "avg_f1": 0.07407407407407408, "avg_em": 0.0, "avg_chrf": 30.540129740555923, "avg_bleu": 1.938878473715838}
{"id": "Wikivoyage_1:2341", "en": "Many governments recommend against traveling to China at this time.", "es": "Muchos gobiernos recomiendan no viajar a China en este momento.", "perturbation": "alteration", "pert_es": "Muchos gobiernos recomiendan viajar a China en este momento.", "bt_pert_es": "Many governments recommend traveling to China at this time.", "questions": "[\"What do many governments recommend against?\", \"What is the recommended action regarding travel?\", \"To which country is travel recommended against?\", \"Why is travel to China recommended against?\"]", "answers": "[\"Traveling to China\", \"Traveling to China\", \"China\", \"None provided\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2343", "en": "People who have traveled to Hubei face particularly severe restrictions.", "es": "Las personas que han viajado a Hubei enfrentan restricciones particularmente estrictas.", "perturbation": "alteration", "pert_es": "Las personas que han viajado a Hubei enfrentan restricciones particularmente flexibles.", "bt_pert_es": "People who have traveled to Hubei face particularly loose restrictions.", "questions": "[\"What restrictions do people who have traveled to Hubei face?\", \"Why do people who have traveled to Hubei face particularly severe restrictions?\", \"What is the nature of the restrictions faced by travelers from Hubei?\", \"What does 'particularly severe restrictions' imply?\"]", "answers": "[\"Loose restrictions\", \"The sentence does not provide a reason for why people who have traveled to Hubei face particularly loose restrictions\", \"The restrictions are described as loose\", \"The term 'particularly loose restrictions' implies that the restrictions are not strict or tight\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 68.22854442900892, "bleu": 49.99999999999999}, {"f1": 0.3333333333333333, "em": false, "chrf": 44.67019229863865, "bleu": 13.445273575332964}, {"f1": 0.25, "em": false, "chrf": 59.004684008162, "bleu": 8.116697886877475}, {"f1": 0.3636363636363637, "em": false, "chrf": 46.751709878267036, "bleu": 7.347053125977879}], "avg_f1": 0.36174242424242425, "avg_em": 0.0, "avg_chrf": 54.66378265351915, "avg_bleu": 19.72725614704708}
{"id": "Wikivoyage_1:2344", "en": "Examples of restrictions that you may encounter in some parts of China (this is not an exhaustive list):", "es": "Ejemplos de las restricciones que puede encontrar en algunas partes de China (esta lista no es exhaustiva):", "perturbation": "alteration", "pert_es": "Ejemplos de las libertades que puede encontrar en algunas partes de China (esta lista no es exhaustiva):", "bt_pert_es": "Examples of the freedoms you can find in some parts of China (this list is not exhaustive):", "questions": "[\"What examples of restrictions may you encounter in some parts of China?\", \"Is the list of restrictions exhaustive?\", \"What types of restrictions are mentioned in the sentence?\"]", "answers": "[\"Freedoms\", \"No\", \"Freedoms\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.8699101249747923, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 5.952380952380952, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 36.274097025785245, "avg_bleu": 33.33333333333335}
{"id": "Wikivoyage_1:2345", "en": "14-day quarantine, self-quarantine, or COVID-19 test upon arrival from other parts of China or from other countries, at your expense", "es": "cuarentena de 14 días, cuarentena voluntaria o prueba de COVID-19 al llegar desde otras partes de China o desde otros países, el costo de lo cual corre por su cuenta", "perturbation": "alteration", "pert_es": "exención de 14 días, cuarentena voluntaria o prueba de COVID-19 al llegar desde otras partes de China o desde otros países, el costo de lo cual corre por su cuenta", "bt_pert_es": "14-day exemption, voluntary quarantine or COVID-19 testing upon arrival from other parts of China or other countries, the cost of which is at your own expense", "questions": "[\"What are the options for entry from other parts of China or other countries?\", \"Is quarantine required upon arrival from other parts of China or other countries?\", \"What is the duration of quarantine?\", \"Is self-quarantine an option upon arrival?\", \"Is a COVID-19 test required upon arrival?\", \"Who is responsible for the cost of quarantine or testing?\"]", "answers": "[\"14-day exemption, voluntary quarantine, or COVID-19 testing\", \"Yes\", \"14 days\", \"Yes\", \"Yes\", \"You\"]", "scores": [{"f1": 0.6153846153846153, "em": false, "chrf": 63.8641599738259, "bleu": 15.619699684601283}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9358974358974358, "avg_em": 0.8333333333333334, "avg_chrf": 93.97735999563764, "avg_bleu": 85.93661661410026}
{"id": "Wikivoyage_1:2348", "en": "requirement to wear a face mask in public", "es": "requisito de usar una mascarilla en público", "perturbation": "alteration", "pert_es": "prohibición de usar una mascarilla en público", "bt_pert_es": "ban on wearing a mask in public", "questions": "[\"What is the requirement in public?\", \"What does the requirement involve?\", \"What is the purpose of wearing a face mask in public?\"]", "answers": "[\"No mask requirement\", \"Not wearing a mask\", \"To protect public health\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 18.11735669961843, "bleu": 19.716118825581447}, {"f1": 0.3333333333333333, "em": false, "chrf": 39.172983210750836, "bleu": 27.516060407455225}, {"f1": 0.22222222222222224, "em": false, "chrf": 13.185646630794695, "bleu": 12.44023474812678}], "avg_f1": 0.2804232804232804, "avg_em": 0.0, "avg_chrf": 23.49199551372132, "avg_bleu": 19.89080466038782}
{"id": "Wikivoyage_1:2350", "en": "shops only accept mobile payments, not cash", "es": "aceptación de pagos móviles únicamente, no en efectivo, por parte de las tiendas", "perturbation": "alteration", "pert_es": "aceptación de pagos en efectivo únicamente, no móviles, por parte de las tiendas", "bt_pert_es": "acceptance of cash only, non-mobile payments by stores", "questions": "[\"What payment methods do shops accept?\", \"Do shops accept cash?\", \"What type of payments are not accepted by shops?\", \"What payment method is preferred by shops?\"]", "answers": "[\"Cash only\", \"Yes\", \"Mobile payments\", \"Cash\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.8125, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.333333333333332, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.166666666666666, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 5.078125, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2354", "en": "access in and out of a town, village, or city completely blocked", "es": "bloqueo del ingreso o la salida de ciertos pueblos, aldeas o ciudades", "perturbation": "alteration", "pert_es": "apertura del ingreso o la salida de ciertos pueblos, aldeas o ciudades", "bt_pert_es": "opening entry to or exit from certain towns, villages or cities", "questions": "[\"What happens to access in and out of a town, village, or city when it is completely blocked?\", \"What does 'completely blocked' mean in this context?\", \"What is blocked when access to a town, village, or city is completely blocked?\"]", "answers": "[\"Access to and from a town, village, or city is prevented\", \"It means that no entry or exit is allowed\", \"Access to and from a town, village, or city\"]", "scores": [{"f1": 0.14285714285714288, "em": false, "chrf": 13.887410183430452, "bleu": 4.196114906296549}, {"f1": 0.19999999999999998, "em": false, "chrf": 15.269312217887041, "bleu": 4.540013809283726}, {"f1": 0.7058823529411765, "em": false, "chrf": 64.62721619658143, "bleu": 33.76459109063278}], "avg_f1": 0.34957983193277314, "avg_em": 0.0, "avg_chrf": 31.261312865966307, "avg_bleu": 14.166906602071018}
{"id": "Wikivoyage_1:2355", "en": "non-resident visitors prohibited from entering apartment complexes", "es": "prohibición de ingreso a complejos de apartamentos a las visitas que no residan en ellos", "perturbation": "alteration", "pert_es": "permiso de ingreso a complejos de apartamentos a las visitas que no residan en ellos", "bt_pert_es": "permission to enter apartment complexes for visitors who do not reside there", "questions": "[\"What is prohibited for non-resident visitors?\", \"What type of visitors are prohibited from entering apartment complexes?\", \"What are apartment complexes restricted from allowing entry to?\"]", "answers": "[\"Permission to enter\", \"Non-resident visitors\", \"Non-resident visitors\"]", "scores": [{"f1": 0, "em": false, "chrf": 15.584340552496931, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 71.86144685083231, "avg_bleu": 66.6666666666667}
{"id": "Wikivoyage_1:2357", "en": "businesses, activities, and attractions closed", "es": "cierre de negocios, transacciones y atracciones", "perturbation": "alteration", "pert_es": "apertura de negocios, transacciones y atracciones", "bt_pert_es": "business opening, transactions and attractions", "questions": "[\"What closed?\", \"What types of entities closed?\"]", "answers": "[\"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.532247765006386, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.532247765006386, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 4.532247765006386, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2359", "en": "restaurants (if they are even open) require a minimum distance between customers", "es": "obligación de mantener una distancia mínima entre los clientes en restaurantes (si es que hay alguno abierto)", "perturbation": "alteration", "pert_es": "obligación de reducir una distancia máxima entre los clientes en restaurantes (si es que hay alguno abierto)", "bt_pert_es": "obligation to reduce a maximum distance between customers in restaurants (if any are open)", "questions": "[\"What requirement do restaurants have if they are open?\", \"What is the minimum distance required between customers in restaurants?\", \"Are restaurants required to have a minimum distance between customers?\", \"What condition must be met for restaurants to operate?\", \"What is the rule regarding customer distance in restaurants?\"]", "answers": "[\"To reduce a maximum distance between customers\", \"The maximum distance\", \"Yes\", \"To have customers at a reduced maximum distance\", \"Reduce a maximum distance between customers\"]", "scores": [{"f1": 0.5454545454545454, "em": false, "chrf": 82.9714813325682, "bleu": 30.213753973567677}, {"f1": 0.25, "em": false, "chrf": 36.467036522565834, "bleu": 14.127216461522432}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 5.555555555555555, "bleu": 0.0}, {"f1": 0.6, "em": false, "chrf": 84.06098080115089, "bleu": 39.76353643835254}], "avg_f1": 0.4790909090909091, "avg_em": 0.2, "avg_chrf": 61.81101084236809, "avg_bleu": 36.82090137468854}
{"id": "Wikivoyage_1:2361", "en": "As of mid-March 2020, Europe is the epicenter of the epidemic, and many European countries have closed their borders to international travel - only border commuters and freight are allowed to cross.", "es": "Desde mediados de marzo de 2020, Europa es el epicentro de la epidemia y muchos países europeos han cerrado sus fronteras y no permiten el viaje internacional; solo se les permite cruzar la frontera a los trabajadores fronterizos y a los transportes de carga de mercancías.", "perturbation": "alteration", "pert_es": "Desde mediados de marzo de 2020, Europa no es el epicentro de la epidemia y muchos países europeos han abierto sus fronteras y permiten el viaje internacional; solo se les prohíbe cruzar la frontera a los trabajadores fronterizos y a los transportes de carga de mercancías.", "bt_pert_es": "Since mid-March 2020, Europe is not the epicenter of the epidemic and many European countries have opened their borders and allowed international travel; Only border workers and freight transporters are prohibited from crossing the border.", "questions": "[\"What was the situation in Europe as of mid-March 2020?\", \"Where was the epicenter of the epidemic as of mid-March 2020?\", \"Which European countries closed their borders to international travel?\", \"What types of people are allowed to cross borders in Europe?\", \"What restrictions were imposed on international travel in Europe?\"]", "answers": "[\"Europe is not the epicenter of the epidemic and many European countries have opened their borders and allowed international travel\", \"Europe\", \"None\", \"Border workers and freight transporters\", \"Only border workers and freight transporters are prohibited from crossing the border\"]", "scores": [{"f1": 0.7441860465116279, "em": false, "chrf": 65.8061770309778, "bleu": 34.27163657253173}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 4.261363636363636, "bleu": 0.0}, {"f1": 0.6666666666666665, "em": false, "chrf": 59.685495551828005, "bleu": 23.643540225079395}, {"f1": 0.30769230769230765, "em": false, "chrf": 36.46708279320131, "bleu": 6.196349981371174}], "avg_f1": 0.5437090041741204, "avg_em": 0.2, "avg_chrf": 53.244023802474146, "avg_bleu": 32.82230535579647}
{"id": "Wikivoyage_1:2362", "en": "Also businesses other than food stores and pharmacies are closed, and public transport has been reduced or stopped.", "es": "Además, se han cerrado los negocios que no sean negocios de venta de alimentos o farmacias y se ha reducido o detenido la circulación del transporte público.", "perturbation": "alteration", "pert_es": "Además, se han abierto los negocios que no sean negocios de venta de alimentos o farmacias y se ha aumentado o facilitado la circulación del transporte público.", "bt_pert_es": "In addition, businesses other than food sales or pharmacies have opened and the circulation of public transportation has been increased or facilitated.", "questions": "[\"What types of businesses are closed besides food stores and pharmacies?\", \"What has been done to public transport?\", \"Are all businesses closed?\", \"What specific changes have been made to public transport?\"]", "answers": "[\"None specified\", \"Increased or facilitated\", \"No\", \"Increased or facilitated\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.906743755583942, "bleu": 0.0}, {"f1": 0.3333333333333333, "em": false, "chrf": 17.172959719734916, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3333333333333333, "em": false, "chrf": 17.172959719734916, "bleu": 27.516060407455225}], "avg_f1": 0.41666666666666663, "avg_em": 0.25, "avg_chrf": 35.56316579876344, "avg_bleu": 38.75803020372762}
{"id": "Wikivoyage_1:2365", "en": "COVID-19 is prevalent also in North America.", "es": "La COVID-19 también es prevalente en América del Norte.", "perturbation": "alteration", "pert_es": "La COVID-19 también es poco prevalente en América del Norte.", "bt_pert_es": "COVID-19 is also low prevalent in North America.", "questions": "[\"Where is COVID-19 prevalent?\", \"What region is mentioned in the sentence?\", \"Is COVID-19 present in North America?\"]", "answers": "[\"North America\", \"North America\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 66.66666666666667, "avg_bleu": 66.6666666666667}
{"id": "Wikivoyage_1:2366", "en": "The borders between Canada, the U.S., and Mexico are closed to non-essential travel, and in many areas bans on big gatherings are in effect (this means places like restaurants are closed, and events are canceled).", "es": "Las fronteras entre Canadá, EE. UU. y México se han cerrado para el viaje no esencial y, en muchas áreas, se han prohibido las reuniones masivas (esto significa que ciertos lugares, como los restaurantes, están cerrados y los eventos se han cancelado).", "perturbation": "alteration", "pert_es": "Las fronteras entre Canadá, EE. UU. y México se han abierto para el viaje no esencial y, en muchas áreas, se han permitido las reuniones masivas (esto significa que ciertos lugares, como los restaurantes, están abiertos y los eventos se han programado).", "bt_pert_es": "The borders between Canada, the US and Mexico have opened to non-essential travel and, in many areas, mass gatherings have been allowed (this means certain places, such as restaurants, are open and events have been scheduled).", "questions": "[\"What borders are closed to non-essential travel?\", \"Which countries have closed borders to non-essential travel?\", \"What type of travel is restricted?\", \"What restrictions are in place regarding big gatherings?\", \"What specific places are closed due to the bans on big gatherings?\", \"What events are canceled due to the bans on big gatherings?\"]", "answers": "[\"None\", \"None\", \"Non-essential travel\", \"Mass gatherings have been allowed\", \"Restaurants are open\", \"Events have been scheduled\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.678571428571429, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.16666666666666666, "em": false, "chrf": 32.22034058646906, "bleu": 7.160476144948854}, {"f1": 0.5, "em": false, "chrf": 85.58206685524561, "bleu": 27.516060407455225}, {"f1": 0.4, "em": false, "chrf": 49.681771337756494, "bleu": 15.97357760615681}], "avg_f1": 0.3444444444444445, "avg_em": 0.16666666666666666, "avg_chrf": 45.89518059022932, "avg_bleu": 25.108352359760158}
{"id": "Wikivoyage_1:2372", "en": "On the other hand, the good news is that many flights are cheaper than usual due to decreased demand, and there's a decent chance you'll get an empty seat next to you.", "es": "Por otra parte, la buena noticia es que muchos vuelos son mucho más baratos que antes debido a la reducción de la demanda y es muy probable que el asiento junto al suyo esté vacío.", "perturbation": "alteration", "pert_es": "Por otra parte, la mala noticia es que muchos vuelos son mucho más caros que antes debido al aumento de la demanda y es muy improbable que el asiento junto al suyo esté vacío.", "bt_pert_es": "On the other hand, the bad news is that many flights are much more expensive than before due to increased demand and it is highly unlikely that the seat next to you will be empty.", "questions": "[\"What is the good news mentioned in the sentence?\", \"Why are many flights cheaper than usual?\", \"What is the reason for decreased flight prices?\", \"What is the chance of getting an empty seat next to you?\", \"What factor contributes to the availability of empty seats?\"]", "answers": "[\"None mentioned\", \"Increased demand\", \"Increased demand\", \"Highly unlikely\", \"Increased demand\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.105018918938598, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 83.69130869130869, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 83.69130869130869, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 3.787878787878788, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 83.69130869130869, "bleu": 49.99999999999999}], "avg_f1": 0.3, "avg_em": 0.0, "avg_chrf": 51.993364756148694, "avg_bleu": 29.999999999999993}
{"id": "Wikivoyage_1:2376", "en": "This is a real concern if you're trying to get out of an affected area.", "es": "Esto puede ser un verdadero problema si está intentando salir de un área afectada.", "perturbation": "alteration", "pert_es": "Esto puede ser un falso problema si está intentando salir de un área afectada.", "bt_pert_es": "This can be a false problem if you are trying to leave an affected area.", "questions": "[\"What is a real concern when trying to get out of an affected area?\", \"Why is it a concern to get out of an affected area?\"]", "answers": "[\"A false problem\", \"Because it might not be a real issue, leading to incorrect assumptions or actions\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.310344827586207, "bleu": 0.0}, {"f1": 0.33333333333333337, "em": false, "chrf": 36.538522044747644, "bleu": 6.837203339116283}], "avg_f1": 0.16666666666666669, "avg_em": 0.0, "avg_chrf": 20.424433436166925, "avg_bleu": 3.4186016695581416}
{"id": "Wikivoyage_1:2377", "en": "For instance, most aggregators are not selling tickets from China to the United States (presumably to avoid falling afoul of restrictions and being on the hook for a passenger's flight out).", "es": "Por ejemplo, la mayoría de los agregadores turísticos no está vendiendo boletos de China a los Estados Unidos (presuntamente para evitar problemas a causa de las restricciones y la obligación de reembolsarle al pasajero un viaje de salida).", "perturbation": "alteration", "pert_es": "Por ejemplo, la mayoría de los agregadores turísticos está vendiendo boletos de China a los Estados Unidos (presuntamente para evitar problemas a causa de las restricciones y la obligación de reembolsarle al pasajero un viaje de salida).", "bt_pert_es": "For example, most travel aggregators are selling tickets from China to the United States (presumably to avoid problems due to restrictions and the obligation to reimburse the passenger for an outbound trip).", "questions": "[\"What is an example given in the sentence?\", \"Why might aggregators not be selling tickets from China to the United States?\", \"What restrictions are likely being avoided by aggregators?\", \"What responsibility might aggregators face if they sell tickets from China to the United States?\", \"What is the likely reason for the absence of ticket sales between China and the United States?\"]", "answers": "[\"Most travel aggregators are selling tickets from China to the United States\", \"To avoid problems due to restrictions and the obligation to reimburse the passenger for an outbound trip\", \"Restrictions\", \"The obligation to reimburse the passenger for an outbound trip\", \"To avoid problems due to restrictions and the obligation to reimburse the passenger for an outbound trip\"]", "scores": [{"f1": 0.9090909090909091, "em": false, "chrf": 85.06574914105981, "bleu": 64.84115071397645}, {"f1": 0.35714285714285715, "em": false, "chrf": 43.46596627690789, "bleu": 8.493098745313143}, {"f1": 0.33333333333333337, "em": false, "chrf": 32.0081886045792, "bleu": 1.8315638888734187}, {"f1": 0.13333333333333333, "em": false, "chrf": 34.22318576208873, "bleu": 5.522397783539471}, {"f1": 0.35714285714285715, "em": false, "chrf": 43.46596627690789, "bleu": 8.493098745313143}], "avg_f1": 0.418008658008658, "avg_em": 0.0, "avg_chrf": 47.64581121230871, "avg_bleu": 17.836261975403126}
{"id": "Wikivoyage_1:2378", "en": "To buy a ticket for an itinerary like this, you may have to contact the airline or use a lesser-known aggregator.", "es": "Para comprar un boleto para este tipo de itinerario, es posible que deba contactar a la aerolínea o usar un agregador menos conocido.", "perturbation": "alteration", "pert_es": "Para comprar un boleto para este tipo de itinerario, es posible que no deba contactar a la aerolínea o usar un agregador muy conocido.", "bt_pert_es": "To purchase a ticket for this type of itinerary, you may not need to contact the airline or use a well-known aggregator.", "questions": "[\"How can you buy a ticket for an itinerary like this?\", \"Do you need to contact the airline to buy a ticket for this itinerary?\", \"Can you use a lesser-known aggregator to buy a ticket for this itinerary?\", \"What are the options for purchasing a ticket for this itinerary?\"]", "answers": "[\"By not contacting the airline or using a well-known aggregator\", \"No\", \"No\", \"Not contacting the airline or using a well-known aggregator\"]", "scores": [{"f1": 0.7999999999999999, "em": false, "chrf": 77.65445527777499, "bleu": 38.260294162784476}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.6153846153846153, "em": false, "chrf": 77.82399447354688, "bleu": 26.269098944241588}], "avg_f1": 0.3538461538461538, "avg_em": 0.0, "avg_chrf": 38.86961243783047, "avg_bleu": 16.132348276756517}
{"id": "Wikivoyage_1:2385", "en": "In uncertain times, plans can change.", "es": "En tiempos inciertos, los planes pueden cambiar.", "perturbation": "alteration", "pert_es": "En tiempos ciertos, los planes pueden cambiar.", "bt_pert_es": "At certain times, plans can change.", "questions": "[\"What happens in uncertain times?\", \"What can change in uncertain times?\", \"What is affected during uncertain times?\"]", "answers": "[\"Plans can change\", \"Plans\", \"Plans\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2386", "en": "Many embassies and consulates have evacuated nonessential staff, and some have shut down operations completely.", "es": "Muchas embajadas y consulados han evacuado al personal no esencial y algunas han detenido sus operaciones completamente.", "perturbation": "alteration", "pert_es": "Muchas embajadas y consulados han reforzado al personal no esencial y algunas han aumentado sus operaciones completamente.", "bt_pert_es": "Many embassies and consulates have reinforced non-essential staff and some have increased their operations entirely.", "questions": "[\"What has been done by many embassies and consulates regarding nonessential staff?\", \"What action have some embassies and consulates taken regarding operations?\", \"Why have embassies and consulates evacuated nonessential staff?\", \"What does 'shut down operations completely' mean in this context?\"]", "answers": "[\"Reinforced non-essential staff\", \"Increased their operations entirely\", \"Not specified\", \"Stopped all operations\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 70.09730412300306, "bleu": 55.03212081491043}, {"f1": 0.25, "em": false, "chrf": 35.82193544185901, "bleu": 15.97357760615681}, {"f1": 0, "em": false, "chrf": 23.777329139856505, "bleu": 0.0}, {"f1": 0.13333333333333333, "em": false, "chrf": 21.57947715697404, "bleu": 1.3699439807202476}], "avg_f1": 0.2625, "avg_em": 0.0, "avg_chrf": 37.81901146542315, "avg_bleu": 18.093910600446872}
{"id": "Wikivoyage_1:2389", "en": "At the very least they can keep you informed about the local situation and notify you about recently introduced travel requirements and restrictions.", "es": "Como mínimo, pueden mantenerlo informado respecto de la situación local y notificarle los requisitos y las restricciones de viaje que se hayan aplicado en forma reciente.", "perturbation": "alteration", "pert_es": "Como mínimo, pueden mantenerlo desinformado respecto de la situación local y notificarle los requisitos y las restricciones de viaje que se hayan aplicado en forma reciente.", "bt_pert_es": "At the very least, they can keep you uninformed about the local situation and notify you of any travel requirements and restrictions that have recently been implemented.", "questions": "[\"What can they keep you informed about?\", \"What do they notify you about?\", \"What is the local situation?\", \"What travel requirements and restrictions are mentioned?\"]", "answers": "[\"The local situation\", \"Travel requirements and restrictions that have recently been implemented\", \"The local situation\", \"Travel requirements and restrictions that have recently been implemented\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 94.9566147882592, "bleu": 55.03212081491043}, {"f1": 0.5333333333333333, "em": false, "chrf": 70.84608774805275, "bleu": 19.070828081828378}, {"f1": 0, "em": false, "chrf": 10.256410256410255, "bleu": 0.0}, {"f1": 0.5333333333333333, "em": false, "chrf": 70.84608774805275, "bleu": 19.070828081828378}], "avg_f1": 0.4666666666666667, "avg_em": 0.0, "avg_chrf": 61.72630013519374, "avg_bleu": 23.293444244641798}
{"id": "Wikivoyage_1:2390", "en": "Ordinary consular services such as visa and passport processing may be suspended or restricted to urgent need, depending on the location and the consulate.", "es": "Los servicios consulares habituales, como el procesamiento de visas y pasaportes, pueden verse suspendidos o restringidos a necesidades urgentes, según la ubicación y el consulado.", "perturbation": "alteration", "pert_es": "Los servicios consulares habituales, como el procesamiento de visas y pasaportes, no pueden verse suspendidos o restringidos a necesidades urgentes, según la ubicación y el consulado.", "bt_pert_es": "Regular consular services, such as visa and passport processing, may not be suspended or restricted to urgent needs, depending on the location and consulate.", "questions": "[\"What ordinary consular services may be suspended or restricted?\", \"What determines whether consular services are suspended or restricted?\", \"Which services are mentioned in the sentence?\", \"What is the basis for suspending or restricting consular services?\", \"What is the role of location and the consulate in consular service restrictions?\"]", "answers": "[\"None\", \"The location and consulate\", \"Visa and passport processing\", \"The location and consulate\", \"The role of location and the consulate is that they determine whether consular services are suspended or restricted\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.6057692307692304, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8275862068965517, "em": false, "chrf": 90.2599317943287, "bleu": 50.7196093945688}], "avg_f1": 0.7655172413793103, "avg_em": 0.6, "avg_chrf": 78.77314020501959, "avg_bleu": 70.14392187891379}
{"id": "Wikivoyage_1:2391", "en": "Although some people call the disease \"Wuhan pneumonia\" (武汉(漢)肺炎/武肺), \"Wuhan disease\", or \"Chinese virus\", the use of these terms is considered racist in China and by many people of Chinese origin.", "es": "Aunque algunas personas llaman a esta enfermedad la \"neumonía de Wuhan\" (武汉(漢)肺炎/武肺), la \"enfermedad de Wuhan\" o el \"virus chino\", el uso de estos términos se considera racista en China y por parte de muchas personas de origen chino.", "perturbation": "alteration", "pert_es": "Aunque algunas personas llaman a esta enfermedad la \"neumonía de Wuhan\" (武汉(漢)肺炎/武肺), la \"enfermedad de Wuhan\" o el \"virus benéfico\", el uso de estos términos se considera racista en China y por parte de muchas personas de origen chino.", "bt_pert_es": "Although some people call this disease \"Wuhan pneumonia\" (武汉(漢)肺炎/武肺), \"Wuhan disease\" or \"beneficial virus\", the use of these terms is considered racist in China and by many people of Chinese origin.", "questions": "[\"What alternative names are used for the disease?\", \"Why is the use of these alternative names considered racist?\", \"What is the official or preferred term for the disease?\", \"Who opposes the use of these terms?\", \"What is the concern regarding the use of terms like 'Wuhan pneumonia' or 'Chinese virus'?\" ]", "answers": "[\"Wuhan pneumonia\", \"The use of these terms is considered racist in China and by many people of Chinese origin\", \"None provided\", \"People in China and many people of Chinese origin\", \"The use of such terms can be seen as racist and may perpetuate stigma and discrimination against people of Chinese origin\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8750000000000001, "em": false, "chrf": 78.11506589198991, "bleu": 24.274588585366175}, {"f1": 0.9047619047619048, "em": false, "chrf": 87.48056058409071, "bleu": 81.37489370974959}], "avg_f1": 0.955952380952381, "avg_em": 0.6, "avg_chrf": 93.11912529521612, "avg_bleu": 81.12989645902317}
{"id": "Wikivoyage_1:2392", "en": "It is still common to refer the disease as \"Wuhan pneumonia\" or \"Chinese virus\" in places like Hong Kong and Taiwan.", "es": "En lugares como Hong Kong o Taiwán sigue siendo común referirse a la enfermedad como \"neumonía de Wuhan\" o \"virus Chino\".", "perturbation": "alteration", "pert_es": "En lugares como Hong Kong o Taiwán sigue siendo común referirse a la enfermedad como \"neumonía de Europa\" o \"virus Chino\".", "bt_pert_es": "In places like Hong Kong or Taiwan, it is still common to refer to the disease as \"European pneumonia\" or \"Chinese virus.\"", "questions": "[\"Where is 'Wuhan pneumonia' or 'Chinese virus' still commonly referred to?\", \"What are the alternative names for the disease mentioned in the sentence?\", \"In which regions is the disease referred to as 'Wuhan pneumonia' or 'Chinese virus'?\", \"What is the disease being referred to in the sentence?\"]", "answers": "[\"Hong Kong or Taiwan\", \"European pneumonia or Chinese virus\", \"Hong Kong or Taiwan\", \"the disease\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 60.93307441785183, "bleu": 35.35533905932737}, {"f1": 0.8000000000000002, "em": false, "chrf": 86.73090089888376, "bleu": 66.87403049764218}, {"f1": 0.75, "em": false, "chrf": 60.93307441785183, "bleu": 35.35533905932737}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8250000000000001, "avg_em": 0.25, "avg_chrf": 77.14926243364685, "avg_bleu": 59.39617715407424}
{"id": "Wikivoyage_1:2397", "en": "There has been a worldwide spike in racist incidents targeting people of East Asian origin, including in major cities such as New York, London and San Francisco.", "es": "Ha habido un gran aumento mundial de incidentes racistas dirigidos a personas de Asia Oriental, incluso en ciudades importantes, como Nueva York, Londres o San Francisco.", "perturbation": "alteration", "pert_es": "Ha habido un gran descenso mundial de incidentes racistas dirigidos a personas de Asia Oriental, incluso en ciudades importantes, como Nueva York, Londres o San Francisco.", "bt_pert_es": "There has been a large global decline in racist incidents directed at East Asian people, including in major cities such as New York, London and San Francisco.", "questions": "[\"What has been observed worldwide?\", \"Where have racist incidents targeting people of East Asian origin been reported?\", \"What type of incidents are targeting people of East Asian origin?\", \"Which major cities have experienced these incidents?\"]", "answers": "[\"A large global decline in racist incidents directed at East Asian people\", \"East Asian people\", \"Racist incidents\", \"New York, London, and San Francisco\"]", "scores": [{"f1": 0.6086956521739131, "em": false, "chrf": 53.22157936632498, "bleu": 17.242221289766626}, {"f1": 0, "em": false, "chrf": 5.150808351055314, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6521739130434783, "avg_em": 0.5, "avg_chrf": 64.59309692934508, "avg_bleu": 54.31055532244168}
{"id": "Wikivoyage_1:2398", "en": "In Hong Kong, Sinophobia, which was already high to begin with, has intensified as a result of the pandemic, with the result that many shops and restaurants are now denying service to mainland Chinese customers and banning Mandarin speakers from their premises (with the exception of Taiwanese).", "es": "En Hong Kong, la sinofobia, que ya era grave desde antes, se ha intensificado como resultado de la pandemia, lo que ha provocado que muchos negocios y restaurantes se nieguen a servir a clientes de China continental y echen de sus instalaciones a quienes hablen mandarín (con la excepción del taiwanés).", "perturbation": "alteration", "pert_es": "En Hong Kong, la sinofilia, que ya era grave desde antes, se ha intensificado como resultado de la pandemia, lo que ha provocado que muchos negocios y restaurantes se nieguen a servir a clientes de China continental y echen de sus instalaciones a quienes hablen mandarín (con la excepción del taiwanés).", "bt_pert_es": "In Hong Kong, already serious Sinophilia has intensified as a result of the pandemic, causing many businesses and restaurants to refuse to serve mainland Chinese customers and kick out Mandarin speakers (with the exception of Taiwanese).", "questions": "[\"What is Sinophobia?\", \"Why has Sinophobia intensified in Hong Kong?\", \"What is the result of the intensified Sinophobia?\", \"Which businesses are denying service to mainland Chinese customers?\", \"Are there any exceptions to the ban on Mandarin speakers?\", \"Who is exempt from the ban on Mandarin speakers?\"]", "answers": "[\"Sinophilia\", \"As a result of the pandemic\", \"Many businesses and restaurants have refused to serve mainland Chinese customers and kicked out Mandarin speakers\", \"Many businesses and restaurants\", \"Yes\", \"Taiwanese\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.791233928430573, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5714285714285714, "em": false, "chrf": 55.24335911270679, "bleu": 18.13423031516851}, {"f1": 0.75, "em": false, "chrf": 65.8305945601756, "bleu": 35.35533905932737}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7202380952380952, "avg_em": 0.5, "avg_chrf": 70.97753126688549, "avg_bleu": 58.91492822908267}
{"id": "Wikivoyage_1:2399", "en": "Levels of xenophobia have also risen in East Asia, with some restaurants and other businesses in Japan and China refusing service to foreign customers.", "es": "Los niveles de xenofobia también han aumentado en Asia Oriental y algunos restaurantes y otros negocios en Japón y China se niegan a servir a clientes extranjeros.", "perturbation": "alteration", "pert_es": "Los niveles de xenofilia también han aumentado en Asia Oriental y algunos restaurantes y otros negocios en Japón y China se apresuran a servir a clientes extranjeros.", "bt_pert_es": "Levels of xenophilia have also increased in East Asia, with some restaurants and other businesses in Japan and China rushing to serve foreign customers.", "questions": "[\"What has risen in East Asia?\", \"What specific actions have restaurants and businesses in Japan and China taken?\", \"Which countries in East Asia are mentioned in the sentence?\", \"What is xenophobia?\", \"What is the impact of xenophobia on businesses in Japan and China?\"]", "answers": "[\"Levels of xenophilia\", \"Rushing to serve foreign customers\", \"Japan and China\", \"Not mentioned in the sentence\", \"Not mentioned in the sentence\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 76.70575067633892, "bleu": 55.03212081491043}, {"f1": 0.6, "em": false, "chrf": 58.116018654834036, "bleu": 23.643540225079395}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 8.938168370042447, "bleu": 0.0}, {"f1": 0.13333333333333333, "em": false, "chrf": 8.500769449172264, "bleu": 2.7757915716335906}], "avg_f1": 0.48, "avg_em": 0.2, "avg_chrf": 50.45214143007753, "avg_bleu": 36.290290522324696}
{"id": "Wikivoyage_1:2400", "en": "In China, there have been incidents of foreigners being refused rooms by hotel staff, and foreign residents, particularly black people, being kicked out of their apartments on short notice by their landlords.", "es": "En China, ha habido incidentes en los que el personal de algunos hoteles se ha negado a darles una habitación a extranjeros y en los que algunos propietarios de apartamentos han echado de los apartamentos con poco tiempo de aviso a sus inquilinos extranjeros, en especial a inquilinos negros.", "perturbation": "alteration", "pert_es": "En China, ha habido incidentes en los que el personal de algunos hoteles se ha ofrecido a darles una habitación a extranjeros y en los que algunos propietarios de apartamentos han acogido en los apartamentos con mucho tiempo de aviso a sus inquilinos extranjeros, en especial a inquilinos blancos.", "bt_pert_es": "In China, there have been incidents where staff at some hotels have offered to give foreigners a room and where some apartment owners have taken in their apartments at long notice to their foreign tenants, especially white tenants.", "questions": "[\"What incidents have occurred in China regarding foreigners and hotels?\", \"Why were foreigners refused rooms by hotel staff?\", \"What happened to foreign residents, particularly black people, in China?\", \"Why were foreign residents kicked out of their apartments?\", \"What is the specific group mentioned in the context of being kicked out of apartments?\"]", "answers": "[\"Staff at some hotels have offered to give foreigners a room\", \"Not specified\", \"Not mentioned\", \"Not specified\", \"black people\"]", "scores": [{"f1": 0, "em": false, "chrf": 39.07652571229409, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.982040044685058, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.044069402046214, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 7.625718671141287, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 87.72426647426647, "bleu": 49.99999999999999}], "avg_f1": 0.1, "avg_em": 0.0, "avg_chrf": 29.890524060886623, "avg_bleu": 9.999999999999998}
{"id": "Wikivoyage_1:2401", "en": "Sources for further information on the coronavirus outbreak include:", "es": "Estas son algunas fuentes de información adicional sobre el coronavirus:", "perturbation": "alteration", "pert_es": "Estas son algunas fuentes de información limitada sobre el coronavirus:", "bt_pert_es": "These are some sources of limited information about the coronavirus:", "questions": "[\"What sources are available for further information on the coronavirus outbreak?\"]", "answers": "[\"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.51665061787835, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.51665061787835, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2402", "en": "The US government Centers for Disease Control and Prevention", "es": "Los Centros para el Control y la Prevención de Enfermedades del gobierno de EE. UU.", "perturbation": "alteration", "pert_es": "Los Centros para la Promoción y el Fomento de Enfermedades del gobierno de EE. UU.", "bt_pert_es": "The US government's Centers for Disease Control and Prevention.", "questions": "[\"What is the US government agency mentioned in the sentence?\", \"What is the role of the Centers for Disease Control and Prevention?\", \"What is the full name of the agency mentioned?\"]", "answers": "[\"Centers for Disease Control and Prevention\", \"The role is not specified in the sentence\", \"Centers for Disease Control and Prevention\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5333333333333333, "em": false, "chrf": 48.130876381525255, "bleu": 8.051153633013374}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8444444444444444, "avg_em": 0.6666666666666666, "avg_chrf": 82.71029212717508, "avg_bleu": 69.35038454433781}
{"id": "Wikivoyage_1:2403", "en": "European Centre for Disease Prevention and Control (daily updates)", "es": "Centro Europeo para la Prevención y el Control de las Enfermedades (actualizaciones diarias)", "perturbation": "alteration", "pert_es": "Centro Europeo para la Promoción y el Fomento de las Enfermedades (actualizaciones diarias)", "bt_pert_es": "European Center for Disease Promotion and Promotion (daily updates)", "questions": "[\"What is the European Centre for Disease Prevention and Control known for?\", \"What kind of updates does the European Centre for Disease Prevention and Control provide?\", \"What is the frequency of the updates from the European Centre for Disease Prevention and Control?\"]", "answers": "[\"It is known for providing daily updates\", \"Daily updates\", \"Daily\"]", "scores": [{"f1": 0, "em": false, "chrf": 14.86234573931165, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 71.62078191310388, "avg_bleu": 66.6666666666667}
{"id": "Wikivoyage_1:2404", "en": "United Kingdom government, - Foreign and Commonwealth Office advice for Travellers", "es": "Gobierno del Reino Unido - Consejos para viajeros del Ministerio de Relaciones Exteriores y de la Mancomunidad de Naciones", "perturbation": "alteration", "pert_es": "Gobierno del Reino Unido - Consejos para no viajeros del Ministerio de Relaciones Exteriores y de la Mancomunidad de Naciones", "bt_pert_es": "UK Government - Foreign and Commonwealth Office Non-Traveller Advice", "questions": "[\"What advice does the United Kingdom government's Foreign and Commonwealth Office provide for travellers?\", \"What is the purpose of the Foreign and Commonwealth Office advice for travellers?\", \"Which government department provides travel advice in the United Kingdom?\"]", "answers": "[\"Non-Traveller Advice\", \"To provide advice for non-travellers\", \"Foreign and Commonwealth Office\"]", "scores": [{"f1": 0, "em": false, "chrf": 52.273409949891935, "bleu": 0.0}, {"f1": 0.20000000000000004, "em": false, "chrf": 38.428138206349935, "bleu": 10.682175159905853}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.39999999999999997, "avg_em": 0.3333333333333333, "avg_chrf": 63.56718271874729, "avg_bleu": 36.8940583866353}
{"id": "Wikivoyage_1:2406", "en": "Partial lists of entry restrictions from IATA and The New York Times", "es": "Listas parciales de restricciones de ingreso de la Asociación Internacional de Transporte Aéreo y del New York Times", "perturbation": "alteration", "pert_es": "Listas parciales de permisos de ingreso de la Asociación Internacional de Transporte Aéreo y del New York Times", "bt_pert_es": "Partial lists of entry permits from the International Air Transport Association and the New York Times", "questions": "[\"What entry restrictions are listed in the partial lists?\", \"Which organizations provided the entry restrictions?\", \"What does the partial list of entry restrictions include?\"]", "answers": "[\"The entry permits\", \"The International Air Transport Association and the New York Times\", \"Entry permits\"]", "scores": [{"f1": 0, "em": false, "chrf": 15.750061347141795, "bleu": 0.0}, {"f1": 0.6666666666666667, "em": false, "chrf": 45.998335527613996, "bleu": 20.164945583740657}, {"f1": 0.5, "em": false, "chrf": 22.390275024088314, "bleu": 49.99999999999999}], "avg_f1": 0.3888888888888889, "avg_em": 0.0, "avg_chrf": 28.04622396628137, "avg_bleu": 23.388315194580215}
{"id": "Wikivoyage_1:2407", "en": "A variety of misinformation and conspiracy theories about the virus are being promoted online and even by some government officials, so be careful which sources you check for information.", "es": "Se están difundiendo en línea diversas teorías conspiratorias e información errónea sobre el virus, incluso por parte de algunos funcionarios gubernamentales, por lo que debe tener cuidado con las fuentes de las que obtiene información.", "perturbation": "alteration", "pert_es": "Se están difundiendo en línea diversas teorías científicas e información precisa sobre el virus, incluso por parte de algunos funcionarios gubernamentales, por lo que no debe tener cuidado con las fuentes de las que obtiene información.", "bt_pert_es": "Various scientific theories and accurate information about the virus are being spread online, including by some government officials, so you should not be careful about the sources you get information from.", "questions": "[\"What types of misinformation are being promoted online?\", \"Who is promoting conspiracy theories about the virus?\", \"What should people be careful about when checking sources for information?\", \"Where is misinformation about the virus being promoted?\", \"What role do government officials play in spreading misinformation?\"]", "answers": "[\"Scientific theories\", \"Some government officials\", \"The sources they get information from\", \"Online\", \"They are spreading misinformation about the virus\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 26.20649125241396, "bleu": 18.393972058572114}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 55.79066340602938, "bleu": 17.965205598154213}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6153846153846153, "em": false, "chrf": 39.30570625606941, "bleu": 19.43309443637607}], "avg_f1": 0.6897435897435897, "avg_em": 0.4, "avg_chrf": 64.26057218290255, "avg_bleu": 51.1584544186205}
{"id": "Wikivoyage_1:2410", "en": "If you normally watch the news twice per day then stick to this schedule and do something else, rather than having the 24-hour news on continuously.", "es": "Si normalmente ve las noticias dos veces al día, siga haciendo esto y haga otras actividades, en vez de tener encendidas las noticias en forma continua o las 24 horas del día.", "perturbation": "alteration", "pert_es": "Si normalmente no ve las noticias dos veces al día, siga haciendo esto y haga otras actividades, en vez de tener encendidas las noticias en forma continua o las 24 horas del día.", "bt_pert_es": "If you don't normally watch the news twice a day, continue doing this and do other activities, instead of having the news on continuously or 24 hours a day.", "questions": "[\"What is the recommended news watching schedule?\", \"What should you do instead of having 24-hour news on continuously?\", \"Why is it recommended to stick to a specific news schedule?\", \"What is the alternative to watching 24-hour news?\", \"How often should you normally watch the news?\"]", "answers": "[\"Twice a day\", \"Do other activities\", \"To avoid having the news on continuously or 24 hours a day\", \"Do other activities\", \"Twice a day\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 16.005946099481154, "bleu": 11.15650800742149}, {"f1": 0.3333333333333333, "em": false, "chrf": 12.055097107610239, "bleu": 27.516060407455225}, {"f1": 0.7058823529411764, "em": false, "chrf": 82.13438823088627, "bleu": 26.269098944241577}, {"f1": 0.3333333333333333, "em": false, "chrf": 12.055097107610239, "bleu": 27.516060407455225}, {"f1": 0.8, "em": false, "chrf": 38.52643170006746, "bleu": 42.88819424803536}], "avg_f1": 0.4916526610644258, "avg_em": 0.0, "avg_chrf": 32.15539204913107, "avg_bleu": 27.069184402921774}
{"id": "wiki_26:2435", "en": "b'Bat SARS-like coronavirus WIV1 (Bat SL-CoV-WIV1), also sometimes called SARS-like coronavirus WIV1, is a strain of Severe acute respiratory syndrome-related coronavirus (SARSr-CoV) isolated from Chinese rufous horseshoe bats (Rhinolophus sinicus).", "es": "El coronavirus de murciélago similar al SARS WIV1 (SL-CoV-WIV1 de murciélago), también llamado, a veces, coronavirus similar al SARS WIV1, es una cepa del coronavirus relacionado con el síndrome de dificultad respiratoria aguda (SARSr-CoV) aislado de los murciélagos de herradura rufos chinos (Rhinolophus sinicus).", "perturbation": "alteration", "pert_es": "El coronavirus de murciélago disimilar al SARS WIV1 (SL-CoV-WIV1 de murciélago), también llamado, a veces, coronavirus disimilar al SARS WIV1, es una cepa del coronavirus no relacionado con el síndrome de dificultad respiratoria aguda (SARSr-CoV) aislado de los murciélagos de herradura rufos chinos (Rhinolophus sinicus).", "bt_pert_es": "Bat coronavirus dissimilar to SARS WIV1 (bat SL-CoV-WIV1), also sometimes called SARS dissimilar coronavirus WIV1, is a strain of the non-acute respiratory distress syndrome-related coronavirus (SARSr-CoV) isolated from Chinese rufous horseshoe bats (Rhinolophus sinicus).", "questions": "[\"What is the name of the bat SARS-like coronavirus mentioned?\", \"What is another name for Bat SARS-like coronavirus WIV1?\", \"From which animals was the coronavirus isolated?\", \"What type of coronavirus is Bat SL-CoV-WIV1?\", \"What is the full name of the coronavirus strain?\", \"What is the host species of the virus?\"]", "answers": "[\"Bat coronavirus dissimilar to SARS WIV1 (bat SL-CoV-WIV1)\", \"SARS dissimilar coronavirus WIV1\", \"Chinese rufous horseshoe bats (Rhinolophus sinicus)\", \"non-acute respiratory distress syndrome-related coronavirus (SARSr-CoV)\", \"Bat SL-CoV-WIV1\", \"Chinese rufous horseshoe bats (Rhinolophus sinicus)\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 47.85132990189124, "bleu": 7.267884212102741}, {"f1": 0.5714285714285715, "em": false, "chrf": 65.9176427309674, "bleu": 31.947155212313625}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 83.33581755754244, "bleu": 32.46679154750989}, {"f1": 0.3333333333333333, "em": false, "chrf": 15.768990432703555, "bleu": 18.393972058572114}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6785714285714285, "avg_em": 0.3333333333333333, "avg_chrf": 68.81229677051745, "avg_bleu": 48.34596717174974}
{"id": "wiki_26:2436", "en": "Like all coronaviruses, virions consist of single-stranded positive-sense RNA enclosed within an envelope.", "es": "Como todos los coronavirus, los viriones se componen de ARN monocatenario positivo dentro de una envoltura.", "perturbation": "alteration", "pert_es": "Como todos los coronavirus, los viriones se componen de ADN monocatenario negativo dentro de una envoltura.", "bt_pert_es": "Like all coronaviruses, virions are composed of negative single-stranded DNA within an envelope.", "questions": "[\"What do virions consist of?\", \"What is the structure of virions?\", \"What type of RNA do virions contain?\", \"What surrounds the RNA in virions?\", \"What is common to all coronaviruses in terms of virion structure?\"]", "answers": "[\"Negative single-stranded DNA within an envelope\", \"Negative single-stranded DNA within an envelope\", \"Negative single-stranded DNA\", \"An envelope\", \"Virions are composed of negative single-stranded DNA within an envelope\"]", "scores": [{"f1": 0.5454545454545454, "em": false, "chrf": 55.06472699700985, "bleu": 19.357693493908812}, {"f1": 0.5454545454545454, "em": false, "chrf": 55.06472699700985, "bleu": 19.357693493908812}, {"f1": 0.3333333333333333, "em": false, "chrf": 53.96057450586065, "bleu": 27.516060407455225}, {"f1": 0.6666666666666666, "em": false, "chrf": 92.72100013663068, "bleu": 49.99999999999999}, {"f1": 0.4444444444444444, "em": false, "chrf": 51.37571607447351, "bleu": 11.339582221952005}], "avg_f1": 0.507070707070707, "avg_em": 0.0, "avg_chrf": 61.63734894219691, "avg_bleu": 25.51420592344497}
{"id": "wiki_26:2437", "en": "The discovery confirms that bats are the natural reservoir of SARS-CoV.", "es": "El hallazgo confirma que los murciélagos son el reservorio natural del SARS-CoV.", "perturbation": "alteration", "pert_es": "El hallazgo confirma que los murciélagos no son el reservorio natural del SARS-CoV.", "bt_pert_es": "The finding confirms that bats are not the natural reservoir of SARS-CoV.", "questions": "[\"What does the discovery confirm?\", \"What is the natural reservoir of SARS-CoV?\", \"What role do bats play in the context of SARS-CoV?\"]", "answers": "[\"That bats are not the natural reservoir of SARS-CoV\", \"SARS-CoV\", \"Bats are not the natural reservoir of SARS-CoV\"]", "scores": [{"f1": 0.9333333333333333, "em": false, "chrf": 93.1191045710571, "bleu": 50.000000000000014}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.923076923076923, "em": false, "chrf": 92.16613607054809, "bleu": 48.892302243490086}], "avg_f1": 0.6188034188034188, "avg_em": 0.0, "avg_chrf": 61.761746880535064, "avg_bleu": 32.96410074783003}
{"id": "wiki_26:2438", "en": "Phylogenetic analysis shows the possibility of direct transmission of SARS from bats to humans without the intermediary Chinese civets, as previously believed.", "es": "El análisis filogenético demuestra la posibilidad de transmisión directa de SARS de los murciélagos a los humanos sin intermediación de las civetas chinas, como se creía anteriormente.", "perturbation": "alteration", "pert_es": "El análisis filogenético demuestra la imposibilidad de transmisión directa de SARS de los murciélagos a los humanos sin intermediación de las civetas chinas, como se creía anteriormente.", "bt_pert_es": "Phylogenetic analysis demonstrates the impossibility of direct transmission of SARS from bats to humans without the intermediation of Chinese civets, as previously believed.", "questions": "[\"What does phylogenetic analysis show about SARS transmission?\", \"What was previously believed about SARS transmission?\", \"Is there direct transmission of SARS from bats to humans?\", \"What role do Chinese civets play in SARS transmission according to the previous belief?\", \"What does the phylogenetic analysis suggest about the transmission pathway of SARS?\"]", "answers": "[\"Phylogenetic analysis shows that direct transmission of SARS from bats to humans is impossible without the intermediation of Chinese civets\", \"That SARS could be directly transmitted from bats to humans\", \"No\", \"Chinese civets are considered intermediaries in the transmission pathway\", \"SARS transmission requires intermediation by Chinese civets, not direct transmission from bats to humans\"]", "scores": [{"f1": 0.7058823529411765, "em": false, "chrf": 74.13120830392981, "bleu": 41.9468515826214}, {"f1": 0.11764705882352941, "em": false, "chrf": 22.118646883863597, "bleu": 4.196114906296549}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.4444444444444445, "em": false, "chrf": 55.22728044075286, "bleu": 10.229197414177778}, {"f1": 0.6086956521739131, "em": false, "chrf": 71.10080736443437, "bleu": 30.57690288450511}], "avg_f1": 0.37533390167661274, "avg_em": 0.0, "avg_chrf": 44.515588598596125, "avg_bleu": 17.389813357520165}
{"id": "wiki_13:2489", "en": "b'COVID-19 drug development is the research process to develop a preventative vaccine or therapeutic prescription drug that would alleviate the severity of 2019-20 coronavirus disease (COVID-19).", "es": "El desarrollo de medicamentos contra la COVID-19 es el proceso de investigación con el fin de desarrollar una vacuna preventiva o un medicamento recetado terapéutico que alivie la gravedad de la enfermedad por coronavirus de 2019-2020 (COVID-19).", "perturbation": "alteration", "pert_es": "El desarrollo de medicamentos a favor de la COVID-19 es el proceso de investigación con el fin de desarrollar una vacuna preventiva o un medicamento recetado terapéutico que empeore la gravedad de la enfermedad por coronavirus de 2019-2020 (COVID-19).", "bt_pert_es": "COVID-19 drug development is the process of research to develop a preventive vaccine or therapeutic prescription drug that worsens the severity of coronavirus disease 2019-2020 (COVID-19).", "questions": "[\"What is the research process for COVID-19 drug development?\", \"What does COVID-19 drug development aim to achieve?\", \"What types of drugs are being developed for COVID-19?\", \"What is the purpose of a preventative vaccine in COVID-19 drug development?\", \"What is the purpose of a therapeutic prescription drug in COVID-19 drug development?\", \"What disease is the drug development targeting?\"]", "answers": "[\"Research to develop a preventive vaccine or therapeutic prescription drug\", \"To develop a preventive vaccine or therapeutic prescription drug that worsens the severity of coronavirus disease 2019-2020 (COVID-19)\", \"A preventive vaccine or therapeutic prescription drug\", \"To prevent coronavirus disease 2019-2020 (COVID-19)\", \"To reduce the severity of coronavirus disease 2019-2020 (COVID-19)\", \"Coronavirus disease 2019-2020 (COVID-19)\"]", "scores": [{"f1": 0.46153846153846156, "em": false, "chrf": 50.45824910528223, "bleu": 19.20461640067359}, {"f1": 0.787878787878788, "em": false, "chrf": 78.38026111658658, "bleu": 38.62242902780995}, {"f1": 0.7142857142857143, "em": false, "chrf": 81.4626300400095, "bleu": 27.77619034011791}, {"f1": 0.6, "em": false, "chrf": 45.91995881117314, "bleu": 17.965205598154213}, {"f1": 0.6153846153846154, "em": false, "chrf": 47.325270143039674, "bleu": 13.134549472120788}, {"f1": 0.5, "em": false, "chrf": 77.07437697565847, "bleu": 18.99589214128981}], "avg_f1": 0.6131812631812632, "avg_em": 0.0, "avg_chrf": 63.43679103195827, "avg_bleu": 22.61648049669438}
{"id": "wiki_13:2490", "en": "The International Clinical Trials Registry Platform of the WHO recorded 536 clinical studies to develop post-infection therapies for COVID-19 infections, with numerous established antiviral compounds for treating other infections under clinical research to be repurposed.", "es": "En la Plataforma de registros internacionales de ensayos clínicos de la OMS se registraron 536 estudios clínicos para el desarrollo de terapias posteriores al contagio, con diversos compuestos antivíricos establecidos para el tratamiento de otras infecciones bajo investigación clínica con el fin de adaptarlos para tratar las infecciones de COVID-19.", "perturbation": "alteration", "pert_es": "En la Plataforma de registros internacionales de ensayos clínicos de la OMS se registraron 536 estudios clínicos para el abandono de terapias posteriores al contagio, con diversos compuestos antivíricos establecidos para el tratamiento de otras infecciones bajo investigación clínica con el fin de adaptarlos para tratar las infecciones de COVID-19.", "bt_pert_es": "A total of 536 clinical trials for discontinuation of post-infection therapies were registered on the WHO International Clinical Trials Registry Platform, with various antiviral compounds established for the treatment of other infections under clinical investigation with the aim of adapting them to treat COVID-19 infections.", "questions": "[\"How many clinical studies were recorded by the International Clinical Trials Registry Platform of the WHO?\", \"What is the purpose of the 536 clinical studies?\", \"What type of therapies are the studies developing?\", \"What is being repurposed in the clinical research?\", \"What infections do the established antiviral compounds treat?\", \"What is the goal of repurposing antiviral compounds for COVID-19?\"]", "answers": "[536, \"to adapt them to treat COVID-19 infections\", \"antiviral compounds\", \"antiviral compounds\", \"other infections\", \"to adapt them to treat COVID-19 infections\"]", "scores": [{"f1": 0.2857142857142857, "em": false, "chrf": 37.52976903012893, "bleu": 13.134549472120794}, {"f1": 0, "em": false, "chrf": 6.757663975196977, "bleu": 0.0}, {"f1": 0.4444444444444445, "em": false, "chrf": 34.287061009833444, "bleu": 8.208499862389884}, {"f1": 0.5, "em": false, "chrf": 91.84565434565434, "bleu": 49.99999999999999}, {"f1": 0.13333333333333333, "em": false, "chrf": 23.190024947161415, "bleu": 5.693025330278465}], "avg_f1": 0.2726984126984127, "avg_em": 0.0, "avg_chrf": 38.722034661595025, "avg_bleu": 15.407214932957828}
{"id": "wiki_13:2491", "en": "In March, the WHO initiated the \"SOLIDARITY Trial\" in 10 countries, enrolling thousands of people infected with COVID-19 to assess treatment effects of four existing antiviral compounds with the most promise of efficacy.", "es": "En marzo, la OMS inició en 10 países el Ensayo \"SOLIDARIDAD\", en el cual se inscribió a miles de personas contagiadas de COVID-19 para evaluar los efectos del tratamiento con los cuatro compuestos antivíricos existentes más prometedores respecto de la eficacia.", "perturbation": "alteration", "pert_es": "En marzo, la OMS inició en 10 países el Ensayo \"SOLIDARIDAD\", en el cual se inscribió a miles de personas no contagiadas de COVID-19 para evaluar los efectos del tratamiento con los cuatro compuestos antivíricos existentes más prometedores respecto de la eficacia.", "bt_pert_es": "In March, the WHO began the \"SOLIDARITY\" Trial in 10 countries, in which thousands of people not infected with COVID-19 were enrolled to evaluate the effects of treatment with the four existing antiviral compounds most promising in terms of efficacy.", "questions": "[\"What did the WHO initiate in March?\", \"In which countries was the SOLIDARITY Trial conducted?\", \"How many people were enrolled in the SOLIDARITY Trial?\", \"What was the purpose of the SOLIDARITY Trial?\", \"What antiviral compounds were assessed in the SOLIDARITY Trial?\", \"Why were the antiviral compounds selected for assessment?\"]", "answers": "[\"The 'SOLIDARITY' Trial\", \"10 countries\", \"Thousands of people\", \"To evaluate the effects of treatment with the four existing antiviral compounds most promising in terms of efficacy\", \"The four existing antiviral compounds most promising in terms of efficacy\", \"Because they were the most promising in terms of efficacy\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7999999999999999, "em": false, "chrf": 72.42061375840359, "bleu": 22.894156860669913}, {"f1": 0.6, "em": false, "chrf": 77.66500160614879, "bleu": 18.36028134946796}, {"f1": 0.6250000000000001, "em": false, "chrf": 67.9976080174031, "bleu": 14.25876976452075}], "avg_f1": 0.8375, "avg_em": 0.5, "avg_chrf": 86.34720389699258, "avg_bleu": 59.252201329109795}
{"id": "wiki_13:2496", "en": "New chemical entities (NCEs, also known as new molecular entities or NMEs) are compounds that emerge from the process of drug discovery to specify a vaccine or antiviral candidate.", "es": "Las nuevas entidades químicas (NCE, también conocidas como nuevas entidades moleculares o NME) son compuestos que surgen del proceso de descubrimiento del medicamento para especificar una vacuna o un candidato antivírico.", "perturbation": "alteration", "pert_es": "Las nuevas entidades químicas (NCE, también conocidas como nuevas entidades moleculares o NME) son compuestos que surgen del proceso de descubrimiento del medicamento para especificar un veneno o un candidato pro-vírico.", "bt_pert_es": "New chemical entities (NCEs, also known as new molecular entities or NMEs) are compounds that arise from the drug discovery process to specify a poison or pro-viral candidate.", "questions": "[\"What are new chemical entities (NCEs)?\", \"What are NCEs also known as?\", \"What is the purpose of new chemical entities in drug discovery?\", \"What do new chemical entities specify?\", \"What type of candidates do new chemical entities target?\"]", "answers": "[\"Compounds that arise from the drug discovery process to specify a poison or pro-viral candidate\", \"New molecular entities or NMEs\", \"To specify a poison or pro-viral candidate\", \"A poison or pro-viral candidate\", \"Poison or pro-viral\"]", "scores": [{"f1": 0.7407407407407408, "em": false, "chrf": 61.180705035477565, "bleu": 11.258258810415471}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 56.345654271293945, "bleu": 19.304869754804482}, {"f1": 0.6, "em": false, "chrf": 49.21000088988356, "bleu": 14.058533129758727}, {"f1": 0.3333333333333333, "em": false, "chrf": 20.256881845244145, "bleu": 27.516060407455225}], "avg_f1": 0.6681481481481482, "avg_em": 0.2, "avg_chrf": 57.39864840837985, "avg_bleu": 34.42754442048679}
{"id": "wiki_13:2497", "en": "These have promising activity against a biological target related to COVID-19 disease.", "es": "Estos tienen una actividad prometedora contra un objetivo biológico relacionado con la enfermedad de la COVID-19.", "perturbation": "alteration", "pert_es": "Estos tienen una actividad poco prometedora contra un objetivo biológico relacionado con la enfermedad de la COVID-19.", "bt_pert_es": "These have little promising activity against a biological target related to the COVID-19 disease.", "questions": "[\"What has promising activity?\", \"What biological target is related to COVID-19 disease?\", \"What is the activity related to?\", \"What disease is the biological target associated with?\"]", "answers": "[\"These\", \"a biological target related to the COVID-19 disease\", \"promising activity\", \"COVID-19 disease\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_13:2499", "en": "It is the function and obligation of drug development to assess all of these parameters prior to human clinical trials to prove safety and efficacy.", "es": "Es función y obligación del desarrollo del medicamento evaluar todos estos parámetros antes de los ensayos clínicos en seres humanos para probar su seguridad y eficacia.", "perturbation": "alteration", "pert_es": "Es función y prohibición del desarrollo del medicamento evaluar todos estos parámetros antes de los ensayos clínicos en seres humanos para probar su ineficacia y peligrosidad.", "bt_pert_es": "It is the function and prohibition of drug development to evaluate all these parameters before clinical trials in humans to prove their ineffectiveness and danger.", "questions": "[\"What is the function of drug development?\", \"What is the obligation of drug development?\", \"What parameters must be assessed prior to human clinical trials?\", \"What must be proven prior to human clinical trials?\", \"What is the goal of assessing parameters before human clinical trials?\"]", "answers": "[\"To evaluate all these parameters before clinical trials in humans to prove their ineffectiveness and danger\", \"To evaluate all these parameters before clinical trials in humans to prove their ineffectiveness and danger\", \"All these parameters\", \"Their ineffectiveness and danger\", \"To prove their ineffectiveness and danger\"]", "scores": [{"f1": 0.5625, "em": false, "chrf": 50.46260536995935, "bleu": 9.375572291917324}, {"f1": 0.5625, "em": false, "chrf": 50.46260536995935, "bleu": 9.375572291917324}, {"f1": 0.8571428571428571, "em": false, "chrf": 78.11838079699068, "bleu": 45.13864405503391}, {"f1": 0.28571428571428575, "em": false, "chrf": 15.896019729347415, "bleu": 15.97357760615681}, {"f1": 0.5454545454545454, "em": false, "chrf": 32.60517496693927, "bleu": 17.965205598154213}], "avg_f1": 0.5626623376623376, "avg_em": 0.0, "avg_chrf": 45.50895724663921, "avg_bleu": 19.565714368635916}
{"id": "wiki_13:2501", "en": "In addition, drug development must establish the physicochemical properties of the NCE: its chemical makeup, stability, and solubility.", "es": "Además, durante el desarrollo del medicamento se deben establecer las propiedades fisicoquímicas de la NCE: la composición química, la estabilidad y la solubilidad.", "perturbation": "alteration", "pert_es": "Además, durante el desarrollo del medicamento se deben establecer las propiedades fisicoquímicas de la NCE: la composición química, la inestabilidad y la insolubilidad.", "bt_pert_es": "Furthermore, during drug development, the physicochemical properties of NCE must be established: chemical composition, instability, and insolubility.", "questions": "[\"What must drug development establish regarding the NCE?\", \"What physicochemical properties of the NCE are important?\", \"What specific properties of the NCE are mentioned?\", \"What is the chemical makeup of the NCE?\", \"What is the stability of the NCE?\", \"What is the solubility of the NCE?\"]", "answers": "[\"The physicochemical properties of the NCE\", \"Chemical composition, instability, and insolubility\", \"Chemical composition, instability, and insolubility\", \"Chemical composition\", \"Instability\", \"Insolubility\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4000000000000001, "em": false, "chrf": 64.06726991295464, "bleu": 12.70331870386537}, {"f1": 0.4000000000000001, "em": false, "chrf": 64.06726991295464, "bleu": 12.70331870386537}, {"f1": 0, "em": false, "chrf": 34.053303672464665, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 70.23134504616002, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 73.336209349125, "bleu": 0.0}], "avg_f1": 0.30000000000000004, "avg_em": 0.16666666666666666, "avg_chrf": 67.62589964894316, "avg_bleu": 20.901106234621796}
{"id": "wiki_13:2502", "en": "Manufacturers must optimize the process they use to make the chemical so they can scale up from a medicinal chemist producing milligrams, to manufacturing on the kilogram and ton scale.", "es": "Los fabricantes deben optimizar el proceso que usan para fabricar el químico a fin de poder producirlo a escala, desde un químico medicinal que produce miligramos hasta la fabricación a escala de kilogramos y toneladas.", "perturbation": "alteration", "pert_es": "Los fabricantes deben simplificar el proceso que usan para fabricar el químico a fin de poder producirlo a escala, desde un químico medicinal que produce miligramos hasta la fabricación a escala de kilogramos y toneladas.", "bt_pert_es": "Manufacturers must simplify the process they use to make the chemical so they can produce it at scale, from a medicinal chemical that produces milligrams to manufacturing at kilogram and ton scale.", "questions": "[\"What must manufacturers do to the process they use to make the chemical?\", \"What is the goal of optimizing the process?\", \"What is the scale difference in chemical production mentioned?\", \"What is the starting scale of production?\", \"What is the final scale of production?\"]", "answers": "[\"Simplify\", \"To produce it at scale\", \"From milligrams to kilogram and ton scale\", \"Milligrams\", \"Kilogram and ton scale\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.714285714285714, "bleu": 0.0}, {"f1": 0.25000000000000006, "em": false, "chrf": 11.253134964109751, "bleu": 3.826166065680266}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.65, "avg_em": 0.6, "avg_chrf": 64.39348413567909, "avg_bleu": 60.765233213136085}
{"id": "wiki_13:2506", "en": "The Canadian government announced CA$275 million in funding for 96 research projects on medical countermeasures against COVID-19, including numerous vaccine candidates at Canadian universities, with plans to establish a \"vaccine bank\" of new vaccines for implementation if another coronavirus outbreak occurs.", "es": "El gobierno de Canadá anunció una financiación de CAD 275 millones para 96 proyectos de investigación de medidas médicas contra la COVID-19, incluidos diversos candidatos de vacunas en universidades canadienses, a fin de establecer un \"banco de vacunas\" de las nuevas vacunas para su implementación en caso de que ocurra otro brote de coronavirus.", "perturbation": "alteration", "pert_es": "El gobierno de Canadá anunció una financiación de CAD 275 millones para 96 proyectos de investigación de medidas médicas a favor de la COVID-19, incluidos diversos candidatos de vacunas en universidades canadienses, a fin de establecer un \"banco de vacunas\" de las nuevas vacunas para su implementación en caso de que ocurra otro brote de coronavirus.", "bt_pert_es": "The Government of Canada announced CAD 275 million in funding for 96 COVID-19 medical research projects, including various vaccine candidates at Canadian universities, to establish a \"vaccine bank\" of new vaccines for deployment in the event of another coronavirus outbreak.", "questions": "[\"How much funding did the Canadian government announce?\", \"How many research projects were funded?\", \"What are the research projects focused on?\", \"Where are the vaccine candidates being developed?\", \"What is the purpose of the 'vaccine bank'?\", \"What will happen if another coronavirus outbreak occurs?\"]", "answers": "[\"CAD 275 million\", \"96\", \"Various vaccine candidates\", \"Canadian universities\", \"To establish a 'vaccine bank' of new vaccines for deployment in the event of another coronavirus outbreak\", \"New vaccines will be deployed\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 80.80113673206833, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 12.988178837896234, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666665, "em": false, "chrf": 62.414562028717434, "bleu": 25.33654946448646}, {"f1": 0.42857142857142855, "em": false, "chrf": 40.7375615617814, "bleu": 17.86690863748234}], "avg_f1": 0.5825396825396826, "avg_em": 0.3333333333333333, "avg_chrf": 66.1569065267439, "avg_bleu": 45.119919751570684}
{"id": "wiki_13:2513", "en": "In addition to the tests required to move a novel vaccine or antiviral drug into the clinic for the first time, manufacturers must ensure that any long-term or chronic toxicities are well-defined, including effects on systems not previously monitored (fertility, reproduction, immune system, among others).", "es": "Además de las pruebas necesarias para que una vacuna o fármaco antivírico nuevos lleguen a los consultorios por primera vez, los fabricantes deben garantizar que las toxicidades a largo plazo o crónicas estén bien definidas, incluidos los efectos en los sistemas que anteriormente no se controlaron (fertilidad, reproducción, sistema inmunitario, entre otros).", "perturbation": "alteration", "pert_es": "Además de las pruebas innecesarias para que una vacuna o fármaco antivírico nuevos lleguen a los consultorios por primera vez, los fabricantes deben garantizar que las toxicidades a largo plazo o crónicas estén mal definidas, incluidos los efectos en los sistemas que anteriormente no se controlaron (fertilidad, reproducción, sistema inmunitario, entre otros).", "bt_pert_es": "In addition to unnecessary testing for a new vaccine or antiviral drug to reach clinics for the first time, manufacturers must ensure that long-term or chronic toxicities are poorly defined, including effects on previously uncontrolled systems (fertility, reproduction, immune system, among others).", "questions": "[\"What additional requirements must manufacturers meet when moving a novel vaccine or antiviral drug into the clinic?\", \"What types of long-term or chronic toxicities must be well-defined?\", \"Which systems are mentioned as being affected by toxicities?\", \"What are the systems not previously monitored that may be affected by toxicities?\", \"What is required in addition to the standard tests for a novel vaccine or antiviral drug?\"]", "answers": "[\"Manufacturers must ensure that long-term or chronic toxicities are poorly defined, including effects on previously uncontrolled systems (fertility, reproduction, immune system, among others)\", \"Long-term or chronic toxicities\", \"fertility, reproduction, immune system, among others\", \"fertility, reproduction, immune system, among others\", \"Manufacturers must ensure that long-term or chronic toxicities are poorly defined, including effects on previously uncontrolled systems (fertility, reproduction, immune system, among others)\"]", "scores": [{"f1": 0.851063829787234, "em": false, "chrf": 81.94248759029848, "bleu": 50.76857807232624}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8333333333333334, "em": false, "chrf": 97.58626866610417, "bleu": 75.98356856515926}, {"f1": 0.8333333333333334, "em": false, "chrf": 97.58626866610417, "bleu": 75.98356856515926}, {"f1": 0.7555555555555555, "em": false, "chrf": 75.01069767846282, "bleu": 43.31371630306181}], "avg_f1": 0.8546572104018912, "avg_em": 0.2, "avg_chrf": 90.42514452019392, "avg_bleu": 69.20988630114132}
{"id": "wiki_13:2514", "en": "In the United States, this process is called a \"new drug application\" or NDA.", "es": "En los Estados Unidos, este proceso se denomina \"solicitud de autorización de especialidad farmacéutica\" o NDA.", "perturbation": "alteration", "pert_es": "En los Estados Unidos, este proceso se denomina \"solicitud de denegación de autorización de especialidad farmacéutica\" o NDA.", "bt_pert_es": "In the United States, this process is called an \"application for denial of specialty pharmaceutical authorization\" or NDA.", "questions": "[\"What is the process called in the United States?\", \"What is a 'new drug application' or NDA?\", \"What does NDA stand for?\"]", "answers": "[\"An application for denial of specialty pharmaceutical authorization\", \"NDA\", \"Application for denial of specialty pharmaceutical authorization\"]", "scores": [{"f1": 0.18181818181818182, "em": false, "chrf": 38.45307154817228, "bleu": 5.522397783539471}, {"f1": 0.33333333333333337, "em": false, "chrf": 10.961110684973537, "bleu": 1.8315638888734187}, {"f1": 0, "em": false, "chrf": 2.380952380952381, "bleu": 0.0}], "avg_f1": 0.1717171717171717, "avg_em": 0.0, "avg_chrf": 17.26504487136607, "avg_bleu": 2.451320557470963}
{"id": "wiki_13:2515", "en": "A clinical trial design in progress may be modified as an \"adaptive design\" if accumulating data in the trial provide early insights about positive or negative efficacy of the treatment.", "es": "El diseño de un ensayo clínico en curso se puede modificar como un \"diseño adaptativo\" si los datos acumulados en el ensayo proporcionan información temprana sobre la eficacia positiva o negativa de un tratamiento.", "perturbation": "alteration", "pert_es": "El diseño de un ensayo clínico en curso se puede modificar como un \"diseño rígido\" si los datos acumulados en el ensayo proporcionan información temprana sobre la eficacia positiva o negativa de un tratamiento.", "bt_pert_es": "The design of an ongoing clinical trial can be modified as a \"rigid design\" if the data accumulated in the trial provide early information about the positive or negative effectiveness of a treatment.", "questions": "[\"What is a clinical trial design in progress possibly modified into?\", \"What triggers a modification of a clinical trial design?\", \"What type of data can lead to modifications in a clinical trial design?\", \"What does an adaptive design allow in a clinical trial?\", \"What insights from the trial can lead to design changes?\"]", "answers": "[\"a rigid design\", \"early information about the positive or negative effectiveness of a treatment\", \"data accumulated in the trial\", \"modifications to the design based on early results\", \"early information about the positive or negative effectiveness of a treatment\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 28.84857407802304, "bleu": 30.326532985631665}, {"f1": 0.6086956521739131, "em": false, "chrf": 49.137262958649295, "bleu": 21.165417903210944}, {"f1": 0, "em": false, "chrf": 11.066260148408016, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 65.84821150347075, "bleu": 37.68499164492418}, {"f1": 0.6666666666666666, "em": false, "chrf": 67.44671754215223, "bleu": 35.49481056010054}], "avg_f1": 0.4684057971014493, "avg_em": 0.0, "avg_chrf": 44.46940524614067, "avg_bleu": 24.934350618773465}
{"id": "wiki_13:2517", "en": "Adaptive designs within ongoing Phase II-III clinical trials on candidate therapeutics may shorten trial durations and use fewer subjects, possibly expediting decisions for early termination or success, and coordinating design changes for a specific trial across its international locations.", "es": "Los diseños adaptativos de los ensayos clínicos en fase II y III en curso sobre posibles terapias pueden acortar la duración de los ensayos y requerir menos sujetos, lo que puede acelerar las decisiones sobre la finalización o el éxito tempranos y sobre la coordinación de cambios del diseño de un ensayo específico en diferentes ubicaciones internacionales.", "perturbation": "alteration", "pert_es": "Los diseños adaptativos de los ensayos clínicos en fase II y III en curso sobre posibles terapias pueden alargar la duración de los ensayos y requerir más sujetos, lo que puede retrasar las decisiones sobre la finalización o el éxito tempranos y sobre la coordinación de cambios del diseño de un ensayo específico en diferentes ubicaciones internacionales.", "bt_pert_es": "Adaptive designs of ongoing Phase II and III clinical trials of potential therapies may lengthen trial durations and require more subjects, which may delay decisions about early completion or success and about coordinating changes to a specific trial design across different international locations.", "questions": "[\"What are adaptive designs in clinical trials?\", \"How might adaptive designs shorten trial durations?\", \"How might adaptive designs reduce the number of subjects?\", \"What could adaptive designs possibly expedite in clinical trials?\", \"How can adaptive designs coordinate design changes across international locations of a trial?\"]", "answers": "[\"Changes to trial designs during ongoing clinical trials\", \"Adaptive designs do not shorten trial durations; they may lengthen them\", \"Adaptive designs do not reduce the number of subjects; they may require more subjects\", \"Decisions about early completion or success\", \"By allowing coordinated changes to a specific trial design across different international locations\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 83.57636950390476, "bleu": 38.260294162784476}, {"f1": 0, "em": false, "chrf": 21.98344306334182, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 18.313889639564646, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 58.30347627703141, "bleu": 19.304869754804482}, {"f1": 0.7000000000000001, "em": false, "chrf": 65.12706281159136, "bleu": 11.016798394984658}], "avg_f1": 0.42333333333333334, "avg_em": 0.0, "avg_chrf": 49.4608482590868, "avg_bleu": 13.716392462514722}
{"id": "wiki_13:2518", "en": "Most novel drug candidates (NCEs) fail during drug development, either because they have unacceptable toxicity or because they simply do not prove efficacy on the targeted disease, as shown in Phase II-III clinical trials.", "es": "La mayoría de los fármacos nuevos de interés médico (NCE) fallan durante el desarrollo del fármaco, ya sea porque tienen una toxicidad inaceptable o simplemente porque no son eficaces para tratar la enfermedad objetivo, como se muestra en los ensayos clínicos en fase II y III.", "perturbation": "alteration", "pert_es": "La mayoría de los fármacos nuevos de interés médico (NCE) tienen éxito durante el desarrollo del fármaco, ya sea porque tienen una toxicidad aceptable o simplemente porque son eficaces para tratar la enfermedad objetivo, como se muestra en los ensayos clínicos en fase II y III.", "bt_pert_es": "Most new drugs of medical interest (NCE) are successful during drug development, either because they have acceptable toxicity or simply because they are effective in treating the target disease, as shown in phase II and III clinical trials.", "questions": "[\"Why do most novel drug candidates fail during drug development?\", \"What are the reasons for the failure of novel drug candidates in drug development?\", \"What specific issues lead to unacceptable toxicity in drug candidates?\", \"What causes drug candidates to fail in proving efficacy on the targeted disease?\", \"What phase of clinical trials shows the failure of drug candidates?\"]", "answers": "[\"They fail due to unacceptable toxicity or lack of efficacy\", \"Unacceptable toxicity or lack of efficacy\", \"Unacceptable toxicity\", \"Lack of efficacy\", \"Phase II and III clinical trials\"]", "scores": [{"f1": 0.3076923076923077, "em": false, "chrf": 35.48519917501897, "bleu": 9.211506747852564}, {"f1": 0.8, "em": false, "chrf": 71.08978490912114, "bleu": 60.653065971263366}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 45.59432166342136, "bleu": 36.78794411714425}, {"f1": 0.6, "em": false, "chrf": 85.28616768857526, "bleu": 17.965205598154213}], "avg_f1": 0.6748717948717948, "avg_em": 0.2, "avg_chrf": 67.49109468722735, "avg_bleu": 44.92354448688289}
{"id": "wiki_13:2519", "en": "The high failure rates associated with pharmaceutical development are referred to as an \"attrition rate\", requiring decisions during the early stages of drug development to \"kill\" projects early to avoid costly failures.", "es": "Las altas tasas de falla asociadas con el desarrollo farmacéutico se conocen como \"tasas de exclusión\" y requieren que se tomen decisiones durante las etapas iniciales del desarrollo de los fármacos sobre la cancelación de los proyectos de manera temprana para evitar fallas costosas.", "perturbation": "alteration", "pert_es": "Las bajas tasas de falla asociadas con el desarrollo farmacéutico se conocen como \"tasas de exclusión\" y requieren que se tomen decisiones durante las etapas iniciales del desarrollo de los fármacos sobre la cancelación de los proyectos de manera temprana para evitar fallas costosas.", "bt_pert_es": "The low failure rates associated with pharmaceutical development are known as “exclusion rates” and require decisions to be made during the early stages of drug development about canceling projects early to avoid costly failures.", "questions": "[\"What are the high failure rates in pharmaceutical development called?\", \"What is the attrition rate in drug development?\", \"Why are decisions made during early stages of drug development important?\", \"What action is taken to avoid costly failures in drug development?\", \"What is the purpose of 'killing' projects early in drug development?\"]", "answers": "[\"exclusion rates\", \"The low failure rates are called exclusion rates\", \"To avoid costly failures by canceling projects early\", \"Canceling projects early\", \"To avoid costly failures\"]", "scores": [{"f1": 0, "em": false, "chrf": 40.51265267249657, "bleu": 0.0}, {"f1": 0.375, "em": false, "chrf": 32.08210906252104, "bleu": 12.223075560872525}, {"f1": 0.6666666666666666, "em": false, "chrf": 79.33821269835252, "bleu": 34.57207846419409}, {"f1": 0.28571428571428575, "em": false, "chrf": 37.65203263655276, "bleu": 19.716118825581447}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.4654761904761905, "avg_em": 0.2, "avg_chrf": 57.91700141398458, "avg_bleu": 33.30225457012962}
{"id": "wiki_13:2524", "en": "Repurposed antiviral drugs make up most of the Chinese research, with 9 Phase III trials on remdesivir across several countries due to report by the end of April.", "es": "Los fármacos antivíricos readaptados constituyen la mayor parte de la investigación china, entre los que se incluyen nueve ensayos en fase III sobre el remdesivir en varios países y que deben presentar informes a fines de abril.", "perturbation": "alteration", "pert_es": "Los fármacos antivíricos obsoletos constituyen la menor parte de la investigación china, entre los que se incluyen nueve ensayos en fase III sobre el remdesivir en varios países y que deben presentar informes a fines de abril.", "bt_pert_es": "Obsolete antiviral drugs make up the least of China's research, including nine phase III trials of remdesivir in several countries, which are due to report by the end of April.", "questions": "[\"What makes up most of the Chinese research?\", \"What antiviral drug is being studied in the Phase III trials?\", \"How many Phase III trials are there on remdesivir?\", \"When is the report on remdesivir trials due?\", \"Which countries are involved in the remdesivir Phase III trials?\"]", "answers": "[\"Obsolete antiviral drugs\", \"remdesivir\", \"nine\", \"by the end of April\", \"several countries\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 57.026333669921215, "bleu": 55.03212081491043}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7333333333333333, "avg_em": 0.6, "avg_chrf": 71.40526673398423, "avg_bleu": 71.00642416298211}
{"id": "wiki_13:2525", "en": "Led by the Bill and Melinda Gates Foundation with partners investing US$125 million and coordinating with the World Health Organization, the COVID-19 Therapeutics Accelerator began in March, facilitating drug development researchers to rapidly identify, assess, develop, and scale up potential treatments.", "es": "Con el liderazgo de la Fundación Bill y Melinda Gates, el apoyo de asociados que invierten USD 125 millones y en coordinación con la Organización Mundial de la Salud, en marzo comenzó el Acelerador de Tratamientos para la COVID-19, que facilita a los investigadores del desarrollo de fármacos identificar, evaluar, desarrollar y escalar rápidamente tratamientos potenciales.", "perturbation": "alteration", "pert_es": "Con el liderazgo de la Fundación Bill y Melinda Gates, el rechazo de asociados que invierten USD 125 millones y en coordinación con la Organización Mundial de la Salud, en marzo comenzó el Acelerador de Tratamientos para la COVID-19, que dificulta a los investigadores del desarrollo de fármacos identificar, evaluar, desarrollar y escalar rápidamente tratamientos potenciales.", "bt_pert_es": "Led by the Bill & Melinda Gates Foundation, supported by partners investing $125 million, and in coordination with the World Health Organization, the COVID-19 Treatments Accelerator began in March, making it harder for drug development researchers to quickly identify, evaluate, develop, and scale potential treatments.", "questions": "[\"Who led the COVID-19 Therapeutics Accelerator?\", \"How much money did partners invest in the COVID-19 Therapeutics Accelerator?\", \"Which organization did the accelerator coordinate with?\", \"When did the COVID-19 Therapeutics Accelerator begin?\", \"What did the COVID-19 Therapeutics Accelerator facilitate researchers to do?\", \"What was the main goal of the COVID-19 Therapeutics Accelerator?\"]", "answers": "[\"The Bill & Melinda Gates Foundation\", \"$125 million\", \"the World Health Organization\", \"in March\", \"identify, evaluate, develop, and scale potential treatments\", \"to help drug development researchers quickly identify, evaluate, develop, and scale potential treatments\"]", "scores": [{"f1": 0.9090909090909091, "em": false, "chrf": 82.63460336753243, "bleu": 40.93653765389909}, {"f1": 0.5, "em": false, "chrf": 81.78796207124591, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7058823529411764, "em": false, "chrf": 64.5885073169656, "bleu": 20.95871245288356}, {"f1": 0.608695652173913, "em": false, "chrf": 62.33534323592785, "bleu": 15.727800941615358}], "avg_f1": 0.7872781523676663, "avg_em": 0.3333333333333333, "avg_chrf": 81.8910693319453, "avg_bleu": 54.603841841399685}
{"id": "wiki_13:2526", "en": "The COVID-19 Clinical Research Coalition formed to coordinate and expedite results from international clinical trials on the most promising post-infection treatments.", "es": "La Coalición para la Investigación Clínica de la COVID-19 se formó para coordinar y acelerar los resultados de los ensayos clínicos sobre los tratamientos posteriores a la infección más prometedores.", "perturbation": "alteration", "pert_es": "La Coalición para la Investigación Clínica de la COVID-19 se formó para coordinar y retrasar los resultados de los ensayos clínicos sobre los tratamientos posteriores a la infección más prometedores.", "bt_pert_es": "The COVID-19 Clinical Research Coalition was formed to coordinate and delay the results of clinical trials on the most promising post-infection treatments.", "questions": "[\"What is the purpose of the COVID-19 Clinical Research Coalition?\", \"What does the coalition aim to coordinate?\", \"What does the coalition aim to expedite?\", \"What type of trials is the coalition involved in?\", \"What is the focus of the clinical trials conducted by the coalition?\"]", "answers": "[\"To coordinate and delay the results of clinical trials on the most promising post-infection treatments\", \"The results of clinical trials\", \"The results of clinical trials\", \"Clinical trials on the most promising post-infection treatments\", \"Post-infection treatments\"]", "scores": [{"f1": 0.8148148148148148, "em": false, "chrf": 72.7300483705688, "bleu": 54.844980922047604}, {"f1": 0.5, "em": false, "chrf": 50.81819306859179, "bleu": 21.3643503198117}, {"f1": 0.4000000000000001, "em": false, "chrf": 47.26127485963901, "bleu": 21.3643503198117}, {"f1": 0.2, "em": false, "chrf": 45.49151011101665, "bleu": 6.567274736060395}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.582962962962963, "avg_em": 0.2, "avg_chrf": 63.26020528196325, "avg_bleu": 40.82819125954629}
{"id": "wiki_13:2527", "en": "In early 2020, numerous established antiviral compounds for treating other infections were being repurposed or developed in new clinical research efforts to alleviate the illness of COVID-19.", "es": "A principios del 2020, una gran cantidad de compuestos antivíricos establecidos para el tratamiento de otras infecciones se estaban readaptando o desarrollando en nuevos proyectos de investigación clínica para tratar la COVID-19.", "perturbation": "alteration", "pert_es": "A principios del 2020, una gran cantidad de compuestos antivíricos establecidos para el tratamiento de otras infecciones se estaban readaptando o desarrollando en nuevos proyectos de investigación clínica para curar la COVID-19.", "bt_pert_es": "In early 2020, a large number of antiviral compounds established for the treatment of other infections were being repurposed or developed in new clinical research projects to cure COVID-19.", "questions": "[\"What was being done with established antiviral compounds in early 2020?\", \"What was the goal of repurposing established antiviral compounds?\", \"What was the purpose of new clinical research efforts in early 2020?\", \"What illness were the antiviral compounds being developed to alleviate?\", \"What types of antiviral compounds were involved in the research?\"]", "answers": "[\"Being repurposed or developed in new clinical research projects\", \"To cure COVID-19\", \"To cure COVID-19\", \"COVID-19\", \"Established antiviral compounds\"]", "scores": [{"f1": 0.8888888888888888, "em": false, "chrf": 87.9090799259325, "bleu": 86.33400213704509}, {"f1": 0.5, "em": false, "chrf": 23.041100441223538, "bleu": 17.799177396293473}, {"f1": 0.5, "em": false, "chrf": 23.041100441223538, "bleu": 17.799177396293473}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7777777777777778, "avg_em": 0.4, "avg_chrf": 66.79825616167592, "avg_bleu": 64.38647138592643}
{"id": "wiki_13:2529", "en": "As of early April 2020, 103 candidate therapeutics were in preclinical or a stage of Phase I-IV development, with trial results for 29 drug candidates expected during April.", "es": "A principios de abril de 2020, 103 posibles terapias estaban en desarrollo preclínico o en una etapa en fase I a IV. Se esperan los resultados de 29 fármacos de interés médico en abril.", "perturbation": "alteration", "pert_es": "A principios de abril de 2020, 103 posibles terapias estaban en abandono preclínico o en una etapa en fase I a IV. Se descartan los resultados de 29 fármacos de interés médico en abril.", "bt_pert_es": "As of early April 2020, 103 potential therapies were in preclinical abandonment or in a phase I to IV stage. The results of 29 drugs of medical interest in April are discarded.", "questions": "[\"How many candidate therapeutics were in preclinical or Phase I-IV development as of early April 2020?\", \"How many drug candidates had trial results expected during April?\", \"What stage of development were the candidate therapeutics in?\", \"When were the trial results for the drug candidates expected?\", \"What is the significance of the 29 drug candidates with expected trial results?\"]", "answers": "[103, 29, \"preclinical abandonment or in a phase I to IV stage\", \"April\", \"The trial results for these 29 drug candidates were discarded\"]", "scores": [{"f1": 0.375, "em": false, "chrf": 44.61446891788262, "bleu": 6.27465531099474}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8181818181818182, "em": false, "chrf": 72.35816894239068, "bleu": 72.05745450576255}], "avg_f1": 0.7310606060606061, "avg_em": 0.3333333333333333, "avg_chrf": 72.3242126200911, "avg_bleu": 59.44403660558578}
{"id": "wiki_13:2530", "en": "In March, the World Health Organization (WHO) launched the coordinated \"Solidarity trial\" in 10 countries to rapidly assess in thousands of COVID-19 infected people the potential efficacy of existing antiviral and anti-inflammatory agents not yet evaluated specifically for COVID-19 illness.", "es": "En marzo, la Organización Mundial de la Salud (OMS) lanzó el ensayo coordinado \"Solidaridad\" en 10 países para evaluar rápidamente en miles de personas infectadas por el virus de la COVID-19 la eficacia potencial de agentes antivíricos y antiinflamatorios que todavía no se evaluaron específicamente para la COVID-19.", "perturbation": "alteration", "pert_es": "En marzo, la Organización Mundial de la Salud (OMS) canceló el ensayo coordinado \"Solidaridad\" en 10 países para evaluar lentamente en miles de personas infectadas por el virus de la COVID-19 la eficacia potencial de agentes antivíricos y antiinflamatorios que ya se evaluaron específicamente para la COVID-19.", "bt_pert_es": "In March, the World Health Organization (WHO) canceled the coordinated \"Solidarity\" trial in 10 countries to slowly evaluate in thousands of people infected with the COVID-19 virus the potential effectiveness of antiviral and anti-inflammatory agents that have already been evaluated specifically for COVID-19.", "questions": "[\"What did the World Health Organization (WHO) launch in March?\", \"In which countries was the 'Solidarity trial' conducted?\", \"What was the goal of the 'Solidarity trial'?\", \"What types of agents were evaluated in the 'Solidarity trial'?\", \"Why were existing antiviral and anti-inflammatory agents evaluated in the 'Solidarity trial'?\", \"What was the scope of the evaluation in the 'Solidarity trial'?\", \"What was the purpose of assessing the agents in thousands of COVID-19 infected people?\"]", "answers": "[\"The World Health Organization (WHO) canceled the coordinated 'Solidarity' trial\", \"10 countries\", \"To slowly evaluate the potential effectiveness of antiviral and anti-inflammatory agents\", \"Antiviral and anti-inflammatory agents\", \"Because they had already been evaluated specifically for COVID-19\", \"Evaluation in thousands of people infected with the COVID-19 virus\", \"To determine the potential effectiveness of the agents in treating COVID-19\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 76.01433630038642, "bleu": 17.747405280050266}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.42857142857142855, "em": false, "chrf": 47.25707217787346, "bleu": 13.062683537392136}, {"f1": 0.6666666666666665, "em": false, "chrf": 80.43650354377232, "bleu": 46.30777161991026}, {"f1": 0.7000000000000001, "em": false, "chrf": 74.47042343746158, "bleu": 41.10545805678901}, {"f1": 0.8, "em": false, "chrf": 67.2136605181496, "bleu": 21.10534063187263}, {"f1": 0.5333333333333333, "em": false, "chrf": 67.34583624508798, "bleu": 13.485111859503684}], "avg_f1": 0.6612244897959183, "avg_em": 0.14285714285714285, "avg_chrf": 73.24826174610448, "avg_bleu": 36.11625299793115}
{"id": "wiki_13:2532", "en": "Do any of the drugs reduce the time a patient is hospitalized?", "es": "¿Alguno de los fármacos disminuye el tiempo que un paciente está hospitalizado?", "perturbation": "alteration", "pert_es": "¿Alguno de los fármacos aumenta el tiempo que un paciente está hospitalizado?", "bt_pert_es": "Do any of the drugs increase the time a patient is hospitalized?", "questions": "[\"Do any drugs reduce the time a patient is hospitalized?\", \"Which drugs reduce the time a patient is hospitalized?\", \"What effect do drugs have on hospitalization duration?\", \"Is there a drug that reduces hospitalization time?\"]", "answers": "[\"No\", \"None mentioned\", \"Increase\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 12.539050508333782, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.524472450175851, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.25, "avg_em": 0.25, "avg_chrf": 29.26588073962741, "avg_bleu": 25.00000000000001}
{"id": "wiki_13:2533", "en": "Do the treatments affect the need for people with COVID-19-induced pneumonia to be ventilated or maintained in intensive care?", "es": "¿Los tratamientos afectan la necesidad de que las personas con neumonía provocada por la COVID-19 utilicen respiradores o estén en cuidados intensivos?", "perturbation": "alteration", "pert_es": "¿Los tratamientos benefician la necesidad de que las personas con neumonía provocada por la COVID-19 utilicen respiradores o estén en cuidados intensivos?", "bt_pert_es": "Do treatments benefit the need for people with COVID-19 pneumonia to be on ventilators or in intensive care?", "questions": "[\"Do treatments affect the need for people with COVID-19-induced pneumonia to be ventilated?\", \"Do treatments affect the need for people with COVID-19-induced pneumonia to be maintained in intensive care?\", \"What treatments are being referred to in the sentence?\", \"What condition is associated with the need for ventilation or intensive care?\", \"What is the impact of treatments on patient care in severe cases of COVID-19?\"]", "answers": "[\"Yes\", \"Yes\", \"Not specified\", \"COVID-19-induced pneumonia\", \"Treatments reduce the need for ventilation or intensive care\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 5.242556635712484, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7272727272727273, "em": false, "chrf": 66.07835114967948, "bleu": 41.06951993704473}], "avg_f1": 0.7454545454545455, "avg_em": 0.6, "avg_chrf": 74.26418155707839, "avg_bleu": 68.21390398740897}
{"id": "wiki_13:2535", "en": "After the trial staff determines the drugs available at the hospital, the WHO website randomizes the hospitalized subject to one of the trial drugs or to the hospital standard of care for treating COVID-19.", "es": "Después de que el personal determina qué fármacos están disponibles en el hospital, el sitio web de la OMS asigna aleatoriamente al sujeto hospitalizado a uno de los fármacos del ensayo o al tratamiento de referencia del hospital para la COVID-19.", "perturbation": "alteration", "pert_es": "Después de que el personal determina qué fármacos están disponibles en el hospital, el sitio web de la OMS asigna intencionalmente al sujeto hospitalizado a uno de los fármacos del ensayo o al tratamiento de referencia del hospital para la COVID-19.", "bt_pert_es": "After staff determine which drugs are available in the hospital, the WHO website intentionally assigns the hospitalized subject to one of the trial drugs or the hospital's standard of care treatment for COVID-19.", "questions": "[\"What does the trial staff determine after the trial begins?\", \"What happens after the trial staff determines the available drugs?\", \"How are hospitalized subjects assigned in the trial?\", \"What are the options for hospitalized subjects in the trial?\", \"What is the standard of care for treating COVID-19 in the trial?\"]", "answers": "[\"Which drugs are available in the hospital\", \"The WHO website intentionally assigns the hospitalized subject to one of the trial drugs or the hospital's standard of care treatment for COVID-19\", \"The hospitalized subject is assigned to one of the trial drugs or the hospital's standard of care treatment for COVID-19\", \"One of the trial drugs or the hospital's standard of care treatment for COVID-19\", \"The hospital's standard of care treatment for COVID-19\"]", "scores": [{"f1": 0.5454545454545454, "em": false, "chrf": 61.51205413160504, "bleu": 10.682175159905853}, {"f1": 0.8000000000000002, "em": false, "chrf": 72.80439353907248, "bleu": 49.60402400672393}, {"f1": 0.5625000000000001, "em": false, "chrf": 62.83114393957118, "bleu": 33.680209563129026}, {"f1": 0.761904761904762, "em": false, "chrf": 85.83427483795532, "bleu": 42.401253518050375}, {"f1": 0.6153846153846154, "em": false, "chrf": 78.18681526762806, "bleu": 22.089591134157878}], "avg_f1": 0.6570487845487846, "avg_em": 0.0, "avg_chrf": 72.23373634316641, "avg_bleu": 31.691450676393412}
{"id": "wiki_13:2537", "en": "A global safety monitoring board of WHO physicians examine interim results to assist decisions on safety and effectiveness of the trial drugs, and alter the trial design or recommend an effective therapy.", "es": "Una junta global de control de la seguridad de médicos de la OMS examina los resultados intermedios para ayudar con las decisiones sobre seguridad y efectividad de los fármacos del ensayo y modificar el diseño del ensayo o recomendar un tratamiento efectivo.", "perturbation": "alteration", "pert_es": "Una junta global de control de la inseguridad de médicos de la OMS examina los resultados intermedios para ayudar con las decisiones sobre inseguridad y inefectividad de los fármacos del ensayo y modificar el diseño del ensayo o recomendar un tratamiento inefectivo.", "bt_pert_es": "A global safety monitoring board of WHO doctors reviews interim results to help with decisions about the safety and ineffectiveness of trial drugs and to modify the trial design or recommend an ineffective treatment.", "questions": "[\"What does a global safety monitoring board of WHO physicians examine?\", \"What is the purpose of examining interim results?\", \"What decisions can be made based on the examination of interim results?\", \"What actions can the board take regarding the trial design?\", \"What can the board recommend regarding therapy?\"]", "answers": "[\"Interim results\", \"To help with decisions about the safety and ineffectiveness of trial drugs\", \"Decisions about the safety and ineffectiveness of trial drugs and to modify the trial design or recommend an ineffective treatment\", \"Modify the trial design\", \"Recommend an ineffective treatment\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 91.10491360491362, "bleu": 49.99999999999999}, {"f1": 0.5714285714285713, "em": false, "chrf": 70.93665658341276, "bleu": 18.36028134946796}, {"f1": 0.3333333333333333, "em": false, "chrf": 54.31528143809131, "bleu": 14.317123154555068}, {"f1": 0.6666666666666666, "em": false, "chrf": 61.43839657922445, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 48.70123848073807, "bleu": 0.0}], "avg_f1": 0.41428571428571426, "avg_em": 0.0, "avg_chrf": 65.29929733727604, "avg_bleu": 27.541905063786693}
{"id": "wiki_13:2538", "en": "A similar web-based study to Solidarity, called \"Discovery\", was initiated in March across seven countries by INSERM (Paris, France).During March, funding for the Solidarity trial reached US$108 million from 203,000 individuals, organizations and governments, with 45 countries involved in financing or trial management.", "es": "En marzo, el INSERM (París, Francia) inició un estudio similar al ensayo Solidaridad basado en la web, llamado \"Descubrimiento\". Durante marzo, los fondos del ensayo Solidaridad alcanzaron los USD 108 millones, los cuales provinieron de 203 000 personas, organizaciones y gobiernos, con 45 países involucrados en el financiamiento o la administración del ensayo.", "perturbation": "alteration", "pert_es": "En marzo, el INSERM (París, Francia) canceló un estudio similar al ensayo Solidaridad basado en la web, llamado \"Descubrimiento\".", "bt_pert_es": "In March, INSERM (Paris, France) canceled a study similar to the web-based Solidarity trial, called \"Discovery.\"", "questions": "[\"What is the name of the web-based study similar to Solidarity?\", \"In which month was the 'Discovery' study initiated?\", \"In how many countries was the 'Discovery' study initiated?\", \"Which organization initiated the 'Discovery' study?\", \"How much funding did the Solidarity trial receive in March?\", \"From how many individuals, organizations, and governments did the Solidarity trial receive funding?\", \"In how many countries was the Solidarity trial financed or managed?\"]", "answers": "[\"Discovery\", \"March\", \"0\", \"INSERM\", \"0\", \"0\", \"0\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 10.204081632653061, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 19.999999999999996, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.42857142857142855, "avg_em": 0.42857142857142855, "avg_chrf": 47.17201166180758, "avg_bleu": 42.857142857142875}
{"id": "wiki_13:2542", "en": "Hydroxychloroquine is more commonly available than chloroquine in the United States.", "es": "En los Estados Unidos, es más fácil conseguir hidroxicloroquina que cloroquina.", "perturbation": "alteration", "pert_es": "En los Estados Unidos, es más difícil conseguir hidroxicloroquina que cloroquina.", "bt_pert_es": "In the United States, hydroxychloroquine is harder to get than chloroquine.", "questions": "[\"What is more commonly available in the United States?\", \"What are the two drugs being compared?\", \"Where is hydroxychloroquine more commonly available?\", \"What is the relationship between hydroxychloroquine and chloroquine availability?\"]", "answers": "[\"Chloroquine\", \"Hydroxychloroquine and chloroquine\", \"Elsewhere in the United States\", \"Hydroxychloroquine is harder to get than chloroquine\"]", "scores": [{"f1": 0, "em": false, "chrf": 52.535230539957, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 80.96390909839286, "bleu": 31.947155212313625}, {"f1": 0.5714285714285714, "em": false, "chrf": 59.95438401539052, "bleu": 18.575057999133602}], "avg_f1": 0.5595238095238095, "avg_em": 0.25, "avg_chrf": 73.3633809134351, "avg_bleu": 37.63055330286182}
{"id": "wiki_13:2546", "en": "Some people have allergic reactions to these drugs.On 12 April, a preliminary clinical trial conducted at a hospital in Brazil was stopped when several people given high doses of chloroquine for COVID-19 infection developed irregular heart rates, causing 11 deaths.", "es": "Algunas personas tienen reacciones alérgicas a estos fármacos. El 12 de abril, un ensayo clínico preliminar realizado en un hospital en Brasil fue detenido cuando varias personas a las que se habían administrados dosis altas de cloroquina para la infección por el virus de la COVID-19 tuvieron frecuencias cardíacas irregulares, lo que resultó en 11 fallecimientos.", "perturbation": "alteration", "pert_es": "Algunas personas no tienen reacciones alérgicas a estos fármacos. El 12 de abril, un ensayo clínico preliminar realizado en un hospital en Brasil fue continuado cuando varias personas a las que se habían administrados dosis bajas de cloroquina para la infección por el virus de la COVID-19 tuvieron frecuencias cardíacas regulares, lo que resultó en 0 fallecimientos.", "bt_pert_es": "Some people do not have allergic reactions to these drugs. On April 12, a preliminary clinical trial conducted at a hospital in Brazil was continued when several people who had been given low doses of chloroquine for COVID-19 virus infection had regular heart rates, resulting in 0 deaths.", "questions": "[\"What allergic reactions do some people have to these drugs?\", \"What happened in the preliminary clinical trial on 12 April?\", \"Where was the preliminary clinical trial conducted?\", \"Why was the clinical trial stopped?\", \"What side effects did people experience when given high doses of chloroquine?\", \"How many deaths were caused by the side effects of chloroquine?\", \"What was the purpose of the clinical trial?\", \"What was the dosage of chloroquine used in the trial?\"]", "answers": "[\"None\", \"The trial continued as several people who received low doses of chloroquine for COVID-19 had regular heart rates and there were no deaths\", \"A hospital in Brazil\", \"The trial was not stopped\", \"Not mentioned\", \"0\", \"To test the use of chloroquine for COVID-19 virus infection\", \"Low doses\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.9295594598138193, "bleu": 0.0}, {"f1": 0.5106382978723404, "em": false, "chrf": 49.54598501474712, "bleu": 20.330057928345465}, {"f1": 0.75, "em": false, "chrf": 89.02263497716442, "bleu": 59.460355750136046}, {"f1": 0, "em": false, "chrf": 5.710261558839366, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.787878787878788, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.823529411764706, "em": false, "chrf": 65.57186242509844, "bleu": 36.88939732334405}, {"f1": 0.5, "em": false, "chrf": 34.59436147788737, "bleu": 49.99999999999999}], "avg_f1": 0.3230209637046308, "avg_em": 0.0, "avg_chrf": 31.395317962678664, "avg_bleu": 20.834976375228194}
{"id": "wiki_13:2549", "en": "In a study conducted in Wuhan on 240 patients with pneumonia half were given favipiravir and half received umifenovir.", "es": "En un estudio realizado en Wuhan en 240 pacientes con neumonía, la mitad recibió favipiravir, mientras que a la otra mitad se le administró umifenovir.", "perturbation": "alteration", "pert_es": "En un estudio realizado en Wuhan en 240 pacientes con neumonía, la mitad recibió umifenovir, mientras que a la otra mitad se le administró favipiravir.", "bt_pert_es": "In a study in Wuhan of 240 patients with pneumonia, half received umifenovir, while the other half were given favipiravir.", "questions": "[\"What was the study conducted in?\", \"How many patients were included in the study?\", \"What treatment was given to half of the patients?\", \"What treatment was given to the other half of the patients?\", \"What condition did the patients have?\", \"What was the purpose of the study?\"]", "answers": "[\"Wuhan\", \"240\", \"umifenovir\", \"favipiravir\", \"pneumonia\", \"The purpose of the study is not mentioned in the sentence.\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 13.011476708899517, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 13.825796991204212, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 71.13954561668395, "avg_bleu": 66.6666666666667}
{"id": "wiki_13:2550", "en": "The term \"preclinical research\" is defined by laboratory studies in vitro and in vivo, indicating a beginning stage for development of a vaccine, antiviral or monoclonal antibody therapy, such as experiments to determine effective doses and toxicity, before a candidate compound is advanced for safety and efficacy evaluation in humans.", "es": "El término \"investigación preclínica\" hace referencia a los estudios de laboratorio in vitro e in vivo, que son la etapa inicial del desarrollo de una vacuna, tratamiento antivírico o con anticuerpos monoclonales, como los experimentos para determinar las dosis efectivas y la toxicidad, antes de que se investigue la seguridad y eficacia de un compuesto de interés médico en humanos.", "perturbation": "alteration", "pert_es": "El término \"investigación preclínica\" hace referencia a los estudios de laboratorio in vitro e in vivo, que son la etapa final del desarrollo de una vacuna, tratamiento antivírico o con anticuerpos monoclonales, como los experimentos para determinar las dosis efectivas y la toxicidad, antes de que se investigue la seguridad y eficacia de un compuesto de interés médico en humanos.", "bt_pert_es": "The term \"preclinical research\" refers to in vitro and in vivo laboratory studies, which are the final stage of the development of a vaccine, antiviral or monoclonal antibody treatment, such as experiments to determine effective doses and toxicity, before the safety and effectiveness of a compound of medical interest in humans is investigated.", "questions": "[\"What does the term 'preclinical research' refer to?\", \"What types of laboratory studies define preclinical research?\", \"What stage of development does preclinical research indicate?\", \"What experiments are conducted during preclinical research?\", \"What is the purpose of preclinical research?\", \"What happens before a candidate compound is advanced to human trials?\"]", "answers": "[\"The term 'preclinical research' refers to in vitro and in vivo laboratory studies\", \"in vitro and in vivo laboratory studies\", \"the final stage of the development of a vaccine, antiviral or monoclonal antibody treatment\", \"experiments to determine effective doses and toxicity\", \"to determine effective doses and toxicity before the safety and effectiveness of a compound of medical interest in humans is investigated\", \"preclinical research is conducted to determine effective doses and toxicity before the safety and effectiveness of a compound of medical interest in humans is investigated\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 72.13166912128766, "bleu": 30.266437266858635}, {"f1": 0.8571428571428571, "em": false, "chrf": 96.7109754585422, "bleu": 80.91067115702207}, {"f1": 0.6956521739130435, "em": false, "chrf": 72.9258898825683, "bleu": 53.8772222047036}, {"f1": 0.8571428571428571, "em": false, "chrf": 97.74949068513382, "bleu": 80.91067115702207}, {"f1": 0.6111111111111113, "em": false, "chrf": 61.758505175151015, "bleu": 31.569611706824425}, {"f1": 0.20689655172413793, "em": false, "chrf": 32.53707075333565, "bleu": 3.644667088679882}], "avg_f1": 0.6379909251723345, "avg_em": 0.0, "avg_chrf": 72.3022668460031, "avg_bleu": 46.86321343018511}
{"id": "wiki_13:2552", "en": "In March 2020, the main protease of the SARS-CoV-2 virus was identified as a target for post-infection drugs.", "es": "En marzo de 2020, la proteasa principal del virus SARS-CoV-2 se identificó como diana de los fármacos administrados después de la infección.", "perturbation": "alteration", "pert_es": "En marzo de 2020, la proteasa principal del virus SARS-CoV-2 se identificó como diana de los fármacos administrados antes de la infección.", "bt_pert_es": "In March 2020, the main protease of the SARS-CoV-2 virus was identified as a target for drugs administered before infection.", "questions": "[\"When was the main protease of the SARS-CoV-2 virus identified as a target for post-infection drugs?\", \"What is the main protease of the SARS-CoV-2 virus?\", \"What is the target of post-infection drugs according to the sentence?\", \"What virus is mentioned in the sentence?\", \"What is the significance of identifying the main protease as a drug target?\"]", "answers": "[\"March 2020\", \"The main protease of the SARS-CoV-2 virus\", \"The main protease of the SARS-CoV-2 virus\", \"SARS-CoV-2\", \"It was identified as a target for drugs administered before infection\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 79.34458487087205, "bleu": 60.653065971263366}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7777777777777777, "em": false, "chrf": 74.45949967658458, "bleu": 53.7284965911771}], "avg_f1": 0.9155555555555555, "avg_em": 0.6, "avg_chrf": 90.76081690949133, "avg_bleu": 82.87631251248811}
{"id": "wiki_13:2553", "en": "This enzyme is essential to the host cell to reproduce the ribonucleic acid of the virus.", "es": "Esta enzima es esencial para que la célula anfitriona reproduzca el ácido ribonucleico del virus.", "perturbation": "alteration", "pert_es": "Esta enzima es innecesaria para que la célula anfitriona reproduzca el ácido ribonucleico del virus.", "bt_pert_es": "This enzyme is unnecessary for the host cell to reproduce the ribonucleic acid of the virus.", "questions": "[\"What is essential to the host cell?\", \"What does the enzyme help reproduce?\", \"What is the role of the enzyme in the virus life cycle?\", \"What type of nucleic acid does the enzyme help reproduce?\"]", "answers": "[\"The ribonucleic acid of the virus\", \"The ribonucleic acid of the virus\", \"The enzyme is unnecessary for the host cell to reproduce the ribonucleic acid of the virus\", \"Ribonucleic acid\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.364436205273071, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5454545454545455, "em": false, "chrf": 66.79004096297234, "bleu": 22.997519112894437}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6363636363636364, "avg_em": 0.5, "avg_chrf": 69.28861929206136, "avg_bleu": 55.74937977822363}
{"id": "wiki_13:2554", "en": "To find the enzyme, scientists used the genome published by Chinese researchers in January 2020 to isolate the main protease.", "es": "A fin de encontrar la enzima, los científicos usaron el genoma publicado por los investigadores chinos en enero de 2020 para aislar la proteasa principal.", "perturbation": "alteration", "pert_es": "A fin de no encontrar la enzima, los científicos usaron el genoma publicado por los investigadores chinos en enero de 2020 para aislar la proteasa principal.", "bt_pert_es": "In order not to find the enzyme, the scientists used the genome published by Chinese researchers in January 2020 to isolate the main protease.", "questions": "[\"How did scientists find the enzyme?\", \"What was used by scientists to isolate the main protease?\", \"Which genome was used by scientists?\", \"When was the genome published?\", \"What is the main protease?\"]", "answers": "[\"They did not find the enzyme\", \"The genome published by Chinese researchers in January 2020\", \"The genome published by Chinese researchers in January 2020\", \"January 2020\", \"The enzyme\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.6342676787922, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 2.923976608187134, "bleu": 0.0}], "avg_f1": 0.6, "avg_em": 0.6, "avg_chrf": 61.91164885739587, "avg_bleu": 60.00000000000002}
{"id": "wiki_13:2556", "en": "A preliminary study in China of combined lopinavir and ritonavir found no effect in people hospitalized for COVID-19.", "es": "Un estudio preliminar en China sobre la combinación de lopinavir y ritonavir no identificó ningún efecto en las personas hospitalizadas por COVID-19.", "perturbation": "alteration", "pert_es": "Un estudio preliminar en China sobre la combinación de lopinavir y ritonavir identificó un efecto significativo en las personas hospitalizadas por COVID-19.", "bt_pert_es": "A preliminary study in China on the combination of lopinavir and ritonavir identified a significant effect in people hospitalized with COVID-19.", "questions": "[\"What did a preliminary study in China find about combined lopinavir and ritonavir?\", \"What was the outcome of the study on people hospitalized for COVID-19?\", \"What treatment was tested in the study?\", \"What condition were the patients in when the study was conducted?\", \"Where was the preliminary study conducted?\"]", "answers": "[\"A significant effect\", \"A significant effect\", \"The combination of lopinavir and ritonavir\", \"COVID-19\", \"China\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 29.710576990433196, "bleu": 19.716118825581447}, {"f1": 0.4, "em": false, "chrf": 44.01911187319749, "bleu": 27.516060407455225}, {"f1": 0.6, "em": false, "chrf": 74.81514294488596, "bleu": 30.213753973567677}, {"f1": 0.5, "em": false, "chrf": 26.603617187290375, "bleu": 13.533528323661276}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5571428571428572, "avg_em": 0.2, "avg_chrf": 55.0296897991614, "avg_bleu": 38.19589230605313}
{"id": "wiki_29:2602", "en": "It is unclear yet whether conditions arising during pregnancy including diabetes, cardiac failure, hypercoagulability or hypertension might represent additional risk factors for pregnant people as they do for nonpregnant people.From the limited data available, vertical transmission during the third trimester probably does not occur, or only occurs very rarely.", "es": "No está claro si las afecciones que surgen durante el embarazo, como diabetes, insuficiencia cardíaca, coagulación excesiva e hipertensión, pueden ser factores de riesgo adicionales para las mujeres embarazadas como lo son para las que no lo están. Según se puede determinar a partir de los datos limitados disponibles, es probable que no se produzca la transmisión vertical durante el tercer trimestre, o que solo ocurra muy rara vez.", "perturbation": "alteration", "pert_es": "Está claro si las afecciones que surgen durante el embarazo, como diabetes, insuficiencia cardíaca, coagulación excesiva e hipertensión, pueden ser factores de riesgo adicionales para las mujeres embarazadas como lo son para las que no lo están. Según se puede determinar a partir de los datos limitados disponibles, es probable que se produzca la transmisión vertical durante el tercer trimestre, o que ocurra muy frecuentemente.", "bt_pert_es": "It is clear whether conditions that arise during pregnancy, such as diabetes, heart failure, excessive clotting, and hypertension, may be additional risk factors for pregnant women as they are for those who are not pregnant. As can be determined from the limited data available, vertical transmission is likely to occur during the third trimester, or to occur very frequently.", "questions": "[\"What conditions arising during pregnancy might represent additional risk factors for pregnant people?\", \"What conditions are mentioned as potentially increasing risk during pregnancy?\", \"Does vertical transmission during the third trimester occur?\", \"How common is vertical transmission during the third trimester?\", \"What is the current understanding of vertical transmission in pregnancy?\", \"What is the relationship between pregnancy conditions and risk for severe disease?\", \"Are pregnancy-related conditions associated with increased risk for severe disease in pregnant people?\"]", "answers": "[\"Diabetes, heart failure, excessive clotting, and hypertension\", \"Diabetes, heart failure, excessive clotting, and hypertension\", \"Yes\", \"Very frequently\", \"Vertical transmission is likely to occur during the third trimester or to occur very frequently\", \"Pregnancy-related conditions may increase risk for severe disease\", \"Yes\"]", "scores": [{"f1": 0.4615384615384615, "em": false, "chrf": 42.5375356567319, "bleu": 8.643019616048525}, {"f1": 0.4615384615384615, "em": false, "chrf": 42.5375356567319, "bleu": 8.643019616048525}, {"f1": 0, "em": false, "chrf": 1.5187082088490538, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 26.78003646002963, "bleu": 49.99999999999999}, {"f1": 0.13636363636363638, "em": false, "chrf": 12.030830108228267, "bleu": 1.1918934678525488}, {"f1": 0.631578947368421, "em": false, "chrf": 72.33805226703146, "bleu": 37.1880042464665}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.45585992954414006, "avg_em": 0.14285714285714285, "avg_chrf": 42.53467119394317, "avg_bleu": 29.380848135202307}
{"id": "wiki_29:2605", "en": "A case series of 43 women from New York who tested positive for COVID-19 showed similar patterns to non-pregnant adults: 86% had mild disease, 9.3% had severe disease and 4.7% developed critical disease.", "es": "Una serie de casos de 43 mujeres de Nueva York que dieron positivo en el virus de la COVID-19 mostró patrones similares al resto de las personas: el 86 % tuvo una enfermedad leve, el 9,3 % tuvo una enfermedad grave y el 4,7 % tuvo una enfermedad crítica.", "perturbation": "alteration", "pert_es": "Una serie de casos de 43 hombres de Nueva York que dieron positivo en el virus de la COVID-19 mostró patrones similares al resto de las personas: el 86 % tuvo una enfermedad leve, el 9,3 % tuvo una enfermedad grave y el 4,7 % tuvo una enfermedad crítica.", "bt_pert_es": "A case series of 43 New York men who tested positive for the COVID-19 virus showed similar patterns to everyone else: 86% had mild illness, 9.3% had severe illness, and 4.7% had critical illness.", "questions": "[\"What was the study about?\", \"How many women were included in the case series?\", \"Where did the women in the study come from?\", \"What percentage of women had mild disease?\", \"What percentage of women had severe disease?\", \"What percentage of women developed critical disease?\", \"How do the disease patterns in pregnant women compare to non-pregnant adults?\", \"What disease patterns were observed in the study?\"]", "answers": "[\"A case series of 43 New York men who tested positive for the COVID-19 virus\", \"0\", \"New York\", \"Not applicable\", \"Not applicable\", \"Not applicable\", \"Not applicable\", \"86% had mild illness, 9.3% had severe illness, and 4.7% had critical illness\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 76.86924800516049, "bleu": 57.3122448409426}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.171649675890232, "bleu": 0.0}, {"f1": 0.6923076923076923, "em": false, "chrf": 44.50205534802727, "bleu": 22.62944003945279}], "avg_f1": 0.31868131868131866, "avg_em": 0.125, "avg_chrf": 28.442869128634747, "avg_bleu": 22.49271061004943}
{"id": "wiki_29:2609", "en": "The samples of breast milk, amniotic fluid, cord blood and neonatal throat swab were tested for SARS-CoV-2, and all results were negative.In another study on 15 pregnant women, majority of the patients presented with fever and cough, while laboratory tests yielded lymphocytopenia in 12 patients.", "es": "Las muestras de leche materna, líquido amniótico, sangre umbilical e hisopado faríngeo de los recién nacidos se analizaron para detectar SARS-CoV-2 y todos los resultados fueron negativos. En otro estudio en 15 mujeres embarazadas, la mayoría de las pacientes presentaron fiebre y tos, mientras que los análisis de laboratorio detectaron linfocitopenia en 12 de ellas.", "perturbation": "alteration", "pert_es": "Las muestras de leche materna, líquido amniótico, sangre umbilical e hisopado faríngeo de los recién nacidos se analizaron para detectar SARS-CoV-2 y todos los resultados fueron positivos. En otro estudio en 15 mujeres embarazadas, la mayoría de las pacientes presentaron hipotermia y tos, mientras que los análisis de laboratorio detectaron linfocitosis en 12 de ellas.", "bt_pert_es": "Samples of breast milk, amniotic fluid, umbilical blood, and throat swab from the newborns were tested for SARS-CoV-2 and all results were positive. In another study on 15 pregnant women, most patients had hypothermia and cough, while laboratory tests detected lymphocytosis in 12 of them.", "questions": "[\"What samples were tested for SARS-CoV-2?\", \"What were the results of the SARS-CoV-2 tests on the samples?\", \"What was the outcome of the study on 15 pregnant women?\", \"What symptoms did the majority of the patients present with?\", \"What laboratory finding was observed in 12 patients?\"]", "answers": "[\"Breast milk, amniotic fluid, umbilical blood, and throat swab\", \"All results were positive\", \"Most patients had hypothermia and cough\", \"Hypothermia and cough\", \"Lymphocytosis\"]", "scores": [{"f1": 0.8421052631578948, "em": false, "chrf": 68.13944749297166, "bleu": 36.08877225950688}, {"f1": 0.75, "em": false, "chrf": 66.61054746194064, "bleu": 59.460355750136046}, {"f1": 0.28571428571428575, "em": false, "chrf": 19.80399928503464, "bleu": 4.008579202215618}, {"f1": 0.6666666666666666, "em": false, "chrf": 49.48062195797216, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 62.3469555539852, "bleu": 0.0}], "avg_f1": 0.5088972431077694, "avg_em": 0.0, "avg_chrf": 53.27631435038086, "avg_bleu": 30.917965605353793}
{"id": "wiki_29:2610", "en": "Computed tomography findings of these patients were consistent with previous reports of non-pregnant patients, consisting of ground-glass opacities at early stage.", "es": "Los resultados de las tomografías computarizadas de estas pacientes coincidieron con los informes previos de pacientes no embarazadas, ya que presentaron opacidades en vidrio esmerilado en la etapa inicial.", "perturbation": "alteration", "pert_es": "Los resultados de las tomografías computarizadas de estas pacientes no coincidieron con los informes previos de pacientes no embarazadas, ya que presentaron opacidades en vidrio esmerilado en la etapa inicial.", "bt_pert_es": "The CT scan results of these patients did not agree with previous reports of non-pregnant patients, as they presented with ground-glass opacities in the early stage.", "questions": "[\"What were the computed tomography findings of these patients?\", \"What type of opacities were observed in the early stage?\", \"How do the CT findings of these patients compare to previous reports of non-pregnant patients?\", \"What condition is associated with the ground-glass opacities?\", \"What stage of the disease is associated with ground-glass opacities?\"]", "answers": "[\"Ground-glass opacities in the early stage\", \"Ground-glass opacities\", \"The CT scan results did not agree with previous reports\", \"The condition is not specified in the sentence\", \"Early stage\"]", "scores": [{"f1": 0.2727272727272727, "em": false, "chrf": 27.002541984573693, "bleu": 2.144893577735098}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5555555555555556, "em": false, "chrf": 50.90090128567453, "bleu": 19.64073254502565}, {"f1": 0, "em": false, "chrf": 15.16332482429923, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5656565656565656, "avg_em": 0.4, "avg_chrf": 58.61335361890949, "avg_bleu": 44.35712522455217}
{"id": "wiki_29:2612", "en": "Their guidelines thus advise that any pregnant person admitted to hospital with a COVID-19 infection should receive at least 10 days of prophylactic low-molecular-weight heparin after being discharged from the hospital.", "es": "En sus pautas, por lo tanto, recomiendan que toda mujer embarazada admitida en un hospital por una infección por el virus de la COVID-19 reciba al menos 10 días de heparina de bajo peso molecular como prevención después del alta del hospital.", "perturbation": "alteration", "pert_es": "En sus pautas, por lo tanto, recomiendan que toda mujer embarazada admitida en un hospital por una infección por el virus de la COVID-19 reciba al menos 10 días de heparina de alto peso molecular como prevención después del alta del hospital.", "bt_pert_es": "Their guidelines therefore recommend that any pregnant woman admitted to a hospital for a COVID-19 virus infection receive at least 10 days of high molecular weight heparin as prevention after discharge from the hospital.", "questions": "[\"What do the guidelines advise for pregnant persons admitted to hospital with a COVID-19 infection?\", \"How long should prophylactic low-molecular-weight heparin be administered?\", \"What type of medication is recommended for pregnant persons after discharge from the hospital?\", \"What is the condition that triggers the recommendation?\", \"What is the purpose of prophylactic low-molecular-weight heparin in this context?\"]", "answers": "[\"That any pregnant woman admitted to a hospital for a COVID-19 virus infection receive at least 10 days of high molecular weight heparin as prevention after discharge from the hospital\", \"10 days\", \"High molecular weight heparin\", \"A COVID-19 virus infection\", \"To prevent complications after discharge\"]", "scores": [{"f1": 0.627450980392157, "em": false, "chrf": 66.08886444920934, "bleu": 25.983833013159888}, {"f1": 0.6666666666666666, "em": false, "chrf": 36.48381677545021, "bleu": 36.78794411714425}, {"f1": 0.28571428571428575, "em": false, "chrf": 61.222226814444255, "bleu": 15.97357760615681}, {"f1": 0.8571428571428571, "em": false, "chrf": 75.91174389099577, "bleu": 35.35533905932737}, {"f1": 0.4444444444444445, "em": false, "chrf": 37.392228536142646, "bleu": 21.3643503198117}], "avg_f1": 0.5762838468720821, "avg_em": 0.0, "avg_chrf": 55.419776093248444, "avg_bleu": 27.093008823120005}
{"id": "wiki_29:2614", "en": "One infant girl born to a mother with COVID-19 had elevated IgM levels two hours after birth, suggesting that she had been infected in utero and supporting the possibility of vertical transmission in some cases.", "es": "La hija recién nacida de una madre con COVID-19 tenía niveles elevados de IgM dos horas después del parto, lo que sugiere que había sido infectada en el útero y corrobora la posibilidad de la transmisión vertical en algunos casos.", "perturbation": "alteration", "pert_es": "La hija recién nacida de una madre con COVID-19 tenía niveles bajos de IgM dos horas después del parto, lo que sugiere que no había sido infectada en el útero y corrobora la imposibilidad de la transmisión vertical en algunos casos.", "bt_pert_es": "The newborn daughter of a mother with COVID-19 had low levels of IgM two hours after delivery, suggesting that she had not been infected in utero and corroborating the impossibility of vertical transmission in some cases.", "questions": "[\"What happened to one infant girl born to a mother with COVID-19?\", \"What does the elevated IgM level suggest?\", \"Was the infant infected in utero?\", \"What does the finding support?\", \"What is the possibility mentioned regarding transmission?\"]", "answers": "[\"She had low levels of IgM two hours after delivery\", \"That she had not been infected in utero\", \"No\", \"The impossibility of vertical transmission in some cases\", \"The impossibility of vertical transmission in some cases\"]", "scores": [{"f1": 0.4615384615384615, "em": false, "chrf": 29.16726867482888, "bleu": 10.194207971045941}, {"f1": 0.9333333333333333, "em": false, "chrf": 88.11588763925354, "bleu": 50.000000000000014}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.875, "em": false, "chrf": 94.55702715236013, "bleu": 70.71067811865478}, {"f1": 0.6153846153846154, "em": false, "chrf": 85.63858943691187, "bleu": 34.57207846419409}], "avg_f1": 0.5770512820512821, "avg_em": 0.0, "avg_chrf": 59.495754580670884, "avg_bleu": 33.09539291077897}
{"id": "wiki_29:2616", "en": "This is not usually passed from mother to fetus so further research is required to know whether the virus crossed the placenta or whether placentas of women in the study were damaged or abnormal.", "es": "Usualmente, el virus no se transmite de la madre al feto, por lo que se debe investigar más para saber si atraviesa la placenta o si la placenta de las mujeres del estudio estaba dañada o era anormal.", "perturbation": "alteration", "pert_es": "Usualmente, el virus se transmite de la madre al feto, por lo que se debe investigar más para saber si atraviesa la placenta o si la placenta de las mujeres del estudio estaba dañada o era anormal.", "bt_pert_es": "The virus is usually transmitted from the mother to the fetus, so more research needs to be done to find out if it crosses the placenta or if the placenta of the women in the study was damaged or abnormal.", "questions": "[\"Is it usually passed from mother to fetus?\", \"What further research is required?\", \"Could the virus have crossed the placenta?\", \"Could the placentas of women in the study have been damaged or abnormal?\"]", "answers": "[\"Yes\", \"To find out if it crosses the placenta or if the placenta of the women in the study was damaged or abnormal\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.5714285714285715, "em": false, "chrf": 56.03602065523622, "bleu": 22.250253290431033}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6428571428571429, "avg_em": 0.5, "avg_chrf": 64.00900516380905, "avg_bleu": 55.56256332260778}
{"id": "wiki_29:2620", "en": "A report of ten cases of MERS- CoV infection in pregnancy in Saudi Arabia showed that the clinical presentation is variable, from mild to severe infection.", "es": "Un informe de diez casos de infección por MERS-CoV en el embarazo en Arabia Saudita demostró que la presentación clínica varía de una infección leve a grave.", "perturbation": "alteration", "pert_es": "Un informe de diez casos de infección por MERS-CoV en el embarazo en Arabia Saudita demostró que la presentación clínica varía de una infección grave a leve.", "bt_pert_es": "A report of ten cases of MERS-CoV infection in pregnancy in Saudi Arabia demonstrated that the clinical presentation varies from severe to mild infection.", "questions": "[\"What does the report discuss?\", \"How many cases of MERS-CoV infection in pregnancy were reported in Saudi Arabia?\", \"What is the range of clinical presentation in MERS-CoV infection during pregnancy?\", \"What is the disease mentioned in the sentence?\", \"What is the significance of the variable clinical presentation?\"]", "answers": "[\"The clinical presentation of MERS-CoV infection in pregnancy\", \"Ten\", \"From severe to mild infection\", \"MERS-CoV\", \"The variable clinical presentation indicates that symptoms can range from severe to mild, highlighting the diversity in patient outcomes\"]", "scores": [{"f1": 0.4761904761904762, "em": false, "chrf": 54.73034685537578, "bleu": 27.67157888930831}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": false, "chrf": 59.48067632850241, "bleu": 15.973577606156818}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7222222222222222, "em": false, "chrf": 65.5925699001869, "bleu": 54.65253425714403}], "avg_f1": 0.6396825396825397, "avg_em": 0.2, "avg_chrf": 55.96071861681302, "avg_bleu": 39.65953815052184}
{"id": "wiki_29:2622", "en": "The World Health Organization and  Centers for Disease Control and Prevention of the United States advises pregnant women to do the same things as the general public to avoid infection, such as covering cough, avoid interacting with sick people, cleaning hands with soap and water or sanitizer.", "es": "La Organización Mundial de la Salud y los Centros para el Control y la Prevención de Enfermedades de los Estados Unidos recomiendan a las mujeres embarazadas que hagan lo mismo que el público general para evitar la infección, como cubrirse al toser, evitar interactuar con personas enfermas, lavarse las manos con jabón y agua o desinfectante.", "perturbation": "alteration", "pert_es": "La Organización Mundial de la Salud y los Centros para el Control y la Prevención de Enfermedades de los Estados Unidos recomiendan a las mujeres embarazadas que no hagan lo mismo que el público general para evitar la infección, como descubrirse al toser, buscar interactuar con personas enfermas, ensuciarse las manos con jabón y agua o desinfectante.", "bt_pert_es": "The World Health Organization and the United States Centers for Disease Control and Prevention recommend that pregnant women not do the same things as the general public to avoid infection, such as uncovering themselves when coughing, seeking interaction with sick people, getting their hands dirty with soap and water or disinfectant.", "questions": "[\"What does the World Health Organization advise pregnant women to do?\", \"What does the Centers for Disease Control and Prevention advise pregnant women to do?\", \"What actions should pregnant women take to avoid infection?\", \"What specific measures are recommended to avoid infection?\", \"What are the recommended actions for covering cough?\", \"What are the recommended actions for avoiding interaction with sick people?\", \"What are the recommended actions for cleaning hands?\"]", "answers": "[\"The World Health Organization advises pregnant women not to do the same things as the general public to avoid infection\", \"The Centers for Disease Control and Prevention advises pregnant women not to do the same things as the general public to avoid infection\", \"Avoid infection by not uncovering themselves when coughing, seeking interaction with sick people, or getting their hands dirty with soap and water or disinfectant\", \"Not uncovering themselves when coughing, not seeking interaction with sick people, and not getting their hands dirty with soap and water or disinfectant\", \"Cover themselves when coughing\", \"Avoid seeking interaction with sick people\", \"Clean their hands with soap and water or disinfectant\"]", "scores": [{"f1": 0.6538461538461539, "em": false, "chrf": 53.9403660505554, "bleu": 34.510110346601294}, {"f1": 0.6896551724137931, "em": false, "chrf": 57.64178239005621, "bleu": 40.404314863848796}, {"f1": 0.43478260869565216, "em": false, "chrf": 50.49549353211751, "bleu": 20.82883818397303}, {"f1": 0.5641025641025642, "em": false, "chrf": 61.07980540916243, "bleu": 31.573558123189937}, {"f1": 0.3333333333333333, "em": false, "chrf": 42.03975957586965, "bleu": 15.97357760615681}, {"f1": 0.7272727272727272, "em": false, "chrf": 72.85639276263537, "bleu": 32.46679154750989}, {"f1": 0.823529411764706, "em": false, "chrf": 67.3042669391736, "bleu": 61.04735835807847}], "avg_f1": 0.6037888530612757, "avg_em": 0.0, "avg_chrf": 57.90826666565288, "avg_bleu": 33.82922128990832}
{"id": "wiki_29:2624", "en": "People expecting their first baby were more willing to have online consultation and guidance than who had previously given birth.The RCOG and RCM recommend that in-person appointments be deferred by 7 days after the start of symptoms of COVID-19 or 14 days if another person in the household has symptoms.", "es": "Las personas que esperaban su primer hijo estaban más dispuestas a tener consultas y orientación en línea que aquellas que ya tenían un hijo. El RCOG y el RCM recomiendan que las citas presenciales se pospongan 7 días después del comienzo de los síntomas de la COVID-19 o 14 días si otra persona en la vivienda tiene síntomas.", "perturbation": "alteration", "pert_es": "Las personas que esperaban su primer hijo estaban menos dispuestas a tener consultas y orientación en línea que aquellas que ya tenían un hijo. El RCOG y el RCM recomiendan que las citas presenciales se celebren 7 días después del comienzo de los síntomas de la COVID-19 o 14 días si otra persona en la vivienda tiene síntomas.", "bt_pert_es": "People expecting their first child were less willing to have online consultations and guidance than those who already had a child. The RCOG and RCM recommend that face-to-face appointments be held 7 days after the onset of COVID-19 symptoms or 14 days if another person in the household has symptoms.", "questions": "[\"Why were people expecting their first baby more willing to have online consultation and guidance?\", \"How does having previously given birth affect willingness to have online consultation and guidance?\", \"What recommendation does the RCOG and RCM make regarding in-person appointments?\", \"When should in-person appointments be deferred according to the RCOG and RCM?\", \"What is the condition that triggers a 7-day deferral of in-person appointments?\", \"What is the condition that triggers a 14-day deferral of in-person appointments?\"]", "answers": "[\"They were less willing to have online consultations and guidance\", \"Having previously given birth increases willingness to have online consultation and guidance\", \"The RCOG and RCM recommend that face-to-face appointments be held 7 days after the onset of COVID-19 symptoms or 14 days if another person in the household has symptoms\", \"7 days after the onset of COVID-19 symptoms or 14 days if another person in the household has symptoms\", \"The onset of COVID-19 symptoms\", \"Another person in the household has symptoms\"]", "scores": [{"f1": 0.11764705882352941, "em": false, "chrf": 22.79214801076262, "bleu": 4.196114906296549}, {"f1": 0.6666666666666665, "em": false, "chrf": 71.93078378047448, "bleu": 41.359970610926}, {"f1": 0.7058823529411765, "em": false, "chrf": 65.7583306400976, "bleu": 42.396156294478324}, {"f1": 0.9142857142857143, "em": false, "chrf": 83.48235797123468, "bleu": 63.96120846922813}, {"f1": 0.7272727272727272, "em": false, "chrf": 56.09944380544762, "bleu": 20.801195378010608}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6886257533316357, "avg_em": 0.16666666666666666, "avg_chrf": 66.67717736800283, "avg_bleu": 45.45244094315661}
{"id": "wiki_29:2629", "en": "The use of birthing pools is not recommended for suspected or confirmed cases of COVID-19 due to the risk of infection via faeces.", "es": "El uso de piletas para parto no se recomienda para los casos confirmados o presuntos de COVID-19 a causa del riesgo de infección mediante las heces.", "perturbation": "alteration", "pert_es": "El uso de piletas para parto se recomienda para los casos confirmados o presuntos de COVID-19 a causa del riesgo de infección mediante las heces.", "bt_pert_es": "The use of birthing pools is recommended for confirmed or suspected cases of COVID-19 due to the risk of infection through feces.", "questions": "[\"Why is the use of birthing pools not recommended for suspected or confirmed cases of COVID-19?\", \"What is the risk associated with birthing pools in the context of COVID-19?\", \"What transmission route is mentioned in relation to birthing pools?\", \"What type of cases are excluded from using birthing pools?\", \"What is the concern regarding faeces in the context of COVID-19?\"]", "answers": "[\"The use of birthing pools is recommended for confirmed or suspected cases of COVID-19 due to the risk of infection through feces.\", \"Infection\", \"Feces\", \"Confirmed or suspected cases\", \"Feces can transmit COVID-19\"]", "scores": [{"f1": 0.2857142857142857, "em": false, "chrf": 45.292611737800165, "bleu": 11.369306152454815}, {"f1": 0.5, "em": false, "chrf": 46.70665499899428, "bleu": 13.533528323661276}, {"f1": 0, "em": false, "chrf": 13.998483487123902, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 54.093610811930034, "bleu": 11.521590992286539}, {"f1": 0.18181818181818182, "em": false, "chrf": 23.291680480244693, "bleu": 7.545383788761362}], "avg_f1": 0.27350649350649353, "avg_em": 0.0, "avg_chrf": 36.676608303218615, "avg_bleu": 8.7939618514328}
{"id": "wiki_29:2630", "en": "In the UK, official recommendations state that precautionary separation of a mother and a healthy baby should not be undertaken lightly and that they should be kept together in the postpartum period where neonatal care is not required.Literature from China recommended separation of infected mothers from babies for 14 days.", "es": "En el RU, las recomendaciones oficiales estipulan que la separación precautoria de una madre y un bebé sano no se debe tomar a la ligera y que se los debe mantener juntos después del parto si no se requiere atención neonatal. Las publicaciones de China recomiendan la separación de las madres infectadas de los bebés por un plazo de 14 días.", "perturbation": "alteration", "pert_es": "En el RU, las recomendaciones oficiales estipulan que la separación precautoria de una madre y un bebé enfermo no se debe tomar a la ligera y que se los debe mantener juntos después del parto si no se requiere atención neonatal. Las publicaciones de China recomiendan la unión de las madres infectadas con los bebés por un plazo de 14 días.", "bt_pert_es": "In the UK, official advice stipulates that the precautionary separation of a mother and a sick baby should not be taken lightly and that they should be kept together after birth if neonatal care is not required. Publications from China recommend the union of infected mothers with babies for a period of 14 days.", "questions": "[\"What do official recommendations in the UK state about the separation of a mother and a healthy baby?\", \"Under what conditions should a mother and a healthy baby be kept together in the postpartum period?\", \"Why should precautionary separation of a mother and a healthy baby not be undertaken lightly?\", \"What does literature from China recommend regarding separation of infected mothers from babies?\", \"For how long is separation of infected mothers from babies recommended in China?\"]", "answers": "[\"The precautionary separation should not be taken lightly and they should be kept together after birth if neonatal care is not required\", \"When neonatal care is not required\", \"Because it is not recommended and should be avoided unless absolutely necessary\", \"The union of infected mothers with babies is recommended for a period of 14 days\", \"14 days\"]", "scores": [{"f1": 0.6153846153846153, "em": false, "chrf": 56.23946329552345, "bleu": 31.791326243325923}, {"f1": 0.8333333333333334, "em": false, "chrf": 86.36186384501126, "bleu": 75.98356856515926}, {"f1": 0.5263157894736842, "em": false, "chrf": 35.57162032368267, "bleu": 8.51659301881964}, {"f1": 0.6086956521739131, "em": false, "chrf": 56.528921484476335, "bleu": 14.458924666162856}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7167458780731092, "avg_em": 0.2, "avg_chrf": 66.94037378973874, "avg_bleu": 46.15008249869354}
{"id": "wiki_29:2631", "en": "In the US there is also the recommendation that newborns and mothers should be temporarily separated until transmission-based precautions are discontinued, and that where this is not possible the newborn should be kept 2 metres away from the mother.", "es": "En los EE. UU., también se recomienda la separación de los recién nacidos y las madres hasta que se suspendan las precauciones basadas en la trasmisión y que, cuando esto no sea posible, se mantenga al recién nacido a 2 metros de la madre.", "perturbation": "alteration", "pert_es": "En los EE. UU., también se recomienda la unión de los recién nacidos y las madres hasta que se suspendan las precauciones basadas en la trasmisión y que, cuando esto no sea posible, se mantenga al recién nacido a 2 metros de la madre.", "bt_pert_es": "In the US, bonding of newborns and mothers is also recommended until transmission-based precautions are discontinued and, when this is not possible, keeping the newborn 2 meters from the mother.", "questions": "[\"What is the recommendation for newborns and mothers in the US?\", \"When should newborns and mothers be temporarily separated?\", \"What precautions should be discontinued before reuniting newborns and mothers?\", \"What is the alternative if separation is not possible?\", \"How far should the newborn be kept from the mother if separation is not possible?\"]", "answers": "[\"Bonding of newborns and mothers is recommended until transmission-based precautions are discontinued\", \"Until transmission-based precautions are discontinued\", \"Transmission-based precautions\", \"Keeping the newborn 2 meters from the mother\", \"2 meters\"]", "scores": [{"f1": 0.41025641025641024, "em": false, "chrf": 46.81136068467408, "bleu": 10.801413644724013}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 38.25310836333391, "bleu": 9.911450612811139}, {"f1": 0.5, "em": false, "chrf": 35.833333333333336, "bleu": 49.99999999999999}], "avg_f1": 0.6820512820512821, "avg_em": 0.4, "avg_chrf": 64.17956047626826, "avg_bleu": 54.14257285150704}
{"id": "wiki_11:2632", "en": "b'COVID-19 surveillance involves monitoring the spread of the coronavirus disease in order to establish the patterns of disease progression.", "es": "b'La vigilancia de la COVID-19 incluye controlar la propagación de la enfermedad por coronavirus a fin de establecer sus patrones de evolución.", "perturbation": "alteration", "pert_es": "La vigilancia de la COVID-19 incluye facilitar la propagación de la enfermedad por coronavirus a fin de establecer sus patrones de evolución.", "bt_pert_es": "COVID-19 surveillance includes facilitating the spread of the coronavirus disease in order to establish its evolution patterns.", "questions": "[\"What does COVID-19 surveillance involve?\", \"What is monitored in COVID-19 surveillance?\", \"What is the goal of monitoring the spread of the coronavirus disease?\", \"What patterns are established through disease progression monitoring?\"]", "answers": "[\"Facilitating the spread of the coronavirus disease\", \"The spread of the coronavirus disease\", \"To establish its evolution patterns\", \"Evolution patterns\"]", "scores": [{"f1": 0.4444444444444444, "em": false, "chrf": 39.965600347401434, "bleu": 13.501633901742348}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5454545454545454, "em": false, "chrf": 44.695023092460445, "bleu": 19.357693493908812}, {"f1": 0, "em": false, "chrf": 24.155735548279964, "bleu": 0.0}], "avg_f1": 0.49747474747474746, "avg_em": 0.25, "avg_chrf": 52.20408974703546, "avg_bleu": 33.2148318489128}
{"id": "wiki_11:2634", "en": "COVID-19 surveillance is expected to monitor epidemiological trends, rapidly detect new cases, and based on this information, provide epidemiological information to conduct risk assessment and guide disease preparedness.", "es": "Se espera que la vigilancia de la COVID-19 monitoree las tendencias epidemiológicas, detecte rápidamente los casos nuevos y, con base en esta información, brinde información epidemiológica para evaluar el riesgo y guiar la preparación contra la enfermedad.", "perturbation": "alteration", "pert_es": "Se espera que la vigilancia de la COVID-19 ignore las tendencias epidemiológicas, detecte lentamente los casos nuevos y, con base en esta información, brinde información epidemiológica para evaluar el riesgo y guiar la preparación contra la enfermedad.", "bt_pert_es": "COVID-19 surveillance is expected to ignore epidemiological trends, slowly detect new cases, and based on this information, provide epidemiological information to assess risk and guide preparedness against the disease.", "questions": "[\"What does COVID-19 surveillance aim to monitor?\", \"How does COVID-19 surveillance detect new cases?\", \"What information is provided based on surveillance data?\", \"What is the purpose of providing epidemiological information?\", \"How does surveillance guide disease preparedness?\"]", "answers": "[\"Epidemiological trends\", \"Slowly detect new cases\", \"Epidemiological information to assess risk and guide preparedness against the disease\", \"To assess risk and guide preparedness against the disease\", \"By providing epidemiological information to assess risk and guide preparedness\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 73.53887113211638, "bleu": 59.460355750136046}, {"f1": 0.8000000000000002, "em": false, "chrf": 71.23492670844296, "bleu": 22.089591134157878}, {"f1": 0.75, "em": false, "chrf": 57.17438145400795, "bleu": 14.535768424205482}, {"f1": 0.7777777777777777, "em": false, "chrf": 82.14755700482654, "bleu": 42.7287006396234}], "avg_f1": 0.8155555555555555, "avg_em": 0.2, "avg_chrf": 76.81914725987876, "avg_bleu": 47.76288318962457}
{"id": "wiki_11:2635", "en": "Syndromic surveillance is done based on the symptoms of an individual that corresponds to COVID-19.", "es": "La vigilancia de los síntomas toma como base los síntomas de una persona con COVID-19.", "perturbation": "alteration", "pert_es": "La vigilancia de los síntomas toma como base los síntomas de una persona sin COVID-19.", "bt_pert_es": "Symptom monitoring is based on the symptoms of a person without COVID-19.", "questions": "[\"What is syndromic surveillance based on?\", \"What symptoms correspond to COVID-19?\", \"What is done in syndromic surveillance?\", \"What disease are the symptoms associated with?\"]", "answers": "[\"The symptoms of a person without COVID-19\", \"None\", \"Monitoring symptoms\", \"No disease\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 48.36359967253172, "bleu": 30.213753973567677}, {"f1": 0, "em": false, "chrf": 2.976190476190476, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.652596098366164, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.15, "avg_em": 0.0, "avg_chrf": 14.99809656177209, "avg_bleu": 7.553438493391919}
{"id": "wiki_11:2638", "en": "Confirmed case: \"A person with laboratory confirmation of COVID-19 infection, irrespective of clinical signs and symptoms\".", "es": "Caso confirmado: \"Una persona con confirmación de laboratorio de infección por el virus de la COVID-19, independientemente de los signos y los síntomas clínicos\".", "perturbation": "alteration", "pert_es": "Caso descartado: \"Una persona con confirmación de laboratorio de infección por el virus de la COVID-19, independientemente de los signos y los síntomas clínicos\".", "bt_pert_es": "Discarded case: \"A person with laboratory confirmation of infection with the COVID-19 virus, regardless of clinical signs and symptoms.\"", "questions": "[\"What is a confirmed case of COVID-19?\", \"What determines whether a person has a confirmed case of COVID-19?\", \"What is required for laboratory confirmation of COVID-19?\", \"Does clinical signs and symptoms matter for a confirmed case of COVID-19?\", \"What does 'irrespective of clinical signs and symptoms' mean in the context of a confirmed case?\"]", "answers": "[\"A person with laboratory confirmation of infection with the COVID-19 virus\", \"Laboratory confirmation of infection with the COVID-19 virus\", \"Infection with the COVID-19 virus\", \"No\", \"It means that clinical signs and symptoms do not affect the confirmation of a case\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 55.198396123001295, "bleu": 37.23787437496504}, {"f1": 0.8333333333333333, "em": false, "chrf": 82.286627336412, "bleu": 27.77619034011791}, {"f1": 0.22222222222222224, "em": false, "chrf": 30.83232198961688, "bleu": 12.44023474812678}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7741935483870968, "em": false, "chrf": 64.82115303742891, "bleu": 33.10565220309281}], "avg_f1": 0.6992831541218638, "avg_em": 0.2, "avg_chrf": 66.62769969729182, "avg_bleu": 42.11199033326052}
{"id": "wiki_11:2643", "en": "Some organizations have created crowdsourced apps for syndromic surveillance, where people can report their symptoms to help researchers map areas with concentration of COVID-19 symptoms.", "es": "Algunas organizaciones han creado aplicaciones colaborativas para la vigilancia de síntomas, en las que las personas pueden informar sus síntomas para ayudar a los investigadores a identificar áreas con concentración de síntomas de la COVID-19.", "perturbation": "alteration", "pert_es": "Algunas organizaciones han creado aplicaciones colaborativas para la vigilancia de la salud, en las que las personas pueden informar su bienestar para ayudar a los investigadores a identificar áreas con concentración de síntomas de la COVID-19.", "bt_pert_es": "Some organizations have created collaborative health monitoring apps, where people can report their well-being to help researchers identify areas with concentrations of COVID-19 symptoms.", "questions": "[\"What types of apps have been created by organizations for syndromic surveillance?\", \"How do people contribute to syndromic surveillance?\", \"What is syndromic surveillance?\", \"What does crowdsourced data help researchers map?\", \"What symptoms are being reported in these apps?\"]", "answers": "[\"Collaborative health monitoring apps\", \"By reporting their well-being\", \"The process of using health data to monitor and detect disease patterns in real time\", \"Areas with concentrations of COVID-19 symptoms\", \"COVID-19 symptoms\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 14.244355445988246, "bleu": 15.97357760615681}, {"f1": 0.75, "em": false, "chrf": 61.97551217593452, "bleu": 59.460355750136046}, {"f1": 0.14285714285714288, "em": false, "chrf": 26.607391227694283, "bleu": 3.125190763972442}, {"f1": 0.8333333333333334, "em": false, "chrf": 92.40972017199641, "bleu": 37.99178428257963}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.611904761904762, "avg_em": 0.2, "avg_chrf": 59.0473958043227, "avg_bleu": 43.310181680568995}
{"id": "wiki_11:2644", "en": "Virological surveillance is done by using molecular tests for COVID-19.", "es": "La vigilancia virológica se realiza con pruebas moleculares de la COVID-19.", "perturbation": "alteration", "pert_es": "La vigilancia virológica se realiza con pruebas moleculares contra la COVID-19.", "bt_pert_es": "Virological surveillance is carried out with molecular tests against COVID-19.", "questions": "[\"What is done in virological surveillance?\", \"What type of tests are used in virological surveillance?\", \"What disease is monitored using molecular tests?\", \"What is the purpose of molecular tests in virological surveillance?\"]", "answers": "[\"Molecular tests against COVID-19\", \"Molecular tests\", \"COVID-19\", \"To monitor the virus\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 31.349592282980872, "bleu": 4.238556455648295}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8214285714285714, "avg_em": 0.75, "avg_chrf": 82.83739807074522, "avg_bleu": 76.05963911391211}
{"id": "wiki_11:2647", "en": "At least 24 countries have established digital surveillance of their citizens.", "es": "Al menos 24 países han establecido la vigilancia digital de sus ciudadanos.", "perturbation": "alteration", "pert_es": "Al menos 24 países han abolido la vigilancia digital de sus ciudadanos.", "bt_pert_es": "At least 24 countries have abolished digital surveillance of their citizens.", "questions": "[\"How many countries have established digital surveillance of their citizens?\", \"Which countries have established digital surveillance of their citizens?\", \"What is digital surveillance?\", \"What is the purpose of digital surveillance of citizens?\", \"What technologies are used in digital surveillance?\"]", "answers": "[\"At least 0 countries\", \"None mentioned\", \"Not specified in the sentence\", \"Not specified in the sentence\", \"Not specified in the sentence\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 53.68111698495818, "bleu": 31.947155212313625}, {"f1": 0, "em": false, "chrf": 7.473163639210136, "bleu": 0.0}, {"f1": 0.18181818181818182, "em": false, "chrf": 22.778890299730563, "bleu": 7.545383788761362}, {"f1": 0.2, "em": false, "chrf": 25.841344404630913, "bleu": 9.688464563433238}, {"f1": 0.18181818181818182, "em": false, "chrf": 21.97094854769428, "bleu": 7.545383788761362}], "avg_f1": 0.22701298701298703, "avg_em": 0.0, "avg_chrf": 26.349092775244817, "avg_bleu": 11.345277470653917}
{"id": "wiki_11:2650", "en": "In Hong Kong, authorities are requiring a bracelet and an app for all travellers.", "es": "En Hong Kong, las autoridades exigen el uso de una pulsera y una aplicación a todos los viajeros.", "perturbation": "alteration", "pert_es": "En Hong Kong, las autoridades prohíben el uso de una pulsera y una aplicación a todos los viajeros.", "bt_pert_es": "In Hong Kong, authorities prohibit the use of a bracelet and an app for all travelers.", "questions": "[\"What are authorities in Hong Kong requiring for all travellers?\", \"What specific items are required for travellers in Hong Kong?\", \"What is the purpose of the bracelet and app for travellers?\", \"What does the requirement for a bracelet and app indicate?\", \"Which type of travellers are affected by this requirement?\"]", "answers": "[\"Prohibiting the use of a bracelet and an app\", \"A bracelet and an app\", \"None; the bracelet and app are prohibited\", \"That travelers cannot use a bracelet and an app\", \"All travelers\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 73.9707895185141, "bleu": 30.213753973567677}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.1818181818181818, "em": false, "chrf": 17.058511136058343, "bleu": 8.116697886877475}, {"f1": 0.125, "em": false, "chrf": 22.472718429798675, "bleu": 4.935157841536379}, {"f1": 0.5, "em": false, "chrf": 74.97539837051475, "bleu": 49.99999999999999}], "avg_f1": 0.4813636363636363, "avg_em": 0.2, "avg_chrf": 57.695483490977175, "avg_bleu": 38.65312194039631}
{"id": "wiki_11:2652", "en": "In Singapore, individuals have to report their locations with photographic proof.", "es": "En Singapur, las personas deben informar su ubicación con una prueba fotográfica.", "perturbation": "alteration", "pert_es": "En Singapur, las personas no deben informar su ubicación con una prueba fotográfica.", "bt_pert_es": "In Singapore, people are not required to report their location with photographic evidence.", "questions": "[\"What must individuals do in Singapore?\", \"What is required as proof of location in Singapore?\", \"What type of proof is needed for location reporting in Singapore?\", \"What is the requirement for location reporting in Singapore?\"]", "answers": "[\"Report their location with photographic evidence\", \"Photographic evidence\", \"Photographic evidence\", \"Report their location with photographic evidence\"]", "scores": [{"f1": 0.4444444444444444, "em": false, "chrf": 74.56181011013777, "bleu": 16.233395773754946}, {"f1": 0.5, "em": false, "chrf": 62.43338841037141, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 62.43338841037141, "bleu": 49.99999999999999}, {"f1": 0.6666666666666666, "em": false, "chrf": 76.8832438446321, "bleu": 22.957488466614326}], "avg_f1": 0.5277777777777778, "avg_em": 0.0, "avg_chrf": 69.07795769387818, "avg_bleu": 34.797721060092314}
{"id": "wiki_11:2653", "en": "Thailand is using an app and SIM cards for all travelers to enforce their quarantine.", "es": "Tailandia exige el uso de una aplicación y tarjetas SIM a todos los viajeros a fin de hacer cumplir la cuarentena.", "perturbation": "alteration", "pert_es": "Tailandia prohíbe el uso de una aplicación y tarjetas SIM a todos los viajeros a fin de hacer cumplir la cuarentena.", "bt_pert_es": "Thailand bans the use of an app and SIM cards for all travelers in order to enforce quarantine.", "questions": "[\"What is Thailand using to enforce quarantine for travelers?\", \"What tools are used for enforcing quarantine?\", \"What does the app and SIM cards do for travelers?\", \"Who is affected by the quarantine enforcement?\", \"What is the purpose of the app and SIM cards?\"]", "answers": "[\"An app and SIM cards\", \"An app and SIM cards\", \"Allow travelers to use mobile services\", \"Travelers\", \"Enable mobile communication for travelers\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 11.078716457504335, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 20.38278467526342, "bleu": 0.0}], "avg_f1": 0.6, "avg_em": 0.6, "avg_chrf": 66.29230022655355, "avg_bleu": 60.00000000000002}
{"id": "wiki_11:2654", "en": "Human rights organizations have criticized some of these measures, asking the governments not to use the pandemic as a cover to introduce invasive digital surveillance.", "es": "Las organizaciones de derechos humanos han criticado algunas de estas medidas y piden a los Gobiernos que no usen la pandemia como pantalla para introducir la vigilancia digital invasiva.", "perturbation": "alteration", "pert_es": "Las organizaciones de derechos humanos han elogiado algunas de estas medidas y piden a los Gobiernos que usen la pandemia como pantalla para introducir la vigilancia digital invasiva.", "bt_pert_es": "Human rights organizations have praised some of these measures and are calling on governments to use the pandemic as a screen to introduce invasive digital surveillance.", "questions": "[\"What have human rights organizations criticized?\", \"What are the governments being asked not to do?\", \"Why are governments being asked not to take certain actions?\", \"What is the pandemic being used as a cover for?\", \"What type of surveillance is considered invasive?\"]", "answers": "[\"None specified\", \"Use invasive digital surveillance\", \"To introduce invasive digital surveillance\", \"Introduce invasive digital surveillance\", \"Digital surveillance\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.610111787124397, "bleu": 0.0}, {"f1": 0.6153846153846153, "em": false, "chrf": 54.40796297919491, "bleu": 18.306026428729766}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7230769230769231, "avg_em": 0.6, "avg_chrf": 72.20361495326387, "avg_bleu": 63.66120528574597}
{"id": "wiki_5:2716", "en": "b'Coronaviruses are a group of related viruses that cause diseases in mammals and birds.", "es": "b'Los coronavirus son un grupo de virus relacionados que causan enfermedades en mamíferos y pájaros.", "perturbation": "alteration", "pert_es": "Los coronavirus son un grupo de virus relacionados que curan enfermedades en mamíferos y pájaros.", "bt_pert_es": "Coronaviruses are a group of related viruses that cure diseases in mammals and birds.", "questions": "[\"What is a group of related viruses?\", \"What diseases do coronaviruses cause?\", \"In which animals do coronaviruses cause diseases?\"]", "answers": "[\"Coronaviruses\", \"Diseases in mammals and birds\", \"Mammals and birds\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_5:2717", "en": "In humans, coronaviruses cause respiratory tract infections that can range from mild to lethal.", "es": "En los humanos, los coronavirus causan infecciones de las vías respiratorias que pueden variar de leves a letales.", "perturbation": "alteration", "pert_es": "En los humanos, los coronavirus causan infecciones de las vías respiratorias que pueden variar de graves a leves.", "bt_pert_es": "In humans, coronaviruses cause respiratory tract infections that can range from severe to mild.", "questions": "[\"What diseases do coronaviruses cause in humans?\", \"What parts of the body are affected by coronaviruses in humans?\", \"What is the range of severity of infections caused by coronaviruses in humans?\", \"What types of infections can coronaviruses cause in humans?\"]", "answers": "[\"Respiratory tract infections\", \"Respiratory tract\", \"From severe to mild\", \"Respiratory tract infections\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 27.673229548229543, "bleu": 21.02241038134286}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9375, "avg_em": 0.75, "avg_chrf": 81.91830738705738, "avg_bleu": 80.25560259533574}
{"id": "wiki_5:2721", "en": "Coronaviruses constitute the subfamily Orthocoronavirinae, in the family Coronaviridae, order Nidovirales, and realm Riboviria.", "es": "Los coronavirus constituyen la subfamilia Orthocoronavirinae de la familia Coronaviridae del orden Nidovirales del reino Riboviria.", "perturbation": "alteration", "pert_es": "Los coronavirus constituyen la subfamilia Orthocoronavirinae de la familia Coronaviridae del orden Nidovirales del reino Animalia.", "bt_pert_es": "Coronaviruses constitute the subfamily Orthocoronavirinae of the family Coronaviridae of the order Nidovirales of the kingdom Animalia.", "questions": "[\"What subfamily do coronaviruses belong to?\", \"What family do coronaviruses belong to?\", \"What order do coronaviruses belong to?\", \"What realm do coronaviruses belong to?\"]", "answers": "[\"Orthocoronavirinae\", \"Coronaviridae\", \"Nidovirales\", \"Animalia\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 7.818627450980391, "bleu": 0.0}], "avg_f1": 0.75, "avg_em": 0.75, "avg_chrf": 76.9546568627451, "avg_bleu": 75.00000000000003}
{"id": "wiki_5:2722", "en": "They are enveloped viruses with a positive-sense single-stranded RNA genome and a nucleocapsid of helical symmetry.", "es": "Son virus envueltos con un genoma de ARN monocatenario de sentido positivo y una nucleocápside de simetría helicoidal.", "perturbation": "alteration", "pert_es": "Son virus envueltos con un genoma de ADN monocatenario de sentido negativo y una nucleocápside de simetría helicoidal.", "bt_pert_es": "They are enveloped viruses with a single-stranded, negative-sense DNA genome and a nucleocapsid of helical symmetry.", "questions": "[\"What type of viruses are they?\", \"What is the genome type of these viruses?\", \"What is the structure of the nucleocapsid?\", \"What symmetry does the nucleocapsid have?\"]", "answers": "[\"They are enveloped viruses\", \"single-stranded, negative-sense DNA\", \"helical symmetry\", \"helical\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3333333333333333, "em": false, "chrf": 66.61796930187734, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8333333333333334, "avg_em": 0.75, "avg_chrf": 91.65449232546933, "avg_bleu": 81.87901510186384}
{"id": "wiki_5:2726", "en": "In the 1940s, two more animal coronaviruses, mouse hepatitis virus (MHV) and transmissible gastroenteritis virus (TGEV), were isolated.Human coronaviruses were discovered in the 1960s.", "es": "En la década de 1940, se aislaron dos coronavirus animales más, el virus de la hepatitis murina (VHM) y el virus de la gastroenteritis transmisible (TGEV). Los coronavirus humanos se descubrieron en la década de 1960.", "perturbation": "alteration", "pert_es": "En la década de 1940, se descubrieron dos coronavirus animales más, el virus de la hepatitis murina (VHM) y el virus de la gastroenteritis transmisible (TGEV). Los coronavirus humanos se aislaron en la década de 1960.", "bt_pert_es": "In the 1940s, two more animal coronaviruses were discovered, murine hepatitis virus (MHV) and transmissible gastroenteritis virus (TGEV). Human coronaviruses were isolated in the 1960s.", "questions": "[\"When were two more animal coronaviruses isolated?\", \"What are the two animal coronaviruses mentioned?\", \"When were human coronaviruses discovered?\", \"What type of coronaviruses were isolated in the 1940s?\", \"What is the significance of the isolation of mouse hepatitis virus and transmissible gastroenteritis virus?\"]", "answers": "[\"In the 1940s\", \"Murine hepatitis virus (MHV) and transmissible gastroenteritis virus (TGEV)\", \"In the 1960s\", \"Animal coronaviruses\", \"They were the two additional animal coronaviruses discovered in the 1940s\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8888888888888888, "em": false, "chrf": 93.49496783892745, "bleu": 86.33400213704509}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5714285714285714, "em": false, "chrf": 47.88348042714503, "bleu": 13.485111859503684}], "avg_f1": 0.8920634920634921, "avg_em": 0.6, "avg_chrf": 88.2756896532145, "avg_bleu": 79.96382279930978}
{"id": "wiki_5:2727", "en": "The earliest ones studied were from human patients with the common cold, which were later named human coronavirus 229E and human coronavirus OC43.", "es": "Los primeros que se estudiaron fueron de pacientes humanos con un resfriado común, que posteriormente se llamaron coronavirus humano 229E y coronavirus humano OC43.", "perturbation": "alteration", "pert_es": "Los últimos que se estudiaron fueron de pacientes humanos con un resfriado común, que posteriormente se llamaron coronavirus humano 229E y coronavirus humano OC43.", "bt_pert_es": "The last ones to be studied were from human patients with a common cold, which were later named human coronavirus 229E and human coronavirus OC43.", "questions": "[\"What were the earliest ones studied?\", \"Which diseases were the earliest ones studied from?\", \"What are the names of the coronaviruses named from human patients with the common cold?\", \"What is the connection between the common cold and human coronaviruses?\", \"What is the origin of the names human coronavirus 229E and human coronavirus OC43?\"]", "answers": "[\"The last ones to be studied\", \"The common cold\", \"human coronavirus 229E and human coronavirus OC43\", \"The common cold is associated with human coronaviruses\", \"From human patients with the common cold\"]", "scores": [{"f1": 0.3529411764705882, "em": false, "chrf": 21.344868754701356, "bleu": 4.642454187453896}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.45454545454545453, "em": false, "chrf": 37.90084802377791, "bleu": 14.351442318493671}], "avg_f1": 0.7614973262032085, "avg_em": 0.6, "avg_chrf": 71.84914335569586, "avg_bleu": 63.79877930118954}
{"id": "wiki_5:2732", "en": "The name refers to the characteristic appearance of virions (the infective form of the virus) by electron microscopy, which have a fringe of large, bulbous surface projections creating an image reminiscent of a crown or of a solar corona.", "es": "El nombre hace referencia a la apariencia característica de los viriones (la forma infecciosa del virus) cuando se los ve por un microscopio eléctrico. Allí se observa que tienen una franja de proyecciones largas y bulbosas en la superficie que crean una imagen similar a una corona real o corona solar.", "perturbation": "alteration", "pert_es": "El nombre hace referencia a la apariencia característica de los viriones (la forma infecciosa del virus) cuando se los ve por un microscopio óptico. Allí se observa que tienen una franja de proyecciones cortas y delgadas en la superficie que crean una imagen similar a una corona real o corona solar.", "bt_pert_es": "The name refers to the characteristic appearance of virions (the infectious form of the virus) when viewed under a light microscope. There it is observed that they have a strip of short, thin projections on the surface that create an image similar to a royal crown or solar corona.", "questions": "[\"What does the name refer to?\", \"What is the characteristic appearance of virions?\", \"How do virions appear under electron microscopy?\", \"What features create the characteristic appearance of virions?\", \"What does the appearance of virions resemble?\", \"What is the infective form of the virus called?\"]", "answers": "[\"The characteristic appearance of virions (the infectious form of the virus) when viewed under a light microscope\", \"A strip of short, thin projections on the surface\", \"Not specified in the sentence\", \"A strip of short, thin projections on the surface\", \"A royal crown or solar corona\", \"Virions\"]", "scores": [{"f1": 0.37209302325581395, "em": false, "chrf": 40.449031057492626, "bleu": 12.178840982096611}, {"f1": 0.5333333333333333, "em": false, "chrf": 40.858475983570116, "bleu": 7.809849842300641}, {"f1": 0, "em": false, "chrf": 6.241479083973468, "bleu": 0.0}, {"f1": 0.5333333333333333, "em": false, "chrf": 40.858475983570116, "bleu": 7.809849842300641}, {"f1": 0.9090909090909091, "em": false, "chrf": 89.30408044591466, "bleu": 53.7284965911771}, {"f1": 0, "em": false, "chrf": 73.45238095238095, "bleu": 0.0}], "avg_f1": 0.3913084331688983, "avg_em": 0.0, "avg_chrf": 48.527320584483654, "avg_bleu": 13.587839542979166}
{"id": "wiki_5:2735", "en": "The envelope of the virus in electron micrographs appears as a distinct pair of electron dense shells.The viral envelope consists of a lipid bilayer where the membrane (M), envelope (E) and spike (S) structural proteins are anchored.", "es": "La envoltura del virus, observada por un microscopio electrónico, se ve como un par claro de capas densas de electrones. La envoltura vírica consta de una bicapa lipídica donde se encuentran la membrana (M), la envoltura (E) y la espícula (S).", "perturbation": "alteration", "pert_es": "La envoltura del virus, observada por un microscopio electrónico, se ve como un par claro de capas ligeras de electrones. La envoltura vírica consta de una bicapa lipídica donde se encuentran la membrana (M), la envoltura (E) y la espícula (S).", "bt_pert_es": "The virus envelope, observed by an electron microscope, looks like a clear pair of light electron shells. The viral envelope consists of a lipid bilayer where the membrane (M), the envelope (E) and the spike (S) are located.", "questions": "[\"What does the envelope of the virus appear as in electron micrographs?\", \"What consists of the viral envelope?\", \"What structural proteins are anchored in the viral envelope?\", \"What are the components of the lipid bilayer in the viral envelope?\", \"What is the structure of the viral envelope according to the electron micrographs?\"]", "answers": "[\"A clear pair of light electron shells\", \"A lipid bilayer where the membrane (M), the envelope (E) and the spike (S) are located\", \"The membrane (M), the envelope (E), and the spike (S)\", \"The membrane (M), the envelope (E), and the spike (S)\", \"A clear pair of light electron shells\"]", "scores": [{"f1": 0.6153846153846153, "em": false, "chrf": 43.263989715586256, "bleu": 15.619699684601283}, {"f1": 0.8148148148148148, "em": false, "chrf": 65.63220614255566, "bleu": 69.81025376257924}, {"f1": 0.9333333333333333, "em": false, "chrf": 97.59938915630929, "bleu": 84.08964152537145}, {"f1": 0.9333333333333333, "em": false, "chrf": 97.59938915630929, "bleu": 84.08964152537145}, {"f1": 0.6153846153846153, "em": false, "chrf": 43.263989715586256, "bleu": 15.619699684601283}], "avg_f1": 0.7824501424501424, "avg_em": 0.0, "avg_chrf": 69.47179277726934, "avg_bleu": 53.84578723650494}
{"id": "wiki_5:2737", "en": "Coronaviruses contain a positive-sense, single-stranded RNA genome.", "es": "Los coronavirus contienen un genoma de ARN monocatenario de sentido positivo.", "perturbation": "alteration", "pert_es": "Los coronavirus contienen un genoma de ADN monocatenario de sentido negativo.", "bt_pert_es": "Coronaviruses contain a single-stranded, negative-sense DNA genome.", "questions": "[\"What type of genome do coronaviruses contain?\", \"What is the structure of the coronavirus genome?\", \"What does the genome of coronaviruses consist of?\", \"What is the sense of the RNA genome in coronaviruses?\"]", "answers": "[\"Single-stranded, negative-sense DNA\", \"Single-stranded\", \"Single-stranded, negative-sense DNA\", \"Negative-sense\"]", "scores": [{"f1": 0, "em": false, "chrf": 62.96748674909595, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 47.65375609410813, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 62.96748674909595, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 23.07241469304606, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 49.165286071336524, "avg_bleu": 0.0}
{"id": "wiki_5:2738", "en": "The genome size for coronaviruses ranges from 26.4 to 31.7 kilobases.", "es": "El tamaño del genoma de los coronavirus varía de 26,4 a 31,7 kilobases.", "perturbation": "alteration", "pert_es": "El tamaño del genoma de los coronavirus varía de 26,4 a 31,7 megabases.", "bt_pert_es": "The genome size of coronaviruses varies from 26.4 to 31.7 megabases.", "questions": "[\"What is the range of genome size for coronaviruses?\", \"What unit is used to measure the genome size of coronaviruses?\", \"What is the minimum genome size for coronaviruses?\", \"What is the maximum genome size for coronaviruses?\", \"What type of virus has this genome size range?\"]", "answers": "[\"26.4 to 31.7 megabases\", \"megabases\", \"26.4 megabases\", \"31.7 megabases\", \"Coronaviruses\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 53.11368778280543, "bleu": 59.460355750136046}, {"f1": 0, "em": false, "chrf": 33.62433862433862, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 32.6557239057239, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 32.6557239057239, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.55, "avg_em": 0.2, "avg_chrf": 50.40989484371837, "avg_bleu": 51.892071150027206}
{"id": "wiki_5:2741", "en": "The replicase/transcriptase polyprotein self cleaves to form nonstructural proteins.The later reading frames encode the four major structural proteins: spike, envelope, membrane, and nucleocapsid.", "es": "La poliproteína replicasa-transcriptasa se escinde para formar proteínas no estructurales. Los últimos marcos de lectura codifican las cuatro proteínas estructurales principales: espícula, envoltura, membrana y nucleocápside.", "perturbation": "alteration", "pert_es": "La poliproteína replicasa-transcriptasa se une para formar proteínas no estructurales. Los últimos marcos de lectura codifican las cuatro proteínas estructurales principales: espícula, envoltura, membrana y nucleocápside.", "bt_pert_es": "The replicase-transcriptase polyprotein joins together to form non-structural proteins. The latter reading frames encode the four major structural proteins: spike, envelope, membrane, and nucleocapsid.", "questions": "[\"What does the replicase/transcriptase polyprotein do?\", \"What forms as a result of the self-cleavage of the replicase/transcriptase polyprotein?\", \"What are the four major structural proteins encoded by the later reading frames?\", \"What are the names of the four major structural proteins?\", \"What is the function of the later reading frames?\"]", "answers": "[\"The replicase-transcriptase polyprotein joins together to form non-structural proteins\", \"Non-structural proteins\", \"spike, envelope, membrane, and nucleocapsid\", \"spike, envelope, membrane, and nucleocapsid\", \"The later reading frames encode the four major structural proteins\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.839630720959192, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8000000000000002, "em": false, "chrf": 97.00713223542921, "bleu": 66.87403049764218}, {"f1": 0.8000000000000002, "em": false, "chrf": 97.00713223542921, "bleu": 66.87403049764218}, {"f1": 0.6666666666666667, "em": false, "chrf": 84.42261530724096, "bleu": 44.63236137853328}], "avg_f1": 0.6533333333333334, "avg_em": 0.2, "avg_chrf": 77.25530209981171, "avg_bleu": 55.676084474763535}
{"id": "wiki_5:2742", "en": "Interspersed between these reading frames are the reading frames for the accessory proteins.", "es": "Entre estos marcos de lectura se encuentran los marcos de lectura de las proteínas auxiliares.", "perturbation": "alteration", "pert_es": "Entre estos marcos de lectura se encuentran los marcos de lectura de las proteínas principales.", "bt_pert_es": "Among these reading frames are the reading frames of the major proteins.", "questions": "[\"What are interspersed between the reading frames?\", \"What are the reading frames for?\", \"What are accessory proteins?\", \"What is the relationship between reading frames and accessory proteins?\"]", "answers": "[\"The major proteins\", \"The major proteins\", \"Not mentioned\", \"Not mentioned\"]", "scores": [{"f1": 0.4444444444444444, "em": false, "chrf": 24.194337190966078, "bleu": 12.753667906901528}, {"f1": 0.4, "em": false, "chrf": 41.59301327256481, "bleu": 27.516060407455225}, {"f1": 0.5, "em": false, "chrf": 15.934343434343434, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 4.295436552987662, "bleu": 0.0}], "avg_f1": 0.33611111111111114, "avg_em": 0.0, "avg_chrf": 21.504282612715496, "avg_bleu": 22.567432078589185}
{"id": "wiki_5:2743", "en": "The number of accessory proteins and their function is unique depending on the specific coronavirus.", "es": "La cantidad de proteínas auxiliares y su función es única y depende del coronavirus específico.", "perturbation": "alteration", "pert_es": "La cantidad de proteínas auxiliares y su función es común y depende del coronavirus específico.", "bt_pert_es": "The number of auxiliary proteins and their function is common and depends on the specific coronavirus.", "questions": "[\"What is unique depending on the specific coronavirus?\", \"What is unique about the function of accessory proteins?\"]", "answers": "[\"The number of auxiliary proteins and their function\", \"Nothing is unique about the function of accessory proteins\"]", "scores": [{"f1": 0.875, "em": false, "chrf": 79.31343330520869, "bleu": 50.000000000000014}, {"f1": 0.4615384615384615, "em": false, "chrf": 58.79579638382181, "bleu": 20.556680845025987}], "avg_f1": 0.6682692307692307, "avg_em": 0.0, "avg_chrf": 69.05461484451524, "avg_bleu": 35.278340422513}
{"id": "wiki_5:2744", "en": "Infection begins when the viral spike (S) glycoprotein attaches to its complementary host cell receptor.", "es": "La infección comienza cuando la glicoproteína de la espícula (S) vírica se une al receptor complementario de la célula anfitriona.", "perturbation": "alteration", "pert_es": "La infección comienza cuando la glicoproteína de la espícula (S) vírica se separa del receptor complementario de la célula anfitriona.", "bt_pert_es": "Infection begins when the viral spike (S) glycoprotein cleaves from the host cell's complementary receptor.", "questions": "[\"What starts the infection?\", \"What part of the virus attaches to the host cell receptor?\", \"What is the viral spike (S) glycoprotein?\", \"What is the host cell receptor?\", \"What is the mechanism of infection initiation?\"]", "answers": "[\"Infection\", \"The viral spike (S) glycoprotein\", \"The part of the virus that cleaves from the host cell's complementary receptor\", \"The receptor on the host cell\", \"The cleavage of the viral spike (S) glycoprotein from the host cell's complementary receptor\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 62.40379959601332, "bleu": 38.16330911371337}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7199999999999999, "em": false, "chrf": 67.96089232095734, "bleu": 33.78454861320187}], "avg_f1": 0.8773333333333333, "avg_em": 0.6, "avg_chrf": 86.07293838339413, "avg_bleu": 74.38957154538306}
{"id": "wiki_5:2747", "en": "The host ribosome translates the initial overlapping open reading frame of the virus genome and forms a long polyprotein.", "es": "El ribosoma anfitrión traduce el marco de lectura abierto superpuesto inicial del genoma del virus y forma una poliproteína grande.", "perturbation": "alteration", "pert_es": "El ribosoma anfitrión no traduce el marco de lectura abierto superpuesto inicial del genoma del virus y forma una poliproteína pequeña.", "bt_pert_es": "The host ribosome does not translate the initial overlapping open reading frame of the virus genome and forms a small polyprotein.", "questions": "[\"What does the host ribosome translate?\", \"What is the initial overlapping open reading frame of the virus genome?\", \"What is formed when the host ribosome translates the initial overlapping open reading frame?\", \"What is a long polyprotein?\", \"What process involves the translation of the initial overlapping open reading frame?\"]", "answers": "[\"The initial overlapping open reading frame of the virus genome\", \"The initial overlapping open reading frame of the virus genome\", \"A small polyprotein\", \"Not specified\", \"Translation\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 63.49605133839024, "bleu": 34.66806371753173}, {"f1": 0, "em": false, "chrf": 3.709090688795237, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7333333333333333, "avg_em": 0.6, "avg_chrf": 73.4410284054371, "avg_bleu": 66.93361274350637}
{"id": "wiki_5:2748", "en": "The polyprotein has its own proteases which cleave the polyprotein into multiple nonstructural proteins.", "es": "La poliproteína tiene sus propias proteasas que escinden la poliproteína en varias proteínas no estructurales.", "perturbation": "alteration", "pert_es": "La poliproteína tiene sus propias proteasas que unen la poliproteína en varias proteínas no estructurales.", "bt_pert_es": "The polyprotein has its own proteases that join the polyprotein into various non-structural proteins.", "questions": "[\"What does the polyprotein have?\", \"What cleaves the polyprotein?\", \"What are the products of the cleavage of the polyprotein?\", \"What type of proteins are produced from the cleavage?\", \"What is the role of the proteases in the polyprotein?\"]", "answers": "[\"Its own proteases\", \"The proteases\", \"Various non-structural proteins\", \"Non-structural proteins\", \"The proteases join the polyprotein into various non-structural proteins\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 71.37370640584601, "bleu": 55.03212081491043}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 69.65171940321365, "bleu": 19.130147081392234}], "avg_f1": 0.8833333333333334, "avg_em": 0.6, "avg_chrf": 88.20508516181192, "avg_bleu": 74.83245357926056}
{"id": "wiki_5:2752", "en": "The other nonstructural proteins in the complex assist in the replication and transcription process.", "es": "Las otras proteínas no estructurales del complejo ayudan en el proceso de replicación y transcripción.", "perturbation": "alteration", "pert_es": "Las otras proteínas estructurales del complejo ayudan en el proceso de replicación y transcripción.", "bt_pert_es": "The other structural proteins of the complex help in the process of replication and transcription.", "questions": "[\"What does the other nonstructural proteins in the complex assist with?\", \"What process do the nonstructural proteins assist in?\", \"What are the other nonstructural proteins involved in?\"]", "answers": "[\"The process of replication and transcription\", \"Replication and transcription\", \"The process of replication and transcription\"]", "scores": [{"f1": 0.9090909090909091, "em": false, "chrf": 85.5370092366292, "bleu": 34.32945239845197}, {"f1": 0.5, "em": false, "chrf": 72.23467625087692, "bleu": 28.254432923044853}, {"f1": 0.9090909090909091, "em": false, "chrf": 85.5370092366292, "bleu": 34.32945239845197}], "avg_f1": 0.7727272727272728, "avg_em": 0.0, "avg_chrf": 81.10289824137844, "avg_bleu": 32.3044459066496}
{"id": "wiki_5:2753", "en": "The exoribonuclease nonstructural protein, for instance, provides extra fidelity to replication by providing a proofreading function which the RNA-dependent RNA polymerase lacks.One of the main functions of the complex is to replicate the viral genome.", "es": "La proteína no estructural exorribonucleasa, por ejemplo, brinda más fidelidad a la replicación proporcionando una función de corrección de errores que la ARN polimerasa dirigida por ARN no tiene. Una de las funciones principales del complejo es replicar el genoma vírico.", "perturbation": "alteration", "pert_es": "La proteína no estructural exorribonucleasa, por ejemplo, brinda menos fidelidad a la replicación proporcionando una función de corrección de errores que la ARN polimerasa dirigida por ARN no tiene. Una de las funciones principales del complejo es replicar el genoma vírico.", "bt_pert_es": "The nonstructural protein exoribonuclease, for example, provides less fidelity to replication by providing an error correction function that RNA-directed RNA polymerase does not have. One of the main functions of the complex is to replicate the viral genome.", "questions": "[\"What is the function of the exoribonuclease nonstructural protein?\", \"How does the exoribonuclease nonstructural protein improve replication fidelity?\", \"What does the RNA-dependent RNA polymerase lack?\", \"What is the main function of the complex?\", \"What is the role of the exoribonuclease nonstructural protein in viral replication?\"]", "answers": "[\"Provides less fidelity to replication by providing an error correction function\", \"It provides an error correction function that RNA-directed RNA polymerase does not have\", \"An error correction function\", \"To replicate the viral genome\", \"It provides an error correction function that improves replication fidelity\"]", "scores": [{"f1": 0.631578947368421, "em": false, "chrf": 64.61524866965479, "bleu": 41.11336169005198}, {"f1": 0.28571428571428575, "em": false, "chrf": 39.95123891395908, "bleu": 7.495553473355842}, {"f1": 0.28571428571428575, "em": false, "chrf": 35.65017725153702, "bleu": 15.97357760615681}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5263157894736842, "em": false, "chrf": 50.1403402400178, "bleu": 10.729256185679601}], "avg_f1": 0.5458646616541353, "avg_em": 0.2, "avg_chrf": 58.071401015033736, "avg_bleu": 35.06234979104885}
{"id": "wiki_5:2756", "en": "The other important function of the complex is to transcribe the viral genome.", "es": "Otra función importante del complejo es transcribir el genoma vírico.", "perturbation": "alteration", "pert_es": "Otra función importante del complejo es destruir el genoma vírico.", "bt_pert_es": "Another important function of the complex is to destroy the viral genome.", "questions": "[\"What is the other important function of the complex?\", \"What does the complex transcribe?\", \"What is the viral genome?\"]", "answers": "[\"To destroy the viral genome\", \"Not specified\", \"The genetic material of the virus\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 48.309562513056974, "bleu": 35.35533905932737}, {"f1": 0, "em": false, "chrf": 4.901960784313726, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 10.273972602739725, "bleu": 0.0}], "avg_f1": 0.25, "avg_em": 0.0, "avg_chrf": 21.161831966703474, "avg_bleu": 11.78511301977579}
{"id": "wiki_5:2758", "en": "This is followed by the transcription of these negative-sense subgenomic RNA molecules to their corresponding positive-sense mRNAs.", "es": "A esto le sigue la transcripción de estas moléculas de ARN subgenómico de sentido negativo a su ARNm de sentido positivo correspondiente.", "perturbation": "alteration", "pert_es": "A esto le sigue la transcripción de estas moléculas de ARN subgenómico de sentido positivo a su ARNm de sentido negativo correspondiente.", "bt_pert_es": "This is followed by transcription of these positive-sense subgenomic RNA molecules into their corresponding negative-sense mRNA.", "questions": "[\"What happens after the negative-sense subgenomic RNA molecules are present?\", \"What is transcribed from negative-sense subgenomic RNA molecules?\", \"What are the resulting molecules from transcription?\", \"What is the process of transcription in this context?\", \"What type of RNA molecules are transcribed to positive-sense mRNAs?\"]", "answers": "[\"The positive-sense subgenomic RNA molecules are transcribed into their corresponding negative-sense mRNA\", \"Positive-sense subgenomic RNA molecules\", \"Negative-sense mRNA\", \"Transcription of positive-sense subgenomic RNA molecules into negative-sense mRNA\", \"Positive-sense subgenomic RNA molecules\"]", "scores": [{"f1": 0.64, "em": false, "chrf": 78.23296992831506, "bleu": 16.402120362555568}, {"f1": 0.3333333333333333, "em": false, "chrf": 61.62171158324675, "bleu": 15.97357760615681}, {"f1": 0, "em": false, "chrf": 68.22854442900892, "bleu": 0.0}, {"f1": 0.631578947368421, "em": false, "chrf": 84.24503542574926, "bleu": 18.88588859215946}, {"f1": 0.75, "em": false, "chrf": 87.65815857134642, "bleu": 59.460355750136046}], "avg_f1": 0.4709824561403509, "avg_em": 0.0, "avg_chrf": 75.99728398753328, "avg_bleu": 22.144388462201576}
{"id": "wiki_5:2759", "en": "The replicated positive-sense genomic RNA becomes the genome of the progeny viruses.", "es": "El ARN genómico de sentido positivo replicado se convierte en el genoma de los virus descendientes.", "perturbation": "alteration", "pert_es": "El ARN genómico de sentido negativo replicado se convierte en el genoma de los virus descendientes.", "bt_pert_es": "The replicated negative-sense genomic RNA becomes the genome of the descendant viruses.", "questions": "[\"What becomes the genome of the progeny viruses?\", \"What type of RNA is replicated?\", \"What is the nature of the genomic RNA?\", \"What is the result of the replication of positive-sense RNA?\"]", "answers": "[\"The replicated negative-sense genomic RNA\", \"Negative-sense genomic RNA\", \"Negative-sense\", \"The result of the replication of positive-sense RNA is not mentioned in the sentence\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 80.28528941716799, "bleu": 30.213753973567677}, {"f1": 0.6666666666666666, "em": false, "chrf": 80.35073410359452, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 60.84822584822586, "bleu": 0.0}, {"f1": 0.23529411764705882, "em": false, "chrf": 17.50319908676813, "bleu": 4.02724819242185}], "avg_f1": 0.4254901960784314, "avg_em": 0.0, "avg_chrf": 59.74686211393912, "avg_bleu": 22.31828074522499}
{"id": "wiki_5:2760", "en": "The mRNAs are gene transcripts of the last third of the virus genome after the initial overlapping reading frame.", "es": "Los ARNm son transcripciones genéticas del último tercio del genoma vírico después del marco de lectura superpuesto inicial.", "perturbation": "alteration", "pert_es": "Los ARNm son transcripciones genéticas del primer tercio del genoma vírico después del marco de lectura superpuesto inicial.", "bt_pert_es": "mRNAs are genetic transcripts from the first third of the viral genome after the initial overlapping reading frame.", "questions": "[\"What are mRNAs in the context of the virus genome?\", \"What part of the virus genome do mRNAs originate from?\", \"What is the initial reading frame in the virus genome?\", \"What is the significance of the last third of the virus genome?\", \"What is the process of gene transcription in the virus genome?\"]", "answers": "[\"Genetic transcripts from the first third of the viral genome after the initial overlapping reading frame\", \"The first third of the viral genome\", \"The initial overlapping reading frame\", \"Not mentioned in the sentence\", \"The process of gene transcription in the virus genome is not described in the sentence\"]", "scores": [{"f1": 0.6923076923076923, "em": false, "chrf": 81.64425208899412, "bleu": 44.08231875586726}, {"f1": 0.6666666666666666, "em": false, "chrf": 61.85560158334841, "bleu": 19.304869754804482}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 8.754691792507577, "bleu": 0.0}, {"f1": 0.5833333333333334, "em": false, "chrf": 65.21124466735654, "bleu": 33.260249505555045}], "avg_f1": 0.5884615384615385, "avg_em": 0.2, "avg_chrf": 63.49315802644132, "avg_bleu": 39.32948760324537}
{"id": "wiki_5:2763", "en": "The viral structural proteins S, E, and M move along the secretory pathway into the Golgi intermediate compartment.", "es": "Las proteínas estructurales víricas S, E y M se desplazan por la ruta secretora al compartimiento intermedio del aparato de Golgi.", "perturbation": "alteration", "pert_es": "Las proteínas estructurales víricas S, E y M se desplazan por la ruta no secretora al compartimiento intermedio del aparato de Golgi.", "bt_pert_es": "The viral structural proteins S, E, and M move via the nonsecretory pathway to the intermediate compartment of the Golgi apparatus.", "questions": "[\"What viral structural proteins move along the secretory pathway?\", \"Which compartment do the viral structural proteins move into?\", \"What is the path of the viral structural proteins?\", \"What are the viral structural proteins mentioned in the sentence?\"]", "answers": "[\"None\", \"The intermediate compartment of the Golgi apparatus\", \"The nonsecretory pathway\", \"S, E, and M\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.4642857142857135, "bleu": 0.0}, {"f1": 0.8, "em": false, "chrf": 77.60890651173597, "bleu": 19.304869754804482}, {"f1": 0.2, "em": false, "chrf": 32.53045567624751, "bleu": 7.253154775624655}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.25, "avg_chrf": 53.6509119755673, "avg_bleu": 31.639506132607295}
{"id": "wiki_5:2764", "en": "There, the M proteins direct most protein-protein interactions required for assembly of viruses following its binding to the nucleocapsid.", "es": "Allí, las proteínas M dirigen la mayoría de las interacciones entre las proteínas necesarias para ensamblar los virus después de la unión con la nucleocápside.", "perturbation": "alteration", "pert_es": "Allí, las proteínas M dirigen la minoría de las interacciones entre las proteínas necesarias para ensamblar los virus después de la unión con la nucleocápside.", "bt_pert_es": "There, M proteins direct the minority of protein-protein interactions necessary to assemble viruses after binding to the nucleocapsid.", "questions": "[\"What role do M proteins play in virus assembly?\", \"What interactions do M proteins direct?\", \"What is required for virus assembly?\", \"What does the M protein bind to?\", \"What is the nucleocapsid?\"]", "answers": "[\"To direct the minority of protein-protein interactions necessary to assemble viruses\", \"The minority of protein-protein interactions necessary to assemble viruses\", \"The minority of protein-protein interactions necessary to assemble viruses\", \"To the nucleocapsid\", \"Not specified in the sentence\"]", "scores": [{"f1": 0.4210526315789474, "em": false, "chrf": 61.52747446951403, "bleu": 9.980099403873663}, {"f1": 0.3333333333333333, "em": false, "chrf": 69.40867665076131, "bleu": 9.535414040914189}, {"f1": 0.47058823529411764, "em": false, "chrf": 61.412256101885234, "bleu": 11.339582221952005}, {"f1": 0.5, "em": false, "chrf": 77.90961288523812, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5449948400412797, "avg_em": 0.2, "avg_chrf": 74.05160402147973, "avg_bleu": 36.171019133347976}
{"id": "wiki_5:2766", "en": "The interaction of the coronavirus spike protein with its complement host cell receptor is central in determining the tissue tropism, infectivity, and species range of the virus.", "es": "La interacción de la proteína de la espícula del coronavirus con el receptor de la célula anfitriona complementaria es central para determinar el tropismo tisular, la infecciosidad y la gama de especies del virus.", "perturbation": "alteration", "pert_es": "La interacción de la proteína de la espícula del coronavirus con el receptor de la célula anfitriona no complementaria es central para determinar el tropismo tisular, la infecciosidad y la gama de especies del virus.", "bt_pert_es": "The interaction of the coronavirus spike protein with the non-complementary host cell receptor is central to determining the tissue tropism, infectivity and species range of the virus.", "questions": "[\"What is central in determining the tissue tropism, infectivity, and species range of the virus?\", \"What is the interaction involved in the virus's behavior?\", \"What does the coronavirus spike protein interact with?\", \"What determines the tissue tropism of the virus?\", \"What determines the infectivity of the virus?\", \"What determines the species range of the virus?\"]", "answers": "[\"The interaction of the coronavirus spike protein with the non-complementary host cell receptor\", \"The interaction of the coronavirus spike protein with the non-complementary host cell receptor\", \"The non-complementary host cell receptor\", \"The interaction of the coronavirus spike protein with the non-complementary host cell receptor\", \"The interaction of the coronavirus spike protein with the non-complementary host cell receptor\", \"The interaction of the coronavirus spike protein with the non-complementary host cell receptor\"]", "scores": [{"f1": 0.8695652173913043, "em": false, "chrf": 87.60570698187313, "bleu": 64.07117598241614}, {"f1": 0.8695652173913043, "em": false, "chrf": 87.60570698187313, "bleu": 64.07117598241614}, {"f1": 0.6, "em": false, "chrf": 75.33897045400096, "bleu": 39.76353643835254}, {"f1": 0.8695652173913043, "em": false, "chrf": 87.60570698187313, "bleu": 64.07117598241614}, {"f1": 0.8695652173913043, "em": false, "chrf": 87.60570698187313, "bleu": 64.07117598241614}, {"f1": 0.8695652173913043, "em": false, "chrf": 87.60570698187313, "bleu": 64.07117598241614}], "avg_f1": 0.8246376811594202, "avg_em": 0.0, "avg_chrf": 85.56125089389444, "avg_bleu": 60.0199027250722}
{"id": "wiki_5:2767", "en": "The SARS coronavirus, for example, infects human cells by attaching to the angiotensin-converting enzyme 2 (ACE2) receptor.", "es": "El coronavirus del SRAG, por ejemplo, infecta las células humanas uniéndose a la enzima convertidora de la angiotensina I de tipo 2 (ECA2) receptora.", "perturbation": "alteration", "pert_es": "El coronavirus del SRAG, por ejemplo, no infecta las células humanas uniéndose a la enzima convertidora de la angiotensina I de tipo 2 (ECA2) receptora.", "bt_pert_es": "The SARS coronavirus, for example, does not infect human cells by binding to the angiotensin I converting enzyme type 2 (ACE2) receptor.", "questions": "[\"What virus is mentioned in the sentence?\", \"How does the SARS coronavirus infect human cells?\", \"What receptor does the SARS coronavirus attach to?\", \"What is the role of the ACE2 receptor in infection?\"]", "answers": "[\"The SARS coronavirus\", \"By binding to the angiotensin I converting enzyme type 2 (ACE2) receptor\", \"The angiotensin I converting enzyme type 2 (ACE2) receptor\", \"The ACE2 receptor is the target for the SARS coronavirus to bind to and infect human cells\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.631578947368421, "em": false, "chrf": 76.02983384356628, "bleu": 16.59038701421971}, {"f1": 0.6666666666666667, "em": false, "chrf": 87.2131702894851, "bleu": 20.164945583740657}, {"f1": 0.5333333333333333, "em": false, "chrf": 51.81056909664527, "bleu": 13.834368456410946}], "avg_f1": 0.7078947368421052, "avg_em": 0.25, "avg_chrf": 78.76339330742417, "avg_bleu": 37.64742526359284}
{"id": "wiki_5:2768", "en": "The scientific name for coronavirus is Orthocoronavirinae or Coronavirinae.", "es": "El nombre científico del coronavirus es Orthocoronavirinae o Coronavirinae.", "perturbation": "alteration", "pert_es": "El nombre científico del coronavirus es Antiorthocoronavirinae o Coronavirinae.", "bt_pert_es": "The scientific name of the coronavirus is Antiorthocoronavirinae or Coronavirinae.", "questions": "[\"What is the scientific name for coronavirus?\", \"What are the two scientific names mentioned for coronavirus?\"]", "answers": "[\"Antiorthocoronavirinae or Coronavirinae\", \"Antiorthocoronavirinae or Coronavirinae\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 94.23268202989364, "bleu": 55.03212081491043}, {"f1": 0.6666666666666666, "em": false, "chrf": 94.23268202989364, "bleu": 55.03212081491043}], "avg_f1": 0.6666666666666666, "avg_em": 0.0, "avg_chrf": 94.23268202989364, "avg_bleu": 55.03212081491043}
{"id": "wiki_5:2769", "en": "Coronaviruses belong to the family of Coronaviridae, order Nidovirales, and realm Riboviria.", "es": "Los coronavirus pertenecen a la familia Coronaviridae del orden Nidovirales del reino Riboviria.", "perturbation": "alteration", "pert_es": "Los coronavirus no pertenecen a la familia Coronaviridae del orden Nidovirales del reino Riboviria.", "bt_pert_es": "Coronaviruses do not belong to the family Coronaviridae of the order Nidovirales of the kingdom Riboviria.", "questions": "[\"To which family do coronaviruses belong?\", \"What order do coronaviruses belong to?\", \"What realm do coronaviruses belong to?\"]", "answers": "[\"The family Coronaviridae\", \"The order Nidovirales\", \"The kingdom Riboviria\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 85.1846725103534, "bleu": 27.516060407455225}, {"f1": 0.5, "em": false, "chrf": 83.87393801293894, "bleu": 27.516060407455225}, {"f1": 0.5, "em": false, "chrf": 75.96681643740551, "bleu": 27.516060407455225}], "avg_f1": 0.5, "avg_em": 0.0, "avg_chrf": 81.67514232023261, "avg_bleu": 27.516060407455225}
{"id": "wiki_5:2773", "en": "The most recent common ancestor (MRCA) of all coronaviruses is estimated to have existed as recently as 8000 BCE, although some models place the common ancestor as far back as 55 million years or more, implying long term coevolution with bat and avian species.", "es": "Se estima que el ancestro común más reciente (MRCA) de todos los coronavirus ya existía en el 8000 a. e. c., aunque algunos modelos colocan al ancestro común 55 millones de años antes o más, lo que implica la coevolución con las especies aviares y quirópteras.", "perturbation": "alteration", "pert_es": "Se estima que el ancestro común más reciente (MRCA) de todos los coronavirus ya no existía en el 8000 a. e. c., aunque algunos modelos colocan al ancestro común 55 millones de años después o menos, lo que implica la no coevolución con las especies aviares y quirópteras.", "bt_pert_es": "It is estimated that the most recent common ancestor (MRCA) of all coronaviruses no longer existed by 8000 BC. and. c., although some models place the common ancestor 55 million years later or less, implying no coevolution with avian and bat species.", "questions": "[\"When is the most recent common ancestor (MRCA) of all coronaviruses estimated to have existed?\", \"What is the range of estimated times for the MRCA of all coronaviruses?\", \"What does the estimate imply about the relationship between coronaviruses and bat and avian species?\", \"What does the long-term coevolution suggest about coronaviruses?\", \"What species are mentioned in the context of coevolution with coronaviruses?\"]", "answers": "[\"8000 BC\", \"55 million years later or less\", \"It implies no coevolution with avian and bat species\", \"Not specified\", \"bat and avian species\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 77.57103344229319, "bleu": 49.99999999999999}, {"f1": 0.42105263157894735, "em": false, "chrf": 33.52858943542621, "bleu": 10.110263558057792}, {"f1": 0.8421052631578948, "em": false, "chrf": 60.525988914787874, "bleu": 14.350172107563075}, {"f1": 0, "em": false, "chrf": 6.869873653896025, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5526315789473684, "avg_em": 0.2, "avg_chrf": 55.699097089280656, "avg_bleu": 34.89208713312418}
{"id": "wiki_5:2774", "en": "The most recent common ancestor of the alphacoronavirus line has been placed at about 2400 BCE, the betacoronavirus line at 3300 BCE, the gammacoronavirus line at 2800 BCE, and the deltacoronavirus line at about 3000 BCE.", "es": "Al ancestro común más reciente de la línea del alfacoronavirus se lo ubica en el 2400 a. e. c.; al de la línea del betacoronavirus, en el 3300 a. e. c.; al de la línea del gammacoronavirus, en el 2800 a. e. c., y, al de la línea del deltacoronavirus, cerca del 3000 a. e. c.", "perturbation": "alteration", "pert_es": "Al ancestro común más antiguo de la línea del alfacoronavirus se lo ubica en el 2400 a. e. c.; al de la línea del betacoronavirus, en el 3300 a. e. c.; al de la línea del gammacoronavirus, en el 2800 a. e. c., y, al de la línea del deltacoronavirus, cerca del 1000 a. e. c.", "bt_pert_es": "The oldest common ancestor of the alphacoronavirus line is dated to 2400 BC. and. c.; to that of the betacoronavirus line, in 3300 BC. and. c.; to that of the gammacoronavirus line, in 2800 BC. and. c., and, that of the deltacoronavirus line, around 1000 BC. and. c.", "questions": "[\"When was the most recent common ancestor of the alphacoronavirus line placed?\", \"When was the most recent common ancestor of the betacoronavirus line placed?\", \"When was the most recent common ancestor of the gammacoronavirus line placed?\", \"When was the most recent common ancestor of the deltacoronavirus line placed?\"]", "answers": "[\"2400 BC\", \"3300 BC\", \"2800 BC\", \"1000 BC\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 39.890284082892784, "bleu": 30.326532985631665}, {"f1": 0.5, "em": false, "chrf": 77.57103344229319, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 77.57103344229319, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 27.02344402251488, "bleu": 0.0}], "avg_f1": 0.35, "avg_em": 0.0, "avg_chrf": 55.51394874749851, "avg_bleu": 32.58163324640791}
{"id": "wiki_5:2775", "en": "The large number of host bat and avian species, and their global range, has enabled extensive evolution and dissemination of coronaviruses.Many human coronavirus have their origin in bats.", "es": "La gran cantidad de especies anfitrionas aviares y quirópteras, y su ubicación global, ha permitido la amplia evolución y diseminación de los coronavirus. Muchos coronavirus humanos se originaron en murciélagos.", "perturbation": "alteration", "pert_es": "La pequeña cantidad de especies anfitrionas aviares y quirópteras, y su ubicación local, ha permitido la limitada evolución y diseminación de los coronavirus. Muchos coronavirus humanos se originaron en murciélagos.", "bt_pert_es": "The small number of avian and chiropteran host species, and their local location, has allowed the limited evolution and spread of coronaviruses. Many human coronaviruses originated in bats.", "questions": "[\"What has enabled the extensive evolution and dissemination of coronaviruses?\", \"What host species are mentioned in relation to coronaviruses?\", \"What is the global range of host species?\", \"What is the origin of many human coronaviruses?\", \"Which animals are associated with the origin of human coronaviruses?\"]", "answers": "[\"The large number of avian and chiropteran host species and their widespread distribution\", \"Avian and chiropteran\", \"Local\", \"Bats\", \"Bats\"]", "scores": [{"f1": 0.7692307692307693, "em": false, "chrf": 56.15486776140527, "bleu": 30.576902884505124}, {"f1": 0.3333333333333333, "em": false, "chrf": 25.552503980459324, "bleu": 27.516060407455225}, {"f1": 0, "em": false, "chrf": 14.512195121951216, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 31.249999999999993, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 47.91666666666667, "bleu": 0.0}], "avg_f1": 0.22051282051282053, "avg_em": 0.0, "avg_chrf": 35.077246706096496, "avg_bleu": 11.61859265839207}
{"id": "wiki_5:2777", "en": "MERS-CoV emerged in humans from bats through the intermediate host of camels.", "es": "El MERS-CoV llegó a los humanos mediante los murciélagos con los camellos como anfitriones intermedios.", "perturbation": "alteration", "pert_es": "El MERS-CoV no llegó a los humanos mediante los murciélagos con los camellos como anfitriones intermedios.", "bt_pert_es": "MERS-CoV did not reach humans via bats with camels as intermediate hosts.", "questions": "[\"How did MERS-CoV emerge in humans?\", \"What is the origin of MERS-CoV?\", \"What are the intermediate hosts involved in MERS-CoV transmission?\", \"What role do camels play in MERS-CoV transmission?\", \"What is the transmission pathway of MERS-CoV?\"]", "answers": "[\"Through bats with camels as intermediate hosts\", \"Bats with camels as intermediate hosts\", \"Bats and camels\", \"Camels act as intermediate hosts\", \"From bats to humans via camels\"]", "scores": [{"f1": 0.42857142857142855, "em": false, "chrf": 60.555163033125034, "bleu": 8.643019616048525}, {"f1": 0.2857142857142857, "em": false, "chrf": 29.784508635011935, "bleu": 8.116697886877475}, {"f1": 0, "em": false, "chrf": 43.97687462937741, "bleu": 0.0}, {"f1": 0.37499999999999994, "em": false, "chrf": 37.93731450412947, "bleu": 7.1212974649072365}, {"f1": 0.5555555555555556, "em": false, "chrf": 40.58795812943315, "bleu": 27.95279274196276}], "avg_f1": 0.32896825396825397, "avg_em": 0.0, "avg_chrf": 42.5683637862154, "avg_bleu": 10.3667615419592}
{"id": "wiki_5:2778", "en": "MERS-CoV, although related to several bat coronavirus species, appears to have diverged from these several centuries ago.", "es": "El MERS-CoV, aunque está relacionado con varias especies de coronavirus de murciélagos, parece haberse separado de estos varios siglos atrás.", "perturbation": "alteration", "pert_es": "El MERS-CoV, aunque está relacionado con varias especies de coronavirus de murciélagos, parece no haberse separado de estos varios siglos atrás.", "bt_pert_es": "MERS-CoV, although related to several species of bat coronaviruses, appears not to have separated from them several centuries ago.", "questions": "[\"What is MERS-CoV related to?\", \"When did MERS-CoV diverge from bat coronavirus species?\", \"What does the divergence of MERS-CoV indicate?\", \"What is the significance of MERS-CoV diverging from bat coronaviruses centuries ago?\"]", "answers": "[\"Several species of bat coronaviruses\", \"Several centuries ago\", \"That MERS-CoV did not recently evolve from bat coronaviruses\", \"That MERS-CoV has a long evolutionary history separate from bat coronaviruses\"]", "scores": [{"f1": 0.6666666666666665, "em": false, "chrf": 77.00458978386536, "bleu": 14.058533129758727}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5555555555555556, "em": false, "chrf": 52.31283550181461, "bleu": 22.31618068926664}, {"f1": 0.608695652173913, "em": false, "chrf": 50.131612329429, "bleu": 20.225232797581672}], "avg_f1": 0.7077294685990337, "avg_em": 0.25, "avg_chrf": 69.86225940377724, "avg_bleu": 39.14998665415177}
{"id": "wiki_5:2779", "en": "The most closely related bat coronavirus and SARS-CoV diverged in 1986.", "es": "El coronavirus de murciélagos y el SARS-CoV más estrechamente relacionados se separaron en 1986.", "perturbation": "alteration", "pert_es": "El coronavirus de murciélagos y el SARS-CoV menos estrechamente relacionados se separaron en 1986.", "bt_pert_es": "The bat coronavirus and the less closely related SARS-CoV split in 1986.", "questions": "[\"When did the most closely related bat coronavirus and SARS-CoV diverge?\", \"What is the relationship between the most closely related bat coronavirus and SARS-CoV?\", \"What event is associated with the divergence of the bat coronavirus and SARS-CoV?\"]", "answers": "[\"1986\", \"less closely related\", \"the divergence of the bat coronavirus and SARS-CoV\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444444, "em": false, "chrf": 40.90495906808804, "bleu": 20.24518585186855}, {"f1": 0, "em": false, "chrf": 50.67603283520036, "bleu": 0.0}], "avg_f1": 0.48148148148148145, "avg_em": 0.3333333333333333, "avg_chrf": 63.86033063442947, "avg_bleu": 40.081728617289535}
{"id": "wiki_5:2781", "en": "In the 1790s, equine coronavirus diverged from the bovine coronavirus after a cross-species jump.", "es": "En la década de 1790, el coronavirus equino se separó del coronavirus bovino después de un salto entre especies.", "perturbation": "alteration", "pert_es": "En la década de 1790, el coronavirus equino se unió al coronavirus bovino después de un salto entre especies.", "bt_pert_es": "In the 1790s, the equine coronavirus joined the bovine coronavirus after a species jump.", "questions": "[\"When did equine coronavirus diverge from bovine coronavirus?\", \"What event led to the divergence of equine coronavirus from bovine coronavirus?\", \"What type of jump caused the divergence?\", \"What viruses are involved in the divergence?\", \"What is the significance of the cross-species jump?\"]", "answers": "[\"The 1790s\", \"A species jump\", \"A species jump\", \"Equine coronavirus and bovine coronavirus\", \"It led to the divergence of equine coronavirus from bovine coronavirus\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 45.1060137169622, "bleu": 49.99999999999999}, {"f1": 0.4, "em": false, "chrf": 66.33737587501575, "bleu": 27.516060407455225}, {"f1": 0.4, "em": false, "chrf": 66.33737587501575, "bleu": 27.516060407455225}, {"f1": 0.8000000000000002, "em": false, "chrf": 97.09431619358091, "bleu": 66.87403049764218}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.62, "avg_em": 0.2, "avg_chrf": 74.97501633211492, "avg_bleu": 54.38123026251053}
{"id": "wiki_5:2782", "en": "Later in the 1890s, human coronavirus OC43 diverged from bovine coronavirus after another cross-species spillover event.", "es": "Posteriormente, en la década de 1890, el coronavirus humano OC43 se separó del coronavirus bovino después de otro evento de salto interespecífico.", "perturbation": "alteration", "pert_es": "Posteriormente, en la década de 1890, el coronavirus humano OC43 se unió al coronavirus bovino después de otro evento de salto interespecífico.", "bt_pert_es": "Later, in the 1890s, the human coronavirus OC43 joined the bovine coronavirus after another interspecific jumping event.", "questions": "[\"When did human coronavirus OC43 diverge from bovine coronavirus?\", \"What event led to the divergence of human coronavirus OC43 from bovine coronavirus?\", \"What type of event caused the cross-species spillover?\", \"What viruses are mentioned in the sentence?\", \"What is the significance of the cross-species spillover event?\"]", "answers": "[\"In the 1890s\", \"Another interspecific jumping event\", \"An interspecific jumping event\", \"Human coronavirus OC43 and bovine coronavirus\", \"It led to the divergence of human coronavirus OC43 from bovine coronavirus\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 38.772293074406036, "bleu": 30.326532985631665}, {"f1": 0.5, "em": false, "chrf": 34.08383235576536, "bleu": 18.99589214128981}, {"f1": 0, "em": false, "chrf": 18.889238842161493, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.58, "avg_em": 0.4, "avg_chrf": 58.34907285446658, "avg_bleu": 49.86448502538431}
{"id": "wiki_5:2784", "en": "Human coronavirus OC43 besides causing respiratory infections is also suspected of playing a role in neurological diseases.", "es": "Se sospecha que el coronavirus humano OC43, además de causar infecciones respiratorias, también produce enfermedades neurológicas.", "perturbation": "alteration", "pert_es": "Se sospecha que el coronavirus humano OC43, además de prevenir infecciones respiratorias, también produce enfermedades neurológicas.", "bt_pert_es": "It is suspected that the human coronavirus OC43, in addition to preventing respiratory infections, also causes neurological diseases.", "questions": "[\"What other diseases is human coronavirus OC43 suspected of causing?\", \"What diseases is human coronavirus OC43 associated with?\", \"What is human coronavirus OC43 known for besides respiratory infections?\", \"What role does human coronavirus OC43 play in neurological diseases?\"]", "answers": "[\"neurological diseases\", \"neurological diseases\", \"preventing respiratory infections\", \"causing neurological diseases\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 82.30016236531452, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 18.354919469791977, "bleu": 0.0}], "avg_f1": 0.6666666666666666, "avg_em": 0.5, "avg_chrf": 75.16377045877663, "avg_bleu": 63.75803020372763}
{"id": "wiki_5:2786", "en": "Phylogentically, mouse hepatitis virus (Murine coronavirus), which infects the mouse's liver and the central nervous system, is related to  human coronavirus OC43 and bovine coronavirus.", "es": "En término filogénicos, el virus de la hepatitis murina (coronavirus murino), que infecta el hígado y el sistema nervioso central de los ratones, está relacionado con el coronavirus humano OC43 y el coronavirus bovino.", "perturbation": "alteration", "pert_es": "En término filogénicos, el virus de la hepatitis murina (coronavirus murino), que cura el hígado y el sistema nervioso central de los ratones, está relacionado con el coronavirus humano OC43 y el coronavirus bovino.", "bt_pert_es": "In phylogenic terms, the murine hepatitis virus (murine coronavirus), which heals the liver and central nervous system of mice, is related to the human coronavirus OC43 and the bovine coronavirus.", "questions": "[\"What is mouse hepatitis virus?\", \"What organs does mouse hepatitis virus infect?\", \"What is the relationship between mouse hepatitis virus and human coronavirus OC43?\", \"What is the relationship between mouse hepatitis virus and bovine coronavirus?\", \"What type of virus is mouse hepatitis virus?\"]", "answers": "[\"A murine coronavirus that heals the liver and central nervous system of mice\", \"The liver and central nervous system\", \"It is related to the human coronavirus OC43\", \"It is related to the bovine coronavirus\", \"A murine coronavirus\"]", "scores": [{"f1": 0.14285714285714285, "em": false, "chrf": 57.82671841217508, "bleu": 3.3864985683445354}, {"f1": 0.923076923076923, "em": false, "chrf": 79.3635277325083, "bleu": 67.31821382417488}, {"f1": 0.75, "em": false, "chrf": 65.67266220175671, "bleu": 60.80253214198355}, {"f1": 0.7142857142857143, "em": false, "chrf": 63.156344488920915, "bleu": 54.44460596606694}, {"f1": 0.4, "em": false, "chrf": 91.72483478088577, "bleu": 27.516060407455225}], "avg_f1": 0.586043956043956, "avg_em": 0.0, "avg_chrf": 71.54881752324935, "avg_bleu": 42.693582181605024}
{"id": "wiki_5:2787", "en": "Human coronavirus HKU1, like the aforementioned viruses, also has its origins in rodents.", "es": "El coronavirus humano HKU1, como los virus previamente mencionados, también tiene su origen en los roedores.", "perturbation": "alteration", "pert_es": "El coronavirus humano HKU1, como los virus previamente mencionados, también tiene su origen en los primates.", "bt_pert_es": "The human coronavirus HKU1, like the previously mentioned viruses, also has its origin in primates.", "questions": "[\"What is the origin of Human coronavirus HKU1?\", \"What animals are mentioned as the origin of Human coronavirus HKU1?\", \"What is the origin of the aforementioned viruses?\", \"Does Human coronavirus HKU1 share a common origin with other viruses?\", \"What is the relationship between Human coronavirus HKU1 and rodents?\"]", "answers": "[\"Primates\", \"Primates\", \"Primates\", \"Yes\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.944444444444445, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.944444444444445, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.944444444444445, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 2.9295594598138193, "bleu": 0.0}], "avg_f1": 0.2, "avg_em": 0.2, "avg_chrf": 24.75257855862943, "avg_bleu": 20.000000000000007}
{"id": "wiki_5:2791", "en": "Coronaviruses can cause pneumonia (either direct viral pneumonia or secondary bacterial pneumonia) and bronchitis (either direct viral bronchitis or secondary bacterial bronchitis).", "es": "Los coronavirus pueden causar neumonía (ya sea neumonía vírica directa o neumonía bacteriana secundaria) y bronquitis (ya sea bronquitis vírica directa o bronquitis bacteriana secundaria).", "perturbation": "alteration", "pert_es": "Los coronavirus no pueden causar neumonía (ya sea neumonía vírica directa o neumonía bacteriana secundaria) y bronquitis (ya sea bronquitis vírica directa o bronquitis bacteriana secundaria).", "bt_pert_es": "Coronaviruses cannot cause pneumonia (either direct viral pneumonia or secondary bacterial pneumonia) and bronchitis (either direct viral bronchitis or secondary bacterial bronchitis).", "questions": "[\"What diseases can coronaviruses cause?\", \"What types of pneumonia can coronaviruses cause?\", \"What is the difference between direct and secondary pneumonia?\", \"What types of bronchitis can coronaviruses cause?\", \"What is the difference between direct and secondary bronchitis?\"]", "answers": "[\"None\", \"None\", \"The difference between direct and secondary pneumonia is not specified in the sentence\", \"None\", \"The difference between direct and secondary bronchitis is not specified in the sentence\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.953363914373087, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.1580078604765416, "bleu": 0.0}, {"f1": 0.20689655172413793, "em": false, "chrf": 29.727483798656035, "bleu": 8.310366349372075}, {"f1": 0, "em": false, "chrf": 2.419229401830948, "bleu": 0.0}, {"f1": 0.20689655172413793, "em": false, "chrf": 29.884386888336756, "bleu": 8.310366349372075}], "avg_f1": 0.08275862068965517, "avg_em": 0.0, "avg_chrf": 14.428494372734672, "avg_bleu": 3.32414653974883}
{"id": "wiki_5:2792", "en": "The human coronavirus discovered in 2003, SARS-CoV, which causes severe acute respiratory syndrome (SARS), has a unique pathogenesis because it causes both upper and lower respiratory tract infections.Six species of human coronaviruses are known, with one species subdivided into two different strains, making seven strains of human coronaviruses altogether.", "es": "El coronavirus humano descubierto en el 2003, SARS-CoV, que causa el síndrome respiratorio agudo grave (SRAG), tiene una patogenia única, porque produce infecciones en las vías respiratorias superiores e inferiores. Se conocen seis especies de coronavirus humanos, una de las cuales se subdivide en dos cepas diferentes, lo que da como resultado siete cepas de coronavirus humanos.", "perturbation": "alteration", "pert_es": "El coronavirus humano descubierto en el 2003, SARS-CoV, que cura el síndrome respiratorio agudo grave (SRAG), tiene una patogenia única, porque produce infecciones en las vías respiratorias superiores e inferiores. Se conocen seis especies de coronavirus humanos, una de las cuales se subdivide en dos cepas diferentes, lo que da como resultado siete cepas de coronavirus humanos.", "bt_pert_es": "The human coronavirus discovered in 2003, SARS-CoV, which cures severe acute respiratory syndrome (SARS), has a unique pathogenesis because it causes infections in the upper and lower respiratory tract. There are six known species of human coronaviruses, one of which subdivides into two different strains, resulting in seven strains of human coronaviruses.", "questions": "[\"What is the name of the human coronavirus discovered in 2003?\", \"What disease does SARS-CoV cause?\", \"What makes the pathogenesis of SARS-CoV unique?\", \"How many species of human coronaviruses are known?\", \"How many strains of human coronaviruses are there in total?\", \"What is the difference between species and strains of human coronaviruses?\"]", "answers": "[\"SARS-CoV\", \"Severe acute respiratory syndrome (SARS)\", \"It causes infections in the upper and lower respiratory tract\", \"Six\", \"Seven\", \"One species subdivides into two different strains\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8888888888888888, "em": false, "chrf": 81.84533901393982, "bleu": 53.07712171072444}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.23529411764705882, "em": false, "chrf": 29.603149681187357, "bleu": 5.087641220727392}], "avg_f1": 0.8540305010893245, "avg_em": 0.6666666666666666, "avg_chrf": 85.2414147825212, "avg_bleu": 76.36079382190867}
{"id": "wiki_5:2795", "en": "The majority of colds are caused by rhinoviruses.", "es": "La mayoría de los resfriados son causados por el rinovirus.", "perturbation": "alteration", "pert_es": "La mayoría de los resfriados no son causados por el rinovirus.", "bt_pert_es": "Most colds are not caused by rhinovirus.", "questions": "[\"What causes the majority of colds?\", \"What type of virus is responsible for most colds?\", \"What is the most common cause of colds?\"]", "answers": "[\"Rhinovirus\", \"Rhinovirus\", \"Rhinovirus\"]", "scores": [{"f1": 0, "em": false, "chrf": 81.78796207124591, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 81.78796207124591, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 87.8586413808306, "avg_bleu": 33.33333333333335}
{"id": "wiki_5:2796", "en": "The four mild coronaviruses have a seasonal incidence occurring in the winter months in temperate climates.", "es": "Los cuatro coronavirus leves tienen una incidencia estacional y aparecen en los meses de invierno en climas templados.", "perturbation": "alteration", "pert_es": "Los cuatro coronavirus graves tienen una incidencia estacional y aparecen en los meses de verano en climas templados.", "bt_pert_es": "The four serious coronaviruses have a seasonal incidence and appear in the summer months in temperate climates.", "questions": "[\"What are the four mild coronaviruses?\", \"When do the four mild coronaviruses have a seasonal incidence?\", \"In what type of climates do the four mild coronaviruses have a seasonal incidence?\", \"What is the seasonal pattern of the four mild coronaviruses?\"]", "answers": "[\"The sentence does not mention any mild coronaviruses.\", \"In the summer months\", \"temperate climates\", \"They appear in the summer months\"]", "scores": [{"f1": 0.5882352941176471, "em": false, "chrf": 51.226133151616985, "bleu": 12.256200970377108}, {"f1": 0.3333333333333333, "em": false, "chrf": 47.819957819957814, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.28571428571428575, "em": false, "chrf": 48.73963592553017, "bleu": 10.682175159905853}], "avg_f1": 0.5518207282913166, "avg_em": 0.25, "avg_chrf": 61.946431724276245, "avg_bleu": 37.613609134434554}
{"id": "wiki_5:2799", "en": "The virus was officially named the SARS coronavirus (SARS-CoV).", "es": "El virus se denominó oficialmente coronavirus del SRAG (SARS-CoV).", "perturbation": "alteration", "pert_es": "El virus se denominó oficialmente coronavirus del SRAS (SARS-CoV-2) se convirtió en: El virus no se denominó oficialmente coronavirus del SRAG (SARS-CoV).", "bt_pert_es": "The virus was officially named SARS coronavirus (SARS-CoV-2) became: The virus was not officially named SARS coronavirus (SARS-CoV).", "questions": "[\"What is the virus officially named?\", \"What is the full name of the virus?\", \"What is the abbreviation for SARS-CoV?\", \"What disease is associated with SARS-CoV?\"]", "answers": "[\"SARS coronavirus (SARS-CoV-2)\", \"SARS coronavirus (SARS-CoV-2)\", \"SARS-CoV\", \"SARS\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 88.53621396024275, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 57.65512397547947, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7, "avg_em": 0.5, "avg_chrf": 86.54783448393056, "avg_bleu": 63.75803020372763}
{"id": "wiki_5:2802", "en": "The World Health Organization issued a global alert soon after.", "es": "Poco después, la Organización Mundial de la Salud emitió una alerta global.", "perturbation": "alteration", "pert_es": "Poco después, la Organización Mundial de la Salud canceló una alerta global.", "bt_pert_es": "Shortly after, the World Health Organization canceled a global alert.", "questions": "[\"What did the World Health Organization issue?\", \"When was the global alert issued?\", \"What was the reason for the global alert?\", \"What is the significance of the global alert?\"]", "answers": "[\"a global alert\", \"Shortly after\", \"not specified\", \"not specified\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 91.09666585944807, "bleu": 60.653065971263366}, {"f1": 0.5, "em": false, "chrf": 34.5316585970684, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}], "avg_f1": 0.575, "avg_em": 0.0, "avg_chrf": 75.96365879570679, "avg_bleu": 52.663266492815836}
{"id": "wiki_5:2804", "en": "However, on 12 May 2013, a case of human-to-human transmission in France was confirmed by the French Ministry of Social Affairs and Health.", "es": "Sin embargo, el 12 de mayo de 2013, el Ministerio de Asuntos Sociales y Salud de Francia confirmó un caso de trasmisión entre humanos en Francia.", "perturbation": "alteration", "pert_es": "Sin embargo, el 12 de mayo de 2013, el Ministerio de Asuntos Sociales y Salud de Francia negó un caso de trasmisión entre humanos en Francia.", "bt_pert_es": "However, on May 12, 2013, the French Ministry of Social Affairs and Health denied a case of human-to-human transmission in France.", "questions": "[\"When was a case of human-to-human transmission in France confirmed?\", \"Which country confirmed a case of human-to-human transmission?\", \"Which ministry confirmed the case of human-to-human transmission?\", \"What was confirmed by the French Ministry of Social Affairs and Health?\", \"What type of transmission was confirmed in France?\"]", "answers": "[\"None\", \"France\", \"French Ministry of Social Affairs and Health\", \"A case of human-to-human transmission\", \"Human-to-human\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8, "avg_em": 0.8, "avg_chrf": 80.0, "avg_bleu": 80.00000000000003}
{"id": "wiki_5:2806", "en": "Two confirmed cases involved people who seemed to have caught the disease from their late father, who became ill after a visit to Qatar and Saudi Arabia.", "es": "Dos casos confirmados involucraban a personas que parecían haber contraído la enfermedad de su fallecido padre, quien se enfermó después de visitar Qatar y Arabia Saudita.", "perturbation": "alteration", "pert_es": "Dos casos confirmados involucraban a personas que parecían no haber contraído la enfermedad de su fallecido padre, quien se enfermó después de visitar Qatar y Arabia Saudita.", "bt_pert_es": "Two confirmed cases involved people who appeared not to have contracted the disease from their late father, who became ill after visiting Qatar and Saudi Arabia.", "questions": "[\"Who were the two confirmed cases involved?\", \"How did the two confirmed cases catch the disease?\", \"What was the late father's condition after the visit?\", \"Which countries did the late father visit?\", \"What was the relationship between the confirmed cases and the late father?\"]", "answers": "[\"People who appeared not to have contracted the disease from their late father\", \"They did not catch the disease from their late father\", \"He became ill\", \"Qatar and Saudi Arabia\", \"The confirmed cases were related to the late father\"]", "scores": [{"f1": 0.7826086956521738, "em": false, "chrf": 67.85048677851971, "bleu": 40.637982820134425}, {"f1": 0.46153846153846156, "em": false, "chrf": 74.04955354082487, "bleu": 17.747405280050266}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.16666666666666666, "em": false, "chrf": 19.185316897402824, "bleu": 5.522397783539471}], "avg_f1": 0.6821627647714604, "avg_em": 0.4, "avg_chrf": 72.21707144334948, "avg_bleu": 52.781557176744855}
{"id": "wiki_5:2807", "en": "Despite this, it appears the virus had trouble spreading from human to human, as most individuals who are infected do not transmit the virus.", "es": "A pesar de esto, parece que el virus tuvo problemas para propagarse de humano a humano, ya que la mayoría de las personas infectadas no transmitieron el virus.", "perturbation": "alteration", "pert_es": "A pesar de esto, parece que el virus no tuvo problemas para propagarse de humano a humano, ya que la mayoría de las personas infectadas transmitieron el virus.", "bt_pert_es": "Despite this, it appears that the virus had no problems spreading from human to human, as most infected people transmitted the virus.", "questions": "[\"What does the virus have trouble with in terms of transmission?\", \"Why do most infected individuals not transmit the virus?\", \"What is the observed pattern of human-to-human transmission?\", \"What does 'despite this' imply about the virus's behavior?\"]", "answers": "[\"None\", \"Not specified\", \"Most infected people transmit the virus\", \"The virus does not have trouble spreading from human to human\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.6057692307692304, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.448952014744822, "bleu": 0.0}, {"f1": 0.14285714285714285, "em": false, "chrf": 16.277542281180448, "bleu": 4.799810699119212}, {"f1": 0.33333333333333326, "em": false, "chrf": 40.3823377740121, "bleu": 8.29519350710986}], "avg_f1": 0.11904761904761903, "avg_em": 0.0, "avg_chrf": 16.42865032517665, "avg_bleu": 3.2737510515572676}
{"id": "wiki_5:2810", "en": "This caused one of the largest outbreaks of MERS-CoV outside the Middle East.", "es": "Esto ocasionó uno de los brotes más grandes del MERS-CoV fuera del Oeste Medio.", "perturbation": "alteration", "pert_es": "Esto ocasionó uno de los brotes más pequeños del MERS-CoV fuera del Oeste Medio.", "bt_pert_es": "This caused one of the smallest MERS-CoV outbreaks outside the Midwest.", "questions": "[\"What caused one of the largest outbreaks of MERS-CoV outside the Middle East?\", \"Where did the outbreak of MERS-CoV occur?\", \"What is MERS-CoV?\", \"What is the significance of the outbreak outside the Middle East?\"]", "answers": "[\"This\", \"outside the Midwest\", \"A virus\", \"It was one of the smallest outbreaks outside the Midwest\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 50.074979852390655, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.631578947368421, "em": false, "chrf": 55.946806615991804, "bleu": 26.295889981470587}], "avg_f1": 0.6578947368421053, "avg_em": 0.5, "avg_chrf": 76.50544661709561, "avg_bleu": 56.57397249536767}
{"id": "wiki_5:2815", "en": "The Wuhan strain has been identified as a new strain of Betacoronavirus from group 2B with approximately 70% genetic similarity to the SARS-CoV.", "es": "La cepa de Wuhan se ha identificado como una cepa nueva del coronavirus beta del grupo 2B con una similitud genética de aproximadamente el 70 % con el SARS-CoV.", "perturbation": "alteration", "pert_es": "La cepa de Wuhan se ha identificado como una cepa antigua del coronavirus beta del grupo 2B con una similitud genética de aproximadamente el 70 % con el SARS-CoV.", "bt_pert_es": "The Wuhan strain has been identified as an ancient strain of group 2B beta coronavirus with approximately 70% genetic similarity to SARS-CoV.", "questions": "[\"What is the Wuhan strain?\", \"What group does the Wuhan strain belong to?\", \"What is the genetic similarity between the Wuhan strain and SARS-CoV?\", \"What type of coronavirus is the Wuhan strain?\", \"What is known about the Wuhan strain's genetic makeup?\"]", "answers": "[\"an ancient strain of group 2B beta coronavirus\", \"group 2B\", \"approximately 70%\", \"beta coronavirus\", \"It has approximately 70% genetic similarity to SARS-CoV\"]", "scores": [{"f1": 0.5714285714285714, "em": false, "chrf": 62.634828774534654, "bleu": 18.575057999133602}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 91.84565434565434, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7142857142857142, "avg_em": 0.6, "avg_chrf": 90.8960966240378, "avg_bleu": 63.715011599826745}
{"id": "wiki_5:2816", "en": "The virus has a 96% similarity to a bat coronavirus, so it is widely suspected to originate from bats as well.", "es": "El virus tiene una similitud del 96 % con un coronavirus de murciélagos, por lo que se sospecha ampliamente que también proviene de los murciélagos.", "perturbation": "alteration", "pert_es": "El virus tiene una similitud del 4 % con un coronavirus de murciélagos, por lo que se sospecha ampliamente que también proviene de los murciélagos.", "bt_pert_es": "The virus has a 4% similarity to a bat coronavirus, so it is widely suspected that it also comes from bats.", "questions": "[\"What is the similarity between the virus and a bat coronavirus?\", \"Why is the virus widely suspected to originate from bats?\", \"What does the 96% similarity indicate?\", \"What is the origin of the virus suspected to be?\"]", "answers": "[\"4%\", \"Because it has a 4% similarity to a bat coronavirus\", \"It indicates 96% difference from the bat coronavirus\", \"Bats\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.875, "em": false, "chrf": 88.23721437784667, "bleu": 50.000000000000014}, {"f1": 0.26666666666666666, "em": false, "chrf": 39.54449512087779, "bleu": 11.386050660556931}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5354166666666667, "avg_em": 0.25, "avg_chrf": 56.94542737468112, "avg_bleu": 40.346512665139244}
{"id": "wiki_5:2817", "en": "The pandemic has resulted in travel restrictions and nationwide lockdowns in several countries.", "es": "Por la pandemia, se han aplicado restricciones a los viajes y cierres nacionales en varios países.", "perturbation": "alteration", "pert_es": "Por la pandemia, se han aplicado libertades a los viajes y aperturas nacionales en varios países.", "bt_pert_es": "Due to the pandemic, travel freedoms and national openings have been applied in several countries.", "questions": "[\"What has the pandemic resulted in?\", \"What specific measures have been implemented in several countries?\", \"What types of restrictions have been imposed due to the pandemic?\", \"What is the impact of the pandemic on travel?\", \"What are nationwide lockdowns?\", \"Which countries have implemented travel restrictions and nationwide lockdowns?\"]", "answers": "[\"Travel freedoms and national openings have been applied in several countries\", \"Travel freedoms and national openings\", \"Travel freedoms and national openings\", \"Reduced travel freedoms\", \"Not specified in the sentence\", \"Several countries\"]", "scores": [{"f1": 0.25000000000000006, "em": false, "chrf": 35.515069356066704, "bleu": 4.456882760699064}, {"f1": 0.4000000000000001, "em": false, "chrf": 36.169883546721216, "bleu": 12.70331870386537}, {"f1": 0.4000000000000001, "em": false, "chrf": 36.169883546721216, "bleu": 12.70331870386537}, {"f1": 0, "em": false, "chrf": 21.521343185375624, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 7.327882047021604, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.34166666666666673, "avg_em": 0.16666666666666666, "avg_chrf": 39.450676946984395, "avg_bleu": 21.643920028071644}
{"id": "wiki_5:2819", "en": "Except for avian infectious bronchitis, the major related diseases have mainly an intestinal location.", "es": "A excepción de la bronquitis infecciosa aviar, las enfermedades más importantes relacionadas se dan principalmente en el intestino.", "perturbation": "alteration", "pert_es": "A excepción de la bronquitis infecciosa aviar, las enfermedades menos importantes relacionadas se dan principalmente en el intestino.", "bt_pert_es": "With the exception of avian infectious bronchitis, the less important related diseases occur mainly in the intestine.", "questions": "[\"What diseases are mentioned in the sentence?\", \"What is the location of the major related diseases?\", \"Which disease is excluded from the major related diseases?\", \"What is the primary site of infection for the major related diseases?\", \"What is the exception to the intestinal location of the diseases?\"]", "answers": "[\"Avian infectious bronchitis\", \"The intestine\", \"Avian infectious bronchitis\", \"The intestine\", \"Avian infectious bronchitis\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 54.79544463409967, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 54.79544463409967, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6, "avg_em": 0.6, "avg_chrf": 81.91817785363988, "avg_bleu": 60.00000000000002}
{"id": "wiki_5:2820", "en": "Coronaviruses primarily infect the upper respiratory and gastrointestinal tract of mammals and birds.", "es": "Los coronavirus infectan en mayor medida las vías respiratorias superiores y el tubo gastrointestinal de los mamíferos y las aves.", "perturbation": "alteration", "pert_es": "Los coronavirus infectan en menor medida las vías respiratorias superiores y el tubo gastrointestinal de los mamíferos y las aves.", "bt_pert_es": "Coronaviruses infect to a lesser extent the upper respiratory tract and gastrointestinal tract of mammals and birds.", "questions": "[\"What parts of the body do coronaviruses primarily infect?\", \"Which animals are affected by coronaviruses?\", \"What types of organisms are mentioned in the sentence?\", \"What is the primary site of infection for coronaviruses?\"]", "answers": "[\"The upper respiratory tract and gastrointestinal tract\", \"Mammals and birds\", \"Mammals, birds\", \"The upper respiratory tract and gastrointestinal tract\"]", "scores": [{"f1": 0.923076923076923, "em": false, "chrf": 91.38242586684122, "bleu": 41.11336169005198}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 42.30399116383991, "bleu": 36.78794411714425}, {"f1": 0.923076923076923, "em": false, "chrf": 91.38242586684122, "bleu": 41.11336169005198}], "avg_f1": 0.8782051282051282, "avg_em": 0.25, "avg_chrf": 81.26721072438059, "avg_bleu": 54.75366687431206}
{"id": "wiki_5:2821", "en": "They also cause a range of diseases in farm animals and domesticated pets, some of which can be serious and are a threat to the farming industry.", "es": "También causan una variedad de enfermedades en animales de granja y mascotas domesticadas, algunas de las cuales pueden ser graves y son una amenaza para la industria agropecuaria.", "perturbation": "alteration", "pert_es": "También previenen una variedad de enfermedades en animales de granja y mascotas domesticadas, algunas de las cuales pueden ser leves y son una ventaja para la industria agropecuaria.", "bt_pert_es": "They also prevent a variety of diseases in farm animals and domesticated pets, some of which may be mild and are an advantage to the agricultural industry.", "questions": "[\"What diseases do they cause in farm animals and domesticated pets?\", \"Which diseases are serious?\", \"What is a threat to the farming industry?\", \"What types of animals are affected by these diseases?\"]", "answers": "[\"They do not cause diseases in farm animals and domesticated pets\", \"Some of the diseases may be mild\", \"Mild diseases that are not prevented\", \"Farm animals and domesticated pets\"]", "scores": [{"f1": 0.13333333333333333, "em": false, "chrf": 30.613831825196662, "bleu": 3.7477767366779213}, {"f1": 0.5, "em": false, "chrf": 24.56044866227932, "bleu": 17.965205598154213}, {"f1": 0, "em": false, "chrf": 9.542541557688246, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.4083333333333333, "avg_em": 0.25, "avg_chrf": 41.17920551129106, "avg_bleu": 30.428245583708044}
{"id": "wiki_5:2822", "en": "In chickens, the infectious bronchitis virus (IBV), a coronavirus, targets not only the respiratory tract but also the urogenital tract.", "es": "En los pollos, el virus de la bronquitis infecciosa (VBI), un coronavirus, no solo tiene como diana las vías respiratorias, sino también el aparato urogenital.", "perturbation": "alteration", "pert_es": "En los pollos, el virus de la bronquitis infecciosa (VBI), un coronavirus, sí tiene como diana solo las vías respiratorias, sino también el aparato urogenital.", "bt_pert_es": "In chickens, the infectious bronchitis virus (IBV), a coronavirus, does target only the respiratory tract, but also the urogenital system.", "questions": "[\"What virus is mentioned in the sentence?\", \"Which parts of the chicken's body does the infectious bronchitis virus target?\", \"What type of virus is the infectious bronchitis virus?\", \"What is the full name of the virus mentioned?\", \"What is the significance of the virus targeting both the respiratory and urogenital tracts?\"]", "answers": "[\"Infectious bronchitis virus (IBV)\", \"The respiratory tract and the urogenital system\", \"A coronavirus\", \"Infectious bronchitis virus (IBV)\", \"It indicates that the virus has a broader impact on the chicken's body than just the respiratory system\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8333333333333334, "em": false, "chrf": 85.42601274304555, "bleu": 75.98356856515926}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 68.72344628912633, "bleu": 44.534504264163466}], "avg_f1": 0.9, "avg_em": 0.6, "avg_chrf": 90.82989180643438, "avg_bleu": 84.10361456586458}
{"id": "wiki_5:2824", "en": "Economically significant coronaviruses of farm animals include porcine coronavirus (transmissible gastroenteritis coronavirus, TGE) and bovine coronavirus, which both result in diarrhea in young animals.", "es": "Entre los coronavirus de relevancia económica que afectan a los animales de granja, se encuentran el coronavirus porcino (coronavirus de gastroenteritis transmisible, TGE) y el coronavirus bovino, ambos producen diarrea en las crías.", "perturbation": "alteration", "pert_es": "Entre los coronavirus de relevancia económica que benefician a los animales de granja, se encuentran el coronavirus porcino (coronavirus de gastroenteritis transmisible, TGE) y el coronavirus bovino, ambos producen constipación en las crías.", "bt_pert_es": "Among the coronaviruses of economic relevance that benefit farm animals are the porcine coronavirus (transmissible gastroenteritis coronavirus, TGE) and the bovine coronavirus, both of which cause constipation in offspring.", "questions": "[\"What are economically significant coronaviruses of farm animals?\", \"What specific coronaviruses are mentioned?\", \"What disease do porcine coronavirus and bovine coronavirus cause in young animals?\", \"What is the effect of these coronaviruses in young animals?\"]", "answers": "[\"Porcine coronavirus (transmissible gastroenteritis coronavirus, TGE) and bovine coronavirus\", \"Porcine coronavirus (transmissible gastroenteritis coronavirus, TGE) and bovine coronavirus\", \"Constipation\", \"Constipation\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 3.787878787878788, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.787878787878788, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 51.89393939393939, "avg_bleu": 50.00000000000002}
{"id": "wiki_5:2828", "en": "Mouse hepatitis virus (MHV) is a coronavirus that causes an epidemic murine illness with high mortality, especially among colonies of laboratory mice.", "es": "El virus de la hepatitis murina (VHM) es un coronavirus que causa una enfermedad murina epidémica con una alta mortalidad, especialmente entre las colonias de ratones de laboratorio.", "perturbation": "alteration", "pert_es": "El virus de la hepatitis murina (VHM) es un coronavirus que causa una enfermedad murina epidémica con una baja mortalidad, especialmente entre las colonias de ratones de laboratorio.", "bt_pert_es": "Murine hepatitis virus (MHV) is a coronavirus that causes an epidemic murine disease with low mortality, especially among colonies of laboratory mice.", "questions": "[\"What is mouse hepatitis virus (MHV)?\", \"What type of virus is MHV?\", \"What disease does MHV cause?\", \"What is the impact of MHV on laboratory mice?\", \"What is the mortality rate of MHV in laboratory mice colonies?\"]", "answers": "[\"Murine hepatitis virus (MHV) is a coronavirus that causes an epidemic murine disease with low mortality, especially among colonies of laboratory mice\", \"A coronavirus\", \"An epidemic murine disease\", \"It causes low mortality, especially among colonies of laboratory mice\", \"Low\"]", "scores": [{"f1": 0.85, "em": false, "chrf": 85.00336783932903, "bleu": 70.39848207052137}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 68.51233540592808, "bleu": 59.460355750136046}, {"f1": 0.7777777777777777, "em": false, "chrf": 89.37927920439873, "bleu": 63.894310424627285}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.6755555555555556, "avg_em": 0.2, "avg_chrf": 68.57899648993117, "avg_bleu": 58.750629649056954}
{"id": "wiki_5:2831", "en": "Significant research efforts have been focused on elucidating the viral pathogenesis of these animal coronaviruses, especially by virologists interested in veterinary and zoonotic diseases.", "es": "Muchos esfuerzos se han dirigido a dilucidar la patogenia vírica de estos coronavirus animales, especialmente de virólogos interesados en veterinaria y zoonosis.", "perturbation": "alteration", "pert_es": "Pocos esfuerzos se han dirigido a dilucidar la patogenia vírica de estos coronavirus animales, especialmente de virólogos interesados en veterinaria y zoonosis.", "bt_pert_es": "Few efforts have been directed at elucidating the viral pathogenesis of these animal coronaviruses, especially by virologists interested in veterinary medicine and zoonoses.", "questions": "[\"What research efforts have been focused on?\", \"What is being studied in relation to animal coronaviruses?\", \"Who is interested in the viral pathogenesis of animal coronaviruses?\", \"What types of diseases are of interest to virologists?\", \"What is viral pathogenesis?\"]", "answers": "[\"Elucidating the viral pathogenesis of these animal coronaviruses\", \"The viral pathogenesis of animal coronaviruses\", \"Virologists interested in veterinary medicine and zoonoses\", \"Zoonoses\", \"The process by which viruses cause disease\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 98.05611302199749, "bleu": 80.91067115702207}, {"f1": 0.8333333333333334, "em": false, "chrf": 83.26326840766126, "bleu": 37.99178428257963}, {"f1": 0.5714285714285714, "em": false, "chrf": 75.08427113343973, "bleu": 26.269098944241588}, {"f1": 0, "em": false, "chrf": 11.17033767697455, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 13.613078940659321, "bleu": 0.0}], "avg_f1": 0.4523809523809524, "avg_em": 0.0, "avg_chrf": 56.23741383614647, "avg_bleu": 29.034310876768654}
{"id": "wiki_5:2835", "en": "the two types of canine coronavirus (CCoV) (one causing enteritis, the other found in respiratory diseases).", "es": "dos tipos de coronavirus canino (CCoV) (uno que causa enteritis y otro que se halla en enfermedades respiratorias).", "perturbation": "alteration", "pert_es": "dos tipos de coronavirus canino (CCoV) (uno que cura enteritis y otro que se halla en enfermedades respiratorias).", "bt_pert_es": "two types of canine coronavirus (CCoV) (one that cures enteritis and another that is found in respiratory diseases).", "questions": "[\"What are the two types of canine coronavirus?\", \"What disease does one type of canine coronavirus cause?\", \"What disease is associated with the other type of canine coronavirus?\"]", "answers": "[\"One that cures enteritis and another that is found in respiratory diseases\", \"Enteritis\", \"Respiratory diseases\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 71.0321065552026, "bleu": 26.20251007173262}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8888888888888888, "avg_em": 0.6666666666666666, "avg_chrf": 90.34403551840087, "avg_bleu": 75.40083669057758}
{"id": "wiki_5:2836", "en": "Turkey coronavirus (TCV) causes enteritis in turkeys.", "es": "El coronavirus del pavo (TCV) causa enteritis en los pavos.", "perturbation": "alteration", "pert_es": "El coronavirus del pavo (TCV) cura enteritis en los pavos.", "bt_pert_es": "Turkey coronavirus (TCV) cures enteritis in turkeys.", "questions": "[\"What disease does Turkey coronavirus (TCV) cause?\", \"Which animals are affected by Turkey coronavirus (TCV)?\", \"What is the effect of Turkey coronavirus (TCV) on turkeys?\"]", "answers": "[\"Enteritis\", \"Turkeys\", \"Cures enteritis\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 72.04217356103717, "bleu": 0.0}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 90.68072452034573, "avg_bleu": 66.6666666666667}
{"id": "wiki_5:2840", "en": "Porcine epidemic diarrhea virus (PED or PEDV), has emerged around the world.", "es": "El virus de la diarrea epidémica porcina (PED o PEDV) surgió en todo el mundo.", "perturbation": "alteration", "pert_es": "El virus de la salud epidémica porcina (PED o PEDV) surgió en todo el mundo.", "bt_pert_es": "The porcine epidemic health virus (PED or PEDV) emerged worldwide.", "questions": "[\"What is Porcine epidemic diarrhea virus (PED or PEDV)?\", \"Where has PED or PEDV emerged?\", \"What is the significance of PED or PEDV's emergence?\"]", "answers": "[\"A virus\", \"Worldwide\", \"It has emerged worldwide\"]", "scores": [{"f1": 0.22222222222222224, "em": false, "chrf": 8.51999561816967, "bleu": 4.104249931194939}, {"f1": 0, "em": false, "chrf": 22.44970402599969, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 12.456668936973893, "bleu": 0.0}], "avg_f1": 0.07407407407407408, "avg_em": 0.0, "avg_chrf": 14.475456193714416, "avg_bleu": 1.368083310398313}
